Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABHD4 FLJ12816 ENSG00000100439 "Abhydrolase domain containing 4, N-acyl phospholipase B" Q8TB40 14 22598237-22613215 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 35.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 35.4" "Cell line enhanced" "Detected in many" "ASC diff: 121.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000600 Uncertain Approved Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA000600: AB_1078081" "unprognostic (5.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.68e-3)" "unprognostic (8.17e-2)" "unprognostic (1.17e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-3)" "unprognostic (3.69e-2)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.56e-2)" "unprognostic (5.18e-2)" "unprognostic (1.37e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" 22.8 28.7 21.6 7.3 23.6 12.6 17.5 22.3 22.4 25.9 27.7 19.2 15.0 26.3 27.4 38.3 15.4 24.7 20.5 21.0 24.5 25.3 22.6 17.6 8.0 27.8 24.5 15.9 14.5 22.8 12.8 17.9 23.3 19.3 13.8 21.7 16.5 33.7 25.5 18.9 17.9 24.5 22.5 14.8 24.9 36.8 24.2 10.1 21.6 27.2 14.8 24.8 26.2 26.0 23.4 38.5 15.5 14.2 121.8 44.0 14.9 10.3 52.2 25.3 46.8 23.5 36.4 2.2 26.7 45.2 27.2 44.5 9.9 26.6 20.6 17.3 3.5 8.7 28.1 77.9 55.6 1.4 30.3 56.1 20.6 33.2 28.2 52.7 26.4 16.0 6.5 41.1 23.5 12.8 0.7 1.3 18.8 94.4 27.7 6.5 13.8 9.8 29.6 24.6 1.0 3.1 69.1 24.3 27.2 30.6 9.5 2.6 18.8 11.0 14.9 18.0 4.1 44.1 25.3 0.8 8.2 1.8 8.9 35.4 6.3 10.2 8.2 4.7 6.8 5.5 5.4 5.5 4.2 3.1 1.7 3.5 25.7 7.3 4.6 0.6 3.4 5.6 21.6 23.6 22.3 22.4 21.0 24.5 27.8 24.5 23.3 22.5 24.2 26.0 5.0 12.8 5.6 2.6 4.7 3.2 7.0 5.2 7.4 3.5 6.2 6.6 6.7 11.5 3.4 3.7 4.2 6.1 4.8 9.8 9.8 13.3 3.1 8.3 6.0 6.5 6.0 4.4 1.1 11.7 2.3 5.2 16.3 12.5 5.1 5.2 9.3 10.3 7.8 8.4 1.2 6.8 4.1 6.9 1.7 4.7 5.6 4.6 1.8 1.0 9.4 6.9 5.2 4.0 3.7 9.8 9.3 8.2 12.4 9.5 13.3 4.7 2.6 3.2 6.6 3.1 6.0 0.7 0.5 13.2 2.7 26.8 5.0 9.7 3.3 11.7 ACP4 ACPT ENSG00000142513 "Acid phosphatase 4" Q9BZG2 19 50790415-50795219 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Hydrolase "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 1.2;testis: 3.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.5;U-266/84: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 16: U-266 - Nucleosome" "unprognostic (9.41e-2)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (3.70e-3)" "unprognostic (7.62e-2)" "unprognostic (3.18e-2)" "unprognostic (3.89e-3)" "unprognostic (5.46e-2)" "unprognostic (2.47e-1)" "unprognostic (5.59e-2)" "unprognostic (3.96e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-3)" "unprognostic (2.36e-1)" "unprognostic (4.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.5 0.0 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.0 0.3 0.2 0.4 0.1 0.2 0.5 0.3 0.1 0.2 0.0 0.5 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.2 0.2 0.1 0.2 2.0 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ACP7 "FLJ16165, PAPL, PAPL1" ENSG00000183760 "Acid phosphatase 7, tartrate resistant (putative)" Q6ZNF0 19 39083913-39111493 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 6.6;lymphoid tissue: 2.6;skin 1: 6.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 33.3;U-87 MG: 45.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA042613 Uncertain "Secreted - unknown location" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" "HPA042613: AB_10963214" "unprognostic (6.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-3)" "unprognostic (1.92e-3)" "unprognostic (1.41e-1)" "unprognostic (3.41e-1)" "unprognostic (4.94e-3)" "unprognostic (2.66e-1)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" "unprognostic (1.51e-5)" "unprognostic (4.36e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-2)" "unprognostic (2.42e-1)" 0.0 0.0 1.7 0.0 3.3 0.0 0.2 6.6 2.7 0.7 0.8 0.0 0.0 0.0 0.4 0.7 0.0 0.2 0.0 2.0 2.2 0.0 0.0 0.0 0.0 3.9 3.7 0.0 0.0 0.3 0.0 0.0 3.8 0.3 0.0 0.0 0.5 0.0 0.0 6.0 0.0 0.0 2.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 2.6 0.1 0.6 4.1 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.6 0.8 0.4 5.2 0.0 0.0 0.0 33.3 0.3 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 9.5 0.3 0.0 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.1 1.1 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.3 6.6 2.7 2.0 2.2 3.9 3.7 3.8 2.0 3.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140672945-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favorable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 10.4 9.1 23.7 10.2 25.1 8.8 11.3 24.6 25.9 11.9 16.5 13.4 7.4 9.7 8.9 17.5 16.0 8.3 10.7 24.3 24.2 12.4 13.3 10.8 14.8 29.1 25.6 11.8 14.4 19.5 12.8 11.2 25.9 13.2 10.9 6.3 15.6 10.7 14.1 26.3 11.0 9.0 26.3 12.2 13.1 6.5 26.4 12.4 12.8 8.4 14.1 11.9 13.7 30.2 32.6 23.2 5.6 24.9 19.3 21.5 31.7 16.5 20.0 17.2 11.2 21.7 22.5 42.4 24.0 11.7 39.4 26.3 27.5 19.0 5.1 31.3 26.1 9.2 8.8 11.1 26.5 6.2 21.8 17.7 56.8 9.9 13.5 17.3 14.8 30.9 16.1 20.9 6.1 41.0 46.4 15.3 8.2 27.0 23.1 36.3 0.3 21.0 9.9 34.9 20.6 14.5 22.7 32.7 23.3 10.1 29.2 12.2 15.6 21.3 7.3 35.0 32.0 14.2 23.2 32.4 31.3 23.9 25.7 0.0 3.0 3.0 4.2 4.1 4.0 7.0 3.8 4.3 4.8 3.0 5.8 3.7 0.1 4.4 2.6 10.1 5.4 2.0 23.7 25.1 24.6 25.9 24.3 24.2 29.1 25.6 25.9 26.3 26.4 30.2 9.0 9.6 3.6 2.3 9.8 12.4 21.3 4.4 5.7 11.4 15.3 11.7 6.4 7.2 3.5 9.2 0.0 32.9 17.8 15.0 5.9 6.3 37.9 5.6 3.4 8.8 16.8 12.2 6.5 7.5 20.2 6.2 5.1 9.3 11.4 98.0 7.1 9.9 31.5 11.8 6.7 13.5 6.1 11.4 16.1 16.4 3.4 14.3 3.6 6.5 8.4 13.3 9.2 8.0 10.8 6.1 15.8 13.5 5.1 19.6 8.3 5.7 4.8 5.9 0.0 9.5 7.2 7.0 6.4 7.3 13.9 33.8 9.6 14.9 14.0 21.2 ADORA2B ENSG00000170425 "Adenosine A2b receptor" P29275 17 15944917-15975746 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;urinary bladder: 14.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 73.5;Basal respiratory cells: 75.6;Langerhans cells: 31.9;Suprabasal keratinocytes: 64.4;Urothelial cells: 32.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.9;myeloid DC: 9.0" "Group enriched" "Detected in many" 97 "dendritic cells: 9.0;granulocytes: 14.9;monocytes: 5.0" "Cell line enhanced" "Detected in many" "GAMG: 160.8;HMC-1: 162.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073747 Uncertain Cytosol NA Yes "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "HPA073747: " "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (4.68e-1)" "unprognostic (7.88e-3)" "unprognostic (2.64e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "unprognostic (1.38e-1)" "unprognostic (1.66e-9)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (1.50e-2)" "unprognostic (2.84e-1)" 0.5 1.1 7.5 1.7 9.4 0.8 0.7 7.0 11.7 2.4 9.0 8.6 0.2 0.7 0.5 9.1 0.9 1.1 1.6 9.1 7.3 0.3 0.1 1.9 0.3 7.7 7.7 0.0 1.3 0.0 1.4 5.0 7.1 1.3 6.6 2.8 1.4 0.1 0.1 8.5 1.3 1.3 6.4 0.2 1.2 0.3 8.3 0.4 0.1 0.5 1.3 14.2 5.2 8.2 34.1 18.3 0.6 0.7 5.8 11.1 0.7 6.4 28.4 18.3 22.6 8.8 34.6 4.4 7.8 5.7 160.8 51.9 7.9 47.8 24.2 9.7 18.0 32.7 5.8 13.0 22.3 0.0 162.6 6.5 20.1 26.0 60.4 31.3 9.3 5.1 1.6 0.1 18.2 8.9 2.2 6.6 1.9 72.0 25.5 0.1 0.4 0.0 19.1 9.1 0.8 1.2 14.3 3.4 9.0 13.4 0.1 5.1 7.7 6.5 17.1 18.3 30.3 2.8 0.0 0.0 25.8 0.0 9.2 14.9 4.2 2.8 0.0 5.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.0 1.7 7.5 9.4 7.0 11.7 9.1 7.3 7.7 7.7 7.1 6.4 8.3 8.2 0.1 3.2 4.2 18.9 0.2 73.5 21.0 75.6 27.3 0.2 1.3 1.9 0.9 1.5 20.2 0.0 0.0 10.9 0.1 10.8 0.0 6.6 0.9 0.9 0.6 1.7 2.4 3.4 0.9 0.9 3.2 4.9 2.0 1.2 0.0 0.1 2.2 0.0 4.5 0.0 1.1 1.7 2.0 1.4 31.9 0.4 0.0 6.7 7.2 3.7 1.3 7.9 0.0 1.0 1.0 1.0 7.2 0.0 0.0 15.6 0.2 0.0 8.3 0.5 0.0 0.7 2.1 0.5 1.4 23.0 64.4 6.2 0.3 0.3 5.7 32.4 ALX3 FND ENSG00000156150 "ALX homeobox 3" O95076 1 110059870-110070672 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 7.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.1;Cone photoreceptor cells: 4.2;Microglial cells: 1.0;NK-cells: 1.0;Rod photoreceptor cells: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in many" 8 "olfactory bulb: 16.7" "Not detected" "Not detected" HPA074290 Approved "Nucleoli fibrillar center" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoli fibrillar center" "HPA074290: " "unprognostic (4.28e-1)" "unprognostic (4.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" 1.1 1.9 1.9 1.5 2.2 1.3 0.1 2.1 2.3 0.1 2.6 0.6 2.1 2.4 0.0 2.5 2.2 1.8 1.1 1.6 1.9 1.0 0.1 1.3 2.9 3.1 2.0 2.8 1.6 1.2 0.9 1.0 3.0 1.0 0.0 5.4 2.5 0.0 3.1 7.2 2.9 0.2 1.7 2.7 1.1 1.9 2.6 0.0 2.3 0.4 0.0 0.8 0.1 2.3 3.6 2.5 4.0 6.5 0.0 0.0 8.5 8.7 12.1 0.0 0.0 3.7 1.7 2.1 3.3 0.1 1.4 5.2 0.0 0.0 0.0 5.0 6.7 1.1 4.3 2.3 0.0 2.0 0.9 0.0 0.0 0.0 0.0 4.7 0.0 3.8 3.0 0.5 0.0 4.0 1.5 2.1 4.6 2.6 5.0 3.2 5.2 1.5 0.0 5.0 5.6 7.7 4.2 6.0 5.7 4.5 2.7 3.4 3.6 4.6 4.3 6.4 2.4 3.6 1.2 2.0 5.3 5.0 3.6 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.2 2.1 2.3 1.6 1.9 3.1 2.0 3.0 1.7 2.6 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.2 0.1 0.4 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 ANKK1 X-kinase ENSG00000170209 "Ankyrin repeat and kinase domain containing 1" Q8NFD2 11 113387779-113400416 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 3.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 7.2;Club cells: 2.4;Ionocytes: 6.1;Respiratory ciliated cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.1;RT4: 1.0" "Not detected" "Not detected" HPA012813 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA012813: AB_1844832" "unprognostic (5.63e-3)" "unprognostic (6.67e-3)" "unprognostic (5.09e-3)" "unprognostic (6.27e-3)" "unprognostic (5.56e-4)" "unprognostic (7.02e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.50e-1)" "unprognostic (3.15e-1)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (5.39e-6)" "unprognostic (3.17e-2)" "unprognostic (3.83e-2)" "unprognostic (2.79e-1)" "unprognostic (4.65e-2)" 0.2 0.5 0.6 0.2 2.7 0.1 0.7 0.5 1.0 1.1 2.0 0.3 0.1 0.4 0.3 0.5 2.0 0.0 0.1 0.4 0.7 0.4 0.3 0.6 0.4 1.0 3.1 0.7 0.3 0.1 3.0 0.0 0.7 1.5 0.0 0.6 1.3 0.3 0.3 3.5 0.6 0.0 0.7 0.8 0.2 1.0 1.1 0.1 0.7 0.0 0.2 0.4 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.5 1.0 0.4 0.7 1.0 3.1 0.7 0.7 1.1 0.7 0.2 0.0 0.5 1.6 0.2 0.6 0.8 7.2 0.0 1.2 0.3 1.1 0.4 0.0 2.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 1.9 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.7 0.2 0.2 6.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.5 1.1 0.0 1.1 0.0 0.0 0.5 0.0 0.0 6.0 0.9 0.0 1.3 0.4 0.1 0.1 0.0 0.6 0.0 0.5 0.2 0.0 0.5 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 60.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 56.4;Fibroblasts: 31.2;Leydig cells: 36.4;Muller glia cells: 57.7;Peritubular cells: 50.8;Skeletal myocytes: 29.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.6;THP-1: 6.8;TIME: 8.4;U-87 MG: 8.3;U-937: 7.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favorable (9.35e-4)" "prognostic favorable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 4.0 1.3 8.2 1.1 7.9 0.3 4.6 7.6 9.7 20.6 6.4 6.0 0.5 5.8 1.4 24.7 6.6 1.3 2.9 7.5 8.6 0.8 2.5 2.3 0.4 8.7 9.5 4.4 0.7 0.0 2.0 0.1 8.5 6.6 0.8 1.3 11.4 2.7 8.2 60.8 2.5 2.1 8.4 0.5 3.9 1.6 9.0 0.5 1.7 3.8 6.7 7.3 20.6 7.6 0.1 0.0 0.0 0.0 2.2 9.6 0.2 1.4 3.6 0.4 1.2 0.4 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.1 2.9 0.1 3.3 0.4 0.3 0.0 0.1 0.4 0.0 0.0 0.0 2.2 0.0 0.0 3.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 8.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.3 7.5 0.0 0.0 2.1 0.0 0.7 0.8 0.1 0.0 0.3 1.1 0.3 0.0 0.2 0.7 0.1 0.7 0.2 0.5 0.7 0.7 8.2 7.9 7.6 9.7 7.5 8.6 8.7 9.5 8.5 8.4 9.0 7.6 1.6 0.0 0.0 6.8 0.3 4.6 16.8 10.2 0.0 1.1 6.3 13.5 1.5 2.8 9.5 1.8 0.0 0.1 2.2 0.0 0.0 0.0 3.5 56.4 10.9 1.3 0.0 2.7 5.6 0.4 0.1 31.2 0.5 17.2 19.1 0.0 2.2 13.9 11.0 0.0 2.1 0.0 14.2 1.2 4.6 5.9 36.4 1.1 5.4 1.0 1.1 57.7 5.2 3.0 0.6 0.1 0.0 50.8 0.4 5.3 0.0 0.1 9.8 2.7 0.0 29.5 6.4 0.1 1.0 10.4 12.4 0.3 5.5 1.1 0.0 13.6 ANO8 "KIAA1623, TMEM16H" ENSG00000074855 "Anoctamin 8" Q9HCE9 19 17323223-17334855 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 73.1;Inhibitory neurons: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049206 Uncertain NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA049206: AB_2680675" "unprognostic (5.12e-2)" "unprognostic (2.79e-1)" "unprognostic (1.59e-1)" "unprognostic (3.07e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (3.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (5.89e-2)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-2)" "unprognostic (4.59e-2)" 6.2 21.0 11.1 4.6 9.9 2.6 6.7 10.0 14.6 5.0 2.8 4.7 4.4 3.8 1.1 11.6 4.9 5.3 5.3 10.6 9.6 7.6 7.1 6.4 4.4 13.2 12.1 3.8 6.9 6.6 4.5 3.4 12.3 4.8 2.3 4.1 7.7 2.7 8.4 18.4 4.7 2.8 11.2 5.5 8.2 3.1 12.7 5.2 6.0 4.9 2.8 3.5 6.4 9.4 6.3 5.5 14.8 16.8 4.4 3.1 24.5 6.3 3.6 3.2 3.6 2.4 13.2 0.5 6.5 6.2 4.5 5.7 3.1 5.1 1.9 27.8 7.6 4.2 18.0 3.7 2.2 0.9 6.9 3.5 4.7 4.2 3.0 8.2 2.4 9.9 3.1 6.2 2.1 4.8 5.6 1.6 8.4 7.1 21.9 9.2 3.1 7.5 5.3 10.3 5.4 17.8 6.8 6.4 5.2 5.4 9.2 2.8 2.5 7.4 4.1 22.9 6.9 10.7 9.2 1.0 11.7 7.8 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 11.1 9.9 10.0 14.6 10.6 9.6 13.2 12.1 12.3 11.2 12.7 9.4 4.4 6.4 1.7 73.1 1.0 0.9 0.4 0.7 2.2 5.2 10.3 9.9 2.4 1.5 1.1 0.0 4.2 3.9 3.4 2.1 0.0 1.8 0.2 2.3 1.6 1.4 0.0 0.4 12.6 1.6 8.7 1.6 10.2 4.6 5.7 5.9 1.1 3.5 1.7 1.7 19.3 2.4 2.0 1.9 1.4 0.3 2.1 2.2 0.0 9.4 0.8 2.5 0.0 12.5 7.8 1.8 0.3 0.7 3.0 0.8 2.3 0.9 0.7 2.7 0.0 1.5 2.4 0.3 0.8 2.1 1.4 2.6 2.2 4.7 2.2 0.8 AP2S1 "CLAPS2, FBH3, FBHOk, HHC3" ENSG00000042753 "Adaptor related protein complex 2 subunit sigma 1" P53680 19 46838136-46850846 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 991.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (1.34e-1)" "unprognostic (5.93e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-1)" "unprognostic (1.30e-1)" "unprognostic (6.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.11e-2)" "unprognostic (9.54e-2)" "unprognostic (2.19e-1)" "unprognostic (5.25e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (5.79e-2)" "unprognostic (3.56e-1)" "unprognostic (3.07e-1)" "unprognostic (6.05e-2)" 120.2 136.5 110.7 80.6 119.9 126.5 95.9 104.9 138.5 83.0 99.6 91.5 67.3 62.1 41.0 188.9 58.6 46.1 107.5 122.1 117.7 106.8 148.9 90.2 62.4 108.0 103.9 52.3 77.2 51.9 72.4 79.1 111.9 90.8 57.4 27.6 99.8 48.8 101.6 125.8 79.8 60.1 106.0 124.6 85.1 69.2 111.3 67.2 61.5 63.7 67.6 82.9 103.4 112.5 380.3 363.2 181.6 198.7 227.1 248.7 122.2 311.0 383.2 349.2 411.0 277.1 189.3 121.1 168.6 476.2 153.6 178.8 144.9 450.6 263.9 115.1 418.6 210.4 220.6 204.0 306.7 142.1 150.0 317.9 259.0 337.9 281.1 259.0 471.1 199.5 186.1 180.4 331.1 403.2 181.1 1060.2 295.7 341.8 268.8 142.8 167.0 170.8 269.2 299.9 177.2 258.8 239.1 298.4 377.0 113.9 248.6 336.4 343.2 246.0 293.8 135.3 375.7 130.8 302.0 134.8 439.0 292.3 437.6 278.6 640.3 406.6 174.3 708.8 145.2 211.5 167.3 174.5 716.8 198.4 153.1 156.3 204.6 188.5 544.6 431.5 233.8 673.1 110.7 119.9 104.9 138.5 122.1 117.7 108.0 103.9 111.9 106.0 111.3 112.5 129.0 38.5 57.2 10.4 85.9 171.6 103.9 341.6 73.4 39.5 179.0 227.8 79.4 137.2 163.9 95.6 16.7 415.2 100.9 397.7 348.3 215.6 80.7 67.8 106.7 190.6 163.7 250.7 14.6 247.2 257.4 130.2 95.8 82.5 92.7 176.1 396.9 308.4 991.6 45.4 13.3 259.6 164.8 515.0 389.5 232.8 92.6 389.5 200.9 4.7 661.1 109.4 160.6 4.5 14.8 249.8 333.9 95.5 94.8 157.6 442.9 432.4 89.0 42.5 98.6 59.1 173.9 78.9 52.5 252.2 253.3 440.5 87.9 230.6 282.1 164.3 APCDD1 B7323 ENSG00000154856 "APC down-regulated 1" Q8J025 18 10454635-10489949 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 129.8" "Cell type enhanced" "Detected in many" "Astrocytes: 120.5;Cholangiocytes: 85.8;Endometrial stromal cells: 429.5;Melanocytes: 80.0;Oligodendrocyte precursor cells: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 32.0;BJ hTERT+: 70.4;HaCaT: 43.0;HHSteC: 18.9;HSkMC: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "unprognostic (1.21e-1)" "unprognostic (2.85e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.39e-4)" "prognostic favorable (8.23e-4)" "unprognostic (5.61e-3)" "unprognostic (6.79e-3)" "unprognostic (1.24e-1)" "unprognostic (5.59e-3)" "unprognostic (2.59e-2)" "unprognostic (3.14e-1)" "unprognostic (7.77e-2)" "unprognostic (2.04e-3)" "unprognostic (1.77e-1)" "unprognostic (3.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" 52.5 14.2 33.4 6.9 31.1 0.4 31.4 30.4 34.3 35.6 17.0 12.8 3.5 32.7 15.6 27.7 32.6 21.9 32.0 39.5 33.0 6.2 1.4 13.2 1.2 33.0 36.9 33.0 8.9 3.4 3.2 26.9 29.8 33.3 13.2 1.6 10.6 14.1 7.3 129.8 14.5 10.6 26.6 4.1 23.8 2.7 33.8 2.2 5.3 18.5 4.7 36.6 35.5 29.6 0.0 0.0 32.0 0.0 5.4 0.0 0.1 2.4 70.4 3.1 4.9 0.1 0.1 0.0 0.0 13.0 0.0 43.0 0.3 0.0 3.3 0.0 1.6 0.1 0.2 0.7 18.9 0.0 0.0 39.3 1.4 6.1 0.0 0.0 0.5 0.0 0.0 0.1 3.1 2.1 1.8 0.5 5.2 15.3 0.0 0.9 0.0 1.2 0.0 0.4 0.8 0.3 0.0 0.0 3.6 2.0 0.0 0.4 0.0 3.8 0.0 0.0 0.3 0.4 0.0 0.1 0.2 0.0 4.8 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.2 33.4 31.1 30.4 34.3 39.5 33.0 33.0 36.9 29.8 26.6 33.8 29.6 3.1 0.0 12.6 120.5 0.4 65.6 3.6 3.6 11.4 4.1 14.1 20.4 4.2 85.8 2.7 3.7 0.0 2.4 1.7 0.1 0.0 11.2 0.7 28.7 429.5 47.1 3.6 0.0 0.2 0.4 0.4 64.4 0.5 10.9 1.3 0.4 1.8 0.2 1.3 0.0 2.1 1.1 2.0 0.3 35.0 0.8 8.7 3.3 80.0 67.5 1.3 0.2 0.0 110.1 15.3 0.2 0.0 37.6 1.6 11.7 0.1 0.1 5.9 2.2 26.3 18.7 28.1 0.3 1.4 13.1 53.8 1.0 4.2 1.3 1.4 4.5 APTX "AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157" ENSG00000137074 Aprataxin Q7Z2E3 9 32886601-33025130 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064930 Supported Supported Nucleoplasm,Nucleoli No No "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nucleoli" "HPA064930: AB_2685386" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (4.04e-1)" "unprognostic (8.16e-2)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-3)" "unprognostic (3.48e-3)" "unprognostic (3.49e-2)" "prognostic favorable (6.01e-5)" "unprognostic (7.87e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.50e-2)" 9.7 14.8 14.6 7.0 14.8 11.0 10.4 14.8 20.2 9.1 13.9 10.2 8.6 8.6 7.6 14.7 8.9 4.9 9.9 14.8 15.0 13.6 15.6 9.3 8.1 14.7 14.6 8.5 9.6 12.1 7.6 7.8 15.0 9.6 11.2 8.0 9.0 6.6 9.8 15.3 8.3 8.6 14.2 8.9 9.7 14.7 15.2 9.3 7.0 6.9 11.0 10.4 9.6 15.0 36.2 26.1 18.4 17.1 19.0 17.4 25.6 24.8 26.0 28.7 31.5 35.1 12.7 27.8 14.6 21.1 18.4 19.4 33.7 32.8 35.1 39.2 11.2 17.9 32.5 37.8 24.4 29.4 15.1 23.8 36.3 32.5 37.9 16.9 26.8 20.2 27.0 24.2 26.0 15.6 24.4 43.2 33.5 24.4 29.0 21.2 14.4 21.5 25.2 21.2 15.6 11.1 21.4 18.0 15.5 17.9 23.0 11.4 17.7 16.2 21.1 29.9 25.0 11.1 21.2 27.5 23.4 23.8 13.2 3.3 14.7 13.4 12.2 15.6 15.2 16.3 12.8 14.6 17.6 16.1 16.0 12.1 5.9 23.1 21.7 15.2 17.3 16.1 14.6 14.8 14.8 20.2 14.8 15.0 14.7 14.6 15.0 14.2 15.2 15.0 14.8 19.2 29.0 31.3 16.9 16.7 23.1 32.9 22.2 15.2 17.9 17.0 14.9 21.5 23.1 9.2 10.4 27.7 15.1 12.6 29.4 25.3 55.6 19.7 18.3 13.3 16.8 20.0 27.3 28.2 27.7 15.6 19.4 18.1 16.5 17.8 8.9 21.4 18.8 13.5 29.0 15.3 34.6 14.7 9.9 48.7 13.4 15.0 14.2 15.9 19.3 18.3 15.5 23.6 43.0 31.9 6.8 10.5 28.3 24.0 13.9 31.7 25.4 16.6 13.1 13.5 20.2 42.2 26.9 25.8 21.2 27.9 15.9 20.5 16.3 23.1 ARF5 ENSG00000004059 "ADP ribosylation factor 5" P84085 7 127588386-127591700 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 3900000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" "unprognostic (6.72e-3)" "unprognostic (2.34e-2)" "unprognostic (1.67e-2)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (3.04e-2)" "unprognostic (5.81e-3)" "unprognostic (9.41e-2)" "unprognostic (2.69e-1)" "unprognostic (2.75e-2)" "unprognostic (7.02e-2)" "unprognostic (1.02e-1)" "unprognostic (9.69e-2)" "unprognostic (1.50e-1)" "unprognostic (1.26e-2)" "unprognostic (3.95e-1)" "unprognostic (2.46e-2)" 100.2 93.7 139.3 72.6 147.7 143.0 99.8 128.4 200.6 100.7 124.4 108.3 92.3 104.8 114.1 227.5 97.5 81.7 118.6 152.0 137.2 125.8 139.0 90.8 102.7 133.8 132.0 72.1 168.1 104.0 100.2 69.3 135.1 98.7 61.3 22.9 103.1 71.1 131.9 199.8 98.5 66.3 131.9 105.8 117.8 82.9 135.2 95.8 80.5 101.4 74.6 92.5 122.1 133.4 157.4 148.9 120.1 386.5 101.6 159.1 163.3 43.9 129.6 118.7 135.8 232.0 211.4 114.7 64.4 132.6 135.9 117.5 92.4 198.0 38.4 104.9 222.8 44.9 137.5 160.2 150.1 69.7 100.1 163.1 196.2 77.7 75.8 94.5 173.2 164.1 105.1 124.1 116.9 531.2 249.0 303.7 179.9 157.1 191.7 148.3 73.9 245.6 198.2 158.7 349.1 226.2 142.8 461.8 116.1 77.6 123.9 108.0 103.7 177.3 75.3 128.0 101.9 115.2 77.5 153.9 181.1 142.0 154.6 289.0 321.4 279.7 144.3 270.3 146.7 129.5 151.1 148.4 409.6 117.2 112.0 122.2 447.5 156.5 216.2 259.6 181.8 381.8 139.3 147.7 128.4 200.6 152.0 137.2 133.8 132.0 135.1 131.9 135.2 133.4 110.3 3.2 12.1 28.4 81.3 105.7 72.9 217.1 130.9 14.8 111.8 180.7 2.0 91.5 83.0 112.2 0.0 151.6 89.7 89.4 201.5 107.8 39.3 90.3 95.7 73.9 119.9 102.2 46.5 90.7 125.0 82.2 135.5 88.2 21.0 91.1 75.7 51.6 102.7 20.2 42.5 108.8 140.4 129.6 221.9 40.7 93.2 123.9 149.4 28.1 118.6 27.6 82.4 27.2 36.2 86.4 134.0 94.8 75.1 57.2 147.5 160.0 58.4 11.9 72.3 58.7 85.4 99.2 116.7 248.3 153.4 146.3 100.2 69.1 125.4 93.4 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512385 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 59.4;Hepatic stellate cells: 46.1;Oligodendrocytes: 129.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 296.7;RT4: 115.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: AB_2680012" "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavorable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 25.6 13.8 36.2 8.3 66.2 10.7 18.8 47.2 54.6 25.9 5.5 22.8 3.0 28.4 3.7 60.8 18.4 7.8 27.3 34.4 37.5 11.8 2.9 28.0 4.1 63.7 59.6 18.1 3.5 3.1 6.2 19.4 54.1 19.9 2.8 8.5 12.8 12.5 10.6 61.1 10.4 11.6 43.0 30.7 13.4 16.1 66.1 5.4 9.5 5.8 11.0 36.3 29.5 97.8 32.5 17.2 15.2 5.1 9.5 31.1 19.6 44.8 49.5 37.7 21.8 56.8 55.1 0.7 35.2 102.5 18.7 296.7 1.7 62.3 26.6 3.5 3.3 0.0 55.1 0.4 47.2 3.0 0.3 18.8 11.8 27.7 17.3 31.0 39.4 6.0 0.6 8.3 21.6 0.0 10.2 6.3 9.0 1.2 6.3 17.0 33.0 10.4 16.0 115.7 3.7 8.8 26.9 0.1 0.3 21.2 6.7 7.9 57.7 62.6 22.9 12.9 12.1 6.5 7.3 1.9 16.3 8.1 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 66.2 47.2 54.6 34.4 37.5 63.7 59.6 54.1 43.0 66.1 97.8 27.2 12.8 1.5 23.8 0.7 9.9 17.5 10.6 9.1 59.4 1.7 3.9 20.4 1.5 13.2 3.7 0.0 27.0 0.2 0.1 0.0 2.9 7.6 8.5 10.0 34.9 0.0 4.0 9.3 1.4 3.1 11.6 3.1 5.7 0.0 4.9 46.1 0.5 5.1 26.9 16.2 0.4 2.0 2.5 4.2 21.0 9.0 1.2 1.8 9.4 0.2 9.6 0.0 20.1 129.2 7.0 0.1 7.2 1.7 15.4 0.0 0.2 8.3 3.4 0.0 10.9 7.6 13.5 2.7 27.5 25.9 16.6 1.8 1.3 0.3 42.2 ARHGEF37 FLJ41603 ENSG00000183111 "Rho guanine nucleotide exchange factor 37" A1IGU5 5 149551947-149634968 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Muller glia cells: 36.8;Oligodendrocytes: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 9.3;neutrophil: 3.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 9.3" "Cell line enhanced" "Detected in many" "EFO-21: 13.9;HaCaT: 26.1;hTCEpi: 33.8" "Region enhanced" "Detected in many" "cerebellum: 10.4" "Low region specificity" "Detected in all" "HPA043885, HPA053487" Uncertain Approved Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 35: Glandular cells - Unknown function" Cytosol "HPA043885: AB_2678715, HPA053487: AB_2682167" "unprognostic (3.51e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-1)" "unprognostic (3.92e-1)" "unprognostic (1.17e-1)" "unprognostic (6.87e-2)" "unprognostic (1.54e-3)" "unprognostic (1.54e-1)" "unprognostic (2.64e-1)" "unprognostic (6.93e-2)" "unprognostic (2.13e-3)" "unprognostic (1.16e-2)" "prognostic favorable (6.85e-4)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.50e-2)" "unprognostic (2.10e-1)" 4.2 3.8 26.9 2.2 38.9 5.2 24.5 33.3 33.8 5.5 34.0 20.8 6.8 7.4 13.6 14.0 10.6 6.3 12.1 23.4 28.6 9.1 2.5 6.4 1.5 41.1 35.9 3.8 10.7 28.1 6.7 3.2 39.5 23.3 7.5 14.4 39.9 35.4 20.4 45.1 7.4 10.2 32.5 1.4 23.3 5.5 35.3 1.6 2.9 10.5 4.8 10.6 8.9 51.3 4.4 1.7 1.2 5.1 0.3 0.6 3.0 0.5 0.9 0.8 0.8 0.0 5.6 0.6 13.9 0.6 1.5 26.1 0.4 2.6 1.6 1.1 1.3 0.4 2.9 0.3 1.0 0.0 0.8 0.7 33.8 2.6 3.3 2.7 4.2 1.8 0.6 1.1 0.0 0.6 0.8 0.8 0.3 10.7 3.1 0.5 0.6 0.0 5.7 2.1 2.1 5.0 3.2 0.3 0.5 0.6 7.7 0.1 3.4 0.3 0.9 0.1 0.7 0.7 1.6 0.5 1.0 0.1 3.6 9.3 0.5 0.3 0.2 0.8 0.3 0.1 0.1 0.2 0.2 0.4 0.5 0.4 3.0 0.2 0.3 0.7 0.1 0.0 26.9 38.9 33.3 33.8 23.4 28.6 41.1 35.9 39.5 32.5 35.3 51.3 9.2 0.0 4.5 5.9 2.8 6.8 9.6 10.4 0.6 4.6 32.7 24.4 15.8 17.2 16.5 9.2 4.2 6.2 4.6 18.2 0.0 3.7 5.3 9.4 2.0 7.4 11.4 14.3 5.1 4.9 1.4 2.7 9.7 9.9 7.0 1.7 6.8 3.2 3.1 5.0 7.5 9.6 8.2 2.5 3.3 1.5 1.8 2.9 3.6 12.2 3.9 36.8 7.2 2.0 62.3 5.1 10.1 10.5 2.0 10.5 15.9 1.4 17.8 7.6 6.6 5.7 4.5 16.0 5.7 4.8 9.7 4.5 3.3 1.5 10.5 5.7 ARHGEF4 "ASEF, KIAA1112, STM6" ENSG00000136002 "Rho guanine nucleotide exchange factor 4" Q9NR80 2 130836914-131047263 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.3;skin 1: 39.8" "Cell type enhanced" "Detected in many" "Astrocytes: 333.3;Excitatory neurons: 83.0;Inhibitory neurons: 83.5;Oligodendrocyte precursor cells: 143.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Group enriched" "Detected in many" 12 "dendritic cells: 1.0;T-cells: 1.4" "Cell line enhanced" "Detected in many" "HaCaT: 39.9;hTCEpi: 78.9;REH: 20.3;SCLC-21H: 52.9" HPA018267 Approved NA NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA018267: AB_1845006" "unprognostic (2.30e-3)" "unprognostic (8.84e-2)" "unprognostic (5.32e-2)" "unprognostic (1.18e-2)" "unprognostic (4.44e-1)" "unprognostic (2.60e-2)" "unprognostic (4.69e-2)" "unprognostic (2.14e-2)" "unprognostic (8.97e-2)" "unprognostic (1.29e-1)" "unprognostic (7.85e-2)" "unprognostic (1.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.68e-2)" "prognostic favorable (7.00e-4)" "unprognostic (3.93e-3)" "unprognostic (9.71e-3)" 5.6 5.0 53.1 1.0 56.8 0.0 2.1 32.5 67.3 11.2 27.3 7.0 0.2 2.9 1.6 34.0 8.4 2.9 1.4 63.1 38.1 0.4 0.9 3.1 0.3 44.4 39.7 7.8 17.9 2.5 15.4 0.2 39.9 5.2 0.8 10.2 5.7 9.3 9.0 39.8 1.3 4.1 41.5 0.2 3.1 5.2 44.6 1.8 6.1 2.6 2.5 4.5 19.9 46.0 4.8 2.0 0.9 16.6 0.1 0.0 0.4 5.3 0.3 0.3 0.2 0.9 1.5 0.0 0.5 2.1 3.6 39.9 2.4 10.5 0.0 0.0 2.2 0.0 7.0 0.0 0.6 0.0 0.1 0.0 78.9 1.2 5.8 0.1 0.1 0.1 0.0 0.0 0.0 2.5 0.0 0.0 5.8 0.7 7.2 20.3 0.2 0.8 3.2 0.1 52.9 7.0 0.8 8.3 0.6 1.6 0.5 0.5 0.0 0.0 0.3 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.5 0.0 0.0 0.5 1.4 0.0 0.0 0.0 1.0 0.5 0.1 53.1 56.8 32.5 67.3 63.1 38.1 44.4 39.7 39.9 41.5 44.6 46.0 0.1 25.6 0.0 333.3 0.0 17.3 1.2 4.8 15.4 18.8 0.9 5.5 3.2 1.5 2.9 0.0 37.5 1.0 2.9 0.3 0.0 0.8 10.9 7.5 1.0 0.5 0.0 2.7 83.0 0.0 0.3 3.5 2.6 5.4 0.0 3.1 0.7 0.4 0.4 28.6 83.5 0.9 0.0 0.6 2.4 8.2 5.0 0.3 5.4 11.2 0.7 3.7 0.0 143.7 28.3 1.5 0.0 10.9 0.0 1.2 0.3 0.9 6.6 13.9 0.0 3.1 1.1 1.1 4.2 17.4 19.9 0.3 0.8 0.4 0.4 0.8 ARL10 ARL10A ENSG00000175414 "ADP ribosylation factor like GTPase 10" Q8N8L6 5 176365487-176401865 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 22.0;Oligodendrocyte precursor cells: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047044 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 60: Granulocytes - Receptor signaling" "HPA047044: AB_2679915" "unprognostic (2.50e-2)" "unprognostic (4.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.37e-1)" "unprognostic (6.31e-2)" "unprognostic (6.00e-3)" "unprognostic (2.78e-1)" "unprognostic (9.29e-2)" "unprognostic (5.92e-3)" "unprognostic (7.96e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-2)" "unprognostic (4.33e-2)" 3.1 1.5 5.5 2.4 5.9 4.1 2.7 7.0 7.1 6.4 1.3 5.7 1.2 4.6 2.8 4.4 3.4 3.6 4.3 5.2 6.0 2.5 1.3 2.5 3.1 2.1 2.4 7.5 1.9 2.2 3.9 3.0 2.3 3.9 1.2 5.3 1.9 3.0 6.7 14.2 3.2 3.3 0.6 2.8 2.5 2.0 8.5 1.8 1.8 1.8 2.3 4.5 5.2 4.7 0.4 0.1 13.5 6.3 7.1 8.6 0.7 4.0 1.7 5.4 5.7 0.4 1.0 1.4 0.8 7.1 0.3 9.0 0.1 1.1 8.1 0.1 5.5 1.2 13.1 1.4 4.3 0.2 1.6 5.1 0.5 7.0 0.0 2.9 9.0 2.6 0.4 1.3 7.3 8.4 2.4 0.3 2.4 1.0 1.5 4.0 3.3 2.6 3.3 4.7 12.5 13.3 3.2 1.8 2.6 5.9 0.4 1.6 6.9 5.1 4.2 3.7 0.7 0.5 3.7 0.4 4.1 0.2 1.7 0.2 0.0 0.0 0.3 0.1 0.5 1.6 1.1 0.7 0.1 1.2 0.7 0.7 0.2 1.5 0.1 0.6 0.5 0.1 5.5 5.9 7.0 7.1 5.2 6.0 2.1 2.4 2.3 0.6 8.5 4.7 2.7 3.2 22.0 15.0 4.5 4.0 4.3 3.8 2.8 13.1 2.1 2.0 11.1 1.5 7.1 7.3 6.2 0.5 1.0 0.6 0.0 2.0 0.8 1.2 8.7 5.6 0.0 0.0 17.5 0.2 0.7 8.5 2.0 2.4 17.1 11.7 4.2 0.6 1.2 20.2 18.2 0.4 4.1 1.9 3.1 0.5 6.5 2.9 3.6 7.5 0.9 3.6 6.2 26.2 20.3 0.9 0.0 7.2 2.9 6.5 0.4 2.0 5.5 4.5 0.0 8.1 7.6 1.5 1.1 6.2 7.5 0.4 3.9 1.9 0.3 2.9 ARL13A ARL13 ENSG00000174225 "ADP ribosylation factor like GTPase 13A" Q5H913 X 100969708-100990831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 5.1" "Group enriched" "Detected in some" 29 "Early spermatids: 69.8;Late spermatids: 55.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037377, HPA037378" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Plasma membrane" "Actin filaments, Cytosol" "HPA037377: AB_2675442, HPA037378: AB_10670932" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" "unprognostic (1.02e-1)" "unprognostic (1.08e-2)" "unprognostic (1.93e-1)" "unprognostic (9.06e-3)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.51e-2)" "unprognostic (4.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (9.37e-4)" "unprognostic (2.14e-1)" 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.1 5.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 55.5 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112727 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;kidney: 7.6;skin 1: 5.6" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Distal tubular cells: 1.9;Inhibitory neurons: 4.6;Oligodendrocyte precursor cells: 2.5;Proximal tubular cells: 10.5" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 3.0 2.6 0.0 3.6 0.1 0.2 3.0 2.7 0.4 1.5 0.0 0.0 0.0 1.6 2.6 0.0 0.0 0.0 3.2 2.1 7.6 1.6 0.0 0.0 4.9 2.9 0.0 0.6 0.3 0.0 0.0 3.1 0.1 0.0 0.1 0.2 0.0 0.1 5.6 0.0 0.0 2.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.5 0.2 1.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.6 3.6 3.0 2.7 3.2 2.1 4.9 2.9 3.1 2.8 3.0 2.1 0.0 0.0 0.0 9.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 ATP6V0A2 "a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1" ENSG00000185344 "ATPase H+ transporting V0 subunit a2" Q9Y487 12 123712353-123761755 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 13.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044279 Approved Supported "Vesicles,Plasma membrane,Focal adhesion sites" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Plasma membrane" "Vesicles, Focal adhesion sites" "HPA044279: AB_10961274" "unprognostic (2.60e-1)" "unprognostic (8.79e-3)" "unprognostic (3.60e-2)" "unprognostic (1.50e-1)" "unprognostic (2.70e-1)" "unprognostic (2.29e-2)" "unprognostic (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (3.77e-2)" "unprognostic (1.75e-1)" "unprognostic (8.85e-3)" "unprognostic (1.63e-1)" "unprognostic (1.26e-1)" "unprognostic (7.48e-2)" "unprognostic (1.12e-1)" "unprognostic (3.47e-1)" "unprognostic (1.58e-1)" 6.6 4.4 5.6 7.0 6.2 10.4 5.7 7.4 6.5 4.7 6.9 5.5 8.7 6.0 3.9 4.3 4.8 3.8 4.7 6.0 6.0 3.8 4.2 6.3 8.3 6.6 5.8 4.1 5.7 3.7 4.9 3.7 6.5 4.7 5.8 6.7 7.6 4.0 6.5 9.4 7.0 5.1 5.6 6.6 8.8 4.9 6.2 7.5 4.8 3.5 8.2 5.3 4.5 7.9 4.8 10.3 12.0 17.8 9.2 7.0 6.7 6.2 6.2 5.4 5.8 6.9 2.7 18.0 4.2 7.6 5.5 9.0 16.1 6.2 4.5 11.4 10.2 27.9 9.2 5.4 10.2 16.8 51.0 6.7 4.4 5.9 7.4 9.0 5.0 15.0 14.5 3.4 8.1 8.4 15.4 24.8 11.5 6.6 6.5 15.7 9.9 6.4 8.3 10.4 7.2 13.6 9.3 6.9 9.4 6.6 5.9 14.4 8.3 8.0 3.1 10.8 9.1 10.8 12.8 14.9 9.4 12.1 6.5 6.3 0.7 13.7 1.7 0.9 1.0 0.9 1.7 1.5 0.8 3.7 1.6 1.8 2.0 1.7 1.5 2.8 1.0 0.8 5.6 6.2 7.4 6.5 6.0 6.0 6.6 5.8 6.5 5.6 6.2 7.9 13.0 6.4 11.0 3.9 20.4 10.1 10.8 4.6 11.4 20.5 7.9 5.3 8.8 12.8 8.3 9.2 12.5 5.2 27.9 17.9 0.0 8.1 10.2 11.0 11.9 10.6 13.2 50.3 21.2 10.9 5.7 11.3 18.3 12.3 75.3 8.7 18.2 11.4 8.4 11.8 19.3 9.8 2.0 9.4 17.2 4.5 8.7 11.3 1.8 7.5 13.2 9.0 25.7 10.6 17.1 9.2 9.0 9.4 19.7 15.7 11.1 4.0 13.5 28.8 6.6 12.4 10.9 23.6 12.6 9.6 14.2 6.8 21.8 5.7 11.4 11.4 BAIAP2 "BAP2, IRSp53, WAML" ENSG00000175866 "BAR/IMD domain containing adaptor protein 2" Q9UQB8 17 81035122-81117432 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Urothelial cells: 185.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 19.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023310, HPA027421" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 18000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cytosol" "HPA023310: AB_1845264, HPA027421: AB_10602392" "unprognostic (2.20e-1)" "unprognostic (1.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (6.97e-3)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (6.77e-2)" "unprognostic (1.45e-2)" "unprognostic (4.23e-2)" "unprognostic (2.94e-1)" "unprognostic (7.04e-2)" "unprognostic (6.77e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-2)" "prognostic unfavorable (7.58e-6)" 23.9 18.2 129.1 7.4 140.0 2.6 27.1 95.7 176.1 49.9 104.6 44.0 6.7 30.9 46.5 132.9 37.6 29.3 24.2 163.7 103.1 38.0 85.7 49.1 6.9 68.0 81.0 13.7 13.4 19.9 56.3 31.8 68.3 61.3 12.1 16.2 57.5 27.6 13.1 132.4 14.7 19.3 70.5 11.8 62.3 26.3 119.9 11.8 27.1 9.8 25.3 23.3 73.2 121.9 99.9 45.1 28.1 36.6 22.2 29.0 32.8 40.2 26.1 35.7 15.8 60.9 49.1 0.5 28.3 35.8 73.5 93.6 26.1 46.1 13.7 0.4 32.8 20.2 41.3 46.4 20.7 0.0 28.2 12.5 53.0 29.5 15.4 32.7 19.5 1.1 26.4 0.6 20.6 51.2 4.0 22.3 11.8 65.6 38.1 6.0 6.6 81.3 108.5 34.5 36.8 39.9 64.2 91.3 110.1 23.1 80.4 22.6 23.8 81.6 78.4 13.8 43.4 1.4 0.3 1.4 72.0 3.3 18.3 0.0 7.9 0.5 3.2 9.4 1.0 0.1 1.2 1.0 10.3 0.1 1.3 1.8 5.4 1.9 9.2 19.5 0.5 3.2 129.1 140.0 95.7 176.1 163.7 103.1 68.0 81.0 68.3 70.5 119.9 121.9 74.1 76.9 39.0 13.4 6.2 63.7 138.4 42.3 94.4 37.1 49.4 37.1 22.5 25.8 47.2 22.0 79.2 77.1 16.6 18.8 7.9 9.8 10.5 80.8 10.4 35.7 49.3 0.8 65.3 5.1 9.2 28.0 88.2 79.7 13.4 3.1 45.0 78.6 43.2 11.8 13.6 29.1 24.4 18.3 58.2 29.4 6.8 31.2 40.9 13.1 18.6 18.5 0.0 4.5 5.9 14.8 8.0 3.8 3.1 77.0 3.7 25.4 110.8 19.1 0.0 10.4 13.3 7.6 33.0 103.6 75.3 101.0 13.9 8.2 14.7 185.1 BLOC1S3 "BLOS3, HPS8" ENSG00000189114 "Biogenesis of lysosomal organelles complex 1 subunit 3" Q6QNY0 19 45178784-45216933 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050111, HPA070609" Approved Approved "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA050111: AB_2681019, HPA070609: " "unprognostic (1.17e-1)" "unprognostic (3.97e-2)" "unprognostic (6.94e-3)" "unprognostic (6.26e-2)" "unprognostic (3.14e-1)" "unprognostic (3.04e-2)" "unprognostic (1.75e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-1)" "unprognostic (9.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.89e-9)" "unprognostic (1.92e-2)" "unprognostic (1.93e-1)" "unprognostic (3.29e-1)" "prognostic favorable (6.86e-4)" 6.7 6.3 7.8 5.9 7.8 12.4 5.7 7.0 8.2 5.7 4.4 5.7 5.3 5.6 5.9 6.4 4.7 3.2 5.2 7.5 6.4 5.7 7.8 5.5 7.6 9.3 8.0 5.6 6.1 4.8 4.4 3.9 8.4 5.7 4.3 3.3 5.6 4.5 4.4 13.2 6.7 4.1 6.8 11.0 7.6 7.2 8.1 4.7 4.7 3.4 7.5 6.6 5.9 9.2 10.4 11.6 3.2 8.1 10.8 7.3 9.7 5.1 8.2 9.5 9.8 7.0 6.6 9.0 12.2 11.9 10.8 16.0 8.5 11.6 6.8 7.9 17.3 12.3 5.5 8.0 15.4 6.0 19.5 10.8 16.3 12.3 17.3 5.4 10.6 5.9 13.2 18.2 5.6 17.8 6.2 9.2 1.8 14.9 14.5 8.9 4.3 7.5 7.0 13.2 6.3 6.0 13.6 22.8 5.1 5.6 9.4 11.1 5.7 9.7 5.5 10.4 8.2 12.7 14.0 6.1 10.6 11.1 7.5 51.1 34.4 30.2 37.4 42.8 31.0 18.4 31.6 28.3 21.4 24.8 25.5 25.5 35.2 24.2 39.9 18.5 29.8 17.8 7.8 7.8 7.0 8.2 7.5 6.4 9.3 8.0 8.4 6.8 8.1 9.2 3.4 0.0 1.7 1.0 5.4 12.7 2.6 1.7 2.2 5.7 4.2 3.2 2.3 1.5 1.5 3.7 0.0 3.7 5.9 4.6 1.9 4.4 17.7 1.9 3.2 5.2 7.2 1.7 2.7 3.7 4.0 3.2 2.0 2.7 8.2 3.0 6.1 6.3 6.1 5.0 2.8 5.0 0.0 8.8 8.9 39.3 6.2 4.7 3.6 1.0 6.8 3.4 11.3 3.5 2.9 5.1 3.2 7.9 4.0 4.9 4.6 4.2 1.7 2.0 0.0 1.9 3.1 1.5 5.1 2.7 13.9 4.5 6.7 3.0 4.1 1.9 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168753-57266641 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.8;choroid plexus: 43.8;thyroid gland: 45.9" "Cell type enhanced" "Detected in many" "Astrocytes: 74.1;Basal squamous epithelial cells: 51.8;Cytotrophoblasts: 137.4;Oligodendrocyte precursor cells: 74.4;Squamous epithelial cells: 44.2;Syncytiotrophoblasts: 56.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 172.1;MCF7: 202.3;OE19: 94.4;RPMI-8226: 77.8;SK-BR-3: 128.4;U-698: 237.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" NA NA 248000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Nucleoplasm, Nucleoli" "HPA057757: AB_2683518" "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 6.5 33.1 1.9 34.6 0.0 1.3 37.2 27.9 8.5 43.8 2.9 2.2 1.2 17.2 23.9 9.5 0.4 13.8 35.6 28.5 6.3 0.0 1.6 1.0 36.2 36.3 0.2 0.5 0.0 2.7 25.7 34.7 5.9 1.7 5.3 3.9 9.2 0.3 22.5 1.9 0.3 32.8 0.6 3.6 0.7 39.7 3.8 45.9 0.0 2.1 6.8 13.0 42.8 0.3 0.7 23.4 5.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 20.0 6.8 172.1 41.3 0.0 8.7 48.3 5.2 0.0 0.0 0.4 17.2 0.1 0.0 0.0 0.0 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 202.3 0.0 0.1 12.3 94.4 0.0 0.1 0.1 77.8 0.0 0.2 0.4 17.8 5.5 128.4 0.5 15.2 0.9 0.4 0.4 0.1 10.9 0.0 0.1 0.2 0.3 237.6 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 34.6 37.2 27.9 35.6 28.5 36.2 36.3 34.7 32.8 39.7 42.8 0.6 6.4 2.2 74.1 0.4 13.8 13.4 12.9 51.8 4.7 0.9 4.6 15.1 0.0 4.2 1.8 0.0 137.4 0.1 0.2 0.0 0.0 5.3 1.7 2.4 1.2 2.4 0.0 0.9 0.0 21.0 13.5 2.0 2.5 21.6 0.1 0.0 0.0 11.0 1.7 4.7 1.5 6.1 0.0 1.9 4.9 0.3 0.4 3.6 2.8 0.1 38.4 0.0 74.4 8.7 0.0 0.3 0.4 2.5 6.6 0.2 2.2 1.9 2.4 0.0 1.3 0.8 1.8 3.4 44.2 9.7 56.9 0.9 0.7 1.5 18.1 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271296-122338159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 8.3;testis: 7.8;urinary bladder: 20.2" "Group enriched" "Detected in some" 9 "Early spermatids: 123.2;Late spermatids: 69.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RT4: 33.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.1 0.0 1.0 0.0 1.4 0.0 0.5 1.2 2.3 0.3 0.7 0.5 0.0 0.1 0.3 0.1 0.4 0.2 0.0 1.1 1.2 0.3 4.0 0.2 0.0 1.4 1.4 0.0 0.1 0.0 0.4 0.1 1.4 0.8 0.0 0.0 0.4 0.0 0.3 8.3 0.1 0.1 1.3 0.0 0.1 7.8 1.2 0.0 0.4 0.0 0.1 20.2 0.5 2.1 0.0 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 1.5 33.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 1.4 1.2 2.3 1.1 1.2 1.4 1.4 1.4 1.3 1.2 2.1 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 123.2 0.6 0.0 0.2 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.4 69.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.5 9.8 1.1 3.8 0.4 0.0 0.1 0.2 1.0 3.1 0.0 0.0 0.4 0.2 10.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 2.9 C12orf29 DKFZp434N2030 ENSG00000133641 "Chromosome 12 open reading frame 29" Q8N999 12 88033846-88050160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039663 Uncertain Approved Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" Vesicles "HPA039663: AB_10795253" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.80e-2)" "unprognostic (6.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.06e-2)" "unprognostic (1.75e-3)" "unprognostic (4.72e-3)" "unprognostic (1.07e-2)" "unprognostic (1.84e-1)" "unprognostic (8.81e-2)" "unprognostic (6.49e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.03e-1)" "unprognostic (9.29e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" 4.7 9.8 7.5 4.5 8.1 8.7 11.0 7.0 10.0 6.5 4.9 4.8 4.8 6.6 12.8 16.1 4.5 5.2 5.8 8.1 7.8 8.4 12.6 5.1 6.8 7.5 7.8 7.5 5.9 7.2 3.1 5.3 7.6 8.2 5.1 5.4 8.3 6.1 4.3 15.5 3.9 5.6 7.8 5.3 5.2 5.6 7.1 6.2 9.9 8.7 8.7 7.4 6.0 8.8 13.1 8.1 7.9 9.2 16.7 21.5 5.8 17.1 14.6 14.4 12.9 7.8 5.0 24.0 2.3 8.8 8.1 11.3 15.5 11.8 24.8 10.4 15.9 20.5 6.5 6.9 20.1 26.9 9.4 14.7 17.8 13.5 16.8 16.8 11.2 9.2 20.3 4.8 22.7 4.6 18.0 13.6 12.0 11.0 15.7 10.4 13.5 19.9 16.3 10.4 19.0 17.0 9.8 22.8 12.5 6.5 14.6 19.2 9.0 12.9 4.3 13.3 13.4 10.7 16.0 14.5 10.0 19.1 11.4 4.5 0.8 0.6 2.7 0.8 4.9 2.0 3.9 3.3 1.0 1.7 4.6 3.9 0.0 3.4 0.9 1.4 2.1 1.8 7.5 8.1 7.0 10.0 8.1 7.8 7.5 7.8 7.6 7.8 7.1 8.8 20.4 9.6 13.6 7.8 17.7 51.5 29.2 29.1 21.6 14.4 19.0 17.8 16.1 20.0 29.6 5.5 6.2 15.3 16.1 5.1 37.2 21.5 34.2 14.2 16.8 17.7 7.8 44.6 22.8 24.2 17.1 26.4 8.2 19.1 10.8 6.7 9.7 16.4 9.6 10.1 20.0 8.9 18.3 6.6 11.7 22.8 32.0 6.6 26.6 4.7 5.3 16.2 11.3 5.0 12.9 22.3 5.0 30.9 13.5 39.7 4.2 33.3 19.7 17.8 6.6 24.9 25.2 50.4 31.7 29.5 71.5 9.3 21.3 8.6 13.0 31.2 C1orf35 "MGC4174, MMTAG2" ENSG00000143793 "Chromosome 1 open reading frame 35" Q9BU76 1 228100726-228105411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046175 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles, Plasma membrane" Cytosol "HPA046175: AB_10959459" "unprognostic (1.12e-1)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.71e-4)" "unprognostic (6.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.64e-2)" "unprognostic (5.44e-3)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "prognostic favorable (7.38e-4)" "unprognostic (6.12e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.70e-1)" "unprognostic (8.58e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" 11.3 12.5 20.6 6.3 20.4 14.3 11.7 19.5 24.4 15.5 18.2 13.4 7.9 13.4 5.5 18.8 13.0 4.0 9.4 20.5 20.3 11.2 11.6 8.6 9.0 20.8 19.7 16.1 12.9 7.4 9.9 7.1 20.6 14.2 3.9 2.7 12.5 8.5 9.6 19.6 10.5 5.0 19.2 10.8 12.3 7.5 20.3 9.2 12.1 3.5 7.3 14.4 14.7 21.0 22.2 24.3 17.0 10.9 8.2 8.3 40.0 16.8 7.4 14.6 10.9 24.1 22.2 22.7 35.6 6.6 10.3 25.4 16.0 16.6 5.3 24.6 76.7 13.9 20.1 23.1 13.3 32.0 16.7 7.6 19.5 14.3 13.1 9.2 16.1 26.1 35.2 13.3 10.7 27.8 42.0 44.4 34.4 28.5 55.6 32.1 24.2 36.4 13.6 18.2 28.1 27.2 16.0 29.4 23.3 4.5 31.0 29.2 15.1 11.8 18.1 32.7 37.2 23.9 12.7 21.6 14.2 18.3 19.2 14.9 29.0 43.3 28.2 35.9 35.2 37.2 31.1 30.7 37.6 29.9 36.1 30.2 4.7 35.9 34.9 49.3 34.7 17.5 20.6 20.4 19.5 24.4 20.5 20.3 20.8 19.7 20.6 19.2 20.3 21.0 37.7 22.4 22.4 10.4 29.8 66.8 35.5 58.5 47.3 51.4 41.1 50.9 18.1 28.6 31.0 38.6 18.8 76.2 49.8 61.6 45.0 38.0 4.4 28.2 31.7 33.9 26.3 57.4 12.9 39.5 59.3 34.3 25.0 43.7 24.7 36.9 32.2 24.4 40.4 47.1 10.1 58.8 54.9 24.2 72.7 5.5 51.3 29.8 32.0 2.8 32.4 42.5 30.9 9.5 14.3 37.5 43.5 46.6 28.1 37.4 47.8 38.3 25.1 54.5 65.7 31.6 44.7 44.0 50.0 54.1 80.6 28.3 47.2 28.0 56.6 25.8 C1QTNF9B CTRP9B ENSG00000205863 "C1q and TNF related 9B" B2RNN3 13 23891099-23897502 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.8;skin 1: 17.9;testis: 8.8" "Cell type enhanced" "Detected in some" "Adipocytes: 4.3;Early spermatids: 2.3;Endothelial cells: 1.4;Late spermatids: 2.1" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Region enriched" "Detected in many" 4 "hippocampal formation: 7.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 4.8;OE19: 3.6" HPA056632 Uncertain "Secreted - unknown location" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA056632: AB_2683197" "unprognostic (3.43e-1)" "unprognostic (3.42e-1)" "unprognostic (2.18e-2)" "unprognostic (9.51e-2)" "unprognostic (2.18e-1)" "unprognostic (4.10e-2)" "unprognostic (2.43e-1)" "unprognostic (3.32e-3)" "unprognostic (1.52e-2)" "unprognostic (7.26e-2)" "unprognostic (3.01e-3)" "unprognostic (7.04e-2)" "unprognostic (5.56e-3)" "unprognostic (3.89e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" 1.2 0.7 1.0 0.6 0.9 0.2 0.4 0.3 1.2 0.3 0.4 0.4 0.5 0.7 0.0 1.6 0.3 0.8 3.5 7.8 1.9 0.2 0.1 0.4 0.2 0.3 0.6 0.4 0.6 0.1 1.1 0.6 0.3 4.2 0.1 0.7 1.6 0.2 4.0 17.9 0.2 0.7 0.3 1.3 0.8 8.8 0.7 0.0 0.5 2.0 0.0 0.6 0.1 0.4 0.7 1.7 0.6 0.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 1.0 0.1 0.0 0.0 1.3 1.7 0.0 0.0 0.0 1.0 1.4 0.3 0.9 0.9 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.8 0.0 4.8 0.4 0.9 0.0 1.1 0.2 0.0 1.1 3.6 1.6 0.6 0.8 1.3 0.0 0.0 2.0 0.0 1.0 0.0 1.7 0.4 0.5 0.2 0.1 1.6 0.4 0.0 1.0 1.4 0.2 0.7 1.9 0.6 0.3 0.0 0.2 0.4 0.3 0.3 0.1 0.2 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.4 0.4 0.7 0.0 0.1 1.0 0.9 0.3 1.2 7.8 1.9 0.3 0.6 0.3 0.3 0.7 0.4 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.0 0.3 0.0 0.0 0.4 0.0 0.0 C22orf23 "EVG1, FLJ32787, LOC84645" ENSG00000128346 "Chromosome 22 open reading frame 23" Q9BZE7 22 37943050-37953669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 95.5" "Group enriched" "Detected in some" 7 "Early spermatids: 292.5;Late spermatids: 312.9;Spermatocytes: 241.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 31.8;U-138 MG: 31.4;U-87 MG: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000650 Approved Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA000650: AB_2732391" "unprognostic (6.09e-3)" "unprognostic (3.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-1)" "unprognostic (7.42e-5)" "unprognostic (1.50e-2)" "unprognostic (2.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.04e-1)" "unprognostic (5.80e-2)" "unprognostic (8.18e-3)" "unprognostic (4.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.82e-2)" "unprognostic (8.46e-2)" 2.9 2.6 3.9 5.6 8.8 3.0 0.8 9.5 5.1 1.7 4.7 3.4 2.9 8.3 1.3 14.0 12.4 6.4 5.1 4.7 7.7 2.3 0.4 5.0 3.6 12.8 10.4 2.5 8.6 1.1 4.8 5.3 11.0 5.0 0.1 3.5 10.3 0.2 5.7 26.0 3.8 0.1 8.2 2.3 9.0 95.5 9.7 0.2 8.2 0.0 0.1 6.2 1.2 16.1 6.6 5.3 11.1 10.3 0.2 0.4 13.7 18.4 0.5 0.5 0.7 6.3 5.9 3.5 5.0 0.4 11.7 31.8 0.4 0.1 0.6 6.7 13.4 2.0 4.6 4.3 0.5 5.4 4.4 0.4 0.2 2.2 0.2 15.4 0.1 2.6 2.3 2.0 0.1 4.1 0.3 3.2 1.6 6.6 4.6 6.0 16.1 1.3 0.1 29.4 5.6 4.0 8.2 3.2 10.3 17.5 3.6 7.3 27.8 31.4 10.2 25.1 10.0 4.6 2.0 1.6 46.9 2.5 18.3 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.8 9.5 5.1 4.7 7.7 12.8 10.4 11.0 8.2 9.7 16.1 0.2 0.0 2.4 1.3 0.0 0.3 0.1 1.8 0.0 0.2 0.3 0.8 0.1 1.5 1.9 0.0 0.0 0.1 0.1 0.1 1.9 0.4 292.5 16.8 0.6 0.6 0.0 0.0 0.5 0.4 0.1 0.5 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 312.9 6.8 0.5 0.0 1.0 0.0 2.2 0.0 1.0 5.6 0.3 0.0 5.3 0.0 0.1 0.0 1.8 37.8 1.2 0.0 0.5 0.4 241.3 5.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 C2CD4D FAM148D ENSG00000225556 "C2 calcium dependent domain containing 4D" B7Z1M9 1 151837819-151840557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;skin 1: 2.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 9.8;Enteroendocrine cells: 5.4;Granulosa cells: 11.5;Syncytiotrophoblasts: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HDLM-2: 19.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (8.17e-3)" "unprognostic (5.08e-1)" "unprognostic (3.00e-1)" "unprognostic (3.60e-2)" "unprognostic (1.62e-2)" "unprognostic (9.03e-4)" "unprognostic (2.69e-1)" "unprognostic (9.66e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.84e-3)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (2.41e-3)" "unprognostic (1.51e-1)" "unprognostic (2.62e-1)" "unprognostic (3.28e-2)" 0.1 0.3 0.6 0.2 0.7 0.0 0.3 0.4 1.1 0.2 0.1 0.3 0.2 0.0 0.0 0.3 0.2 0.2 0.2 1.3 0.0 0.5 0.2 0.3 0.3 0.9 0.7 0.0 0.8 0.0 0.6 0.0 1.0 0.6 0.0 0.0 1.4 0.2 0.2 2.3 0.2 0.0 0.3 0.2 0.7 0.3 0.8 0.0 0.2 0.0 0.0 0.1 0.2 1.8 2.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 19.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.7 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 2.0 1.3 1.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.4 1.1 1.3 0.0 0.9 0.7 1.0 0.3 0.8 1.8 0.1 0.0 0.0 0.0 0.3 0.8 1.2 0.0 0.0 0.0 3.0 2.4 0.5 1.5 0.0 0.0 0.0 1.0 0.6 0.9 9.8 0.2 0.0 1.6 0.2 0.3 5.4 0.0 1.5 0.5 0.2 0.2 1.5 1.8 0.0 11.5 0.0 0.1 0.1 0.0 0.2 2.7 2.0 0.0 0.3 0.3 0.6 0.1 3.6 0.0 0.0 2.0 1.0 0.0 2.2 0.4 2.1 0.4 1.7 1.3 0.3 0.8 0.0 0.2 0.0 0.8 0.2 0.2 0.7 0.4 1.0 10.7 2.5 0.0 2.5 1.6 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62319015-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 159.7;Spermatocytes: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 28.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 408.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Plasma membrane" Cytosol "HPA048286: AB_2680340" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 7.6 15.9 35.4 5.9 37.3 1.3 35.6 32.3 44.5 6.7 23.0 8.3 3.5 7.8 8.1 18.8 4.2 6.5 10.2 37.6 36.7 15.0 3.4 6.9 5.8 32.2 31.4 9.1 12.6 3.8 31.0 5.0 33.0 17.9 4.3 27.2 12.4 5.5 1.3 17.3 4.8 7.1 33.5 4.3 6.2 32.8 33.8 3.7 9.1 1.3 9.2 12.7 9.3 33.0 0.1 22.1 27.2 0.0 18.9 24.8 19.3 33.6 21.2 41.7 41.0 0.3 36.8 0.0 0.1 20.4 84.6 6.7 0.0 21.4 32.1 0.0 14.5 20.5 0.0 0.0 12.0 0.3 45.2 11.3 28.9 47.8 39.6 0.9 21.0 0.0 2.4 0.3 43.0 408.7 0.0 0.0 33.4 31.9 41.9 0.1 0.0 11.8 37.0 64.3 45.9 40.8 21.3 90.0 38.7 20.5 34.0 25.1 0.5 22.2 0.2 105.1 34.8 24.1 0.0 0.0 22.1 0.0 78.4 9.2 4.7 0.7 0.2 17.9 0.0 4.1 3.9 3.3 5.4 1.4 1.1 0.8 0.5 0.9 28.1 7.6 7.9 2.4 35.4 37.3 32.3 44.5 37.6 36.7 32.2 31.4 33.0 33.5 33.8 33.0 8.7 22.4 11.8 11.8 3.3 36.8 23.6 41.5 31.3 34.7 90.2 77.0 7.7 11.5 38.1 22.0 4.2 21.4 8.0 2.6 60.7 35.7 159.7 11.3 14.8 12.1 87.4 2.1 34.8 55.1 19.6 20.9 4.1 12.6 1.3 7.9 5.7 3.1 32.0 37.0 33.4 3.8 44.7 10.0 27.2 62.9 14.0 13.4 46.2 3.7 56.6 35.4 0.0 13.0 15.8 35.8 0.8 10.5 0.5 21.8 2.7 41.5 12.3 28.0 0.0 15.8 21.6 173.2 53.5 30.8 28.7 9.9 5.0 20.6 3.9 23.3 C4orf3 "ALN, HCVFTP1" ENSG00000164096 "Chromosome 4 open reading frame 3" Q8WVX3 4 119296419-119304445 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 1070.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026907 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" "HPA026907: AB_10600760" "unprognostic (2.97e-1)" "unprognostic (4.68e-2)" "unprognostic (3.32e-1)" "unprognostic (6.85e-3)" "unprognostic (9.30e-2)" "unprognostic (7.15e-3)" "unprognostic (2.04e-1)" "unprognostic (8.85e-2)" "unprognostic (4.90e-2)" "unprognostic (7.11e-2)" "unprognostic (9.94e-3)" "unprognostic (1.84e-1)" "prognostic favorable (3.46e-4)" "unprognostic (8.32e-2)" "unprognostic (2.65e-1)" "unprognostic (3.90e-1)" "unprognostic (1.59e-1)" 80.0 67.8 96.4 54.1 107.1 34.1 69.4 103.1 148.1 123.2 83.3 80.2 60.5 79.7 77.9 268.2 68.9 65.1 107.8 90.1 99.6 97.9 110.8 70.3 61.3 107.9 104.9 85.5 51.5 55.5 56.6 60.3 106.4 71.8 43.6 74.7 89.6 69.8 79.6 89.3 67.3 70.6 109.6 63.1 49.6 39.8 109.2 64.8 71.4 59.7 56.8 75.9 150.2 112.8 116.8 13.7 58.4 49.8 107.1 97.0 34.1 59.3 31.6 35.3 62.6 15.6 44.5 95.9 36.6 87.3 31.0 24.8 29.6 54.1 61.8 57.1 21.3 40.9 33.5 67.9 35.9 64.7 42.8 96.4 64.5 30.0 14.4 120.6 52.8 29.1 33.8 50.4 137.6 41.8 50.9 64.0 24.2 60.7 20.9 32.9 62.6 27.3 53.5 32.2 38.4 54.8 46.4 58.5 43.2 56.9 32.6 37.5 55.7 80.3 34.6 52.5 21.4 51.3 59.8 37.2 156.7 36.7 40.9 257.8 110.0 145.4 85.1 132.6 92.9 126.7 109.6 101.5 95.1 104.8 120.4 114.4 239.4 109.6 128.0 131.6 112.9 157.1 96.4 107.1 103.1 148.1 90.1 99.6 107.9 104.9 106.4 109.6 109.2 112.8 213.2 157.0 150.5 11.4 211.3 315.5 292.0 809.1 132.1 79.1 198.4 191.9 544.4 158.7 456.3 222.5 25.0 321.5 228.9 117.0 383.5 288.5 38.1 272.5 148.7 245.6 68.4 78.6 22.2 179.1 403.9 215.0 46.4 134.3 186.1 108.0 234.9 446.4 317.4 153.1 21.6 170.2 408.9 303.5 298.4 31.0 167.4 244.9 199.3 16.9 423.9 233.4 253.3 6.6 16.3 207.6 196.8 215.5 239.0 392.5 500.1 1070.2 542.7 78.9 197.2 145.8 246.0 182.7 67.0 245.9 346.6 445.7 203.2 150.3 135.8 428.1 C9orf16 "EST00098, FLJ12823, MGC4639" ENSG00000171159 "Chromosome 9 open reading frame 16" Q9BUW7 9 128160265-128163924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 325.2" "Cell type enhanced" "Detected in all" "Late spermatids: 869.5;Urothelial cells: 938.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020725 Uncertain Approved Microtubules NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Microtubules "HPA020725: AB_1845816" "unprognostic (8.85e-2)" "prognostic favorable (7.60e-4)" "prognostic unfavorable (9.91e-4)" "unprognostic (6.42e-3)" "unprognostic (3.98e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.13e-5)" "unprognostic (8.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-3)" "unprognostic (2.13e-1)" "unprognostic (3.09e-3)" "unprognostic (4.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.00e-3)" "unprognostic (2.48e-2)" 81.3 325.2 174.9 22.8 145.7 66.8 75.7 96.3 295.9 75.5 121.4 62.8 24.4 67.0 9.3 89.0 53.3 27.8 78.3 314.3 114.6 85.4 63.0 59.0 41.2 123.0 114.2 42.4 93.6 18.5 81.6 12.8 136.5 93.4 8.9 5.9 100.1 32.7 41.8 160.6 52.8 13.1 107.4 88.8 64.0 51.7 148.2 41.6 53.5 11.7 22.2 108.2 100.1 154.2 36.4 48.0 26.9 150.2 18.0 39.7 63.1 34.2 27.9 27.7 21.9 23.9 95.4 41.0 67.6 14.9 6.7 103.5 7.5 27.3 1.5 77.0 60.7 29.2 57.3 48.7 31.5 32.6 72.0 30.0 39.8 14.5 7.2 21.9 39.5 111.9 78.5 79.4 15.1 210.4 109.0 139.0 60.4 74.2 89.1 102.0 17.9 170.7 35.7 31.9 67.1 98.9 60.8 54.1 74.0 6.5 60.8 30.1 48.2 28.9 69.4 37.3 30.0 76.5 61.5 63.8 80.1 45.9 29.4 221.4 119.4 205.0 155.7 105.1 169.6 168.8 178.4 153.3 135.4 178.0 139.9 144.2 138.0 165.9 92.5 144.4 254.8 142.0 174.9 145.7 96.3 295.9 314.3 114.6 123.0 114.2 136.5 107.4 148.2 154.2 146.3 6.4 4.8 11.8 149.7 197.2 356.6 519.8 124.1 77.1 265.6 298.3 33.9 108.7 199.9 355.0 14.6 97.1 209.8 291.7 309.1 223.8 162.2 100.5 88.4 151.9 407.8 139.5 26.4 354.5 88.3 103.8 77.5 120.2 162.0 112.7 133.2 106.4 247.4 18.5 19.2 254.0 193.3 247.3 251.6 869.5 76.7 203.1 224.1 9.4 236.7 91.4 311.0 8.0 11.6 223.6 233.9 83.1 129.0 281.5 131.2 224.9 93.7 46.1 72.3 58.1 197.3 30.7 82.9 142.3 233.4 60.3 215.2 155.3 205.9 938.8 CAPNS1 "30K, CANP, CANPS, CAPN4, CDPS" ENSG00000126247 "Calpain small subunit 1" P04632 19 36139953-36150353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006872 Approved Approved Nucleoplasm,Cytosol NA NA 9000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "HPA006872: AB_1078382" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.03e-1)" "unprognostic (2.82e-3)" "unprognostic (1.25e-3)" "unprognostic (2.04e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-1)" "unprognostic (5.53e-2)" "unprognostic (7.10e-3)" "unprognostic (1.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-2)" 425.4 357.9 363.0 171.4 374.4 235.7 371.7 359.4 507.1 368.1 353.9 371.4 263.2 303.5 193.8 761.7 306.6 197.8 692.5 379.8 411.1 488.5 273.5 396.7 167.4 401.0 392.3 267.6 250.9 330.9 317.9 147.3 401.0 357.0 287.6 136.2 374.9 281.4 491.3 211.9 341.4 290.0 356.5 363.6 311.1 273.6 400.3 200.8 329.9 373.4 275.1 354.8 402.5 384.1 395.2 977.6 240.0 342.7 566.3 683.0 48.2 315.8 673.4 631.3 488.1 223.3 572.2 141.9 463.7 1067.5 225.6 207.0 291.3 780.8 514.7 592.4 142.9 166.0 259.7 373.0 655.0 166.7 393.9 740.8 477.9 411.1 577.5 767.3 699.8 173.5 204.4 554.4 978.6 522.7 295.4 301.4 137.9 754.6 490.6 156.5 194.7 262.3 1208.8 368.7 159.1 199.4 385.1 532.0 155.5 279.4 308.6 261.4 460.6 555.5 424.3 188.1 318.7 198.4 277.6 126.8 630.4 225.9 480.8 24.8 50.1 22.6 44.4 75.6 28.5 29.4 30.9 36.4 46.1 32.3 18.7 25.2 25.2 24.6 83.4 58.7 34.7 21.1 363.0 374.4 359.4 507.1 379.8 411.1 401.0 392.3 401.0 356.5 400.3 384.1 172.7 125.0 98.6 10.4 49.3 30.7 76.2 69.1 29.6 21.1 91.7 75.1 149.5 130.1 85.9 163.7 0.0 74.9 107.1 250.1 62.6 226.3 102.9 168.5 118.3 136.6 107.8 47.3 13.4 251.3 87.8 83.3 66.8 234.4 63.4 84.7 157.1 78.4 155.1 16.8 11.9 220.3 52.9 244.6 86.9 230.2 93.2 130.5 39.2 15.9 208.4 78.2 109.2 6.6 21.9 254.2 187.5 76.0 50.2 98.0 243.5 135.3 74.6 33.1 46.0 64.3 92.9 120.1 6.5 109.1 28.8 70.1 62.8 132.2 165.6 112.4 CARMIL3 "BC008134, C14orf121, crml-1, LRRC16B" ENSG00000186648 "Capping protein regulator and myosin 1 linker 3" Q8ND23 14 24052009-24069729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.6;pituitary gland: 8.1;skin 1: 3.9;testis: 2.2" "Cell type enhanced" "Detected in single" "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 5.5;HMC-1: 3.7;Karpas-707: 3.3;SCLC-21H: 5.4;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030596 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "HPA030596: AB_10603012" "unprognostic (2.67e-2)" "unprognostic (2.07e-3)" "unprognostic (1.50e-1)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (1.29e-4)" "unprognostic (6.13e-2)" "unprognostic (8.92e-4)" "unprognostic (4.02e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-4)" "unprognostic (4.49e-2)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-2)" "unprognostic (4.19e-1)" "unprognostic (2.16e-1)" 0.1 0.3 2.0 0.3 1.5 0.2 0.3 3.6 2.1 0.3 0.0 0.5 0.5 0.2 0.0 0.6 0.1 0.3 0.1 1.9 1.3 0.7 0.2 0.3 0.3 2.0 1.4 0.1 0.7 0.0 8.1 0.0 2.0 0.3 0.1 1.0 0.6 0.0 0.0 3.9 0.7 0.0 0.5 0.5 0.3 2.2 1.9 0.1 0.5 0.0 0.4 0.1 0.5 1.8 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.2 0.8 0.0 0.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 5.4 2.6 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.5 3.6 2.1 1.9 1.3 2.0 1.4 2.0 0.5 1.9 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 CBR3 SDR21C2 ENSG00000159231 "Carbonyl reductase 3" O75828 21 36135079-36146562 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 56.3;salivary gland: 41.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 102.5;Basal squamous epithelial cells: 107.0;Peritubular cells: 75.6;Squamous epithelial cells: 230.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 9 "B-cells: 23.9;NK-cells: 11.5;T-cells: 33.7" "Cell line enhanced" "Detected in many" "RPMI-8226: 64.9" "Region enhanced" "Detected in all" "basal ganglia: 48.6" "Low region specificity" "Detected in many" HPA018434 Uncertain Supported Nucleoplasm,Cytosol Yes NA 2800000 "Cluster 30: Non-specific - Translation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Cytosol" "HPA018434: AB_1846110" "unprognostic (3.64e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.22e-2)" "unprognostic (6.12e-2)" "unprognostic (2.98e-2)" "unprognostic (3.75e-1)" "unprognostic (9.10e-2)" "prognostic unfavorable (5.95e-6)" "unprognostic (3.13e-1)" "unprognostic (1.80e-1)" "unprognostic (3.99e-3)" "unprognostic (1.94e-1)" 17.3 2.3 12.8 4.0 14.7 1.4 15.3 13.9 19.8 12.4 11.2 7.8 3.0 7.5 11.0 56.3 8.8 6.5 6.1 13.2 12.4 2.7 0.8 4.6 2.9 12.8 12.1 11.2 1.6 0.6 2.4 2.9 12.3 9.9 3.6 0.6 41.4 5.1 3.1 21.6 5.4 6.1 12.0 3.1 5.2 3.1 12.2 2.0 4.6 7.8 7.6 11.6 16.8 12.4 33.5 9.5 4.0 8.2 31.0 47.8 5.9 35.4 42.4 40.6 32.1 0.4 6.9 0.0 10.2 37.2 13.7 15.0 5.5 7.2 16.2 45.3 17.2 1.4 10.0 0.3 2.6 0.1 0.1 6.8 0.8 28.1 3.6 19.1 24.9 3.7 0.0 0.3 12.1 25.4 3.1 14.7 3.2 10.3 41.5 6.7 7.6 64.9 13.7 14.2 2.1 2.9 27.3 32.6 53.3 2.2 9.8 3.9 17.1 25.7 2.2 28.8 35.0 1.5 0.6 0.0 26.9 0.9 47.3 0.0 0.6 0.1 2.2 0.5 3.0 23.6 25.1 7.7 2.4 23.9 33.7 23.5 0.9 11.5 1.0 0.7 10.9 11.5 12.8 14.7 13.9 19.8 13.2 12.4 12.8 12.1 12.3 12.0 12.2 12.4 41.7 0.0 3.2 6.8 5.2 71.0 22.1 102.5 107.0 0.8 23.1 38.6 0.2 2.8 23.0 0.0 0.0 1.2 2.9 1.9 9.8 4.7 0.7 13.1 7.5 26.5 0.0 1.7 3.9 0.7 0.3 53.4 7.7 14.7 5.7 1.1 14.3 0.3 8.4 0.0 5.5 12.6 69.2 3.8 41.3 4.0 67.7 5.8 65.8 2.8 20.9 1.9 0.0 1.5 0.5 2.6 1.7 75.6 1.4 43.4 1.3 0.2 13.1 0.6 0.0 21.4 19.7 0.4 0.2 230.4 46.7 0.3 7.0 1.0 8.1 21.1 CCDC137 MGC16597 ENSG00000185298 "Coiled-coil domain containing 137" Q6PK04 17 81666737-81673904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052637, HPA053914" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitotic chromosome" "HPA052637: AB_2681894, HPA053914: AB_2682306" "unprognostic (3.04e-1)" "unprognostic (5.82e-2)" "unprognostic (1.76e-1)" "unprognostic (3.07e-2)" "unprognostic (1.68e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (8.32e-4)" "unprognostic (2.21e-2)" "unprognostic (8.33e-3)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (4.26e-2)" "unprognostic (2.01e-1)" "unprognostic (3.93e-1)" "unprognostic (1.39e-1)" 8.2 9.5 13.8 12.3 13.7 17.7 7.6 13.5 17.5 10.7 14.2 9.3 11.4 7.5 5.5 23.1 7.8 6.1 6.5 13.7 13.8 10.2 10.8 7.7 16.3 14.4 14.3 6.7 8.2 7.0 6.2 7.7 14.7 11.7 5.8 2.8 9.9 6.4 7.7 22.8 10.7 6.0 13.4 15.6 8.8 10.4 14.5 11.8 7.8 4.5 11.5 9.8 13.8 14.3 38.0 62.8 21.5 35.3 13.9 13.1 35.2 41.6 19.7 53.0 30.6 55.1 22.8 33.8 22.4 21.2 36.6 47.9 34.5 43.8 30.6 19.4 51.7 51.6 30.1 48.0 20.7 46.6 37.5 19.8 26.3 47.6 26.3 14.6 37.4 41.1 53.3 19.1 28.3 34.5 45.7 56.6 46.9 32.9 59.8 55.4 34.6 24.1 19.8 29.6 45.1 57.7 41.1 87.8 37.1 28.9 58.8 48.3 27.8 82.0 53.5 34.9 65.9 53.1 28.7 36.8 30.8 42.9 48.8 2.2 7.7 11.7 11.5 9.6 6.3 10.4 8.7 8.8 7.5 13.2 9.2 8.8 3.3 13.1 11.9 12.9 9.8 5.9 13.8 13.7 13.5 17.5 13.7 13.8 14.4 14.3 14.7 13.4 14.5 14.3 17.9 22.4 17.0 5.9 29.8 31.7 22.8 19.7 74.6 6.8 17.4 13.7 6.7 15.7 20.9 12.9 2.1 25.7 31.5 19.7 19.6 25.2 1.7 26.5 32.9 20.3 7.2 37.5 4.5 21.4 41.0 16.5 29.0 29.4 19.6 28.1 15.4 11.8 24.3 18.5 4.6 17.0 14.2 12.9 11.5 1.7 13.7 16.8 16.0 4.7 24.2 13.8 37.0 4.0 5.0 35.2 16.0 13.5 25.7 40.0 12.4 15.9 21.6 9.1 6.6 13.7 22.3 30.8 44.9 57.0 34.4 20.8 29.7 22.8 22.4 24.2 CCDC160 ENSG00000203952 "Coiled-coil domain containing 160" A6NGH7 X 134237047-134246207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 16.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 45.0;Early spermatids: 14.8;Endometrial ciliated cells: 28.1;Respiratory ciliated cells: 36.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 29.7;RPTEC TERT1: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (7.45e-3)" "unprognostic (2.79e-2)" "prognostic favorable (2.31e-4)" "unprognostic (1.98e-1)" "unprognostic (5.11e-4)" "unprognostic (4.22e-2)" "unprognostic (2.07e-2)" "prognostic favorable (7.62e-6)" "unprognostic (3.32e-2)" "unprognostic (4.51e-2)" "prognostic favorable (2.21e-4)" "unprognostic (5.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.44e-3)" 0.2 0.0 2.2 0.1 2.2 0.2 3.9 2.8 2.7 2.9 3.9 0.2 0.0 0.7 1.7 0.4 3.3 1.1 0.1 2.2 2.4 6.0 0.0 0.4 0.5 2.5 2.5 1.3 0.5 5.1 0.6 0.2 2.7 1.8 0.1 1.0 16.5 2.6 1.0 0.3 0.0 0.0 2.1 0.4 1.0 2.0 2.3 0.0 0.2 0.0 0.1 0.5 0.3 2.6 0.0 0.0 29.7 2.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 8.3 2.4 0.0 0.1 0.0 0.3 0.4 2.9 3.7 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.2 2.8 2.7 2.2 2.4 2.5 2.5 2.7 2.1 2.3 2.6 0.2 0.0 0.0 5.5 0.0 0.0 1.0 9.3 0.6 0.3 9.6 9.0 0.5 1.5 10.2 9.2 0.0 0.0 0.0 0.0 45.0 3.2 14.8 28.1 0.5 0.3 0.0 0.0 0.4 0.0 0.3 0.8 0.0 2.5 0.0 0.8 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.6 0.1 1.8 1.0 0.0 6.9 0.0 6.0 5.6 0.2 0.0 0.4 0.0 1.8 0.0 7.7 36.0 0.6 0.0 0.7 0.6 6.7 10.1 2.3 0.0 0.0 0.1 0.1 0.0 1.4 CCDC190 "C1orf110, MGC48998" ENSG00000185860 "Coiled-coil domain containing 190" Q86UF4 1 162824458-162868815 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 2.3;choroid plexus: 1.0;esophagus: 3.3;lung: 1.8" "Cell type enriched" "Detected in some" 4 "Respiratory ciliated cells: 26.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 3.9;hTERT-RPE1: 4.8;HUVEC TERT2: 4.8;LHCN-M2: 7.3;TIME: 16.7;U-2197: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028579, HPA028584, HPA028592" Uncertain Approved Vesicles NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001" "unprognostic (4.29e-1)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (8.33e-3)" "unprognostic (3.04e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (7.41e-5)" "unprognostic (2.64e-1)" "unprognostic (1.52e-1)" "unprognostic (5.26e-1)" "unprognostic (1.70e-1)" 0.1 0.1 0.9 0.0 1.0 0.0 0.0 0.3 1.0 0.1 1.0 0.0 0.0 0.1 0.3 3.3 0.5 0.4 0.5 1.4 2.1 0.0 0.0 1.8 0.0 1.6 2.1 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.5 0.0 0.1 0.3 2.3 0.0 0.1 0.1 0.4 0.1 0.0 2.3 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 3.9 2.4 4.8 4.8 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.4 0.0 8.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.3 1.0 1.4 2.1 1.6 2.1 1.0 0.5 2.3 2.3 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.6 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 26.2 0.0 0.0 0.4 0.5 0.1 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.5 CCER2 ENSG00000262484 "Coiled-coil glutamate rich protein 2" I3L3R5 19 38908980-38912158 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "Melanocytes: 617.2" "Group enriched" "Detected in many" 5 "glioma: 5.1;testis cancer: 1.9;urothelial cancer: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.4;THP-1: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069716 Uncertain "Secreted - unknown location" NA NA 8800 "Cluster 27: Brain & Skin - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" "HPA069716: AB_2686183" "unprognostic (6.58e-2)" "unprognostic (2.24e-2)" "unprognostic (5.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (2.76e-3)" "unprognostic (3.88e-2)" "unprognostic (2.16e-1)" "unprognostic (5.97e-2)" "unprognostic (1.45e-1)" "unprognostic (4.08e-3)" "unprognostic (3.82e-2)" "unprognostic (1.01e-9)" "unprognostic (1.75e-2)" "unprognostic (3.87e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.32e-4)" 0.5 0.6 2.2 0.2 2.4 0.7 0.8 2.3 3.4 1.2 1.8 0.9 0.3 0.7 0.3 1.2 1.1 0.1 0.9 2.3 2.2 1.8 2.9 0.5 0.3 2.9 2.2 0.7 0.5 0.2 2.5 0.1 2.4 1.4 0.1 1.0 0.9 0.2 2.3 4.2 0.9 0.1 2.1 1.1 0.6 4.9 2.2 0.4 1.2 0.0 0.1 0.9 0.8 2.4 0.1 1.4 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.6 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.9 0.2 0.9 0.0 0.9 0.2 0.4 0.3 0.0 0.2 0.7 0.1 0.2 0.1 0.6 0.4 0.2 0.1 0.1 0.0 0.1 1.0 1.4 0.0 0.0 0.7 0.0 0.0 0.6 0.5 0.2 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.4 2.3 3.4 2.3 2.2 2.9 2.2 2.4 2.1 2.2 2.4 0.1 3.2 0.0 3.9 0.1 76.9 0.1 0.1 0.0 2.5 0.4 0.5 0.4 1.5 0.1 1.8 4.2 0.4 0.4 0.3 0.0 0.0 1.4 0.3 0.2 0.6 1.2 0.4 2.3 0.0 0.1 0.8 0.0 0.5 0.0 0.3 0.0 0.6 0.2 0.0 3.3 0.2 0.0 0.3 7.2 4.9 0.3 0.2 617.2 0.0 0.0 1.3 0.0 3.5 2.2 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.4 3.8 0.0 0.4 0.7 1.1 2.1 0.0 3.0 0.3 0.4 0.2 0.6 0.1 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958423-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 8.0" "Cell type enhanced" "Detected in many" "Astrocytes: 17.9;Club cells: 18.7;Oligodendrocytes: 14.9;Respiratory ciliated cells: 39.6;Syncytiotrophoblasts: 14.9" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 36.4" "Low region specificity" "Detected in some" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: AB_2680091" "unprognostic (2.42e-1)" "prognostic favorable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favorable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.9 0.4 1.0 0.3 1.5 1.0 0.8 1.2 2.0 2.0 0.3 0.7 0.4 0.6 0.4 3.4 2.0 0.4 0.7 0.9 1.8 0.5 0.3 2.1 0.4 1.6 1.7 0.3 0.5 0.3 1.7 0.4 1.5 8.0 0.3 0.4 2.0 0.5 1.0 0.6 0.8 0.4 0.6 0.8 1.2 0.7 1.9 0.9 0.6 0.3 3.0 2.7 1.3 2.6 0.0 0.7 0.2 0.0 0.6 0.2 0.4 0.2 0.0 0.1 0.0 0.8 0.8 0.1 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.1 7.9 0.1 0.1 0.0 0.3 0.3 0.1 1.1 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.1 0.0 0.0 0.7 0.1 36.4 0.8 0.1 0.4 0.2 0.1 0.4 0.2 0.4 0.2 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.0 1.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.5 1.2 2.0 0.9 1.8 1.6 1.7 1.5 0.6 1.9 2.6 4.3 6.4 6.1 17.9 0.1 0.1 1.2 6.6 0.0 0.5 1.6 0.5 0.7 0.0 18.7 0.0 0.0 1.7 0.0 0.2 0.0 0.0 3.2 2.1 0.4 2.1 0.0 2.5 9.3 0.0 0.0 0.3 0.0 0.4 1.3 0.0 0.7 0.1 0.6 0.0 8.4 0.0 6.1 1.3 0.4 1.7 0.0 1.4 0.0 7.5 0.6 0.2 1.0 7.1 14.9 0.0 0.0 0.0 0.4 10.9 0.2 0.1 39.6 0.0 0.0 0.5 2.4 0.9 0.2 0.2 0.0 14.9 0.2 0.1 0.2 7.4 CDRT15 ENSG00000223510 "CMT1A duplicated region transcript 15" Q96T59 17 14235673-14236862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 20.9" "Group enriched" "Detected in some" 24 "Early spermatids: 117.5;Late spermatids: 88.5;Spermatocytes: 43.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 3.8" HPA055952 Uncertain Approved "Plasma membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane" "HPA055952: AB_2682983" "unprognostic (3.27e-2)" "unprognostic (1.77e-2)" "unprognostic (8.61e-2)" "unprognostic (9.33e-2)" "unprognostic (5.15e-3)" "unprognostic (2.90e-1)" "unprognostic (6.16e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-3)" "unprognostic (2.66e-1)" "unprognostic (2.55e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-7)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (6.81e-2)" "unprognostic (2.38e-2)" 0.1 0.4 0.1 1.2 0.2 0.6 0.1 1.4 0.5 0.2 0.4 0.2 0.7 0.2 0.2 0.3 0.1 0.4 0.3 0.3 0.0 0.1 0.4 0.3 2.7 0.6 0.1 0.4 0.2 0.0 0.1 0.1 0.6 0.2 0.0 0.4 0.7 0.0 0.1 3.3 0.8 0.0 0.1 0.9 0.4 20.9 0.2 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.7 1.3 0.9 2.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 2.5 0.3 2.1 0.4 0.0 0.3 0.9 0.0 0.0 0.0 2.1 3.8 1.2 2.6 1.8 0.0 1.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 1.0 1.0 0.4 0.0 0.5 1.0 1.6 0.8 1.5 1.2 0.8 0.3 0.8 0.0 1.0 1.0 1.8 0.2 0.5 0.3 2.7 0.4 0.5 1.1 3.2 0.4 0.8 0.9 0.7 0.8 0.9 0.5 1.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 1.4 0.5 0.3 0.0 0.6 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.5 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CELSR2 "ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3" ENSG00000143126 "Cadherin EGF LAG seven-pass G-type receptor 2" Q9HCU4 1 109249539-109275751 "G-protein coupled receptors, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.8" "Cell type enhanced" "Detected in many" "Horizontal cells: 97.6;Oligodendrocytes: 48.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 8 "amygdala: 13.3;basal ganglia: 21.6;cerebral cortex: 44.6;hippocampal formation: 50.8;white matter: 26.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 47.9;HaCaT: 48.4;MCF7: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013952 Uncertain Approved Cytosol NA NA 1300000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA013952: AB_1846518" "unprognostic (4.46e-3)" "unprognostic (1.07e-2)" "unprognostic (3.00e-2)" "unprognostic (4.71e-2)" "unprognostic (2.19e-1)" "unprognostic (5.30e-2)" "unprognostic (3.51e-2)" "unprognostic (2.98e-1)" "unprognostic (1.33e-1)" "unprognostic (1.59e-2)" "unprognostic (1.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.94e-2)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-2)" "unprognostic (5.16e-2)" 0.9 1.4 13.3 0.5 21.6 0.3 4.1 0.1 44.6 5.6 0.0 2.9 0.8 2.2 3.1 13.9 16.1 1.1 5.2 50.8 0.0 4.7 0.6 1.1 0.7 4.1 0.6 0.6 3.8 6.0 2.9 0.9 1.0 3.0 0.7 5.7 5.6 7.9 8.9 24.7 1.1 1.6 0.6 0.4 2.0 9.4 1.5 1.2 9.1 4.0 2.4 1.9 9.4 26.6 14.0 12.8 47.9 8.9 0.1 0.0 13.0 1.6 1.1 2.9 0.8 2.0 0.4 2.5 10.9 1.0 2.2 48.4 12.5 7.8 1.5 0.3 5.3 1.1 11.8 2.8 1.0 0.8 6.2 0.2 18.5 1.2 0.8 10.8 0.5 7.7 8.5 0.6 0.0 56.6 1.4 0.7 15.7 1.6 2.5 12.8 4.4 0.7 10.3 4.7 19.5 9.2 7.6 16.2 10.1 11.3 15.3 3.1 0.0 0.0 8.5 0.8 12.4 3.2 1.0 0.7 2.6 1.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 21.6 0.1 44.6 50.8 0.0 4.1 0.6 1.0 0.6 1.5 26.6 0.9 9.6 5.0 15.0 0.2 15.7 5.1 19.7 9.6 13.2 16.4 16.3 13.5 2.8 11.3 18.4 4.2 2.2 1.9 1.3 1.9 2.6 5.1 12.8 1.4 1.5 1.8 0.0 34.0 0.4 1.3 1.2 2.6 17.7 1.3 5.5 0.4 7.1 1.1 97.6 27.7 0.9 2.0 0.8 3.4 9.3 3.4 0.9 10.6 5.6 1.0 29.9 3.1 24.6 48.1 1.5 0.5 19.2 0.4 4.3 0.2 3.1 8.4 5.2 6.6 5.0 4.9 1.6 6.8 31.0 22.9 0.5 1.5 0.0 2.0 6.9 CENPT "C16orf56, CENP-T, FLJ13111" ENSG00000102901 "Centromere protein T" Q96BT3 16 67828157-67847811 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Spermatocytes: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041220, HPA058036" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA041220: AB_2677367, HPA058036: AB_2683585" "unprognostic (9.84e-2)" "unprognostic (2.86e-2)" "unprognostic (3.04e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (6.66e-3)" "unprognostic (1.18e-2)" "unprognostic (2.81e-1)" "unprognostic (8.04e-2)" "unprognostic (3.15e-2)" "prognostic favorable (2.96e-4)" "unprognostic (6.64e-3)" "prognostic unfavorable (1.57e-7)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (9.74e-3)" 7.0 5.6 7.2 3.1 7.1 5.3 6.4 7.4 10.0 7.9 5.7 8.1 2.4 7.0 1.4 6.6 7.3 1.8 8.0 7.4 7.8 6.3 5.3 6.3 3.6 7.5 7.3 7.7 9.6 4.9 4.3 4.2 7.6 6.5 2.0 0.8 5.8 4.3 8.2 24.8 6.3 4.7 6.8 5.5 7.4 19.6 7.3 4.4 5.1 5.6 2.3 7.3 6.9 7.2 7.6 7.4 10.0 10.2 8.1 7.8 14.7 29.5 13.6 30.2 24.1 7.9 5.6 3.3 7.1 19.8 5.3 12.4 7.5 13.2 10.3 5.3 9.5 1.2 3.2 11.3 5.1 0.6 6.9 8.5 7.7 20.7 4.4 4.4 12.3 8.1 19.3 3.6 14.5 11.9 9.8 10.7 13.5 5.9 7.1 13.4 4.5 17.6 11.2 3.1 3.9 6.8 22.2 4.6 5.8 6.3 6.1 10.0 9.7 4.3 7.4 6.6 7.0 7.0 5.8 19.4 3.3 6.1 7.4 1.4 7.2 6.3 6.5 6.6 7.0 4.9 6.0 8.2 6.0 6.1 5.3 7.0 3.4 5.4 4.3 6.0 8.5 5.1 7.2 7.1 7.4 10.0 7.4 7.8 7.5 7.3 7.6 6.8 7.3 7.2 21.0 16.0 11.3 10.4 17.4 21.0 20.2 24.4 12.5 24.9 20.3 19.3 8.2 14.3 17.2 20.2 8.4 31.5 25.4 27.5 5.9 19.0 52.2 8.8 17.8 19.7 13.1 30.3 16.9 14.2 25.0 23.0 34.1 11.2 8.2 20.9 17.5 9.4 15.2 25.2 12.3 11.3 24.4 8.5 17.8 47.9 24.2 17.9 17.8 7.5 9.8 13.7 21.6 12.1 8.4 19.7 17.8 22.2 26.9 11.1 16.3 10.3 12.2 10.5 26.3 19.9 25.1 89.8 33.5 12.8 19.5 30.1 22.6 24.3 13.7 13.6 CGB2 ENSG00000104818 "Chorionic gonadotropin subunit beta 2" Q6NT52 19 49031890-49033238 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Cell type enriched" "Detected in some" 6 "Syncytiotrophoblasts: 40.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 29.9;U-266/70: 12.1;U-266/84: 15.6" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.05e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.8 0.7 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 4.1 0.0 0.5 0.0 0.1 0.3 0.0 29.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.3 0.8 0.0 3.9 12.1 15.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.2 0.2 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.5 1.8 0.0 0.0 40.0 0.0 0.0 0.0 0.0 CHMP1A "CHMP1, KIAA0047, PCOLN3, PRSM1, Vps46A" ENSG00000131165 "Charged multivesicular body protein 1A" Q9HD42 16 89640816-89657738 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transcription, Transcription regulation, Transport" Repressor Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA006776 Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Centrosome, Cytosol" "HPA006776: AB_1078520" "unprognostic (7.12e-2)" "unprognostic (1.64e-2)" "unprognostic (1.08e-1)" "unprognostic (1.41e-2)" "unprognostic (7.29e-2)" "unprognostic (8.03e-3)" "unprognostic (1.28e-3)" "unprognostic (3.92e-3)" "unprognostic (2.42e-1)" "unprognostic (3.53e-1)" "unprognostic (2.21e-1)" "unprognostic (2.56e-1)" "unprognostic (7.98e-3)" "unprognostic (1.59e-2)" "unprognostic (4.19e-2)" "unprognostic (3.24e-1)" "unprognostic (1.73e-1)" 30.3 31.2 46.3 21.1 44.5 31.4 29.4 41.2 53.4 34.3 36.9 42.7 37.8 35.8 17.0 65.4 31.6 24.8 33.1 46.8 42.7 36.6 30.6 28.7 27.5 45.3 44.3 25.0 25.7 30.4 24.8 24.7 44.0 33.5 23.0 5.4 31.8 22.1 50.0 48.7 42.5 22.4 44.3 31.6 34.0 37.3 45.7 30.5 28.3 25.9 24.3 35.6 36.9 44.2 70.5 66.3 29.5 46.2 42.2 38.2 75.3 53.0 54.3 79.3 38.7 97.1 111.5 37.7 53.2 70.1 52.9 88.3 52.6 69.7 36.7 34.2 82.7 31.0 23.4 108.5 57.8 23.0 31.7 54.7 75.6 74.6 33.8 42.7 41.2 46.2 69.9 18.2 45.6 141.4 55.1 88.3 58.1 78.6 63.5 60.1 58.3 39.8 60.4 43.0 52.7 70.8 103.5 34.3 38.1 27.5 117.6 48.5 63.1 52.7 61.6 65.3 45.8 52.1 59.1 51.1 88.1 54.9 62.5 66.7 51.6 108.9 54.4 62.7 42.0 36.3 43.6 50.1 44.2 33.4 27.5 33.4 86.0 49.8 82.3 49.4 58.5 64.1 46.3 44.5 41.2 53.4 46.8 42.7 45.3 44.3 44.0 44.3 45.7 44.2 31.1 32.1 23.6 17.3 27.5 23.8 24.5 28.8 13.1 24.6 33.9 27.6 16.8 28.6 26.6 31.3 8.4 57.7 43.2 147.3 37.2 55.3 56.4 27.2 26.3 28.3 44.3 16.2 8.8 59.5 74.4 26.9 36.2 35.0 27.9 33.0 23.2 31.1 47.6 43.7 7.9 57.7 30.5 30.4 23.8 125.5 20.5 28.3 23.2 11.2 62.8 36.3 43.3 11.1 9.5 84.7 121.6 24.0 14.8 31.7 109.6 40.9 22.4 20.5 26.3 17.1 27.1 45.4 33.3 26.3 32.5 66.2 28.6 28.8 58.2 36.5 CLEC12B ENSG00000256660 "C-type lectin domain family 12 member B" Q2HXU8 12 10010627-10018796 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 5.1;skin 1: 4.2;testis: 13.1" "Cell type enriched" "Detected in some" 5 "Melanocytes: 80.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "GAMG: 2.8;U-937: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (2.08e-2)" "unprognostic (4.81e-2)" "unprognostic (3.60e-1)" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (3.36e-3)" "unprognostic (4.14e-4)" "unprognostic (7.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-5)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" "unprognostic (5.48e-1)" "unprognostic (8.95e-4)" 0.4 0.0 0.0 0.5 0.1 5.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.8 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 4.2 0.1 0.1 0.0 1.6 0.1 13.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.8 9.5 0.3 2.2 80.0 0.0 2.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.0 CLN8 "C8orf61, EPMR, FLJ39417, TLCD6" ENSG00000182372 "CLN8 transmembrane ER and ERGIC protein" Q9UBY8 8 1755778-1801711 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 136.8;Syncytiotrophoblasts: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 76.7" "Lineage enriched" "Detected in all" 5 "dendritic cells: 76.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (5.86e-2)" "unprognostic (1.95e-2)" "unprognostic (6.40e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (4.05e-3)" "unprognostic (1.21e-1)" "unprognostic (3.45e-1)" "unprognostic (3.03e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-3)" "unprognostic (1.83e-1)" "prognostic favorable (4.36e-8)" "unprognostic (1.36e-1)" "unprognostic (1.70e-1)" "unprognostic (6.24e-2)" "unprognostic (8.38e-2)" 5.4 5.2 11.4 3.7 15.7 9.1 4.3 14.6 12.4 4.7 6.6 4.9 5.0 3.2 11.2 9.8 3.3 7.5 6.2 10.6 11.3 6.2 8.9 8.9 6.5 18.2 15.2 2.5 10.1 8.0 3.5 6.0 18.5 3.8 4.4 3.8 5.1 3.6 5.9 13.2 6.3 4.0 16.9 7.9 6.8 5.9 15.1 3.2 5.1 3.3 7.2 4.4 5.8 24.3 3.6 8.5 6.2 6.5 8.3 8.4 14.8 8.3 5.1 4.2 5.2 8.6 10.0 4.4 2.3 8.2 5.6 13.7 4.9 15.6 8.6 3.3 3.6 4.4 3.2 4.9 4.7 3.7 19.1 8.4 12.2 5.8 4.1 10.1 9.2 3.2 6.0 2.6 13.1 9.0 6.0 3.2 6.1 14.0 7.3 4.2 4.3 3.4 7.8 15.4 3.2 3.9 3.5 8.1 4.6 12.7 16.2 4.2 17.3 11.3 3.2 0.9 5.2 1.5 5.4 5.0 11.4 7.3 16.9 7.4 10.6 4.7 6.4 13.6 7.1 10.3 6.9 4.5 10.6 14.0 6.7 4.4 3.7 5.1 12.5 76.7 8.0 6.4 11.4 15.7 14.6 12.4 10.6 11.3 18.2 15.2 18.5 16.9 15.1 24.3 18.3 9.6 17.5 6.2 30.1 54.7 71.6 38.6 26.7 27.6 23.4 13.2 7.7 20.0 37.2 31.3 31.3 38.0 115.3 28.5 15.6 27.2 5.4 20.5 6.9 34.7 19.7 40.8 7.4 19.0 18.0 32.7 13.7 37.2 27.3 17.1 27.8 28.5 44.1 40.4 7.6 17.5 50.8 54.6 136.8 5.9 8.1 69.8 21.4 8.4 22.3 13.9 23.7 10.1 27.1 19.3 20.7 12.0 9.1 76.5 19.5 10.6 27.1 26.1 13.1 22.5 16.8 34.4 23.5 20.1 63.5 131.6 22.0 16.1 15.4 61.2 CLTB Lcb ENSG00000175416 "Clathrin light chain B" P09497 5 176392501-176416539 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 1839.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 704.2;MCF7: 641.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003692, HPA036458" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles "Plasma membrane, Cytosol" "CAB003692: AB_425372, HPA036458: AB_2675136" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (4.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (1.83e-2)" "unprognostic (1.74e-2)" "unprognostic (1.93e-1)" "unprognostic (7.42e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.89e-5)" "unprognostic (3.55e-1)" "unprognostic (7.50e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-2)" 102.9 133.6 125.8 50.1 125.1 40.6 82.9 117.8 176.7 180.4 125.3 133.9 92.3 85.9 23.2 473.7 82.4 34.1 320.8 130.8 129.6 90.4 82.5 96.5 32.9 136.9 122.8 107.2 68.2 70.1 112.8 57.5 138.1 88.1 45.5 37.9 128.6 44.4 322.5 453.1 99.7 41.2 114.5 68.7 123.3 38.9 127.9 43.7 69.5 120.8 58.5 106.2 300.8 133.6 229.1 107.6 29.9 128.2 65.7 49.2 244.4 286.3 110.9 178.6 127.0 140.3 103.9 49.6 165.0 130.2 71.8 213.3 51.4 704.2 69.7 341.7 95.3 33.6 163.3 87.7 102.9 53.2 85.6 52.6 241.5 98.1 114.7 36.0 84.7 39.2 65.2 123.4 100.3 641.9 84.5 81.1 24.4 189.5 158.2 91.3 52.9 165.2 95.6 92.0 127.7 43.7 136.6 148.0 103.6 34.7 61.4 101.9 185.2 64.0 96.3 117.5 165.1 96.5 73.3 68.5 51.4 112.7 74.4 6.6 19.7 61.7 13.6 15.8 7.0 5.9 11.9 13.2 20.0 10.1 10.0 10.0 36.6 15.0 20.8 16.1 24.9 8.1 125.8 125.1 117.8 176.7 130.8 129.6 136.9 122.8 138.1 114.5 127.9 133.6 113.7 57.7 19.8 8.5 54.7 634.0 238.7 155.7 180.4 310.5 105.5 124.6 208.5 72.9 93.4 82.8 64.6 141.1 82.3 794.5 135.0 324.7 9.5 58.4 72.7 102.2 151.8 43.6 25.4 453.1 586.9 136.7 193.2 85.2 48.2 40.8 70.3 96.3 111.9 336.5 24.1 348.5 114.0 80.7 226.1 13.7 122.1 88.4 220.5 6.5 85.7 136.1 107.1 8.0 15.2 1839.9 786.9 129.8 76.4 391.4 545.7 269.7 49.6 64.3 78.9 79.6 161.4 15.9 29.1 415.6 803.0 386.5 81.3 151.2 289.7 436.0 CNTNAP3 "CASPR3, CNTNAP3A, FLJ14195, KIAA1714" ENSG00000106714 "Contactin associated protein family member 3" Q9BZ76 9 39072767-39288315 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 26.1;Excitatory neurons: 18.6;Hepatic stellate cells: 30.0;Inhibitory neurons: 103.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "neutrophil: 7.3" "Lineage enriched" "Detected in single" 74 "granulocytes: 7.3" "Cell line enhanced" "Detected in many" "A549: 18.9;AF22: 22.5;TIME: 14.5;WM-115: 37.9" HPA047731 Uncertain "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA047731: AB_2680137" "unprognostic (9.06e-3)" "unprognostic (3.07e-2)" "unprognostic (5.74e-2)" "unprognostic (7.89e-2)" "unprognostic (7.03e-2)" "unprognostic (2.33e-3)" "unprognostic (4.58e-2)" "unprognostic (1.34e-2)" "unprognostic (1.51e-1)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.15e-2)" "unprognostic (1.20e-1)" "unprognostic (1.95e-3)" "unprognostic (1.93e-3)" 2.7 0.4 4.8 0.5 7.6 1.2 3.2 0.4 2.7 1.3 2.7 4.0 0.8 0.6 0.5 7.2 2.2 1.2 4.0 5.0 3.3 1.8 0.8 1.1 0.3 0.9 5.4 0.3 0.4 0.1 1.1 1.6 0.9 1.5 1.3 2.7 3.4 1.4 0.4 7.2 1.8 2.3 0.1 2.6 0.6 1.8 1.7 2.5 1.2 0.7 0.6 1.0 2.5 2.8 1.1 18.9 22.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 1.4 4.7 1.9 4.4 0.0 0.0 1.6 0.0 5.2 0.5 0.2 0.3 0.0 0.5 4.1 0.0 1.7 9.4 8.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.9 0.2 5.7 0.0 0.6 5.4 0.4 0.8 2.1 0.7 6.7 0.0 3.7 2.4 0.0 3.2 14.5 0.0 2.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 4.8 7.6 0.4 2.7 5.0 3.3 0.9 5.4 0.9 0.1 1.7 2.8 8.0 3.2 1.7 26.1 0.0 6.2 4.0 1.8 18.2 1.3 0.9 3.0 3.5 4.3 1.5 1.8 2.1 0.8 0.0 0.1 0.0 0.4 1.9 1.4 0.7 7.5 3.5 0.0 18.6 0.2 2.5 1.2 0.0 0.2 0.0 0.1 30.0 1.3 0.1 0.0 103.1 0.3 0.0 1.6 0.8 0.9 0.3 0.2 0.0 13.1 0.0 10.5 0.0 3.0 13.3 0.7 0.0 0.0 1.2 1.4 0.0 1.9 4.1 0.7 0.0 0.5 0.9 1.7 8.8 10.4 7.7 0.7 0.4 0.0 0.1 2.7 CNTNAP3B ENSG00000154529 "Contactin associated protein family member 3B" Q96NU0 9 41890314-42129510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 69.6;Hepatic stellate cells: 91.8;Inhibitory neurons: 161.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 38 "granulocytes: 3.7" "Cell line enhanced" "Detected in many" "A549: 29.9;AF22: 41.8;WM-115: 28.5" HPA047731 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA047731: AB_2680137" "unprognostic (2.68e-2)" "unprognostic (9.63e-3)" "unprognostic (2.20e-2)" "unprognostic (2.87e-1)" "unprognostic (1.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.20e-3)" "unprognostic (5.70e-2)" "unprognostic (2.27e-1)" "unprognostic (7.20e-2)" "unprognostic (3.74e-3)" "unprognostic (1.64e-1)" "unprognostic (7.74e-2)" "unprognostic (5.78e-3)" "unprognostic (7.93e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-4)" 8.9 1.6 6.1 1.4 10.0 0.3 10.1 2.9 6.3 3.7 6.4 8.6 1.4 2.5 0.7 9.3 5.0 2.5 5.7 7.1 7.4 7.0 2.6 3.4 1.0 4.7 9.0 1.1 1.5 0.4 2.9 3.8 4.4 2.8 2.8 6.3 6.6 2.1 1.6 8.8 3.7 3.2 2.5 3.8 2.1 1.9 5.1 2.4 2.1 1.6 1.1 3.2 4.2 3.4 0.2 29.9 41.8 0.0 1.3 0.5 0.1 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.1 0.6 3.7 2.4 2.3 0.0 0.1 1.3 0.0 5.4 2.6 0.9 1.4 0.0 3.3 3.4 0.4 0.5 10.4 7.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 4.1 1.0 9.0 0.0 0.7 11.9 1.4 0.8 3.0 0.3 1.1 0.0 5.8 1.3 0.0 4.2 7.4 0.2 2.8 0.1 0.8 0.0 0.0 0.0 0.0 1.3 28.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 6.1 10.0 2.9 6.3 7.1 7.4 4.7 9.0 4.4 2.5 5.1 3.4 69.6 0.0 6.3 34.6 0.6 4.2 7.8 2.4 15.4 2.6 3.9 11.8 7.1 4.3 1.2 3.7 0.0 3.1 0.3 0.3 0.0 2.1 2.0 2.8 0.3 35.0 1.8 2.7 34.6 3.3 2.1 6.2 0.0 1.3 1.3 0.4 91.8 7.5 0.1 0.0 161.6 1.6 6.1 3.8 0.8 1.4 0.9 0.5 5.4 33.7 0.0 27.9 0.0 8.0 1.3 2.0 0.0 0.7 0.0 3.2 0.0 9.7 11.1 1.0 0.0 0.7 3.6 0.8 7.0 8.4 5.3 0.7 0.7 0.2 0.1 6.0 CSNK2A2 "CK2alpha', CSNK2A1" ENSG00000070770 "Casein kinase 2 alpha 2" P19784 16 58157907-58198106 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 112.7" "Group enriched" "Detected in all" 5 "Early spermatids: 227.4;Late spermatids: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 92000 "Cluster 46: Basophils - DNA binding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" "unprognostic (9.49e-2)" "unprognostic (1.87e-1)" "unprognostic (5.45e-2)" "unprognostic (1.23e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.40e-5)" "prognostic unfavorable (1.80e-4)" "unprognostic (6.84e-3)" "unprognostic (2.93e-3)" "unprognostic (2.40e-1)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (2.06e-3)" "unprognostic (7.07e-2)" "unprognostic (3.23e-1)" "unprognostic (3.14e-2)" 21.0 14.1 19.3 9.0 20.2 6.4 19.0 18.9 22.1 23.0 23.7 32.1 10.0 21.0 29.0 15.7 20.3 14.1 21.2 20.0 19.7 17.3 15.9 16.2 14.2 19.1 20.4 32.4 34.2 23.9 15.7 15.5 19.2 15.5 12.4 13.5 17.0 16.7 41.1 64.8 14.2 21.9 19.8 12.6 27.9 112.7 20.3 18.3 18.0 26.8 17.3 24.2 19.6 19.9 28.1 35.3 24.5 19.1 46.2 62.5 27.6 24.7 41.8 47.7 30.7 64.0 23.2 44.2 38.8 29.6 18.9 29.2 41.6 37.2 53.4 16.9 28.3 23.4 18.0 56.1 66.5 32.6 20.5 66.9 88.9 33.8 65.9 62.0 45.4 43.6 53.4 15.1 31.0 15.8 41.2 21.9 23.4 16.6 45.7 48.4 38.7 25.7 33.1 28.7 20.5 18.4 39.7 20.3 63.6 41.9 13.9 24.6 33.6 27.8 33.7 23.3 25.7 36.2 30.2 63.2 24.3 21.8 24.4 1.1 0.2 0.3 0.7 0.1 0.4 0.6 1.1 0.4 0.2 0.6 1.8 1.3 0.0 0.7 0.1 1.9 0.0 0.1 19.3 20.2 18.9 22.1 20.0 19.7 19.1 20.4 19.2 19.8 20.3 19.9 30.6 12.8 22.5 19.2 16.7 29.6 10.9 13.0 8.6 24.0 19.3 19.9 24.4 12.8 7.6 9.2 4.2 15.9 28.3 16.4 7.9 14.5 227.4 24.7 37.8 25.8 16.8 10.3 27.7 17.2 26.1 17.7 8.6 29.5 8.2 37.0 19.6 17.0 16.9 18.5 19.1 11.9 4.1 25.5 23.0 281.0 14.3 23.1 12.4 20.6 14.2 25.3 18.6 20.6 26.1 25.0 11.5 19.5 9.2 18.1 16.0 16.3 13.4 21.7 13.1 29.2 23.2 48.1 36.8 12.6 29.0 24.5 20.3 35.6 17.5 23.0 CYP26B1 P450RAI-2 ENSG00000003137 "Cytochrome P450 family 26 subfamily B member 1" Q9NR63 2 72129238-72147862 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;skin 1: 31.4" "Group enriched" "Detected in many" 4 "Leydig cells: 75.8;Peritubular cells: 229.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 9.8;HaCaT: 14.8;RH-30: 18.4;U-2 OS: 19.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012567 Uncertain Approved Cytosol "Intracellular and membrane" No No "Cluster 27: Brain & Skin - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "HPA012567: AB_1847429" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (2.19e-4)" "unprognostic (3.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.17e-4)" "unprognostic (8.41e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (7.55e-3)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.55e-1)" "unprognostic (9.44e-3)" "unprognostic (2.04e-2)" 26.2 4.3 12.0 1.9 3.3 0.1 15.0 12.3 7.0 5.0 0.4 3.2 3.7 2.5 1.5 3.9 5.5 1.1 8.5 6.7 1.3 8.8 1.0 2.7 4.9 48.0 10.4 4.5 0.6 0.8 9.3 3.3 49.9 2.6 1.2 4.2 9.9 7.3 5.9 31.4 4.7 1.6 0.0 3.5 1.2 13.8 0.7 19.3 14.4 2.3 2.9 3.2 4.2 3.5 0.6 5.9 0.0 0.1 9.8 4.0 5.9 0.9 0.1 0.2 0.2 1.8 0.5 0.0 0.5 0.7 3.0 14.8 8.5 0.0 0.1 0.0 2.7 0.0 7.0 0.9 0.2 0.0 0.3 0.0 0.5 0.0 0.3 3.0 1.1 4.0 0.6 0.1 0.9 2.9 0.0 0.1 0.0 0.1 1.0 0.1 18.4 0.0 0.0 1.3 0.6 0.1 3.0 0.0 3.5 1.2 0.3 0.9 0.0 1.6 19.3 9.0 3.0 0.1 1.2 0.0 6.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 3.3 12.3 7.0 6.7 1.3 48.0 10.4 49.9 0.0 0.7 3.5 2.4 0.0 0.0 2.0 1.2 14.7 1.1 0.8 0.6 0.2 2.3 0.8 1.4 4.3 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.2 4.1 0.2 0.2 19.0 1.8 5.3 5.3 0.0 0.9 15.6 0.0 0.3 0.0 1.5 34.6 0.8 0.1 0.0 0.7 0.0 0.0 6.1 19.1 9.6 75.8 0.4 7.2 0.0 0.0 7.4 0.0 2.0 0.5 0.4 1.5 229.9 0.0 0.5 0.2 0.1 0.2 0.3 0.0 5.7 20.7 1.5 3.8 1.6 9.7 0.1 0.8 7.5 0.1 0.4 DAZ3 ENSG00000187191 "Deleted in azoospermia 3" Q9NR90 Y 24763069-24813492 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047113 Approved NA NA "Cluster 27: Brain & Skin - Unknown function" "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DBI "ACBD1, ACBP" ENSG00000155368 "Diazepam binding inhibitor, acyl-CoA binding protein" P07108 2 119366921-119372560 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 2215.1;Proximal tubular cells: 2834.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 2479.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051428 Approved NA NA 9100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" "HPA051428: AB_2681482" "unprognostic (1.24e-1)" "prognostic favorable (5.77e-5)" "unprognostic (4.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.71e-2)" "unprognostic (1.92e-2)" "unprognostic (7.28e-3)" "unprognostic (1.70e-3)" "unprognostic (1.71e-1)" "unprognostic (2.85e-2)" "unprognostic (1.45e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (1.03e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (1.45e-1)" 358.3 153.9 486.0 158.7 470.8 121.9 717.3 495.6 726.7 218.6 452.3 322.8 312.8 73.5 653.7 667.7 85.8 129.7 515.4 493.0 498.5 536.2 971.1 236.0 182.9 499.4 495.1 86.0 143.8 866.9 76.9 116.3 510.0 451.5 297.3 116.3 369.9 215.1 273.0 451.0 229.6 97.2 512.7 115.5 185.1 201.3 487.6 173.3 133.7 460.5 324.5 136.5 327.7 516.4 543.0 276.9 557.1 257.2 1339.7 1131.9 350.7 281.3 708.7 387.0 746.1 580.6 427.8 747.3 312.1 440.6 938.5 277.9 397.0 588.3 345.9 498.2 262.1 641.4 279.9 775.8 335.6 206.1 2479.2 648.2 376.5 596.2 222.1 255.4 464.3 358.8 77.0 679.2 558.8 559.1 436.5 585.9 370.2 349.7 429.7 157.4 541.4 658.5 948.1 816.5 263.2 210.1 235.3 548.5 634.9 388.8 338.0 952.8 332.5 259.3 329.8 288.8 346.3 220.9 170.5 610.0 365.7 364.8 315.3 1180.7 439.9 1077.9 472.9 489.1 347.3 461.4 367.8 465.2 748.8 505.3 279.1 419.2 285.8 450.7 402.5 791.0 615.7 792.2 486.0 470.8 495.6 726.7 493.0 498.5 499.4 495.1 510.0 512.7 487.6 516.4 505.2 150.6 613.0 46.0 256.7 289.2 249.4 724.2 190.1 37.9 806.5 1025.9 1079.6 663.4 390.0 310.8 14.6 796.5 395.6 737.5 1197.4 466.9 844.4 154.8 194.7 206.2 371.3 108.8 5.2 670.3 643.2 258.2 243.1 185.6 433.4 219.4 167.8 2215.1 1069.4 30.3 3.9 495.0 524.9 305.0 785.7 325.7 152.2 476.1 1058.3 15.0 871.5 928.6 552.0 33.2 25.0 372.7 612.0 127.5 192.0 355.0 753.6 2834.8 340.5 59.1 151.2 267.2 289.9 462.0 30.1 972.6 684.9 516.3 260.8 456.0 673.2 361.0 DCST1 FLJ32785 ENSG00000163357 "DC-STAMP domain containing 1" Q5T197 1 155033824-155050930 "Enzymes, Predicted membrane proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 2.6;skin 1: 3.1;testis: 6.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 12.5;Early spermatids: 37.0;Late spermatids: 18.8;Rod photoreceptor cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;HeLa: 2.2;RPMI-8226: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060314 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA060314: AB_2684250" "unprognostic (1.44e-1)" "unprognostic (7.66e-2)" "unprognostic (3.77e-2)" "unprognostic (1.05e-4)" "unprognostic (3.58e-2)" "unprognostic (8.75e-4)" "unprognostic (1.46e-2)" "unprognostic (2.66e-1)" "unprognostic (6.01e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.89e-2)" "unprognostic (8.33e-15)" "unprognostic (7.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.38e-1)" "unprognostic (1.23e-1)" 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.3 0.0 0.0 3.1 0.8 0.0 0.0 0.1 0.2 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.3 1.1 0.6 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 1.4 0.7 0.2 0.0 0.3 2.1 0.0 0.0 0.0 0.5 0.1 0.1 2.2 0.1 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.4 0.0 0.1 0.1 0.1 0.9 0.0 0.4 2.4 0.0 0.3 0.3 0.7 0.2 0.8 0.1 0.4 1.5 0.0 0.0 0.1 0.1 0.3 0.1 0.4 0.4 0.1 0.3 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 1.0 0.2 0.0 0.7 0.0 1.3 0.0 12.5 0.0 0.0 0.0 0.0 0.0 37.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 18.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 6.6 0.0 0.0 0.1 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 DGCR2 "DGS-C, IDD, KIAA0163, LAN, SEZ-12" ENSG00000070413 "DiGeorge syndrome critical region gene 2" P98153 22 19036282-19122454 "Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000873 Uncertain NA NA 84000 "Cluster 5: Granulocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA000873: AB_1847632" "unprognostic (1.68e-1)" "unprognostic (4.27e-2)" "unprognostic (4.03e-2)" "unprognostic (1.33e-2)" "unprognostic (6.28e-2)" "unprognostic (8.51e-2)" "unprognostic (1.05e-1)" "unprognostic (6.86e-2)" "unprognostic (2.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (2.06e-2)" "prognostic favorable (8.72e-7)" "unprognostic (3.63e-2)" "unprognostic (2.29e-1)" "unprognostic (6.27e-2)" "unprognostic (6.28e-3)" 25.3 28.6 45.7 14.9 40.4 7.4 26.4 34.6 48.9 30.0 24.7 34.0 26.2 32.9 12.9 46.5 27.7 19.0 33.6 44.1 42.8 31.1 30.6 28.6 16.8 45.2 43.3 35.9 44.6 26.3 33.1 16.4 43.6 34.7 16.0 9.1 33.7 23.5 27.2 61.3 28.8 15.6 38.3 25.5 30.2 25.3 52.0 16.7 39.8 19.5 12.5 31.2 32.1 38.6 43.2 26.5 32.6 58.3 57.9 23.2 31.8 28.3 34.8 27.2 26.8 45.7 47.9 22.7 38.7 30.7 19.4 79.7 24.2 27.2 11.4 19.4 44.4 15.3 16.0 37.0 35.1 28.8 33.4 33.3 61.6 21.1 24.3 23.4 30.3 14.2 115.6 19.3 14.0 45.0 15.2 31.0 27.3 67.8 19.1 26.5 34.4 8.9 46.2 46.8 44.4 32.8 52.1 36.0 32.6 17.6 33.5 25.9 27.0 50.0 25.6 26.3 23.1 21.5 8.5 14.9 23.7 16.5 38.9 9.5 10.3 16.5 6.1 5.3 5.3 4.3 6.5 6.1 6.8 4.7 7.8 6.4 23.5 4.6 3.9 4.0 9.5 11.3 45.7 40.4 34.6 48.9 44.1 42.8 45.2 43.3 43.6 38.3 52.0 38.6 16.4 19.2 27.0 34.3 10.0 9.7 10.8 17.1 17.6 30.1 23.4 20.6 18.0 30.0 23.3 27.6 14.6 17.2 9.5 59.7 0.0 24.9 13.7 9.6 11.2 13.7 19.9 4.2 35.7 21.9 19.0 13.5 27.0 16.9 8.2 24.5 21.4 27.3 12.1 37.0 43.7 30.3 18.3 18.5 4.7 22.2 17.1 10.4 8.8 22.5 16.4 18.5 11.3 54.8 32.6 30.9 24.0 22.6 11.1 18.8 27.7 10.6 14.0 23.0 13.1 14.4 15.1 12.6 12.9 22.1 12.4 10.8 11.8 17.7 28.4 16.8 DKK4 ENSG00000104371 "Dickkopf WNT signaling pathway inhibitor 4" Q9UBT3 8 42374063-42377229 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;esophagus: 4.9" "Group enriched" "Detected in some" 5 "Basal prostatic cells: 5.2;Early spermatids: 2.1;Pancreatic endocrine cells: 4.4;Prostatic glandular cells: 3.7;Spermatocytes: 2.2;Urothelial cells: 5.3" "Cancer enriched" "Detected in many" 20 "endometrial cancer: 174.4" "Group enriched" "Detected in some" 4 "cerebellum: 3.7;midbrain: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "OE19: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA052916 Uncertain "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA052916: AB_2681987" "unprognostic (1.64e-1)" "unprognostic (5.84e-2)" "unprognostic (1.97e-1)" "unprognostic (5.37e-3)" "unprognostic (3.23e-1)" "unprognostic (2.91e-2)" "unprognostic (2.13e-2)" "unprognostic (1.99e-1)" "unprognostic (6.80e-2)" "unprognostic (2.71e-2)" "unprognostic (1.63e-2)" "unprognostic (6.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (8.11e-2)" 0.2 0.0 0.0 0.0 0.0 0.1 0.8 3.7 0.1 1.0 0.0 0.0 2.4 0.0 0.7 4.9 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 3.1 0.0 0.0 0.0 0.9 0.0 0.6 0.1 0.0 0.1 0.9 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.8 1.4 0.5 0.3 0.0 0.0 0.4 1.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.7 3.1 0.6 0.0 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.3 5.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.1 0.3 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.2 0.1 0.4 0.0 0.0 0.0 0.0 0.1 5.3 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.3;prostate: 12.9;skin 1: 12.7" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 96.9;Basal respiratory cells: 56.8;Basal squamous epithelial cells: 64.3;Breast myoepithelial cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 24.1;HBEC3-KT: 13.1;hTCEpi: 38.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No "Cluster 40: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 0.8 0.5 3.8 0.7 4.5 0.9 2.9 6.9 7.0 2.9 1.8 0.4 0.4 0.6 2.0 12.3 0.6 0.3 1.7 4.4 4.2 0.5 0.7 0.5 0.9 2.7 2.6 1.1 0.8 0.1 0.8 0.6 2.7 12.9 0.0 0.6 8.1 5.2 0.2 12.7 0.6 0.1 2.6 0.7 0.4 1.0 3.5 2.3 0.7 0.0 0.9 0.8 6.7 3.2 7.9 2.8 0.8 11.3 0.0 0.6 2.5 2.8 3.0 3.1 1.4 2.7 0.4 1.5 1.7 0.5 3.8 24.1 8.0 13.1 0.7 1.5 3.0 0.6 1.5 4.2 0.8 0.5 1.6 1.3 38.5 0.9 7.1 1.0 0.0 4.5 0.7 1.1 1.2 3.0 0.6 0.6 1.0 3.0 2.9 1.6 1.4 0.7 0.4 2.6 8.3 0.8 0.9 0.3 0.4 0.6 0.7 2.4 0.8 1.1 3.6 0.8 5.6 1.8 0.4 2.5 0.1 1.1 0.8 0.3 0.1 0.1 0.1 0.0 0.8 0.1 0.5 0.5 0.0 0.2 0.2 0.1 0.2 0.8 0.1 0.5 0.0 0.1 3.8 4.5 6.9 7.0 4.4 4.2 2.7 2.6 2.7 2.6 3.5 3.2 0.3 0.0 0.5 0.3 0.4 10.1 96.9 56.8 64.3 1.3 0.6 26.7 0.6 0.0 6.0 0.0 0.0 1.3 0.5 0.0 0.0 0.1 0.3 0.1 3.0 0.7 1.2 0.0 6.1 0.0 2.7 0.4 0.0 0.2 0.0 4.7 0.0 0.0 0.1 11.8 2.8 0.0 2.0 0.0 0.4 0.5 0.3 0.6 1.8 2.8 0.0 0.6 0.0 3.0 0.9 0.1 0.0 0.0 0.1 12.9 0.0 0.0 1.1 1.2 0.0 0.5 1.1 1.7 7.0 6.7 2.6 0.3 1.3 0.4 0.0 8.3 DLX2 TES-1 ENSG00000115844 "Distal-less homeobox 2" Q07687 2 172099438-172102900 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.0" "Cell type enhanced" "Detected in some" "dendritic cells: 6.5;Early spermatids: 6.9;Gastric mucus-secreting cells: 5.6;Inhibitory neurons: 10.0;Melanocytes: 5.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "hypothalamus: 3.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "AN3-CA: 79.7;HEK 293: 50.8" "Region enhanced" "Detected in many" "olfactory bulb: 29.4" "Region enriched" "Detected in many" 5 "olfactory bulb: 23.2" HPA056965 Approved "Nuclear speckles" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear speckles" "HPA056965: AB_2683291" "unprognostic (8.12e-2)" "unprognostic (3.56e-1)" "unprognostic (2.48e-2)" "unprognostic (1.28e-2)" "unprognostic (4.07e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (3.03e-2)" "unprognostic (2.41e-1)" "unprognostic (8.74e-2)" "unprognostic (3.53e-2)" "unprognostic (3.01e-1)" "unprognostic (6.69e-10)" "unprognostic (9.38e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-1)" "unprognostic (7.95e-3)" 0.0 0.3 1.4 0.0 1.1 0.1 0.2 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 79.7 0.5 0.3 2.2 4.3 1.0 0.7 0.2 0.5 0.2 0.0 2.4 2.0 3.8 4.1 2.6 0.3 0.2 0.1 50.8 1.3 8.8 2.0 0.2 0.4 0.3 0.0 3.7 0.1 0.5 0.3 0.0 2.0 0.6 0.0 0.5 0.2 0.1 0.6 0.1 0.0 1.1 0.0 0.4 0.0 0.1 0.1 2.8 0.0 2.1 1.2 5.0 1.3 0.6 0.4 0.4 5.5 0.0 3.0 0.5 0.1 0.1 0.5 4.7 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.0 0.9 0.4 3.0 0.0 0.0 0.0 0.0 0.5 0.1 1.4 0.0 0.0 0.0 1.3 1.8 0.2 0.9 0.6 0.0 3.1 3.6 0.4 0.0 0.2 0.0 0.0 0.4 6.5 1.0 0.0 0.0 6.9 1.6 0.3 0.5 0.0 0.0 0.1 0.0 0.3 0.2 5.6 1.1 0.0 0.0 0.0 0.0 0.5 0.0 10.0 1.1 0.0 0.0 0.3 0.1 0.0 1.8 5.4 1.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.4 0.1 1.3 0.0 0.1 0.0 0.0 0.3 1.5 0.9 0.7 1.6 0.0 0.4 1.5 0.2 0.6 0.0 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423443 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.6;esophagus: 1.5;pituitary gland: 2.0;testis: 1.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.9;Basal squamous epithelial cells: 17.6;Early spermatids: 10.8;Squamous epithelial cells: 5.9" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Region enhanced" "Detected in single" "white matter: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;HBEC3-KT: 3.3;RH-30: 11.7;SH-SY5Y: 2.4;SiHa: 2.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 61: Squamous epithelial cells - Keratinization" Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: AB_2684911" "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 1.4 0.0 0.9 3.3 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 2.4 2.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.4 0.3 0.2 0.6 0.5 0.3 0.2 0.8 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 17.6 0.0 0.1 0.0 1.3 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 10.8 0.1 0.1 0.1 1.2 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.2 1.3 1.0 5.9 0.0 0.0 0.0 0.0 0.1 0.0 DUSP14 "MKP-L, MKP6" ENSG00000276023 "Dual specificity phosphatase 14" O95147 17 37489891-37513501 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 44.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 179.7;Basal prostatic cells: 239.3;Cytotrophoblasts: 162.8;Endometrial ciliated cells: 146.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBF TERT88: 36.4;SuSa: 24.9;WM-115: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019911 Approved Approved Nucleoplasm,Cytosol NA Yes 79000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Cytosol" "HPA019911: AB_1847888" "unprognostic (1.32e-1)" "unprognostic (3.06e-1)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (4.60e-1)" "unprognostic (3.22e-2)" "unprognostic (3.43e-3)" "unprognostic (2.02e-3)" "unprognostic (2.18e-1)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (3.81e-1)" "prognostic unfavorable (6.97e-9)" "unprognostic (7.93e-2)" "unprognostic (1.97e-1)" "unprognostic (1.73e-1)" "unprognostic (1.41e-3)" 15.3 14.2 10.9 1.3 11.2 0.3 12.4 11.2 17.0 12.8 10.9 10.3 0.0 9.5 5.5 17.4 7.5 1.2 14.1 11.0 10.9 8.7 15.2 8.6 0.4 11.9 11.1 5.6 6.6 1.0 14.5 0.9 10.6 6.4 1.0 9.9 13.1 0.3 11.0 44.1 5.5 0.8 10.4 2.8 7.6 13.7 10.8 4.4 23.1 4.4 2.7 7.2 17.1 10.7 2.6 0.2 4.9 2.1 0.1 0.6 2.1 10.4 7.8 14.3 15.6 1.2 17.9 0.2 0.9 7.6 0.2 2.8 0.2 6.1 36.4 0.2 0.7 0.0 1.6 6.2 1.5 0.5 3.0 8.5 5.5 4.8 2.5 10.2 0.3 0.2 0.6 3.1 11.4 0.4 9.7 1.7 0.3 3.8 0.0 2.5 0.6 2.5 17.5 2.4 1.9 0.3 0.5 17.6 4.1 24.9 0.8 3.9 1.4 10.8 5.8 0.1 5.8 0.1 0.3 0.1 0.1 0.0 37.5 1.1 0.0 0.7 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.7 1.6 0.0 0.2 0.0 0.0 0.2 10.9 11.2 11.2 17.0 11.0 10.9 11.9 11.1 10.6 10.4 10.8 10.7 15.0 6.4 5.4 2.9 8.3 179.7 239.3 74.8 129.1 6.8 42.6 46.0 15.0 4.3 39.6 7.3 8.4 162.8 16.6 0.3 29.4 34.8 36.4 146.9 18.5 21.7 2.4 11.4 12.0 15.1 82.1 30.2 3.1 85.3 87.0 10.6 14.6 15.7 19.7 15.2 5.3 1.2 36.7 2.8 34.8 52.5 13.7 5.9 62.2 4.7 25.3 16.1 15.5 3.0 3.3 74.8 2.9 6.0 9.9 64.9 0.1 16.9 61.3 24.5 0.0 13.2 45.2 26.0 33.4 44.0 92.6 67.9 18.2 26.3 1.1 67.0 DUSP7 "MKP-X, PYST2" ENSG00000164086 "Dual specificity phosphatase 7" Q16829 3 52048919-52056571 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 117.3;Squamous epithelial cells: 51.6;Suprabasal keratinocytes: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "hTCEpi: 109.8;hTERT-HME1: 92.6" "Low region specificity" "Detected in all" HPA073007 Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 28: Keratinocytes - Keratinization" "HPA073007: " "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (6.16e-3)" "unprognostic (2.32e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-1)" "unprognostic (8.67e-3)" "unprognostic (7.38e-3)" "unprognostic (7.74e-3)" "prognostic unfavorable (8.84e-6)" "unprognostic (4.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.29e-2)" "unprognostic (9.46e-2)" 13.1 10.0 23.3 7.6 28.4 3.6 11.5 19.5 27.5 27.0 7.5 8.4 4.1 14.6 3.9 64.1 10.1 8.7 22.2 24.2 21.2 10.6 5.2 24.9 10.2 25.8 27.2 8.7 7.0 6.2 7.2 14.1 22.3 11.5 3.8 2.6 13.2 7.9 23.1 65.6 7.9 6.7 19.5 26.2 9.1 12.0 27.2 8.1 9.1 20.5 10.8 13.5 45.5 38.4 21.3 4.4 5.2 11.9 16.4 14.1 6.2 21.0 39.8 20.4 14.7 5.8 10.6 5.8 5.7 31.3 10.3 24.6 19.8 76.0 13.8 5.0 8.1 27.8 10.9 10.3 13.3 25.1 16.2 14.8 109.8 26.5 92.6 14.1 19.8 16.8 16.2 16.4 16.5 5.9 18.7 35.2 12.9 5.9 37.6 15.5 4.5 15.6 8.5 9.1 6.5 19.0 9.4 8.5 14.9 4.2 3.0 59.4 26.0 39.1 25.3 41.7 65.4 7.9 7.9 9.3 21.7 41.5 12.7 0.9 3.4 1.7 5.3 10.3 7.2 0.9 6.3 3.8 4.7 0.5 4.5 4.1 1.3 2.5 10.3 7.1 4.5 1.7 23.3 28.4 19.5 27.5 24.2 21.2 25.8 27.2 22.3 19.5 27.2 38.4 17.0 9.6 1.1 0.0 2.9 117.3 31.5 13.5 21.1 4.9 6.6 7.2 18.9 0.0 5.2 0.0 0.0 0.6 13.4 1.6 1.9 3.1 1.7 2.9 8.1 18.7 2.4 1.7 5.5 2.6 4.3 7.8 0.5 2.8 0.0 1.3 23.6 0.9 8.1 0.0 4.4 2.5 0.0 16.7 12.0 0.5 8.7 9.0 21.4 5.6 10.3 0.9 9.2 5.5 20.2 12.1 1.3 4.9 1.6 17.5 0.6 1.3 1.5 1.0 26.3 3.3 8.6 3.5 5.5 51.6 135.2 1.2 7.3 4.1 3.4 29.3 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA Yes 890000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 268.6 261.9 912.5 186.7 967.7 126.8 268.0 895.2 1292.9 354.2 894.7 325.8 162.8 319.4 322.3 719.9 544.2 242.7 257.5 975.4 944.7 352.6 238.4 222.6 241.6 896.1 898.5 247.0 225.1 228.2 309.7 259.2 914.2 225.9 327.4 181.3 245.4 264.6 85.6 626.7 206.3 390.1 935.1 185.2 244.5 360.3 909.7 306.5 176.1 163.9 357.8 389.8 474.4 1001.2 721.6 811.4 779.2 600.8 677.1 713.6 250.8 968.0 451.6 785.6 466.7 770.8 472.3 400.6 510.3 945.1 753.0 629.6 949.3 818.3 781.0 528.3 617.9 390.4 532.9 1062.5 676.2 412.8 620.5 436.2 863.0 584.6 477.5 855.7 831.8 421.5 502.0 446.1 1056.8 960.1 541.4 894.8 642.2 917.7 935.7 543.0 403.0 499.2 1143.1 659.8 535.2 392.0 789.3 677.7 926.6 812.6 673.6 595.3 635.2 592.3 502.1 525.6 852.2 264.0 562.8 404.6 656.8 645.1 776.6 516.6 291.9 384.2 200.6 303.3 155.3 310.4 207.2 211.7 281.8 219.0 132.0 165.7 50.1 282.9 334.8 461.6 373.5 353.0 912.5 967.7 895.2 1292.9 975.4 944.7 896.1 898.5 914.2 935.1 909.7 1001.2 810.1 195.5 101.9 79.3 341.4 922.2 359.1 1275.0 356.8 138.4 800.0 949.4 170.8 303.1 764.6 399.1 83.4 524.6 484.1 689.9 1113.2 691.2 1407.2 1842.5 528.5 541.9 480.8 332.9 111.2 538.9 897.4 538.5 240.5 488.1 316.7 611.9 521.9 499.0 732.1 85.8 62.8 801.6 1121.0 329.4 706.1 4098.6 516.6 466.3 595.9 42.2 701.6 164.0 248.2 47.3 156.4 754.9 798.6 701.8 234.9 304.7 533.4 1125.0 2679.6 193.5 368.1 440.7 1016.3 961.5 721.4 1005.4 1610.1 1006.6 396.6 586.3 498.2 389.6 DYNLT3 "TCTE1L, TCTEX1L" ENSG00000165169 "Dynein light chain Tctex-type 3" P51808 X 37836757-37847571 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 738.3;Glandular and luminal cells: 265.2;Late spermatids: 445.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003938 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 44: Endometrium - Transcription" "HPA003938: AB_1847920" "unprognostic (1.27e-1)" "unprognostic (5.14e-2)" "unprognostic (1.00e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (4.77e-4)" "unprognostic (1.13e-1)" "unprognostic (5.15e-3)" "unprognostic (6.91e-2)" "unprognostic (2.72e-1)" "unprognostic (2.37e-1)" "unprognostic (3.59e-2)" "unprognostic (1.88e-1)" "unprognostic (3.65e-3)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" "unprognostic (2.72e-1)" "unprognostic (2.69e-2)" 29.0 60.8 25.9 17.7 27.7 27.1 24.4 26.4 35.1 33.3 22.4 23.7 12.1 32.7 25.4 63.6 18.7 37.4 32.0 30.4 39.1 50.3 44.9 24.7 14.7 35.0 33.4 23.0 13.9 40.3 23.4 26.4 38.1 27.2 22.2 33.1 19.2 27.7 12.6 11.4 14.9 37.2 26.5 18.4 23.5 16.9 30.1 14.8 26.5 18.2 21.9 32.8 30.7 26.6 48.2 13.9 1.4 0.1 58.1 67.0 7.5 32.0 35.0 17.7 29.2 25.8 25.2 16.9 15.5 65.5 51.2 18.9 20.1 27.5 34.8 28.7 23.4 13.4 66.0 13.6 29.1 0.0 9.5 29.3 38.4 43.2 19.1 53.0 55.3 0.0 6.9 23.9 82.5 15.7 0.4 20.8 8.1 24.7 69.2 24.0 0.1 27.9 32.4 34.7 30.8 13.1 58.9 12.0 97.7 2.8 14.7 14.3 29.8 36.7 19.9 43.0 36.7 15.9 15.4 19.7 88.8 22.0 46.4 20.6 9.5 7.3 17.2 14.0 35.9 17.5 24.0 22.9 6.3 12.3 20.5 20.2 7.6 16.5 8.7 7.3 14.7 14.7 25.9 27.7 26.4 35.1 30.4 39.1 35.0 33.4 38.1 26.5 30.1 26.6 62.0 38.5 28.9 6.2 37.8 15.4 121.8 48.7 10.8 28.2 38.9 20.8 31.8 25.8 46.8 64.4 2.1 12.5 31.9 26.0 133.1 53.8 738.3 80.4 75.6 47.4 55.7 8.6 22.9 46.9 29.1 64.7 42.8 265.2 87.6 15.4 42.8 34.0 38.2 70.7 24.8 18.4 85.5 31.5 80.0 445.7 44.1 42.5 42.7 12.2 49.0 57.2 28.8 7.1 7.6 102.1 28.0 103.4 22.9 116.7 20.2 143.6 53.0 50.8 39.5 53.2 81.6 13.1 5.8 74.7 22.7 45.4 68.0 27.4 17.7 118.8 EFNA3 "Ehk1-L, EPLG3, LERK3" ENSG00000143590 "Ephrin A3" P52797 1 155078837-155087538 "Predicted membrane proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.9;skin 1: 102.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 63.2;Basal squamous epithelial cells: 44.3;Extravillous trophoblasts: 30.0;Squamous epithelial cells: 32.6;Suprabasal keratinocytes: 108.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 46.3;SCLC-21H: 26.8;T-47d: 25.3" "Low region specificity" "Detected in all" CAB010494 Uncertain NA NA "Cluster 15: NK-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 28: Keratinocytes - Keratinization" "CAB010494: AB_2097783" "unprognostic (3.75e-2)" "unprognostic (1.53e-2)" "unprognostic (1.56e-2)" "unprognostic (1.51e-2)" "unprognostic (3.88e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.86e-2)" "unprognostic (3.56e-1)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (9.66e-10)" "unprognostic (2.83e-3)" "unprognostic (6.38e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-3)" 1.3 2.1 14.0 0.7 15.1 0.2 5.2 7.4 23.3 13.1 5.0 3.5 1.0 1.3 3.8 30.9 0.8 0.6 1.0 17.9 12.3 1.6 3.4 0.7 0.6 13.9 10.6 1.6 1.1 5.6 14.5 0.8 13.3 2.3 3.6 3.2 5.5 0.5 0.8 102.4 1.5 0.7 8.7 1.2 1.1 3.6 12.5 1.1 1.0 0.6 2.4 0.9 28.0 15.4 6.1 1.5 2.6 16.6 2.9 1.5 1.9 0.3 0.5 0.7 1.0 1.0 2.6 4.7 2.7 0.6 1.5 10.0 18.4 3.7 0.6 2.8 4.0 0.6 0.6 1.3 0.3 0.7 3.3 0.8 4.5 0.3 1.1 7.7 1.4 3.0 3.0 2.9 0.6 8.3 0.9 2.5 1.8 46.3 4.8 6.0 1.5 15.6 2.0 0.2 26.8 8.2 1.0 17.7 0.5 2.3 25.3 0.9 0.5 1.8 5.1 0.8 0.5 5.6 2.6 1.1 3.1 2.4 0.2 0.0 0.6 0.8 0.8 0.8 0.8 1.0 0.6 0.4 1.4 1.2 0.9 0.5 0.0 2.7 0.3 1.1 1.6 0.4 14.0 15.1 7.4 23.3 17.9 12.3 13.9 10.6 13.3 8.7 12.5 15.4 3.8 0.0 0.6 2.0 2.1 63.2 3.8 13.6 44.3 1.5 16.9 12.2 0.2 0.0 4.4 0.0 0.0 1.1 3.5 8.6 1.9 3.9 0.6 1.6 0.7 4.2 1.2 0.0 6.5 2.9 30.0 1.5 0.0 1.6 0.0 1.6 1.1 1.1 2.1 3.3 7.9 9.1 2.0 1.2 6.8 1.1 1.2 1.3 8.8 1.0 0.8 9.6 3.1 0.0 1.3 3.2 7.4 0.4 0.4 9.9 6.1 1.3 1.1 1.3 0.0 1.1 8.8 6.5 9.3 32.6 108.8 2.9 2.2 10.1 7.4 3.8 EFNA5 "AF1, EPLG7, LERK7" ENSG00000184349 "Ephrin A5" P52803 5 107376894-107670937 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Astrocytes: 291.2;Excitatory neurons: 798.5;Inhibitory neurons: 373.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 35.2;RPTEC TERT1: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013282, HPA054047" Approved Approved Vesicles,Cytosol NA Yes 10000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Cytosol" "CAB013282: AB_2533353, HPA054047: AB_2682355" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.15e-3)" "unprognostic (3.98e-3)" "unprognostic (2.74e-2)" "unprognostic (8.91e-4)" "unprognostic (9.46e-3)" "unprognostic (4.92e-1)" "unprognostic (2.28e-3)" "unprognostic (1.26e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.92e-7)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (1.27e-1)" 4.1 1.1 4.5 2.0 6.5 0.1 4.0 1.3 13.6 10.1 0.0 2.3 0.8 1.1 2.0 7.1 2.9 2.7 6.8 3.1 10.2 3.4 0.3 2.4 0.8 0.9 0.3 4.0 0.5 2.5 2.7 2.4 0.6 4.3 2.3 2.5 5.6 4.7 0.5 9.7 0.8 2.2 0.0 5.3 2.5 1.4 2.1 1.4 1.0 1.4 2.5 3.5 4.8 5.4 12.7 22.2 35.2 0.0 16.7 14.2 3.6 0.3 6.3 4.5 11.6 0.2 13.9 0.0 20.5 2.4 7.1 13.1 19.4 18.0 3.6 0.0 12.9 0.1 11.9 0.0 3.1 0.6 0.0 16.0 15.4 0.0 14.4 3.9 13.8 0.0 0.0 0.0 8.3 12.0 0.0 0.0 4.6 0.1 1.9 0.0 16.9 0.4 50.9 15.5 5.8 14.7 6.0 8.9 3.8 11.2 3.9 2.2 0.2 28.3 5.0 17.4 7.1 1.2 0.0 8.3 12.4 0.8 31.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.4 0.1 0.7 0.0 0.0 0.0 0.1 4.5 6.5 1.3 13.6 3.1 10.2 0.9 0.3 0.6 0.0 2.1 5.4 1.1 9.6 24.4 291.2 0.0 15.9 22.5 18.5 6.2 4.3 11.8 8.5 30.6 11.5 26.0 14.7 0.0 20.3 3.3 4.3 23.5 1.7 1.8 3.2 14.8 8.2 12.0 0.0 798.5 1.3 3.3 16.9 5.6 6.3 0.0 0.1 9.7 0.0 1.7 6.7 373.1 8.5 18.3 0.3 7.0 3.7 18.3 0.4 8.8 37.5 3.6 4.7 2.1 26.2 8.7 13.9 4.9 21.8 1.7 14.1 0.0 0.1 19.6 1.4 0.0 1.3 3.7 0.1 4.0 14.9 24.2 3.8 2.2 2.3 5.9 23.1 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356403-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol No NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Cytosol "HPA001581: AB_2666367, HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 19.3 12.6 39.7 5.5 59.6 0.0 22.7 51.7 45.6 47.3 28.0 24.4 3.1 29.2 9.9 44.1 28.6 8.7 15.0 35.6 39.3 10.0 1.8 12.1 3.6 63.0 57.6 41.9 2.2 22.2 8.4 10.4 54.8 36.8 3.3 10.6 26.2 22.5 3.6 59.0 9.6 12.5 44.8 7.6 11.9 5.4 49.9 3.2 17.5 5.1 4.8 25.3 42.9 76.0 4.7 0.0 73.2 39.5 17.1 20.0 57.7 5.3 11.3 2.0 0.9 0.0 0.0 0.0 0.0 30.3 0.3 27.5 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 11.6 18.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.1 0.0 0.0 0.0 22.6 0.1 0.0 24.1 7.8 66.5 15.1 2.6 0.0 8.7 17.6 0.0 0.0 7.6 0.0 19.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 59.6 51.7 45.6 35.6 39.3 63.0 57.6 54.8 44.8 49.9 76.0 2.0 0.0 6.7 17.0 0.0 11.6 11.6 5.6 9.6 5.0 20.3 16.3 0.7 0.0 4.1 0.0 6.2 9.3 0.2 0.0 1.9 0.1 0.9 0.6 18.9 1.8 0.0 0.0 0.2 0.0 14.7 15.7 0.0 0.7 0.0 4.4 1.8 0.0 1.6 0.0 0.3 0.0 0.0 0.0 3.7 0.8 20.2 0.4 7.2 1.9 0.0 9.0 0.0 22.1 48.9 0.0 0.0 13.9 0.1 7.6 0.0 0.3 1.1 9.3 6.6 12.6 8.9 2.2 0.5 22.7 13.4 18.1 0.5 0.3 0.0 7.0 EGLN3 "HIFPH3, PHD3" ENSG00000129521 "Egl-9 family hypoxia inducible factor 3" Q9H6Z9 14 33924227-34462774 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 110.3;skin 1: 118.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 213.7;Cardiomyocytes: 105.8;Distal enterocytes: 135.5;Extravillous trophoblasts: 115.9;Suprabasal keratinocytes: 231.6" "Cancer enhanced" "Detected in all" "renal cancer: 50.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 25.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 25.5" "Cell line enhanced" "Detected in many" "RH-30: 44.6;RPTEC TERT1: 38.2;RT4: 122.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064895 Supported Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA064895: AB_2685384" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" "unprognostic (1.75e-1)" "unprognostic (8.87e-2)" "unprognostic (6.88e-2)" "unprognostic (1.38e-2)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.39e-3)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" "unprognostic (2.93e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.37e-1)" "unprognostic (5.21e-2)" "unprognostic (4.71e-2)" "unprognostic (6.30e-2)" 14.6 0.8 32.9 9.4 40.9 0.3 10.0 38.2 37.5 12.3 15.4 25.9 35.7 10.0 4.4 27.0 9.4 13.8 110.3 29.7 38.9 16.3 4.9 8.3 5.7 34.3 37.5 2.1 4.3 0.3 3.4 25.4 32.2 9.1 20.0 15.2 11.2 12.0 20.8 118.2 40.9 11.7 31.9 4.9 37.7 1.1 42.9 4.9 2.8 6.4 9.8 51.3 20.8 36.1 31.1 8.0 0.9 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 8.2 0.0 10.0 0.1 0.9 0.9 15.0 29.4 0.0 3.1 8.0 8.3 20.5 1.0 0.0 0.0 0.4 4.0 14.5 0.0 0.1 0.0 0.0 2.3 16.9 0.0 0.4 2.7 0.7 0.1 24.3 26.7 2.8 0.0 44.6 11.1 38.2 122.9 6.2 7.0 2.0 11.8 3.2 18.2 12.0 0.1 0.0 0.2 3.2 0.0 1.8 0.4 6.7 0.1 7.2 0.0 0.5 0.0 0.0 1.8 0.1 0.0 0.0 0.0 1.2 0.9 2.6 0.0 0.1 0.1 0.1 1.1 0.0 25.5 0.0 0.9 32.9 40.9 38.2 37.5 29.7 38.9 34.3 37.5 32.2 31.9 42.9 36.1 6.0 0.0 0.6 36.2 1.6 213.7 49.0 56.6 3.4 11.6 16.0 17.0 105.8 4.3 24.8 9.2 2.1 11.4 16.0 135.5 9.8 15.6 1.8 42.3 8.5 25.1 16.2 0.4 1.0 6.9 115.9 16.8 74.9 17.2 1.3 0.1 12.5 0.3 3.1 1.7 4.3 31.6 12.2 1.9 62.8 4.9 2.5 10.8 40.9 0.0 0.9 11.6 0.0 6.6 54.2 46.6 41.9 0.7 0.4 17.4 59.7 20.5 37.2 2.4 0.0 17.7 9.4 1.7 0.3 4.1 231.6 103.0 4.5 1.2 14.1 25.7 EHD3 PAST3 ENSG00000013016 "EH domain containing 3" Q9NZN3 2 31234152-31269451 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.7;esophagus: 43.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 24.3;Hepatic stellate cells: 120.3;Syncytiotrophoblasts: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 5.6" "Lineage enriched" "Detected in many" 7 "B-cells: 20.8" "Cell line enhanced" "Detected in many" "BJ: 79.7;BJ hTERT+: 192.2;HEL: 77.4;U-266/70: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751" Approved Approved "Plasma membrane" NA NA 15000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713" "unprognostic (3.44e-1)" "unprognostic (8.88e-2)" "unprognostic (2.21e-1)" "unprognostic (3.79e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (5.49e-2)" "unprognostic (1.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.72e-2)" "unprognostic (9.92e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (4.88e-3)" "unprognostic (9.41e-2)" "unprognostic (4.79e-3)" "unprognostic (4.92e-3)" 2.5 9.1 20.5 5.9 29.5 1.9 3.2 10.5 38.7 5.5 1.1 2.5 1.6 4.4 3.0 43.9 4.5 3.4 15.9 29.5 18.5 20.0 11.0 5.7 6.8 11.7 17.8 2.5 1.3 21.1 9.1 11.7 13.9 5.5 1.7 9.0 5.9 4.4 2.3 3.1 3.7 4.6 9.6 7.3 2.2 1.3 31.1 2.7 3.2 5.1 11.1 6.6 6.0 26.2 1.8 8.4 4.5 3.9 7.5 11.3 0.7 79.7 192.2 7.5 6.9 0.0 0.9 0.6 2.9 26.0 6.5 0.8 0.2 5.2 5.3 3.2 7.1 77.4 0.4 0.0 25.7 0.0 0.2 18.1 2.3 7.3 3.0 20.0 0.1 0.2 0.3 0.4 5.6 12.6 1.0 0.1 17.7 0.0 4.3 2.8 0.3 1.8 5.8 8.9 2.2 12.1 0.8 1.3 0.0 14.1 1.2 0.0 0.0 5.8 5.4 0.3 6.5 48.7 6.5 0.1 14.8 0.0 12.4 0.6 0.5 0.5 2.1 1.0 1.1 20.8 1.0 1.4 0.5 5.6 0.9 0.5 1.2 0.8 2.8 0.0 0.5 10.2 20.5 29.5 10.5 38.7 29.5 18.5 11.7 17.8 13.9 9.6 31.1 26.2 1.9 0.0 0.0 2.6 16.2 0.8 1.8 1.7 10.2 9.7 0.6 6.2 24.3 5.7 0.9 0.0 0.0 4.1 0.6 0.0 0.0 0.5 0.1 0.7 2.3 8.4 1.8 6.1 17.1 0.2 8.4 3.3 1.1 0.5 0.0 0.4 120.3 5.0 1.7 0.0 11.1 0.1 0.0 16.1 0.4 0.0 1.2 5.9 0.0 4.7 1.1 9.0 0.0 22.6 5.4 0.2 0.1 3.0 5.8 2.6 0.0 0.2 0.4 5.9 19.7 3.0 7.0 0.6 2.7 10.7 0.9 43.9 1.4 0.7 0.1 4.7 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363398-43368074 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Enhanced Supported "Endoplasmic reticulum" NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: AB_2683173" "unprognostic (5.23e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 78.5 54.7 77.2 39.8 115.6 52.9 66.6 121.1 116.9 57.1 61.4 63.9 51.6 46.5 30.6 176.6 38.9 42.4 47.2 76.8 93.2 59.7 45.8 59.6 40.1 152.0 110.1 28.9 55.4 46.2 27.2 51.0 140.7 58.7 48.6 8.4 72.7 48.8 24.1 201.9 55.4 50.8 114.8 57.1 70.6 18.6 107.7 22.2 66.8 28.0 55.7 68.5 86.8 165.7 108.0 119.5 22.6 44.8 148.4 138.2 70.2 125.2 154.5 153.5 122.4 105.9 182.5 73.9 94.3 193.6 130.3 119.4 79.7 152.2 93.2 94.6 53.9 96.6 77.3 77.1 128.2 84.2 98.0 106.2 168.2 180.9 198.4 114.8 155.0 27.7 68.1 54.8 178.5 79.5 19.9 69.5 33.5 136.9 120.2 43.6 59.9 89.7 195.5 128.7 27.4 28.8 73.7 258.4 105.8 66.8 121.2 82.4 132.2 129.7 82.5 161.2 161.3 26.6 31.2 35.4 127.8 85.2 120.1 134.9 189.6 172.7 105.1 180.0 93.4 109.0 98.4 103.2 212.8 94.2 63.5 88.0 133.0 114.7 179.6 148.8 113.8 203.1 77.2 115.6 121.1 116.9 76.8 93.2 152.0 110.1 140.7 114.8 107.7 165.7 44.0 19.2 12.5 7.5 28.1 15.6 25.9 61.1 29.6 5.7 60.3 37.5 4.7 34.3 40.2 40.5 10.4 93.4 36.0 114.0 7.9 91.5 3.4 22.9 26.3 43.6 19.2 67.8 3.8 100.1 127.4 26.1 48.4 45.2 21.0 52.6 24.7 16.7 74.9 3.3 3.4 33.8 46.8 46.3 37.5 4.6 20.2 41.5 12.4 7.5 92.5 13.7 32.0 3.0 66.1 133.3 63.9 25.6 19.0 44.7 66.0 23.3 14.5 9.5 19.7 10.0 39.7 8.4 11.2 70.1 31.0 95.9 31.5 50.8 47.2 49.2 ELOVL7 FLJ23563 ENSG00000164181 "ELOVL fatty acid elongase 7" A1L3X0 5 60751791-60844274 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Microglial cells: 190.2;Oligodendrocytes: 90.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.9;neutrophil: 1.3" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "GAMG: 41.9;HDLM-2: 29.3;HEL: 37.3" "Low region specificity" "Detected in all" HPA036337 Approved NA NA "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" "HPA036337: AB_10670797" "unprognostic (6.34e-2)" "unprognostic (1.96e-2)" "unprognostic (1.51e-2)" "prognostic unfavorable (3.87e-5)" "unprognostic (3.84e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.54e-9)" "unprognostic (6.95e-2)" "unprognostic (1.01e-3)" "unprognostic (2.94e-1)" "unprognostic (6.30e-3)" 10.5 5.5 23.1 2.2 24.9 1.0 22.1 29.5 26.5 3.6 36.2 8.8 11.8 2.2 0.9 5.0 2.8 19.3 0.9 18.3 30.0 16.2 1.0 3.8 2.5 31.8 26.3 0.5 8.5 21.0 2.7 0.8 32.9 22.0 11.5 10.5 4.7 1.2 0.5 26.2 21.3 3.7 30.1 0.5 3.3 0.8 32.9 1.8 16.8 1.0 4.0 7.6 6.7 32.2 20.7 7.6 0.1 0.5 0.0 0.0 18.6 0.0 4.3 2.5 8.4 9.6 21.4 0.0 9.1 0.0 41.9 1.2 11.9 8.3 3.8 29.3 6.9 37.3 0.9 3.2 0.2 3.0 15.2 0.1 14.6 0.3 12.3 0.9 0.0 6.5 5.9 7.2 0.0 17.8 0.1 0.3 2.4 1.9 0.1 1.6 1.9 1.2 19.4 18.5 7.8 1.2 10.9 8.8 5.0 2.0 14.2 0.6 0.2 1.5 9.0 0.2 7.2 18.5 19.7 0.3 13.2 0.8 0.4 1.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.5 23.1 24.9 29.5 26.5 18.3 30.0 31.8 26.3 32.9 30.1 32.9 32.2 14.5 12.8 3.1 4.9 0.5 31.1 13.1 1.4 4.6 2.3 3.1 1.4 0.7 20.0 4.8 12.9 0.0 0.2 0.3 8.8 5.9 6.8 0.1 6.5 1.6 21.1 4.8 1.3 29.5 3.1 0.0 2.0 5.6 20.4 12.7 0.4 0.4 0.0 0.1 0.0 26.0 17.0 0.0 0.0 16.6 0.0 0.0 4.9 10.6 190.2 2.0 3.5 0.0 6.0 90.8 7.1 13.3 0.0 0.1 23.4 29.7 8.9 1.7 6.7 0.0 1.0 0.8 0.2 1.1 2.9 38.2 2.9 0.9 0.2 15.9 8.6 ENO1 "ENO1L1, MBP-1, MPB1, PPH" ENSG00000074800 "Enolase 1" P06733 1 8861000-8879190 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Plasminogen activation, Transcription, Transcription regulation" "DNA-binding, Lyase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 2259.3;Extravillous trophoblasts: 2078.5;Muller glia cells: 2624.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018614, HPA068284, HPA068721, CAB069394, CAB080034" Supported Enhanced "Plasma membrane,Cytosol" NA NA 310000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 27: Brain & Skin - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane, Cytosol" "CAB018614: AB_2099061, CAB069394: , CAB080034: , HPA068284: , HPA068721: AB_2732119" "unprognostic (6.51e-3)" "unprognostic (9.50e-3)" "unprognostic (3.56e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (2.71e-4)" "unprognostic (1.82e-2)" "prognostic unfavorable (1.30e-8)" "unprognostic (2.37e-2)" "unprognostic (5.58e-2)" "unprognostic (9.72e-2)" "unprognostic (1.67e-2)" "unprognostic (1.46e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.36e-3)" 463.4 418.4 552.9 553.3 591.7 792.8 409.1 679.7 749.9 370.7 585.6 382.6 401.2 321.7 125.7 1049.4 281.6 302.0 328.2 638.1 599.6 1063.6 612.2 453.2 492.4 624.1 607.7 295.0 220.8 347.2 245.7 362.7 602.9 279.2 358.3 741.5 581.3 354.2 231.0 548.1 382.3 471.3 583.4 394.9 321.6 217.7 585.3 455.6 271.4 146.5 695.4 485.9 519.7 571.5 3637.0 3088.4 1461.8 1258.6 1194.2 1323.8 1316.6 1919.1 2110.9 4044.1 3767.4 1986.9 2041.5 2586.5 2496.8 2328.5 1651.8 1736.8 2511.5 5127.7 4081.0 1780.5 2645.9 2191.3 2848.0 2511.0 1789.6 4421.6 1290.1 1377.4 1526.1 3208.9 4825.9 3045.2 2630.1 1294.6 2444.4 982.3 2664.2 1784.1 1685.2 2354.5 1600.3 1290.4 3063.4 1712.4 2172.9 4259.0 4815.0 843.6 1961.4 1211.1 2251.0 3232.5 2407.8 1748.4 1621.8 1302.1 2424.7 2774.5 2444.5 2402.3 3328.3 2771.0 2120.4 3906.9 4313.8 3556.1 2388.6 195.9 1198.7 232.3 528.4 822.7 597.3 411.2 552.5 543.2 1216.4 386.1 443.4 466.0 230.6 635.3 830.6 336.1 700.0 2171.2 552.9 591.7 679.7 749.9 638.1 599.6 624.1 607.7 602.9 583.4 585.3 571.5 140.0 278.9 499.1 99.6 222.3 416.5 570.9 1939.8 348.8 178.2 242.7 324.6 69.6 283.1 657.4 606.9 70.9 1045.4 194.0 455.9 925.4 2259.3 281.3 205.3 227.7 314.3 189.0 145.4 32.0 1399.1 2078.5 303.5 144.8 248.4 297.2 408.6 133.5 351.7 1147.4 482.9 33.2 297.3 787.3 356.4 524.5 699.6 171.5 454.2 448.2 30.9 1558.2 2624.9 279.1 28.6 26.9 1433.6 366.9 135.1 211.0 555.7 742.2 1005.4 245.7 216.6 151.2 156.1 402.5 215.1 154.3 468.1 349.6 1001.8 285.6 609.8 528.4 444.2 EPB41L1 "4.1N, KIAA0338" ENSG00000088367 "Erythrocyte membrane protein band 4.1 like 1" Q9H4G0 20 36091504-36232799 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 156.4;Inhibitory neurons: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "A549: 163.5;HaCaT: 237.9;OE19: 192.9;SK-BR-3: 185.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054104, HPA056817" Enhanced Supported "Plasma membrane" NA NA 33000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" "HPA054104: AB_2682380, HPA056817: AB_2683244" "unprognostic (2.01e-2)" "unprognostic (7.77e-2)" "unprognostic (1.76e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (1.19e-1)" "unprognostic (2.31e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" "unprognostic (3.87e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (9.30e-4)" "unprognostic (1.78e-1)" "prognostic favorable (4.39e-10)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.26e-2)" 55.1 122.1 68.6 8.1 73.8 0.4 25.7 66.0 97.2 37.7 0.0 31.2 13.8 27.9 31.0 46.3 45.3 40.3 21.3 64.7 81.7 64.7 8.9 30.1 4.4 101.5 80.3 41.8 29.3 37.0 21.1 21.8 94.0 26.9 20.9 39.5 56.6 42.6 12.0 14.2 16.7 27.2 53.0 8.1 64.2 18.3 75.0 4.5 24.8 15.4 14.0 40.7 31.7 79.9 53.5 163.5 57.7 21.5 36.8 22.8 53.8 16.8 37.7 35.1 27.9 108.7 93.7 3.0 26.4 52.7 71.7 237.9 26.7 19.6 26.2 0.5 14.9 0.4 52.7 107.6 11.3 0.2 19.4 19.9 9.4 32.9 2.7 44.7 8.6 13.0 2.7 41.5 30.5 34.2 1.8 0.9 21.4 192.9 49.9 2.6 16.0 66.3 30.5 84.6 20.1 24.5 74.9 185.6 6.4 43.9 45.8 2.4 7.3 40.9 43.0 20.8 3.7 50.3 19.0 0.6 71.2 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 68.6 73.8 66.0 97.2 64.7 81.7 101.5 80.3 94.0 53.0 75.0 79.9 14.5 16.0 22.1 27.7 0.4 2.9 5.0 11.1 30.7 31.9 12.8 9.4 8.5 28.6 16.5 47.8 156.4 1.5 0.8 23.8 19.6 22.2 2.9 10.6 8.7 9.2 15.5 0.0 56.8 10.8 0.5 11.0 50.4 7.5 52.5 13.3 10.0 3.7 6.9 32.0 75.7 6.0 4.1 1.3 2.2 2.7 15.8 6.0 3.6 3.7 0.0 22.7 0.0 24.6 73.1 31.6 15.7 42.2 2.1 5.1 8.0 37.1 21.9 8.7 32.9 6.8 35.1 4.6 7.1 43.2 1.7 1.1 0.8 7.1 13.2 18.0 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 66.0;skin 1: 65.8" "Cell type enhanced" "Detected in many" "Muller glia cells: 226.6;Sertoli cells: 105.2;Suprabasal keratinocytes: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 6 "MOLT-4: 39.6;RT4: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035784 Uncertain "Nuclear speckles" "Intracellular and membrane" NA NA "Cluster 30: Non-specific - Translation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 5: Muller glia cells - Visual perception" "Nuclear speckles" "HPA035784: AB_2674781" "unprognostic (1.90e-2)" "prognostic favorable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favorable (4.68e-5)" 9.2 0.7 26.9 1.8 42.0 2.2 3.6 9.7 66.0 18.6 9.2 2.6 0.0 8.9 2.3 10.6 13.5 1.5 3.2 27.7 14.4 4.0 1.5 4.0 2.3 12.9 14.1 7.9 12.4 0.9 2.4 0.4 12.9 14.3 0.1 2.8 5.7 7.3 1.4 65.8 5.0 1.6 12.6 4.3 3.3 5.0 16.7 14.5 9.4 0.7 2.3 7.8 18.5 48.7 0.2 0.0 0.0 0.8 7.5 3.0 0.0 0.9 0.8 0.2 0.1 1.0 2.3 0.0 0.0 0.1 0.0 8.8 0.4 0.0 0.0 2.0 0.3 0.6 0.0 0.3 1.2 9.7 0.4 1.7 0.8 3.0 0.0 0.1 0.5 5.2 2.1 0.0 0.1 0.2 39.6 5.8 6.8 1.4 3.6 0.8 0.0 0.0 0.0 71.7 0.0 0.0 3.3 2.0 0.0 1.5 6.1 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.6 0.0 0.0 3.5 0.0 0.0 0.8 0.4 0.0 0.3 0.3 1.6 1.1 0.6 0.5 0.3 1.4 0.7 0.5 0.0 0.1 0.0 1.0 0.7 26.9 42.0 9.7 66.0 27.7 14.4 12.9 14.1 12.9 12.6 16.7 48.7 1.9 3.2 1.7 6.2 12.5 54.4 30.7 13.3 42.1 12.1 1.8 6.7 3.0 45.8 10.0 7.3 2.1 0.2 1.9 0.1 5.9 28.2 0.9 5.7 20.0 2.8 1.8 8.6 65.1 6.8 0.0 15.6 6.1 7.2 0.0 3.2 1.8 3.5 4.2 0.0 43.4 0.1 0.0 13.2 10.4 8.3 30.1 8.9 12.4 8.4 7.1 226.6 5.2 5.5 4.6 32.4 0.1 9.8 1.6 11.0 0.0 0.6 4.9 6.6 105.2 31.5 20.5 0.5 7.2 40.0 118.5 0.3 14.0 0.7 0.1 22.2 EPN2 "EHB21, KIAA1065" ENSG00000072134 "Epsin 2" O95208 17 19215615-19336715 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Oligodendrocyte precursor cells: 868.6;Oligodendrocytes: 258.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 10.9;eosinophil: 29.0;neutrophil: 9.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 29.0" "Cell line enhanced" "Detected in many" "SuSa: 127.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049809, HPA053360" Approved Supported Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Vesicles "HPA049809: AB_2680893, HPA053360: AB_2682126" "unprognostic (1.38e-2)" "unprognostic (2.54e-2)" "unprognostic (2.58e-2)" "unprognostic (2.09e-1)" "unprognostic (1.94e-1)" "unprognostic (8.12e-3)" "unprognostic (6.73e-3)" "unprognostic (1.43e-1)" "unprognostic (8.89e-2)" "unprognostic (4.58e-3)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.32e-1)" "unprognostic (9.40e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (8.15e-5)" 20.5 13.9 62.1 9.7 64.9 11.5 16.7 50.4 62.8 36.3 32.7 28.3 9.6 29.5 11.5 40.3 26.6 14.6 32.5 62.6 56.2 21.3 9.3 18.6 6.5 61.6 63.6 22.5 14.6 15.3 18.1 21.6 57.5 23.6 9.5 19.1 17.9 23.4 22.4 50.1 13.3 22.5 46.6 14.3 15.9 19.7 63.6 4.7 17.8 17.0 8.4 27.0 33.8 91.6 31.3 30.4 43.9 19.2 22.8 36.3 34.5 29.4 18.9 17.9 15.3 20.2 9.2 4.9 28.2 29.5 16.8 29.0 19.8 22.1 21.9 23.6 21.2 3.2 20.3 9.2 23.7 1.4 13.1 20.5 19.5 28.3 22.7 23.2 38.8 6.6 8.6 3.9 15.8 22.5 1.3 2.1 11.1 41.3 19.8 7.1 18.8 8.1 21.0 8.6 13.0 28.8 20.9 13.9 14.7 127.9 21.0 4.0 35.6 19.7 22.3 30.9 12.9 6.7 4.3 3.9 54.0 0.5 31.1 10.9 1.3 29.0 1.6 0.8 1.2 3.0 1.1 1.3 0.5 3.4 1.3 1.2 9.0 0.7 1.0 0.6 1.0 0.7 62.1 64.9 50.4 62.8 62.6 56.2 61.6 63.6 57.5 46.6 63.6 91.6 60.0 54.5 29.3 74.4 13.7 24.1 36.6 21.2 43.9 68.3 32.8 33.4 44.5 25.8 25.0 38.6 47.9 27.6 3.3 7.2 27.4 22.5 36.8 69.2 35.0 42.5 6.0 13.5 51.3 8.4 39.8 36.1 15.8 40.6 14.0 37.3 15.0 10.4 8.4 35.3 45.0 16.8 10.2 5.1 6.2 72.7 46.6 5.9 5.4 54.4 1.6 38.3 2.1 868.6 258.3 23.3 14.9 39.5 14.4 32.0 7.0 14.2 43.2 82.3 26.3 50.5 63.7 45.8 38.3 63.9 48.9 21.9 7.4 35.0 7.8 40.1 ESYT3 "CHR3SYT, FAM62C" ENSG00000158220 "Extended synaptotagmin 3" A0FGR9 3 138434586-138481686 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;skin 1: 7.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 37.7;Excitatory neurons: 9.4;Inhibitory neurons: 9.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;NTERA-2: 3.3;SCLC-21H: 3.5;SK-MEL-30: 1.7;SuSa: 1.4" "Region enhanced" "Detected in many" "hypothalamus: 7.3" "Low region specificity" "Detected in all" HPA039200 Approved NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 11: Alveolar cells - Smell perception" "HPA039200: AB_10805356" "unprognostic (4.48e-2)" "unprognostic (3.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-4)" "unprognostic (2.23e-1)" "unprognostic (8.22e-2)" "unprognostic (3.55e-3)" "prognostic favorable (8.30e-4)" "unprognostic (3.38e-1)" "unprognostic (5.57e-2)" "unprognostic (6.19e-3)" "unprognostic (4.88e-3)" "unprognostic (3.16e-5)" "unprognostic (3.46e-1)" "unprognostic (1.12e-1)" "unprognostic (2.13e-1)" "unprognostic (6.43e-2)" 0.1 0.1 2.5 0.0 2.0 0.0 0.7 5.1 2.2 0.8 0.2 3.8 0.0 2.2 0.0 0.4 0.2 0.3 0.5 2.1 2.3 0.9 0.0 4.7 0.0 2.2 2.1 0.5 1.0 0.8 1.9 0.3 2.5 0.2 0.2 0.1 0.3 0.0 0.4 7.7 0.3 1.5 1.3 0.0 1.7 0.5 2.4 0.0 4.7 0.0 0.4 1.0 0.7 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.8 0.8 0.1 0.2 1.3 0.0 0.0 0.2 0.0 0.1 0.4 0.5 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 3.5 0.0 1.2 0.1 1.7 1.4 0.3 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.0 5.1 2.2 2.1 2.3 2.2 2.1 2.5 1.3 2.4 1.5 0.1 38.5 37.7 4.2 0.1 0.8 0.8 0.5 1.2 1.9 0.9 1.3 2.5 1.5 4.5 1.8 4.2 0.8 0.0 0.1 0.0 1.0 0.2 1.5 0.8 0.7 0.0 0.0 9.4 0.9 0.4 0.9 3.6 2.2 0.0 0.5 0.4 0.1 0.2 0.0 9.7 0.0 0.0 0.0 0.4 0.2 0.3 0.2 1.8 1.0 0.0 0.3 0.0 2.0 0.5 0.7 0.1 0.0 0.0 1.1 0.0 0.3 0.8 3.9 0.0 1.4 0.3 1.5 1.7 0.5 1.6 0.7 0.1 0.7 0.2 0.1 EXOC1 "BM-102, FLJ10893, SEC3, SEC3L1, Sec3p" ENSG00000090989 "Exocyst complex component 1" Q9NV70 4 55853648-55905086 "Predicted intracellular proteins, Transporters" "Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037706, HPA044873" Uncertain Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" "Microtubules, Cytosol" "HPA037706: AB_10670525, HPA044873: AB_2679125" "unprognostic (7.10e-3)" "unprognostic (4.48e-2)" "unprognostic (8.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.81e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.63e-4)" "unprognostic (2.84e-3)" "unprognostic (4.65e-2)" "unprognostic (2.04e-2)" "unprognostic (4.03e-3)" "unprognostic (1.55e-1)" "unprognostic (1.94e-1)" "unprognostic (3.11e-1)" "unprognostic (2.93e-2)" "unprognostic (6.24e-2)" "prognostic favorable (5.50e-5)" 19.7 16.5 18.1 17.3 20.4 12.7 20.0 20.4 20.0 18.9 18.7 18.0 16.8 16.6 20.4 29.3 16.5 15.5 16.5 18.3 20.0 15.9 10.2 17.4 18.3 21.1 19.2 15.1 12.9 20.5 14.5 20.8 20.3 14.3 19.1 18.5 17.4 12.8 13.6 28.1 16.2 15.7 20.4 20.8 15.6 16.9 20.1 13.9 16.3 13.5 20.0 16.2 20.1 25.1 21.8 12.4 21.9 25.3 36.9 45.9 14.6 30.2 30.1 24.1 25.1 8.6 37.1 20.9 20.6 32.6 29.1 25.4 18.0 23.9 34.5 11.1 12.4 19.4 14.8 10.1 34.7 21.3 26.4 37.4 32.1 25.1 27.6 31.2 39.9 16.0 28.3 20.1 53.0 13.8 15.6 21.5 13.9 31.2 23.4 18.0 16.4 17.1 26.9 23.6 16.2 28.7 18.0 29.2 25.5 18.5 18.6 22.6 48.5 29.7 24.2 25.8 26.3 23.9 12.7 18.4 38.6 23.4 28.8 21.3 14.6 13.1 6.5 19.0 8.8 8.4 9.2 9.5 14.3 8.3 8.3 6.0 19.5 12.5 23.6 6.4 11.6 7.9 18.1 20.4 20.4 20.0 18.3 20.0 21.1 19.2 20.3 20.4 20.1 25.1 44.7 41.7 38.0 77.4 24.5 34.8 14.8 34.0 22.2 48.8 26.4 21.2 29.1 17.2 35.6 22.0 31.3 60.8 21.4 38.3 19.6 23.6 45.3 41.0 47.5 39.0 22.2 19.6 72.6 20.0 31.6 28.9 22.4 37.2 36.7 35.5 40.0 12.3 40.9 28.6 86.5 28.8 24.4 37.7 47.4 16.7 21.5 37.8 40.9 56.2 38.7 40.3 22.6 73.4 138.0 36.2 32.4 23.7 19.0 17.4 37.6 21.9 44.7 32.5 32.9 25.9 27.9 47.6 31.6 42.5 39.9 51.2 27.8 44.6 28.7 26.8 FAM156B TMEM29B ENSG00000179304 "Family with sequence similarity 156 member B" Q8NDB6 X 52891306-52908560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 80.8" "HPA056640, HPA056643" Uncertain NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA056640: AB_2683200, HPA056643: AB_2683201" "unprognostic (2.91e-1)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (3.24e-5)" "unprognostic (2.97e-1)" 26.7 39.7 33.6 12.0 34.1 13.6 25.7 34.3 38.2 23.0 38.4 19.8 18.4 17.4 18.5 17.5 22.5 17.1 25.2 34.3 33.9 33.2 27.3 19.0 20.4 34.0 32.9 23.5 23.2 10.6 48.1 50.0 33.7 25.7 18.7 14.2 15.7 19.9 7.9 49.0 18.3 18.0 31.8 31.9 19.8 24.2 36.2 10.6 22.4 5.6 13.2 22.5 17.8 33.8 5.0 8.4 11.9 29.1 14.2 29.2 37.2 10.5 16.5 13.0 18.4 10.9 18.9 4.4 3.5 35.1 11.5 9.2 25.3 19.5 16.6 3.7 10.6 3.4 80.8 18.0 26.9 8.0 8.6 37.5 15.3 20.3 13.1 43.0 12.4 16.0 10.8 19.5 32.9 10.2 8.3 33.3 13.8 8.4 14.2 14.4 9.9 13.4 14.3 9.6 10.2 12.6 3.3 22.7 9.4 31.8 9.5 11.2 15.8 47.7 8.5 20.1 12.0 5.5 8.4 13.2 21.6 29.3 8.2 0.0 4.0 1.0 0.9 5.5 1.3 0.8 0.6 0.9 6.1 1.6 1.8 0.6 0.8 2.5 5.4 3.5 2.0 2.7 33.6 34.1 34.3 38.2 34.3 33.9 34.0 32.9 33.7 31.8 36.2 33.8 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 FAM180B LOC399888 ENSG00000196666 "Family with sequence similarity 180 member B" Q6P0A1 11 47586678-47589194 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.5;brain: 5.9;breast: 5.2;choroid plexus: 5.1;skin 1: 6.3" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.4;Fibroblasts: 20.4;Langerhans cells: 11.9;Melanocytes: 5.4;Peritubular cells: 4.1;Suprabasal keratinocytes: 6.3" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029408 Uncertain "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "HPA029408: AB_10601319" "unprognostic (1.28e-2)" "unprognostic (4.99e-3)" "unprognostic (7.48e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.64e-2)" "unprognostic (1.21e-3)" "unprognostic (1.04e-1)" "unprognostic (2.69e-1)" "unprognostic (3.87e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-5)" "unprognostic (5.65e-2)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" 6.5 0.1 0.8 0.0 2.0 0.1 5.2 5.9 1.7 0.4 5.1 0.6 0.0 0.2 0.0 0.1 0.4 0.4 0.7 0.6 0.8 0.0 0.0 0.2 0.0 1.9 1.3 0.1 0.1 0.0 0.2 0.0 1.5 0.0 0.0 0.1 1.1 0.0 1.0 6.3 0.2 0.1 1.3 0.1 0.5 0.5 1.6 0.7 4.3 2.9 0.1 0.4 0.2 2.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.0 5.9 1.7 0.6 0.8 1.9 1.3 1.5 1.3 1.6 2.6 0.8 0.0 0.0 1.0 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 20.4 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 11.9 0.3 2.5 0.3 5.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.0 6.3 0.1 0.3 0.0 0.0 0.0 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Cluster 26: Non-specific - Mitochondria" "Cluster 27: Brain & Skin - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favorable (5.53e-4)" 10.6 9.6 14.5 5.5 13.9 8.7 12.3 12.3 17.6 14.8 7.2 14.6 13.8 10.7 2.6 17.7 12.3 5.3 11.6 13.8 11.7 12.2 13.3 9.1 6.2 18.9 11.6 12.5 18.6 8.4 11.6 2.3 13.5 13.4 4.7 1.7 13.9 5.8 3.3 25.2 15.4 3.3 12.7 11.8 14.4 9.0 14.4 4.7 11.4 2.5 3.8 12.7 14.6 14.3 15.6 16.3 1.9 9.4 2.0 6.8 8.2 8.8 7.3 8.5 8.9 2.8 11.0 13.9 9.7 5.2 3.0 7.5 3.7 6.3 1.4 22.6 7.6 4.6 2.9 6.5 9.0 3.9 8.1 6.6 13.0 4.3 7.8 4.7 5.0 22.5 12.9 15.0 5.1 17.2 5.9 3.1 1.4 25.5 17.5 11.6 3.9 8.4 10.4 8.0 3.3 9.6 8.8 15.6 5.6 0.9 11.8 12.3 6.7 3.8 10.4 11.9 10.7 16.1 8.8 6.1 9.9 9.2 6.2 0.0 1.9 10.8 2.4 2.7 3.2 2.0 4.2 3.4 2.6 6.5 3.3 2.6 1.7 3.0 2.7 1.0 3.9 1.4 14.5 13.9 12.3 17.6 13.8 11.7 18.9 11.6 13.5 12.7 14.4 14.3 19.8 9.6 8.9 3.6 17.5 21.5 22.3 23.7 14.8 15.1 21.1 26.3 5.4 10.0 21.2 23.9 12.5 11.8 22.1 41.4 21.5 22.2 6.4 18.2 9.1 12.0 25.7 9.7 11.7 32.9 10.9 13.9 17.9 18.0 15.2 8.6 11.4 12.5 11.0 11.8 9.5 32.4 22.4 13.2 18.2 2.4 18.6 14.3 23.2 2.8 14.4 14.6 34.0 5.5 8.5 23.8 42.8 18.4 12.7 12.2 100.4 22.6 22.4 12.5 13.1 13.5 13.8 37.4 37.4 22.3 29.8 6.2 21.8 12.9 34.8 23.4 FAT2 "CDHF8, CDHR9, HFAT2, MEGF1" ENSG00000086570 "FAT atypical cadherin 2" Q9NYQ8 5 151504093-151568944 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 113.4;esophagus: 50.9;skin 1: 56.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 18.0;Basal respiratory cells: 31.6;Basal squamous epithelial cells: 27.9;Early spermatids: 16.0;Extravillous trophoblasts: 20.6;Squamous epithelial cells: 53.2;Suprabasal keratinocytes: 19.6" "Group enriched" "Detected in many" 6 "cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6" "Region enriched" "Detected in many" 7 "cerebellum: 113.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 35.1;EFO-21: 21.0;HaCaT: 51.7;HBEC3-KT: 23.6;hTCEpi: 70.5" "Region enriched" "Detected in some" 18 "cerebellum: 32.0" "Region enriched" "Detected in many" 56 "cerebellum: 224.4" CAB033680 Enhanced NA NA 300000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "CAB033680: AB_2100956" "unprognostic (8.06e-3)" "unprognostic (6.01e-2)" "unprognostic (3.47e-1)" "unprognostic (4.80e-3)" "unprognostic (1.33e-1)" "unprognostic (4.43e-1)" "unprognostic (9.78e-3)" "unprognostic (2.28e-1)" "unprognostic (8.25e-2)" "unprognostic (2.65e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-7)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (6.77e-2)" "unprognostic (3.64e-3)" 0.4 0.2 0.4 0.0 3.8 0.1 3.6 113.4 4.8 11.5 0.0 0.1 0.1 0.1 1.7 50.9 1.0 0.0 0.1 0.5 0.4 0.6 0.1 0.2 0.0 15.1 2.8 0.1 0.2 0.2 0.5 0.9 17.2 5.3 0.0 0.1 8.9 4.8 0.2 56.0 0.2 0.0 0.4 0.1 0.1 13.2 0.5 2.2 0.1 0.0 3.4 2.9 24.4 2.2 1.7 0.0 0.0 0.1 0.0 0.0 35.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 21.0 0.0 0.2 51.7 0.0 23.6 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 70.5 0.0 3.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.7 0.1 0.0 0.1 1.1 0.2 0.5 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.8 113.4 4.8 0.5 0.4 15.1 2.8 17.2 0.4 0.5 2.2 0.1 0.0 0.0 0.7 0.0 18.0 5.8 31.6 27.9 0.0 3.4 12.8 1.9 0.0 11.1 1.8 0.0 0.4 0.0 0.0 0.0 0.0 16.0 0.1 0.0 0.3 0.0 0.0 5.0 0.0 20.6 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 2.9 0.0 0.0 0.0 1.5 7.8 0.0 0.0 7.2 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.1 3.0 0.0 0.0 0.0 0.4 0.5 0.1 53.2 19.6 1.0 0.1 0.0 0.0 13.0 FBXO27 "Fbg5, Fbx27" ENSG00000161243 "F-box protein 27" Q8NI29 19 38990714-39032785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 37.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 36.1;Suprabasal keratinocytes: 17.8;Syncytiotrophoblasts: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 35.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA046800, HPA062242" Approved Approved Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "HPA046800: AB_2679813, HPA062242: AB_2684723" "prognostic favorable (2.15e-4)" "unprognostic (7.32e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (1.48e-3)" "unprognostic (4.38e-3)" "unprognostic (1.02e-1)" "unprognostic (8.95e-2)" "unprognostic (1.67e-1)" "unprognostic (7.31e-3)" "unprognostic (6.80e-2)" "unprognostic (9.31e-2)" "unprognostic (2.25e-2)" "unprognostic (8.72e-3)" "unprognostic (6.04e-2)" "unprognostic (7.51e-2)" "unprognostic (3.21e-2)" 13.3 3.7 17.5 2.1 15.9 2.7 6.2 23.8 18.7 6.3 6.4 6.8 2.2 4.7 2.4 15.4 5.3 5.5 19.6 15.4 8.9 6.4 7.5 3.2 3.7 10.7 6.7 10.2 4.8 2.5 4.1 3.8 9.1 8.9 8.7 4.9 7.4 7.8 1.6 37.5 4.9 7.4 4.9 3.1 3.8 4.7 11.1 4.0 4.6 2.4 4.0 7.7 9.7 13.1 9.1 11.4 0.3 7.2 15.3 0.8 3.3 1.2 6.7 5.2 4.9 3.8 3.4 0.9 17.5 10.3 9.0 15.5 0.6 6.6 3.4 0.8 0.4 0.3 3.0 0.6 2.7 0.9 2.5 5.5 10.2 5.4 0.4 8.2 3.3 0.4 5.4 1.2 7.2 8.1 0.6 1.4 8.1 3.0 20.4 0.2 0.1 1.1 3.4 35.3 0.4 10.8 17.7 2.2 0.1 4.8 9.2 1.7 4.0 0.5 0.4 0.3 0.9 3.5 8.9 1.9 9.0 0.2 0.3 1.1 0.3 0.2 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.6 0.4 0.3 1.7 1.7 0.2 0.5 0.3 0.2 17.5 15.9 23.8 18.7 15.4 8.9 10.7 6.7 9.1 4.9 11.1 13.1 0.2 3.2 15.0 2.3 0.1 5.9 4.1 1.4 9.1 7.5 3.8 4.2 9.5 7.2 6.4 1.8 0.0 36.1 0.5 0.2 1.9 1.5 3.7 1.9 3.6 3.2 0.0 0.0 4.8 0.8 4.8 2.7 6.1 1.6 7.6 2.3 1.4 3.2 4.9 8.4 4.6 0.2 8.2 0.3 4.9 2.5 2.8 2.1 0.0 1.0 1.1 5.6 0.0 3.0 4.1 0.3 0.0 4.1 1.9 2.3 6.9 7.3 4.7 3.0 0.0 1.8 1.5 6.4 2.0 13.5 17.8 27.0 1.3 0.4 0.2 5.3 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536092 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 201.8;Excitatory neurons: 529.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 23.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 14.2 9.5 37.9 15.0 43.1 19.8 14.2 54.3 66.9 8.7 6.7 9.5 7.8 8.6 24.3 14.3 15.6 9.2 24.7 48.2 23.0 6.7 11.2 11.4 16.1 17.1 20.9 9.1 12.8 7.8 9.2 9.4 18.1 7.8 10.3 18.0 11.8 7.5 26.0 63.1 10.4 9.1 11.8 16.2 13.0 22.8 29.4 14.7 10.3 19.7 20.3 11.9 10.7 47.4 9.8 8.0 19.1 14.2 12.2 9.4 16.2 13.4 12.9 8.5 8.1 15.7 12.0 24.7 3.9 13.7 6.5 5.2 16.9 30.9 12.1 16.2 8.0 11.9 10.7 10.9 12.7 29.2 10.6 14.8 45.7 15.2 24.4 8.4 15.2 20.5 19.2 25.7 10.8 13.7 34.9 10.6 9.7 8.0 6.1 32.2 8.0 5.3 9.8 17.0 12.7 10.2 8.5 11.3 7.5 21.6 6.4 12.6 15.6 11.3 12.6 5.4 8.2 79.0 47.5 24.4 9.4 9.2 8.3 23.5 2.7 1.6 4.0 3.0 2.7 2.8 3.1 2.7 1.6 1.8 3.4 2.5 4.8 7.1 2.2 2.1 2.9 1.3 37.9 43.1 54.3 66.9 48.2 23.0 17.1 20.9 18.1 11.8 29.4 47.4 29.5 9.6 22.9 80.0 48.1 201.8 36.5 29.9 120.1 74.9 32.1 30.9 61.8 12.8 15.1 9.2 31.3 10.9 54.7 22.2 3.9 14.3 17.4 37.7 37.3 36.1 14.5 30.1 529.6 13.5 39.9 27.2 21.4 61.6 15.8 19.1 17.9 18.3 10.5 11.8 186.5 16.4 32.6 18.8 47.0 10.2 15.2 33.7 28.4 172.4 28.0 37.0 35.0 102.5 99.8 18.7 18.2 11.3 174.5 36.3 8.9 7.5 11.9 41.4 13.1 33.2 25.5 74.1 87.2 57.0 174.9 31.2 46.2 18.7 14.9 70.5 FGF11 "FHF3, FLJ16061, MGC102953, MGC45269" ENSG00000161958 "Fibroblast growth factor 11" Q92914 17 7438273-7444937 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 31.2" "Cell type enhanced" "Detected in many" "Astrocytes: 10.4;Basal respiratory cells: 10.2;Horizontal cells: 18.5;Muller glia cells: 15.2;Suprabasal keratinocytes: 9.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 10.4;HaCaT: 18.4;LHCN-M2: 12.1" "Low region specificity" "Detected in all" "HPA066605, HPA075188" Enhanced Approved Centrosome NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 5: Muller glia cells - Visual perception" Centrosome "HPA066605: AB_2685693, HPA075188: AB_2732283" "unprognostic (7.35e-2)" "unprognostic (1.14e-2)" "unprognostic (7.67e-3)" "unprognostic (2.79e-4)" "unprognostic (9.15e-2)" "unprognostic (3.28e-2)" "unprognostic (7.31e-2)" "unprognostic (3.11e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.69e-2)" "unprognostic (2.89e-3)" "unprognostic (2.00e-6)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.90e-3)" "unprognostic (4.97e-3)" 4.0 31.2 7.8 1.5 9.3 0.9 3.4 12.4 6.7 10.9 4.0 1.2 0.6 2.1 0.6 19.9 1.6 1.5 16.5 7.5 6.7 8.1 0.8 1.1 3.5 10.0 9.3 1.7 0.8 0.7 1.5 0.7 9.1 1.6 0.4 14.8 5.8 0.5 7.5 18.5 1.6 1.2 6.5 2.4 1.0 2.4 12.1 2.0 7.0 8.6 5.2 1.4 15.4 6.7 10.4 0.6 5.5 0.1 3.2 0.1 2.7 0.3 3.4 0.4 0.7 0.2 1.1 3.1 0.7 0.2 0.1 18.4 2.1 5.8 1.3 6.4 4.5 5.6 0.7 1.4 0.5 0.2 6.0 0.6 1.6 0.4 0.2 0.6 0.2 2.3 2.2 0.2 12.1 2.4 1.9 2.5 2.0 0.4 0.2 4.9 5.1 1.3 0.7 0.8 1.2 5.7 0.7 0.7 0.5 3.1 0.3 0.4 0.2 0.3 5.7 0.0 0.3 0.4 1.5 0.9 1.4 3.5 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 9.3 12.4 6.7 7.5 6.7 10.0 9.3 9.1 6.5 12.1 6.7 1.8 0.0 0.0 10.4 0.3 5.5 0.4 10.2 7.4 4.7 1.5 1.5 0.4 1.5 4.5 1.8 6.2 0.4 0.5 1.0 3.9 0.6 3.3 1.5 0.9 2.4 0.0 0.0 0.1 0.2 0.4 0.9 0.0 3.9 0.0 2.0 1.4 0.2 0.4 18.5 0.8 0.5 0.0 0.6 2.6 4.6 1.8 0.9 1.8 2.8 0.0 15.2 0.0 5.5 0.3 1.1 0.2 2.2 0.2 0.5 0.8 0.2 7.0 2.8 0.0 2.3 1.6 3.4 2.7 6.3 9.7 0.7 0.5 0.1 0.6 1.2 FGF22 ENSG00000070388 "Fibroblast growth factor 22" Q9HCT0 19 639879-644371 "Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;skin 1: 13.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.4;Horizontal cells: 13.5;Muller glia cells: 4.7;Rod photoreceptor cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AN3-CA: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (2.84e-3)" "unprognostic (1.04e-2)" "unprognostic (1.17e-1)" "unprognostic (5.25e-4)" "unprognostic (1.16e-1)" "unprognostic (3.66e-3)" "unprognostic (2.85e-1)" "unprognostic (1.27e-2)" "unprognostic (1.10e-4)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (3.55e-2)" "unprognostic (2.91e-1)" "unprognostic (1.31e-1)" "unprognostic (8.36e-2)" 0.5 0.3 2.6 0.0 2.8 0.0 0.6 2.4 4.9 0.7 1.3 0.6 0.2 0.6 0.0 0.5 1.0 0.0 0.3 2.5 2.1 0.4 0.2 0.3 0.0 2.6 2.6 2.9 0.2 0.0 0.6 0.0 2.7 1.1 0.0 0.1 0.6 0.1 0.7 13.5 0.4 0.0 1.8 0.2 0.6 1.1 2.9 0.0 0.2 0.0 0.0 0.9 0.9 3.0 0.2 0.3 0.1 1.9 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.1 0.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.7 0.0 0.0 0.3 0.1 0.2 0.4 0.7 0.5 0.0 0.1 0.0 0.3 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.1 0.2 0.1 0.0 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.8 2.4 4.9 2.5 2.1 2.6 2.6 2.7 1.8 2.9 3.0 0.6 3.2 0.0 1.0 0.6 0.8 1.3 0.0 0.0 8.4 0.5 0.6 1.4 1.5 0.1 0.0 0.0 0.4 1.2 0.6 0.0 0.1 0.6 0.6 0.6 0.5 0.0 0.4 1.6 0.0 0.4 1.1 0.0 1.0 0.0 0.5 0.7 0.4 0.2 13.5 0.9 0.5 0.0 0.0 1.0 0.2 0.3 0.1 1.8 0.0 0.2 4.7 0.0 0.0 1.6 0.4 0.1 0.0 0.7 1.5 0.8 0.5 0.2 6.4 0.0 1.9 0.9 1.1 2.0 0.0 1.0 3.4 1.6 0.2 0.5 0.6 FGFR3 "ACH, CD333, CEK2, JTK4" ENSG00000068078 "Fibroblast growth factor receptor 3" P22607 4 1793293-1808872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 148.3;esophagus: 139.7;skin 1: 271.5" "Cell type enhanced" "Detected in many" "Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004231, HPA067204" Enhanced Supported "Endoplasmic reticulum" "Secreted - unknown location" NA NA 2500000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Endoplasmic reticulum" "CAB004231: AB_627596, HPA067204: AB_2685804" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (5.90e-2)" "unprognostic (1.24e-3)" "unprognostic (7.22e-2)" "unprognostic (2.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (2.88e-2)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" "unprognostic (1.98e-1)" "unprognostic (4.74e-2)" "unprognostic (1.97e-1)" 1.6 1.6 118.0 1.5 140.6 1.4 5.5 115.6 104.0 23.7 37.4 12.2 19.5 1.5 2.8 139.7 2.2 7.9 4.8 100.8 107.6 39.3 40.7 7.4 0.4 144.7 129.2 0.5 76.4 0.2 16.1 9.3 109.8 13.8 5.2 0.2 20.2 15.0 1.3 271.5 14.7 0.4 108.9 4.0 7.8 17.6 148.3 1.7 1.5 0.9 11.1 23.1 60.9 81.2 0.0 3.8 19.5 5.6 0.0 0.3 22.1 2.4 0.3 0.8 0.4 48.2 1.0 0.0 17.8 0.7 0.7 34.9 5.5 0.3 0.3 0.2 19.3 14.2 3.9 80.6 0.1 0.0 0.6 0.0 10.9 0.2 0.1 0.1 0.1 2.3 16.7 0.1 0.0 23.9 0.8 0.5 36.1 19.5 0.1 1.2 1.0 0.3 2.8 64.1 5.7 1.6 1.9 4.0 0.0 22.2 20.4 2.5 1.0 0.0 2.1 0.5 1.6 0.1 0.0 0.0 0.2 1.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.0 140.6 115.6 104.0 100.8 107.6 144.7 129.2 109.8 108.9 148.3 81.2 2.2 0.0 32.5 410.4 1.1 103.8 4.1 29.8 23.9 0.0 4.8 1.5 3.1 91.5 37.6 14.7 0.0 0.5 1.6 36.1 0.0 5.0 7.9 3.0 1.7 3.4 4.2 0.0 0.5 0.7 12.0 3.2 3.6 4.0 0.0 0.1 16.1 30.4 0.6 0.0 1.3 20.7 4.1 1.2 6.5 1.3 0.6 0.6 12.4 14.0 0.6 0.1 0.0 34.2 2.2 0.4 18.0 0.4 0.0 4.2 21.2 9.9 9.8 0.6 0.0 0.7 2.9 0.4 25.9 55.0 88.7 0.8 0.7 0.1 17.0 12.8 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592816-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 256.5;Hofbauer cells: 274.2;monocytes: 1028.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 600.3;Hep G2: 464.9;K-562: 533.6;NB-4: 600.9;PC-3: 508.2;SH-SY5Y: 482.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 4300000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 3: Monocytes - Immune response regulation" Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203" "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 27.5 39.7 41.5 31.1 62.2 8.3 24.9 26.3 57.2 33.7 10.7 12.1 4.4 19.7 0.7 69.4 15.6 7.6 15.8 39.4 28.2 17.3 8.3 27.6 14.5 49.4 42.7 47.7 5.5 2.3 20.2 27.9 22.8 10.3 1.7 3.4 23.8 2.4 7.3 56.3 12.6 5.7 20.9 55.6 9.3 42.5 79.0 9.0 25.6 2.1 8.3 20.4 41.6 77.1 62.3 139.3 91.2 326.3 34.8 65.4 600.3 144.2 62.4 24.2 26.1 98.5 15.6 1.3 172.0 63.5 24.3 231.3 52.2 229.9 2.1 70.6 28.7 4.8 142.0 464.9 18.0 0.2 13.9 40.8 66.6 46.1 37.2 40.4 118.3 0.7 533.6 0.9 31.6 6.9 2.0 600.9 238.4 4.2 508.2 140.0 22.3 2.3 34.9 5.9 73.1 482.4 121.0 2.6 5.3 58.5 3.9 38.4 246.4 167.4 289.3 99.1 151.0 0.9 0.8 0.7 107.8 0.6 317.2 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 41.5 62.2 26.3 57.2 39.4 28.2 49.4 42.7 22.8 20.9 79.0 77.1 90.0 3.2 4.1 1.6 8.3 181.2 26.7 75.1 189.5 9.4 32.3 44.3 10.4 1.5 13.4 1.8 0.0 6.7 10.8 3.9 0.0 12.8 14.3 8.0 37.8 120.6 42.1 28.0 12.1 5.1 110.8 48.9 10.7 10.1 16.5 256.5 84.6 0.8 274.2 0.0 10.9 5.4 8.2 28.0 136.1 12.3 25.4 27.4 51.6 23.4 1028.2 73.5 0.0 4.5 43.2 15.5 1.1 9.1 4.2 7.5 0.4 0.4 2.9 2.6 0.0 29.7 46.3 5.7 8.0 121.2 147.2 14.6 12.2 8.3 2.6 28.0 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168617 "Metabolic proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 27.7" "Cell type enhanced" "Detected in many" "Hofbauer cells: 37.2;Microglial cells: 23.4;Oligodendrocyte precursor cells: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 4.5;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.6;plasmacytoid DC: 4.7" "Group enriched" "Detected in many" 29 "dendritic cells: 4.7;T-cells: 15.0" "Cell line enhanced" "Detected in many" "WM-115: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol NA NA 35000 "Cluster 32: T-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: AB_2675854" "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 4.3 4.9 9.2 3.9 9.3 0.7 3.7 8.4 12.6 11.0 7.6 6.1 3.8 9.1 3.1 7.8 6.0 5.6 5.0 9.1 9.5 1.4 0.9 5.2 2.9 13.4 9.5 6.3 1.4 3.0 4.2 5.1 10.1 4.8 6.3 0.5 25.6 3.6 1.9 27.7 5.0 9.9 10.7 2.7 2.4 4.8 15.9 22.3 1.9 1.9 3.2 6.7 10.6 13.1 0.1 0.9 5.4 2.3 4.7 9.6 10.9 3.2 3.2 1.8 2.6 0.6 0.2 1.1 0.7 10.4 3.3 12.2 0.3 1.8 0.6 0.1 0.6 0.4 0.2 0.4 3.4 0.3 2.7 11.7 4.6 5.5 0.6 4.0 3.7 4.3 1.6 0.2 3.4 0.4 4.2 0.2 1.9 11.5 1.3 2.7 2.4 0.2 0.0 0.4 0.3 2.2 1.0 0.0 6.7 1.0 0.0 0.3 3.4 0.3 1.6 0.5 0.1 0.2 0.2 2.5 1.9 0.4 43.3 0.0 0.1 0.0 0.5 0.0 0.0 0.1 4.5 0.3 0.0 0.1 15.0 4.6 0.3 0.2 0.1 4.7 1.3 2.2 9.2 9.3 8.4 12.6 9.1 9.5 13.4 9.5 10.1 10.7 15.9 13.1 0.7 0.0 0.5 2.9 0.1 4.2 2.0 3.3 7.4 0.0 2.2 2.4 1.0 1.5 0.9 0.0 0.0 0.3 0.3 1.5 0.0 0.6 0.2 0.2 2.1 1.2 0.0 2.7 0.5 0.0 0.4 7.5 0.0 0.3 0.0 1.2 1.4 0.0 37.2 0.0 0.3 1.3 4.1 1.3 0.8 0.0 4.7 9.6 5.4 23.4 0.7 0.4 0.0 24.6 0.5 0.3 2.5 5.3 0.0 0.5 0.0 0.0 0.1 0.1 0.0 3.7 3.3 0.6 0.3 4.2 8.1 0.8 0.7 0.1 4.1 1.4 GAN "GAN1, GIG, KLHL16" ENSG00000261609 Gigaxonin Q9H2C0 16 81314944-81390809 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 24.8" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 130.4;Urothelial cells: 188.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011825, HPA049473" Approved Supported Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" Microtubules "CAB011825: AB_732515, HPA049473: AB_2680782" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (8.23e-2)" "unprognostic (2.51e-2)" "unprognostic (8.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.42e-4)" "unprognostic (1.90e-1)" "unprognostic (3.86e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-3)" "unprognostic (5.91e-3)" "unprognostic (3.12e-3)" "unprognostic (5.93e-2)" "unprognostic (9.98e-2)" "unprognostic (1.46e-2)" "unprognostic (5.86e-2)" 1.3 0.9 7.3 0.7 5.7 0.7 2.4 6.6 4.7 2.6 1.0 2.3 0.8 1.3 1.1 5.4 1.3 0.6 1.5 6.9 8.8 1.0 1.1 1.7 0.7 9.3 8.6 1.4 1.2 0.8 1.4 0.8 5.5 2.0 1.2 3.2 2.3 0.7 1.5 24.8 1.4 0.9 8.7 0.9 1.8 0.9 8.7 0.9 1.1 1.4 1.3 1.5 4.3 9.2 1.6 2.0 1.5 2.1 1.9 1.0 10.4 1.2 0.7 0.8 0.3 5.1 1.8 2.5 1.4 1.6 0.4 3.1 2.7 1.3 1.8 0.6 1.4 2.2 1.8 4.1 2.0 2.1 2.4 1.1 3.8 1.3 3.5 1.1 1.7 2.1 2.8 1.1 1.1 9.1 1.9 2.9 4.0 2.2 0.6 3.7 1.4 1.0 1.6 5.0 1.5 1.0 4.3 4.2 1.4 3.6 2.9 2.0 2.5 2.3 2.1 0.8 1.9 2.2 2.7 5.8 1.2 2.4 1.7 0.7 0.4 0.2 0.8 0.4 0.7 0.4 0.8 0.6 0.2 0.5 0.7 0.9 0.3 0.9 0.3 0.9 0.6 0.2 7.3 5.7 6.6 4.7 6.9 8.8 9.3 8.6 5.5 8.7 8.7 9.2 12.2 12.8 8.2 69.5 9.9 91.3 66.8 15.0 34.1 28.4 15.4 18.5 12.5 7.2 29.5 5.5 89.6 19.3 17.4 27.5 0.0 9.4 2.3 11.6 19.3 14.7 5.4 12.6 21.2 6.7 15.4 14.1 17.3 14.0 1.3 7.2 12.1 6.7 5.6 23.5 29.5 15.1 10.2 6.8 30.9 4.6 9.6 8.6 37.4 14.0 7.5 14.0 9.2 22.1 18.3 18.6 16.8 12.8 11.0 75.0 14.8 3.8 30.1 43.8 6.6 20.2 17.6 11.9 16.4 67.1 130.4 21.3 16.1 5.3 15.6 188.7 GAS2L1 GAR22 ENSG00000185340 "Growth arrest specific 2 like 1" Q99501 22 29306582-29312785 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 84.6;Late spermatids: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 77.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019858 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 51: Myeloid cells - Hemostasis" "Plasma membrane" "Cell Junctions" "HPA019858: AB_1849486" "unprognostic (3.66e-1)" "unprognostic (5.22e-2)" "unprognostic (1.38e-1)" "unprognostic (4.95e-3)" "unprognostic (1.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-3)" "unprognostic (8.99e-2)" "unprognostic (1.28e-1)" "unprognostic (6.05e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "prognostic favorable (8.44e-4)" "unprognostic (4.23e-2)" "unprognostic (9.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-2)" 22.6 36.3 46.7 5.5 41.8 6.5 22.4 39.4 58.5 16.2 30.4 25.8 18.1 18.4 5.3 34.3 16.5 4.2 33.5 45.4 37.8 21.0 18.6 19.3 2.3 50.0 43.3 8.9 14.4 6.6 22.1 4.1 42.2 22.2 2.0 4.0 24.7 16.9 6.5 52.8 17.8 4.4 41.8 29.1 27.4 51.3 47.3 1.1 15.6 3.9 1.8 17.6 19.6 37.4 20.4 23.1 3.5 14.5 5.5 5.2 22.6 29.7 8.9 12.3 6.4 10.6 14.2 0.1 13.1 15.9 12.9 60.5 6.0 16.8 2.2 27.6 2.9 26.5 19.9 7.5 7.0 0.2 17.8 5.6 11.5 11.9 4.7 8.9 16.5 26.2 12.8 4.1 9.0 17.2 0.5 14.8 5.3 13.5 51.6 0.6 10.3 1.7 7.5 12.8 1.2 19.0 23.0 30.3 17.0 4.4 30.2 4.1 35.5 77.0 53.0 34.6 30.3 0.3 0.4 0.3 34.1 1.0 19.3 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 46.7 41.8 39.4 58.5 45.4 37.8 50.0 43.3 42.2 41.8 47.3 37.4 34.5 6.4 1.7 28.1 0.4 28.2 7.0 12.3 21.6 3.6 24.0 18.4 5.6 14.3 8.3 1.8 6.2 24.8 0.8 13.4 7.9 12.2 33.8 19.2 9.2 26.2 1.8 19.6 14.8 6.7 14.3 12.0 9.2 10.0 1.3 28.9 84.6 12.0 14.1 13.5 11.4 5.1 20.3 14.5 23.0 89.7 9.6 37.6 12.4 7.5 7.6 5.4 0.0 4.0 4.0 10.2 7.2 11.7 0.2 6.1 41.7 10.1 4.3 20.9 39.5 35.3 23.5 5.4 12.4 27.9 32.4 6.7 2.2 17.8 11.8 4.6 GDPD2 "FLJ20207, GDE3, OBDPF" ENSG00000130055 "Glycerophosphodiester phosphodiesterase domain containing 2" Q9HCC8 X 70423031-70433390 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 20.8;lymphoid tissue: 59.2;skin 1: 47.8" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 56.7;Distal enterocytes: 30.4;Muller glia cells: 29.9;Proximal enterocytes: 92.2" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 9.2;NTERA-2: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 45: Enterocytes - Digestion" "unprognostic (1.53e-3)" "unprognostic (5.79e-2)" "unprognostic (5.37e-2)" "unprognostic (5.00e-7)" "unprognostic (3.15e-3)" "unprognostic (3.65e-2)" "unprognostic (2.86e-2)" "unprognostic (4.66e-2)" "unprognostic (1.19e-1)" "unprognostic (8.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.41e-2)" "unprognostic (5.52e-2)" "unprognostic (2.22e-1)" "unprognostic (8.91e-2)" 0.0 0.0 10.4 0.5 9.8 0.1 0.9 7.6 10.3 0.0 8.9 4.8 11.1 0.0 4.9 0.2 0.2 0.2 0.7 8.5 11.0 0.5 0.0 0.0 0.0 9.4 14.4 0.1 0.0 0.0 3.2 0.1 10.4 0.0 3.9 3.6 1.0 0.3 0.5 47.8 20.8 0.1 9.0 59.2 1.8 0.0 12.4 0.0 0.0 0.0 0.0 0.7 0.1 10.8 0.0 0.0 9.2 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 19.8 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.4 9.8 7.6 10.3 8.5 11.0 9.4 14.4 10.4 9.0 12.4 10.8 0.0 0.0 0.0 12.7 0.0 56.7 0.0 0.6 0.0 0.2 0.0 0.0 1.9 0.0 0.2 0.0 0.0 7.0 0.0 30.4 0.0 0.0 0.0 0.3 0.0 0.2 1.2 0.0 0.0 0.0 3.5 0.2 3.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 92.2 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 12.1 3.3 0.2 0.0 3.1 0.2 GEMIN4 "DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97" ENSG00000179409 "Gem nuclear organelle associated protein 4" P57678 17 744421-753999 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065699, HPA067891" Uncertain Supported "Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear bodies, Cytosol" "HPA065699: AB_2685534, HPA067891: AB_2685918" "unprognostic (1.85e-1)" "unprognostic (3.36e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-2)" "unprognostic (1.60e-1)" "unprognostic (7.41e-3)" "unprognostic (2.00e-2)" "unprognostic (7.95e-2)" "unprognostic (1.98e-2)" "unprognostic (1.63e-1)" "unprognostic (1.89e-2)" "unprognostic (8.67e-3)" "unprognostic (4.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (4.74e-2)" "unprognostic (8.56e-3)" 12.4 7.7 3.0 8.2 3.0 15.5 12.3 10.5 6.2 13.4 5.9 9.5 8.0 12.1 5.7 14.8 12.3 13.0 11.2 2.9 3.3 4.9 8.6 9.8 13.6 2.3 2.4 15.6 9.7 6.3 5.7 6.6 2.6 14.4 6.3 3.4 11.7 8.2 13.9 38.9 9.8 8.5 2.1 10.0 14.5 48.9 3.1 13.2 15.6 10.1 12.3 11.8 12.4 2.6 44.8 77.8 25.5 38.3 15.8 19.9 31.7 25.0 17.4 44.4 39.1 44.5 23.6 77.9 32.5 21.6 23.6 55.4 48.3 47.0 35.3 29.6 72.3 28.0 40.9 25.1 11.3 30.1 36.8 19.3 23.3 36.5 25.6 15.4 25.3 44.9 39.6 31.7 24.0 31.7 49.8 17.0 24.7 37.4 33.0 53.1 12.1 36.6 18.9 32.5 26.4 21.4 25.7 26.1 11.7 18.2 27.8 21.7 20.2 27.3 24.6 35.6 61.4 5.3 12.4 44.8 23.5 41.9 31.8 1.6 7.0 0.3 7.9 9.6 13.6 11.8 8.6 8.4 9.3 12.3 10.1 10.2 0.9 8.7 11.6 5.2 6.0 10.0 3.0 3.0 10.5 6.2 2.9 3.3 2.3 2.4 2.6 2.1 3.1 2.6 2.9 16.0 6.7 1.3 8.5 20.4 14.3 6.6 9.1 2.9 4.6 4.7 38.4 4.3 8.5 0.0 0.0 8.4 4.4 3.1 3.9 7.5 148.3 2.6 3.9 5.8 1.2 3.0 1.2 6.4 8.3 6.4 7.7 2.9 1.3 11.1 4.6 5.2 5.4 5.0 1.5 7.0 8.2 3.9 5.7 157.2 11.5 2.6 5.4 1.0 4.8 2.4 2.1 0.0 0.5 8.4 1.8 6.8 4.3 7.4 2.3 2.2 4.4 1.4 0.0 6.2 6.4 57.0 11.2 8.7 16.1 4.0 3.2 7.4 8.7 9.8 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Human disease related genes, Predicted intracellular proteins" "Congenital muscular dystrophy, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 345.8" "Cell type enhanced" "Detected in all" "Distal enterocytes: 501.1;Pancreatic endocrine cells: 296.7;Paneth cells: 285.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 11000 "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 51.0 54.8 80.0 22.4 91.5 3.3 54.3 88.7 94.4 99.8 64.7 120.2 24.7 53.7 17.6 345.8 48.9 23.4 66.1 74.5 82.1 104.1 58.4 76.3 15.9 89.4 91.4 34.4 43.5 20.8 56.0 28.7 88.1 63.6 41.1 17.9 100.9 31.0 65.1 150.2 45.5 17.5 82.0 37.7 78.7 24.9 91.1 18.6 55.8 23.3 21.0 74.1 140.1 92.3 328.1 148.6 44.7 70.6 40.6 40.7 35.2 119.7 59.8 96.7 87.3 80.3 120.6 4.7 220.3 85.2 64.6 183.8 38.7 100.6 32.6 33.8 69.0 63.9 100.7 79.7 123.7 6.9 75.3 46.7 98.5 58.8 51.3 57.4 66.0 47.2 30.1 54.4 49.9 243.8 21.3 13.3 48.6 182.1 147.8 21.7 37.4 43.7 121.6 281.6 41.8 46.2 67.1 163.2 157.0 23.1 102.5 35.1 115.4 135.7 74.6 191.7 130.1 50.5 70.5 17.3 113.9 51.9 146.2 3.0 0.7 0.1 5.1 1.1 4.7 1.9 5.1 5.1 1.1 0.8 4.2 3.3 0.3 1.5 0.5 3.6 12.0 1.7 80.0 91.5 88.7 94.4 74.5 82.1 89.4 91.4 88.1 82.0 91.1 92.3 30.6 28.9 15.2 22.9 8.3 113.9 77.4 52.1 35.9 69.8 73.6 31.6 14.8 37.1 62.8 82.8 35.5 36.3 19.3 501.1 52.8 167.9 1.1 92.2 30.5 32.4 43.1 1.7 28.8 164.3 77.1 32.6 69.3 76.8 10.2 37.3 23.2 18.0 55.9 75.7 32.2 87.8 42.7 10.8 29.8 2.4 20.5 16.1 58.7 10.3 23.4 73.3 18.6 17.1 71.6 296.7 285.4 25.2 6.8 120.4 36.0 52.7 38.0 46.0 19.7 18.1 44.5 6.4 20.4 107.0 169.8 25.7 22.9 47.7 138.1 199.7 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435595-121449727 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease variant, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 250.0;Astrocytes: 276.2;Basal keratinocytes: 234.9;Cardiomyocytes: 199.7;Endometrial stromal cells: 215.5;Granulosa cells: 494.3;Suprabasal keratinocytes: 378.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 462.7;HUVEC TERT2: 362.3;NTERA-2: 365.8;SuSa: 453.4;U-87 MG: 350.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 121.2 287.6 313.5 24.7 310.2 0.9 60.6 260.1 409.0 261.7 193.1 17.5 18.2 98.7 10.6 74.9 32.7 99.9 168.9 273.6 362.6 21.2 10.6 67.9 21.1 340.3 380.9 43.5 19.4 236.2 31.3 290.2 307.4 83.3 19.7 3.3 35.6 148.0 10.3 388.2 24.7 112.5 335.9 4.2 30.7 36.9 373.3 24.3 169.1 22.1 34.9 116.0 184.9 341.0 0.1 43.5 186.8 0.4 99.7 61.5 0.4 142.5 286.9 46.9 113.7 0.7 0.4 0.0 15.8 55.8 40.2 18.3 5.1 87.4 151.3 0.1 51.6 2.3 15.7 0.0 124.1 0.0 0.4 164.6 92.1 172.5 61.7 462.7 362.3 0.0 0.1 4.3 9.4 8.4 0.1 80.6 365.8 0.1 47.2 0.1 0.0 3.7 188.6 21.0 0.4 2.9 0.0 0.3 0.1 453.4 14.9 0.3 269.5 143.8 39.4 122.8 93.5 0.1 0.1 0.1 350.4 0.1 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.5 310.2 260.1 409.0 273.6 362.6 340.3 380.9 307.4 335.9 373.3 341.0 152.2 250.0 80.0 276.2 0.1 234.9 133.6 71.1 77.4 0.3 9.5 20.1 199.7 0.0 17.5 1.8 2.1 53.4 0.4 0.0 0.0 76.9 0.5 21.5 215.5 166.6 0.0 0.0 0.3 4.2 7.9 124.4 0.5 51.7 8.8 494.3 33.9 0.1 8.6 0.0 0.6 0.0 4.1 0.9 55.3 1.7 2.5 3.6 44.4 15.0 0.6 0.3 0.0 4.0 1.0 10.8 0.0 4.1 0.1 29.7 0.0 0.1 6.2 0.3 0.0 5.9 80.2 0.9 1.8 68.3 378.2 20.0 4.9 127.1 0.4 52.7 GJA9 "CX58, CX59, GJA10" ENSG00000131233 "Gap junction protein alpha 9" P57773 1 38874069-38881587 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "GAMG: 1.0" "Low region specificity" "Detected in all" HPA067850 Uncertain NA NA "Cluster 24: B-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "HPA067850: AB_2685910" "unprognostic (2.00e-1)" "unprognostic (8.78e-2)" "unprognostic (4.55e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-2)" "unprognostic (1.20e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-2)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (4.11e-3)" "unprognostic (2.32e-2)" 0.1 0.1 0.3 0.0 0.4 0.0 0.0 0.2 0.5 0.1 0.0 0.3 0.2 0.0 0.0 0.4 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.1 1.4 1.7 0.1 0.1 0.0 0.2 0.0 0.7 0.1 0.2 0.4 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.8 0.5 0.0 0.2 0.0 0.0 0.2 0.3 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.4 0.2 0.5 0.1 0.1 1.4 1.7 0.7 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJB6 "CX30, DFNA3, ED2, EDH, HED" ENSG00000121742 "Gap junction protein beta 6" O95452 13 20221962-20232365 "Disease related genes, Human disease related genes, Predicted membrane proteins" Hearing "Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 95.6;esophagus: 195.4;vagina: 139.3" "Cell type enhanced" "Detected in some" "Astrocytes: 58.8;Basal keratinocytes: 12.2;Basal respiratory cells: 15.6;Ionocytes: 12.2;Squamous epithelial cells: 31.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 145.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 2.6" "Lineage enriched" "Detected in single" 5 "T-cells: 2.6" "Cell line enriched" "Detected in some" 10 "RT4: 186.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014846 Supported "Cell Junctions" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "Cell Junctions" "HPA014846: AB_1847135" "unprognostic (5.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "unprognostic (7.90e-2)" "unprognostic (2.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.83e-1)" "unprognostic (8.96e-2)" "unprognostic (9.64e-2)" "unprognostic (2.82e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-2)" "unprognostic (1.14e-11)" "unprognostic (8.99e-2)" "unprognostic (1.16e-1)" "unprognostic (6.35e-3)" "unprognostic (5.04e-2)" 0.5 0.2 55.8 0.3 59.4 95.6 3.8 73.0 80.9 65.9 36.0 0.0 0.0 0.9 0.2 195.4 0.4 1.3 0.1 50.2 63.5 0.0 0.1 0.3 0.8 60.0 71.8 0.0 0.1 0.0 4.4 0.0 57.5 0.2 0.1 0.0 34.5 0.0 0.1 56.8 0.2 0.0 47.7 0.2 0.3 1.4 76.3 37.6 5.3 0.0 15.4 10.3 139.3 42.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 4.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 186.3 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 1.1 0.6 0.5 0.0 0.0 0.0 2.6 0.2 55.8 59.4 73.0 80.9 50.2 63.5 60.0 71.8 57.5 47.7 76.3 42.7 0.0 0.0 0.0 58.8 0.0 12.2 1.7 15.6 4.0 0.0 0.0 0.1 0.6 0.0 4.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.9 5.8 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 12.2 0.0 0.4 4.6 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.1 0.3 31.0 3.8 0.0 0.3 0.0 0.0 2.4 GLTP ENSG00000139433 "Glycolipid transfer protein" Q9NZD2 12 109850945-109880541 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 334.1;skin 1: 276.6" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 266.5;Suprabasal keratinocytes: 479.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056461, HPA065503" Approved Supported Cytosol NA NA 25000 "Cluster 7: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" Cytosol "HPA056461: AB_2683138, HPA065503: " "unprognostic (1.18e-1)" "prognostic favorable (2.01e-5)" "unprognostic (7.46e-2)" "unprognostic (6.22e-3)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (6.63e-2)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (2.47e-1)" "unprognostic (3.03e-1)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (2.20e-1)" "prognostic favorable (4.17e-6)" "unprognostic (3.28e-2)" 19.0 21.7 59.1 17.5 98.8 19.3 27.1 93.6 75.1 94.4 43.1 38.4 14.6 15.9 34.8 334.1 13.6 14.2 21.0 62.3 69.9 53.2 15.1 24.4 19.3 110.3 89.5 18.2 23.8 31.4 12.5 17.8 102.5 29.4 31.8 7.0 84.7 19.1 18.6 276.6 32.1 18.8 84.0 21.5 21.6 16.3 87.3 18.0 23.5 18.1 108.2 33.6 178.0 138.5 39.3 27.9 15.5 16.7 36.2 41.4 11.0 47.4 58.2 36.0 29.7 11.3 14.9 34.5 25.3 57.8 17.5 47.3 24.2 54.9 50.7 35.0 21.5 22.6 15.9 16.5 31.6 24.6 25.5 30.1 68.8 64.6 45.3 53.9 61.3 34.8 10.1 22.5 53.2 52.9 33.6 19.8 28.1 32.0 36.8 29.3 36.4 36.3 20.5 116.1 20.0 19.8 30.1 77.1 26.0 14.1 36.1 8.6 83.2 41.4 21.9 61.5 36.5 30.1 27.7 23.8 83.0 25.1 25.9 42.6 65.7 37.3 51.5 66.0 32.4 23.9 31.0 46.5 48.8 21.5 20.1 35.8 32.9 42.4 57.0 8.0 37.6 40.6 59.1 98.8 93.6 75.1 62.3 69.9 110.3 89.5 102.5 84.0 87.3 138.5 48.1 25.6 60.9 10.4 37.5 145.4 109.1 72.1 88.2 11.4 55.6 44.4 14.6 18.6 62.7 44.1 14.6 86.5 48.3 95.6 199.6 39.0 20.5 30.1 33.3 47.9 32.4 10.1 9.9 56.5 20.0 35.0 28.5 59.1 20.8 19.0 34.2 15.3 34.5 13.5 11.4 39.2 50.8 61.6 84.6 11.7 23.0 55.3 60.5 13.1 61.8 23.4 64.9 21.6 140.1 53.5 40.0 18.0 26.2 80.6 102.3 38.2 25.2 12.3 39.5 23.5 37.3 22.9 20.8 266.5 479.2 210.6 46.3 31.4 59.1 129.0 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4" "Cell line enhanced" "Detected in all" "BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 19000000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 17.4 20.5 29.3 30.0 39.7 20.6 28.0 38.9 31.1 30.8 17.9 19.7 15.8 15.1 30.8 56.2 15.4 23.4 26.2 27.1 34.3 11.4 24.8 39.0 61.4 42.6 37.9 21.3 14.9 28.3 6.6 57.9 44.3 21.1 26.3 11.7 17.0 17.9 7.2 81.8 16.3 20.0 39.0 36.0 15.8 11.6 36.2 72.3 13.0 10.5 77.9 40.3 49.5 46.7 22.3 14.8 15.1 71.7 98.0 48.2 207.1 35.0 75.1 19.0 25.6 30.3 26.1 71.9 35.1 26.9 51.1 60.0 16.7 291.8 27.2 41.4 10.5 11.7 16.8 37.9 23.7 19.1 117.1 65.4 287.0 24.4 16.4 26.0 27.6 85.1 11.4 30.7 30.1 9.6 38.4 18.0 10.2 11.4 32.3 17.7 7.1 46.3 18.4 43.3 3.9 13.4 29.1 133.0 58.3 52.0 30.7 22.5 24.6 46.0 17.6 38.3 10.6 75.2 96.8 187.0 53.1 30.1 19.4 7.6 40.4 2.4 3.7 13.6 2.7 30.9 4.3 3.9 39.6 29.8 6.1 4.8 8.7 4.4 3.4 28.0 5.4 18.6 29.3 39.7 38.9 31.1 27.1 34.3 42.6 37.9 44.3 39.0 36.2 46.7 5.8 16.0 23.0 5.5 25.0 14.9 18.5 63.2 26.7 5.8 5.4 15.5 30.9 0.0 29.7 18.4 2.1 53.6 8.3 4.4 1.9 7.2 0.5 5.7 6.8 7.3 3.6 5.0 2.2 8.1 224.7 10.2 10.7 7.7 69.6 16.3 8.6 24.2 100.8 6.7 2.7 5.4 10.2 55.7 32.5 1.6 8.1 67.8 8.8 2.8 52.5 8.0 7.2 3.5 9.5 6.0 4.7 13.9 28.8 6.7 6.2 5.4 19.9 3.7 0.0 7.9 6.9 1.8 4.2 45.6 23.9 52.5 5.6 6.4 6.7 36.5 GNG14 ENSG00000283980 "G protein subunit gamma 14" A0A1W2PPG7 19 12687998-12688422 "Predicted intracellular proteins" Transducer "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 1.0;skin 1: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;HEK 293: 2.1;MCF7: 2.2;U-266/84: 1.2" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" 0.1 0.0 0.2 0.0 0.5 0.4 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 2.2 0.2 0.5 0.2 0.0 0.6 0.1 0.0 0.3 0.0 0.8 0.3 0.5 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.2 0.8 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 GP1BB "CD42c, GPIbbeta" ENSG00000203618 "Glycoprotein Ib platelet subunit beta" P13224 22 19723539-19724771 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.2;heart muscle: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 74.0;neutrophil: 74.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 74.5" "Cell line enriched" "Detected in some" 4 "K-562: 85.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA 4400000 "Cluster 34: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" 2.7 2.0 39.0 0.2 40.1 2.7 2.5 26.1 51.0 9.2 11.1 2.9 0.0 4.8 0.0 11.2 4.4 0.0 27.1 53.2 18.3 2.9 1.2 4.1 0.2 16.2 15.4 6.3 2.2 2.5 22.1 0.2 15.6 3.4 0.0 0.6 2.4 0.0 1.4 24.4 1.4 0.1 7.9 10.1 2.3 4.2 28.0 0.1 3.1 0.5 0.1 1.6 7.2 22.9 0.0 1.1 1.6 0.7 0.0 0.0 0.2 1.5 0.0 0.1 0.4 0.0 0.1 0.2 0.3 0.0 0.3 0.8 0.1 0.1 0.0 0.0 7.7 4.1 0.1 0.0 0.0 0.0 10.3 0.2 0.1 0.3 0.0 0.0 0.0 0.2 85.4 0.1 0.5 0.1 0.3 19.2 0.4 0.1 2.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.9 1.3 0.2 0.0 2.9 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 74.0 8.5 12.5 1.6 3.1 0.8 0.5 0.5 0.2 3.6 0.9 1.0 0.8 74.5 1.1 0.6 12.6 2.2 417.7 39.0 40.1 26.1 51.0 53.2 18.3 16.2 15.4 15.6 7.9 28.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPC2 "cerebroglycan, DKFZp547M109, FLJ38962" ENSG00000213420 "Glypican 2" Q8N158 7 100169606-100177381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lymphoid tissue: 5.2;skin 1: 5.7;testis: 11.9" "Cell type enhanced" "Detected in many" "Early spermatids: 37.7;Enteroendocrine cells: 10.7;Spermatocytes: 13.6" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 39.8;AN3-CA: 15.8;BEWO: 14.2;SH-SY5Y: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB025423 Uncertain "Intracellular and membrane" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "CAB025423: " "unprognostic (4.33e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-4)" "unprognostic (3.42e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-3)" "unprognostic (6.67e-2)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-4)" "unprognostic (7.25e-4)" "unprognostic (1.67e-4)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "prognostic favorable (9.94e-4)" 0.5 0.3 1.1 1.0 0.9 1.1 0.7 1.1 1.4 1.3 0.6 0.8 0.3 1.8 0.1 0.5 0.9 0.2 0.5 1.1 0.9 0.5 0.1 0.4 1.2 1.2 1.0 1.6 0.2 0.7 0.8 0.1 1.1 0.7 0.4 0.5 0.8 0.2 0.4 5.7 0.9 0.4 1.2 1.1 0.3 11.9 1.0 5.2 0.2 0.0 0.5 0.6 1.0 1.5 0.1 0.2 39.8 15.8 0.0 0.0 14.2 1.3 0.0 0.2 0.3 0.0 0.5 3.5 0.9 0.4 2.3 1.4 1.4 0.5 0.0 0.0 1.2 0.3 0.6 0.1 0.7 0.8 6.1 1.3 0.8 0.9 0.0 0.7 2.0 9.2 1.6 0.0 1.0 0.6 9.7 1.2 7.0 0.7 2.3 10.7 2.9 0.1 0.2 0.7 10.5 43.5 0.8 1.0 1.6 5.6 0.7 0.8 1.5 0.4 6.2 0.9 0.3 1.4 0.5 4.9 0.4 2.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 1.1 1.4 1.1 0.9 1.2 1.0 1.1 1.2 1.0 1.5 0.6 0.0 0.0 1.0 2.2 1.8 1.0 0.6 1.8 0.2 1.1 1.7 2.3 0.0 0.1 1.8 4.2 0.4 0.2 0.4 0.0 1.4 37.7 0.9 2.1 0.8 10.7 2.1 0.2 1.0 0.8 1.6 2.6 0.8 0.0 7.9 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.6 0.4 6.4 0.9 1.0 0.0 1.0 0.6 1.2 2.1 8.0 1.1 1.3 0.4 1.2 0.1 0.8 0.0 0.1 0.4 2.3 0.0 1.8 2.8 13.6 5.7 0.3 3.8 0.4 0.9 1.6 1.1 0.7 GPR143 OA1 ENSG00000101850 "G protein-coupled receptor 143" P51810 X 9725346-9786297 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.2;choroid plexus: 14.4" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 40.6;Melanocytes: 126.3" "Cancer enriched" "Detected in all" 9 "melanoma: 84.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "basophil: 3.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 159.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA003648 Enhanced NA NA "Cluster 34: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA003648: AB_2667028" "unprognostic (4.60e-2)" "prognostic favorable (8.73e-4)" "unprognostic (7.43e-3)" "unprognostic (5.41e-2)" "unprognostic (4.62e-3)" "unprognostic (2.00e-2)" "unprognostic (3.05e-1)" "unprognostic (2.64e-3)" "unprognostic (3.78e-1)" "unprognostic (5.89e-2)" "unprognostic (8.18e-2)" "unprognostic (8.40e-2)" "prognostic favorable (2.45e-5)" "unprognostic (2.75e-1)" "unprognostic (2.07e-1)" "unprognostic (8.76e-2)" "unprognostic (1.59e-2)" 0.6 1.1 10.6 0.1 13.0 0.0 1.7 11.8 11.5 2.0 14.4 1.4 0.5 3.2 5.3 2.4 2.8 0.9 0.1 10.8 13.1 4.6 1.7 1.0 0.5 12.6 14.2 3.3 1.2 2.9 2.7 6.1 12.3 2.6 1.4 0.9 3.3 4.4 0.0 8.9 0.5 1.0 11.4 0.0 0.7 0.8 13.1 1.8 3.2 0.0 1.6 1.1 1.1 12.2 1.9 0.4 4.6 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.4 0.1 0.2 1.1 0.1 0.1 0.3 0.0 0.2 0.6 2.3 0.0 3.4 0.1 1.6 0.0 0.0 24.2 6.7 0.0 0.0 0.0 0.0 12.1 0.0 0.1 11.1 0.0 0.1 0.0 0.1 0.1 22.2 3.2 0.9 0.0 0.3 0.0 159.6 10.8 1.9 0.0 4.6 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 3.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 10.6 13.0 11.8 11.5 10.8 13.1 12.6 14.2 12.3 11.4 13.1 12.2 0.1 0.0 0.0 9.8 0.2 5.5 1.3 1.8 2.2 0.5 2.1 1.7 0.9 0.0 4.9 7.3 0.0 40.6 0.0 0.8 1.9 4.9 0.2 1.7 1.6 1.5 0.0 0.0 0.6 0.6 2.1 1.0 0.0 1.3 0.0 1.8 2.9 0.3 4.8 0.0 0.3 0.8 2.0 0.0 1.6 1.8 1.8 0.1 126.3 1.0 0.0 1.2 0.0 0.5 0.6 1.2 0.2 6.4 0.0 1.8 0.2 5.0 3.2 0.2 0.0 0.0 0.7 0.2 1.3 4.2 0.6 10.1 0.7 1.0 2.0 1.8 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 10.5;skin 1: 17.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0" "Low region specificity" "Detected in many" "HPA038129, HPA070760" Approved Approved "Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA038129: AB_2675846, HPA070760: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavorable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favorable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.1 0.0 1.7 0.6 1.6 0.0 0.9 5.9 2.1 0.9 0.4 6.2 3.6 0.0 0.0 4.4 0.3 0.2 0.0 0.6 6.7 5.7 0.3 10.5 0.0 5.5 4.9 0.1 5.7 2.1 4.2 0.0 5.7 1.9 3.4 0.1 2.8 1.1 0.1 17.4 8.0 0.1 1.8 0.0 5.1 3.0 9.7 0.0 3.4 0.0 0.5 0.6 2.0 1.0 10.2 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.7 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.0 1.7 0.3 0.3 0.1 3.7 12.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 5.9 2.1 0.6 6.7 5.5 4.9 5.7 1.8 9.7 1.0 0.0 19.2 3.7 0.0 0.0 1.7 2.8 1.9 2.8 0.3 1.4 1.0 0.2 7.2 2.1 3.7 0.0 0.0 0.0 30.4 0.0 11.3 9.3 0.0 0.0 0.1 6.6 0.0 0.7 20.2 0.0 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.9 30.8 0.0 0.0 0.3 20.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 13.1 0.4 0.0 2.1 21.7 4.0 1.8 0.1 0.0 0.0 0.2 2.9 0.8 2.4 6.1 0.0 0.1 0.0 7.3 1.3 GPSM2 "DFNB82, LGN, Pins" ENSG00000121957 "G protein signaling modulator 2" P81274 1 108875350-108934545 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.9;tongue: 54.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 133.5;Oligodendrocyte precursor cells: 134.7;Oligodendrocytes: 127.4;Syncytiotrophoblasts: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 3.2;T-reg: 1.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;T-cells: 1.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007327, HPA008408, CAB018962" Uncertain Supported Cytosol NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol "CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939" "unprognostic (1.97e-1)" "unprognostic (6.80e-2)" "prognostic favorable (7.86e-5)" "unprognostic (1.37e-3)" "unprognostic (3.18e-2)" "unprognostic (1.97e-2)" "unprognostic (8.57e-6)" "unprognostic (7.12e-2)" "unprognostic (2.76e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.55e-3)" "prognostic unfavorable (3.02e-4)" "unprognostic (6.27e-3)" "unprognostic (1.00e-1)" "unprognostic (5.14e-3)" "unprognostic (6.00e-2)" 5.3 3.5 27.3 4.4 39.5 14.4 7.5 33.8 25.2 12.6 10.8 15.3 9.1 6.8 2.6 34.1 4.2 2.6 4.3 23.3 29.5 2.3 2.9 9.0 6.4 33.9 36.3 3.3 3.6 9.7 3.1 7.7 33.9 5.9 15.2 8.6 10.1 4.7 10.7 37.7 11.5 10.5 32.1 2.7 5.1 11.5 34.1 18.4 3.2 54.4 13.2 6.0 17.7 46.9 135.6 16.2 36.8 27.7 36.4 20.2 30.0 24.2 61.4 29.9 45.4 16.0 31.7 30.5 6.7 33.4 21.0 28.3 25.3 59.1 39.6 30.7 15.8 19.8 34.7 16.5 4.8 28.6 18.5 4.1 113.9 29.4 129.8 9.4 26.9 19.5 14.9 42.3 58.4 37.8 26.1 12.2 8.7 52.1 29.4 20.1 66.7 6.6 24.3 18.6 30.4 26.9 37.0 69.2 26.9 10.3 27.6 24.3 18.0 21.7 36.7 64.8 48.5 18.4 20.9 28.6 34.3 47.4 108.9 0.1 0.3 3.2 0.2 0.3 0.1 0.2 0.2 0.2 0.3 0.4 0.4 0.3 0.3 0.1 0.1 0.1 1.8 0.1 27.3 39.5 33.8 25.2 23.3 29.5 33.9 36.3 33.9 32.1 34.1 46.9 4.6 16.0 3.3 63.0 5.7 62.7 18.8 12.9 47.3 47.7 3.0 3.7 2.5 2.8 12.5 7.3 133.5 46.3 6.7 10.8 11.7 2.5 54.0 5.2 20.6 5.1 9.1 33.9 11.7 1.9 47.7 19.5 8.6 9.2 2.5 14.4 2.9 1.6 9.0 43.7 24.0 14.1 10.2 5.3 11.3 21.3 18.6 4.9 26.6 3.7 5.3 8.0 2.1 134.7 127.4 4.8 7.8 5.3 5.3 5.6 8.4 0.9 9.0 48.1 0.0 43.6 6.9 20.6 28.9 24.0 40.6 89.2 7.1 10.0 18.7 15.5 GRIFIN ENSG00000275572 "Galectin-related inter-fiber protein" A4D1Z8 7 2474844-2476894 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Cell type enhanced" "Detected in single" "Astrocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "unprognostic (1.18e-2)" "unprognostic (2.98e-2)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.68e-2)" "unprognostic (4.31e-1)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" 0.3 0.1 0.4 0.0 0.3 0.2 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.1 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.0 0.3 0.7 0.5 0.9 0.9 0.6 0.4 1.5 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSS ENSG00000100983 "Glutathione synthetase" P48637 20 34928432-34956027 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 164.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054508, HPA059315" Enhanced Supported Nucleoplasm NA NA 28000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA054508: AB_2682509, HPA059315: AB_2683976" "unprognostic (5.80e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (7.21e-2)" "unprognostic (3.63e-2)" "unprognostic (5.68e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (2.90e-2)" "unprognostic (8.52e-2)" "unprognostic (3.64e-1)" "unprognostic (6.49e-2)" "unprognostic (1.50e-1)" "prognostic favorable (7.31e-6)" "unprognostic (3.35e-3)" "unprognostic (1.96e-1)" "unprognostic (1.42e-3)" "unprognostic (1.52e-1)" 18.8 46.9 24.2 17.7 25.6 27.1 23.8 21.4 26.2 21.1 24.6 41.1 30.4 17.4 67.7 43.4 26.9 17.9 24.8 25.4 25.3 42.7 44.8 21.7 15.9 23.7 25.1 14.3 15.7 27.7 26.4 19.8 25.5 34.2 40.6 15.7 28.9 18.6 20.4 34.6 28.4 19.1 22.9 23.7 28.5 23.7 25.9 21.5 23.2 16.9 18.5 22.9 26.1 25.4 63.7 75.7 36.2 51.2 41.4 42.8 51.5 52.9 48.7 81.6 67.1 139.9 75.5 44.8 68.6 54.9 78.7 58.7 53.6 134.8 68.5 20.9 30.4 176.1 46.8 140.1 58.1 44.8 59.5 45.3 141.8 77.0 128.8 36.3 58.4 59.5 87.1 35.7 100.6 70.1 72.5 63.5 21.4 83.2 96.0 64.8 72.7 106.9 117.7 63.9 71.0 41.3 93.6 86.5 70.9 19.7 106.5 40.5 46.7 93.1 52.5 61.7 46.5 35.7 35.9 49.1 79.4 48.6 56.7 17.5 36.2 8.7 30.4 39.2 27.6 12.8 24.0 31.4 43.6 8.7 27.7 23.7 8.4 29.3 36.6 23.9 32.6 29.0 24.2 25.6 21.4 26.2 25.4 25.3 23.7 25.1 25.5 22.9 25.9 25.4 10.6 19.2 10.5 13.4 9.9 26.3 32.5 72.4 38.7 23.0 32.8 20.8 17.1 27.1 38.1 25.8 10.4 79.4 19.1 58.1 25.4 51.6 55.6 14.8 18.2 16.1 23.4 26.9 12.2 47.2 52.5 19.3 37.2 16.4 17.7 80.1 10.0 27.3 59.9 35.3 13.8 50.6 48.8 17.2 17.3 164.1 10.2 26.8 16.0 5.6 31.0 29.6 19.6 10.1 9.9 39.8 40.1 18.4 19.6 21.4 33.8 121.5 18.1 16.9 26.3 12.0 21.0 14.7 18.9 38.1 24.2 49.0 20.6 52.1 77.7 33.0 H2AX H2AFX ENSG00000188486 "H2A.X variant histone" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Yes Yes "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563" "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 13.2 20.7 35.2 12.6 37.8 24.9 8.0 39.0 42.2 13.3 20.6 18.6 13.3 14.0 2.1 43.6 13.1 3.1 13.4 33.7 32.3 17.0 13.9 14.3 16.0 43.9 38.9 18.7 11.6 3.4 24.3 11.0 37.8 15.7 4.3 6.6 11.4 4.7 12.4 18.1 18.8 3.5 38.0 24.0 16.1 15.4 37.8 30.5 10.4 3.6 12.0 11.8 15.7 51.8 132.1 77.9 120.3 72.3 10.9 7.9 126.4 146.0 44.0 80.3 70.4 124.0 55.1 89.7 85.9 34.0 60.5 134.0 57.5 41.7 21.5 133.4 161.0 182.2 20.7 129.8 11.4 90.5 108.9 6.7 9.0 34.2 21.0 13.1 40.7 115.4 149.9 143.1 38.9 335.6 207.8 269.9 87.5 60.0 162.6 200.7 141.6 42.7 37.5 56.3 127.6 152.0 116.0 66.6 20.6 20.6 99.8 68.2 50.9 77.7 204.2 63.8 110.2 38.7 40.8 92.3 17.9 145.2 155.0 3.8 1.3 4.2 1.6 0.6 0.8 0.9 1.7 1.7 1.8 0.8 1.1 1.0 0.6 2.2 0.8 0.8 1.6 1.2 35.2 37.8 39.0 42.2 33.7 32.3 43.9 38.9 37.8 38.0 37.8 51.8 43.7 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 83.2 34.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 106.6 9.4 0.0 0.0 0.0 0.0 0.0 0.0 45.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 64.2 7.2 0.0 0.0 0.0 H2BC21 "H2B, H2B.1, H2B/q, H2BE, H2BFQ, HIST2H2BE" ENSG00000184678 "H2B clustered histone 21" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 86.5;Syncytiotrophoblasts: 160.2" "Cancer enhanced" "Detected in all" "prostate cancer: 87.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 58.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 58.6" "Cell line enhanced" "Detected in many" "Karpas-707: 56.8;U-266/70: 93.7;U-266/84: 53.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA Yes "Cluster 50: Neutrophils - Cellular senescence" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 17.8 15.3 35.1 7.2 40.2 21.2 17.7 38.7 38.7 60.8 38.7 22.0 5.2 7.4 22.8 41.7 27.5 5.5 77.3 33.5 37.2 46.3 18.0 37.2 6.2 41.6 38.0 61.7 13.4 9.5 32.5 14.8 39.0 95.2 6.1 69.1 23.5 6.6 62.8 84.0 14.8 6.2 41.0 27.3 32.0 13.7 38.9 20.1 15.2 29.2 3.4 25.1 79.5 55.8 2.8 2.8 4.5 0.9 23.5 6.3 2.2 9.7 6.5 4.0 1.3 1.1 4.4 0.5 2.6 8.6 5.7 10.9 3.6 1.7 2.2 3.4 2.8 0.8 11.5 2.1 7.4 0.8 12.6 21.4 7.9 1.7 6.6 4.8 1.3 4.0 12.0 56.8 5.0 16.8 3.1 5.1 2.8 22.6 5.8 3.6 1.7 13.7 3.8 2.3 30.3 4.9 33.4 4.5 2.7 10.7 23.4 2.4 1.7 3.0 33.6 2.2 0.9 93.7 53.8 2.6 4.0 3.6 1.9 21.3 4.8 8.2 1.3 6.2 2.3 1.5 1.8 2.1 3.3 3.8 2.2 2.2 58.6 1.3 12.3 8.9 2.2 10.1 35.1 40.2 38.7 38.7 33.5 37.2 41.6 38.0 39.0 41.0 38.9 55.8 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.5 0.0 0.0 0.0 0.0 25.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 20.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 160.2 0.3 0.0 0.0 0.0 H2BC7 "H2B/g, H2BFG, HIST1H2BF" ENSG00000277224 "H2B clustered histone 7" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 7.4" "Cell type enhanced" "Detected in single" "Hofbauer cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "U-266/70: 24.8;U-266/84: 18.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.9 0.2 0.6 0.2 1.1 1.2 1.6 4.0 0.9 3.3 1.5 1.4 0.0 0.1 0.0 3.2 1.8 0.2 0.4 0.8 0.6 1.4 0.6 1.7 0.3 1.9 1.7 0.8 0.2 0.0 0.6 0.2 2.4 7.4 0.2 0.6 1.1 0.0 0.0 0.9 0.7 0.0 2.1 2.3 0.7 0.6 1.2 1.7 0.6 0.1 0.4 0.4 4.5 2.4 0.5 0.3 0.2 0.5 0.3 0.0 0.2 0.2 0.1 0.7 0.1 0.7 0.1 0.6 1.0 0.0 0.3 1.0 0.5 0.1 0.3 0.8 0.2 0.4 1.8 0.2 0.1 0.1 0.9 0.3 0.1 0.2 0.1 0.0 0.1 0.5 2.0 4.5 0.0 0.1 4.0 1.6 0.6 0.8 0.6 1.5 0.7 3.0 0.1 0.1 2.4 0.4 4.9 0.9 0.1 0.3 4.4 0.2 0.1 0.3 2.2 0.0 0.6 24.8 18.8 1.3 0.1 1.2 0.5 0.0 0.0 0.6 0.2 0.1 0.6 0.2 0.2 0.3 0.1 1.0 0.2 0.5 2.4 0.2 0.3 0.3 0.2 0.5 0.6 1.1 4.0 0.9 0.8 0.6 1.9 1.7 2.4 2.1 1.2 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 HDAC5 "FLJ90614, KIAA0600, NY-CO-9" ENSG00000108840 "Histone deacetylase 5" Q9UQL6 17 44076746-44123702 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 118.9;Syncytiotrophoblasts: 218.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019400, HPA030991" Approved Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nuclear speckles" "Golgi apparatus, Cytosol" "CAB019400: AB_2116626, HPA030991: AB_10795286" "unprognostic (1.30e-2)" "prognostic favorable (6.14e-4)" "unprognostic (6.65e-2)" "unprognostic (8.06e-2)" "unprognostic (3.49e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (8.80e-3)" "unprognostic (3.80e-2)" "unprognostic (2.37e-2)" "unprognostic (4.91e-3)" "unprognostic (4.30e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.51e-2)" "unprognostic (3.11e-1)" "unprognostic (6.00e-2)" "unprognostic (1.76e-2)" 30.8 24.7 39.3 10.9 33.5 20.7 28.8 48.8 48.5 40.6 3.3 36.3 11.6 33.2 15.5 45.1 34.1 15.9 53.5 40.4 31.6 24.8 17.4 33.6 14.0 37.6 41.1 45.0 22.5 31.5 48.1 22.6 35.1 29.2 7.3 24.3 22.9 15.1 77.5 71.3 22.9 14.8 22.4 26.4 24.0 19.7 40.0 10.4 30.8 28.6 11.6 29.2 37.0 50.3 8.7 5.5 14.9 3.5 28.2 21.7 53.6 22.8 56.1 11.3 18.1 12.3 9.1 13.5 9.0 54.4 16.5 6.9 17.6 9.8 4.7 21.2 28.7 26.3 18.6 28.6 12.2 8.7 35.7 31.2 16.5 12.8 15.8 19.0 9.3 10.6 20.0 26.5 65.5 6.7 14.3 26.2 16.4 6.7 13.0 54.7 41.6 35.4 1.2 3.8 38.6 20.3 6.7 27.6 31.2 21.8 39.3 49.6 5.1 27.8 17.5 6.6 11.7 43.6 39.7 16.2 16.0 10.7 13.4 11.6 9.2 9.7 5.4 13.5 3.8 7.2 4.3 5.4 11.1 7.5 4.5 4.0 20.9 4.5 16.8 9.7 4.1 7.3 39.3 33.5 48.8 48.5 40.4 31.6 37.6 41.1 35.1 22.4 40.0 50.3 24.0 12.8 13.7 11.1 20.4 29.2 32.3 9.0 26.2 87.8 23.8 21.3 27.1 30.0 11.9 20.2 118.9 21.9 19.6 22.4 21.5 17.2 20.2 17.1 10.7 22.1 46.0 9.3 18.9 8.7 53.1 24.1 10.2 25.1 12.6 47.0 24.3 9.3 22.7 82.4 31.0 14.9 6.1 18.5 17.8 10.0 48.4 29.8 14.2 12.2 16.5 18.9 11.3 14.1 26.2 11.5 16.5 43.6 14.2 41.2 21.5 7.3 12.4 60.4 65.7 31.8 40.1 4.2 32.7 28.1 32.8 218.1 17.0 29.9 11.3 25.3 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530263 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 18.7;skin 1: 4.8" "Cell type enhanced" "Detected in some" "Adipocytes: 24.8;Astrocytes: 53.5;Muller glia cells: 113.4;Oligodendrocyte precursor cells: 15.6" "Cancer enriched" "Detected in some" 5 "glioma: 3.8" "Group enriched" "Detected in many" 4 "amygdala: 10.3;basal ganglia: 14.2;cerebral cortex: 5.1;hypothalamus: 12.4;thalamus: 18.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" No NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: AB_2685492, HPA076164: AB_2732303" "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 0.5 0.0 10.3 0.0 14.2 0.0 0.3 0.7 5.1 0.4 0.0 0.5 0.0 0.2 0.0 0.8 0.2 0.0 2.5 2.8 12.4 0.1 0.3 0.3 0.0 1.1 0.9 0.1 0.0 0.0 2.5 0.0 1.0 0.4 0.0 0.0 0.1 0.0 0.1 4.8 0.2 0.0 0.4 0.2 0.1 0.9 18.7 0.0 0.5 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 14.2 0.7 5.1 2.8 12.4 1.1 0.9 1.0 0.4 18.7 0.0 24.8 0.0 0.0 53.5 0.2 0.1 0.3 0.2 1.8 2.9 1.1 2.8 1.4 0.0 0.3 0.0 0.0 0.0 0.4 4.0 0.0 0.0 0.0 5.4 0.8 5.1 0.0 0.0 0.7 0.0 0.0 0.3 0.0 8.9 0.0 0.1 0.0 0.0 0.0 3.3 0.8 4.9 0.0 0.0 0.8 0.0 0.0 0.3 0.0 1.9 0.0 113.4 0.0 15.6 0.3 0.0 2.9 0.0 0.0 0.5 0.1 0.0 0.0 7.7 0.0 1.0 6.2 0.0 0.4 6.2 1.4 0.0 0.5 0.0 3.0 0.2 HESX1 "ANF, RPX" ENSG00000163666 "HESX homeobox 1" Q9UBX0 3 57197838-57227606 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Spermatocytes: 36.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 6.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 73.5;U-266/84: 23.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024187 Approved Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA024187: AB_1850620" "unprognostic (6.47e-2)" "unprognostic (1.66e-3)" "unprognostic (5.50e-2)" "unprognostic (1.19e-3)" "unprognostic (5.04e-2)" "unprognostic (2.83e-2)" "unprognostic (3.96e-1)" "unprognostic (3.21e-2)" "unprognostic (1.93e-1)" "unprognostic (3.46e-3)" "unprognostic (9.48e-2)" "unprognostic (2.79e-3)" "unprognostic (1.39e-3)" "unprognostic (4.17e-2)" "unprognostic (3.15e-2)" "unprognostic (4.50e-3)" "unprognostic (1.14e-1)" 1.3 1.8 1.7 1.0 1.7 5.9 2.6 2.2 2.2 1.2 1.4 1.0 1.1 0.9 3.4 1.0 1.1 1.6 1.1 1.7 1.7 2.1 3.8 1.4 1.8 1.9 1.7 1.4 1.8 1.6 1.8 1.1 1.9 1.5 0.8 2.0 1.1 2.0 0.8 4.2 1.0 0.6 1.8 2.2 1.9 6.3 1.8 1.3 2.5 0.6 1.3 0.9 1.0 1.9 1.3 1.2 2.6 4.3 0.4 1.6 0.8 0.1 0.5 0.8 1.4 0.6 3.9 3.4 0.6 0.1 1.0 0.2 1.2 1.4 1.0 2.0 2.9 5.0 1.8 0.4 2.9 1.6 0.5 4.1 1.2 0.4 2.8 2.1 0.7 7.2 0.8 4.3 0.3 0.3 2.2 9.1 73.5 1.1 0.8 0.8 1.6 1.7 3.6 0.7 1.1 3.5 1.0 1.4 2.7 1.2 1.0 7.0 0.5 3.3 1.3 1.0 1.4 12.2 23.7 10.1 1.2 3.1 1.6 0.5 0.8 0.4 0.2 1.6 0.0 0.6 0.2 0.1 0.5 0.5 0.2 0.1 1.4 0.7 0.2 1.8 0.0 0.2 1.7 1.7 2.2 2.2 1.7 1.7 1.9 1.7 1.9 1.8 1.8 1.9 1.0 0.0 0.5 6.5 0.9 0.4 0.6 1.4 0.0 0.3 1.3 1.8 0.8 1.5 0.4 1.8 0.0 1.5 1.7 0.9 0.0 0.4 0.5 1.7 0.7 1.2 0.0 0.0 1.7 0.2 1.1 0.6 0.5 0.4 0.0 1.0 1.4 1.0 2.1 1.7 1.5 0.1 2.0 1.6 0.6 0.4 0.9 2.0 0.0 6.5 1.1 1.6 0.0 3.0 5.1 0.5 0.2 0.4 0.2 0.7 0.7 1.2 0.9 2.6 0.0 0.8 0.5 36.3 7.6 0.3 1.1 0.5 0.7 2.7 0.7 0.4 HOPX "HOP, LAGY, NECC1, OB1, SMAP31" ENSG00000171476 "HOP homeobox" Q9BPY8 4 56647988-56681899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 716.7;skin 1: 1439.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8" "Cancer enhanced" "Detected in many" "glioma: 43.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 518.2;NK-cell: 781.6" "Group enriched" "Detected in all" 15 "NK-cells: 781.6;T-cells: 518.2" "Cell line enhanced" "Detected in many" "HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018632, HPA030180" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" Cytosol "CAB018632: AB_2120833, HPA030180: AB_10603770" "unprognostic (2.32e-1)" "unprognostic (1.81e-2)" "unprognostic (8.03e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (2.88e-1)" "unprognostic (7.79e-2)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-5)" "unprognostic (3.40e-2)" "unprognostic (1.51e-1)" "unprognostic (7.10e-2)" "unprognostic (5.33e-2)" 9.5 33.7 212.8 27.7 235.6 12.1 112.2 215.4 322.0 250.1 239.2 30.5 17.2 19.1 541.4 716.7 10.5 35.1 48.8 237.4 212.0 24.0 2.9 372.8 18.4 237.6 211.6 9.4 5.3 13.3 11.7 59.6 218.5 26.9 7.0 22.1 172.0 64.7 19.2 1439.9 11.3 115.6 238.8 11.9 33.9 45.3 215.0 15.8 224.5 31.8 190.4 34.1 368.6 234.2 0.0 0.0 0.0 0.0 5.0 15.7 5.9 0.0 0.0 1.4 1.0 0.0 0.0 12.6 0.7 0.3 2.3 2.2 1.4 0.0 1.9 31.2 0.2 0.1 0.0 0.0 2.0 0.0 0.1 2.6 11.9 3.6 0.0 3.4 66.9 0.0 0.0 0.5 3.2 0.5 0.1 1.0 0.1 3.6 0.0 0.0 0.0 0.3 0.0 50.5 1.0 0.6 0.0 0.0 0.0 4.6 0.0 0.0 76.2 0.0 0.2 0.5 0.1 26.0 0.1 0.1 3.2 0.0 0.0 5.7 1.1 2.0 518.2 3.5 282.0 43.4 123.6 227.6 2.6 36.5 20.9 150.8 11.2 781.6 4.5 3.6 9.1 365.6 212.8 235.6 215.4 322.0 237.4 212.0 237.6 211.6 218.5 238.8 215.0 234.2 14.5 750.0 569.2 38.2 23.3 414.6 42.2 8.7 59.7 3.5 3.4 3.0 14.8 2.8 125.6 1.8 0.0 2.3 345.3 0.8 1.9 0.4 33.3 2.8 4.0 28.7 8.4 30.5 62.2 0.2 5.5 16.7 5.6 5.2 10.1 99.5 5.3 1.2 4.0 0.0 7.9 11.1 4.1 11.4 30.9 45.9 3.1 7.9 35.6 14.0 41.4 166.4 1150.4 7.1 6.7 1.7 0.0 3.0 9.6 31.3 1.2 0.6 12.5 5.6 32.9 3.7 104.8 3.3 15.3 31.6 377.2 321.8 219.9 0.1 1.4 28.8 HPS4 "BLOC3S2, KIAA1667, LE" ENSG00000100099 "HPS4 biogenesis of lysosomal organelles complex 3 subunit 2" Q9NQG7 22 26443423-26483837 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 86.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033106, HPA050189" Approved Approved Centrosome NA NA "Cluster 46: Basophils - DNA binding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 52: Non-specific - Transcription" Centrosome "CAB033106: AB_2264349, HPA050189: AB_2681046" "unprognostic (1.55e-2)" "unprognostic (1.02e-1)" "unprognostic (9.82e-2)" "unprognostic (5.30e-3)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (1.83e-3)" "unprognostic (1.59e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (2.23e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (6.46e-2)" 6.6 8.9 10.4 6.5 11.4 10.3 6.7 11.1 10.5 9.0 12.2 6.7 5.4 6.9 7.7 9.9 9.2 6.1 4.5 10.3 11.5 8.6 8.5 6.5 8.5 10.9 10.8 12.1 12.7 12.1 11.0 5.6 11.2 8.3 5.5 7.6 6.6 7.7 4.6 14.0 7.3 7.1 10.7 9.0 8.1 13.1 11.4 13.0 9.8 5.0 9.6 6.9 8.4 10.5 16.3 7.5 15.5 15.9 11.5 13.6 8.2 9.7 18.8 21.4 19.1 7.9 7.8 15.4 7.5 11.8 12.1 13.2 14.9 21.0 19.3 11.4 15.4 15.6 6.3 13.3 20.5 18.4 17.0 13.3 17.1 19.5 34.5 18.1 14.2 25.5 17.4 19.0 15.7 6.9 31.2 6.2 9.3 15.0 8.0 86.3 18.3 20.4 9.9 10.1 17.6 13.0 9.4 10.6 46.7 11.6 11.5 13.9 8.8 24.8 46.2 12.4 12.2 28.1 23.4 50.5 16.2 11.8 16.3 10.8 3.2 3.1 4.8 2.3 4.5 5.5 3.9 4.1 4.3 4.7 4.5 5.0 1.1 7.2 2.1 5.7 2.8 4.7 10.4 11.4 11.1 10.5 10.3 11.5 10.9 10.8 11.2 10.7 11.4 10.5 16.6 12.8 32.4 28.7 38.7 12.5 28.3 28.9 17.1 52.6 14.4 12.4 6.3 17.2 25.5 42.3 114.7 21.7 31.7 11.6 17.6 20.4 24.3 16.3 17.2 18.6 26.5 48.1 18.4 27.1 19.4 14.1 28.1 14.1 42.4 40.6 22.5 14.2 24.8 43.7 31.1 20.1 44.7 18.3 12.2 24.3 32.6 19.1 48.0 19.7 14.9 23.7 21.6 32.6 36.4 45.0 13.6 19.9 25.1 29.4 18.0 15.7 28.1 119.3 0.0 16.0 12.2 32.3 46.6 11.1 14.9 20.0 20.6 23.6 21.4 26.9 HR "ALUNC, AU" ENSG00000168453 "HR lysine demethylase and nuclear receptor corepressor" O43593 8 22114419-22133384 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Oxidoreductase" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 20.9;skin 1: 52.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 91.4;Cone photoreceptor cells: 33.3;Distal enterocytes: 27.5;Gastric mucus-secreting cells: 26.5;Paneth cells: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 21.2;HaCaT: 81.7;OE19: 39.9;SiHa: 28.8;T-47d: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054888 Supported Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "HPA054888: AB_2682630" "unprognostic (9.11e-2)" "unprognostic (2.12e-2)" "unprognostic (7.32e-2)" "unprognostic (4.68e-3)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" "unprognostic (1.75e-1)" "unprognostic (2.27e-2)" "unprognostic (8.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" 2.4 1.0 4.3 1.8 6.7 0.0 2.7 7.8 14.5 3.8 0.0 9.0 4.8 1.6 0.1 20.9 1.1 1.3 2.3 3.1 4.8 0.6 0.4 0.8 0.3 11.3 9.0 0.6 0.5 0.0 2.7 0.1 12.0 3.8 3.2 1.8 5.1 4.2 0.7 52.7 4.7 1.5 2.4 0.5 7.7 5.3 8.8 0.6 4.3 0.9 1.2 3.0 11.7 11.5 1.9 21.2 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.0 2.6 0.0 20.7 1.5 1.0 81.7 0.0 2.0 0.0 0.0 0.0 0.0 17.8 0.1 4.7 0.0 0.1 4.1 12.9 0.0 1.4 1.3 0.0 2.1 0.0 0.2 0.0 12.7 1.5 0.3 0.0 39.9 16.3 1.9 0.0 0.5 0.3 5.7 1.0 4.7 28.8 6.4 6.5 0.3 30.0 0.0 0.0 0.4 17.2 0.0 0.9 0.0 0.0 0.0 0.2 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 6.7 7.8 14.5 3.1 4.8 11.3 9.0 12.0 2.4 8.8 11.5 1.9 0.0 0.0 1.3 0.0 12.0 4.5 4.3 10.8 91.4 4.0 3.9 2.7 0.0 1.4 1.8 33.3 0.1 0.1 27.5 0.0 0.1 0.3 1.6 1.2 0.6 7.8 0.0 8.7 0.7 0.2 2.1 26.5 2.1 0.0 0.3 1.8 0.3 0.0 10.1 3.9 8.1 0.0 0.0 2.1 1.9 3.4 0.1 21.4 0.0 0.0 3.2 0.0 2.0 9.2 0.3 31.2 7.2 0.0 3.0 11.0 0.1 1.3 8.8 0.0 5.8 3.3 0.1 0.3 15.5 17.8 0.8 0.3 0.2 19.5 6.8 HRAS HRAS1 ENSG00000174775 "HRas proto-oncogene, GTPase" P01112 11 532242-537287 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002015, HPA049830, HPA070222" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Cytosol" "CAB002015: , HPA049830: AB_2680903, HPA070222: " "unprognostic (3.06e-2)" "unprognostic (2.98e-2)" "unprognostic (7.01e-2)" "unprognostic (3.08e-3)" "unprognostic (3.49e-3)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (1.50e-1)" "unprognostic (2.88e-3)" "unprognostic (9.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.58e-2)" "unprognostic (1.38e-1)" 28.1 24.6 64.6 3.5 67.2 2.9 27.0 62.1 86.8 30.4 58.3 34.3 2.8 23.6 12.5 80.1 18.9 3.6 56.8 64.4 64.6 33.8 21.8 27.1 4.3 65.6 65.3 20.0 20.5 13.1 38.2 9.0 66.9 38.3 6.9 10.2 27.3 12.3 59.0 69.9 19.5 8.9 64.2 20.6 24.2 16.5 64.8 9.2 20.5 25.2 10.2 34.5 44.2 65.4 59.0 105.6 44.2 25.6 22.2 17.5 39.6 49.9 25.1 64.5 29.5 62.4 29.7 20.4 10.9 63.2 60.7 43.7 46.0 114.1 19.3 19.5 108.4 6.6 43.7 56.1 38.5 13.9 12.0 28.3 118.0 42.0 51.5 19.6 31.5 34.3 29.7 32.3 40.9 110.6 34.0 50.5 26.5 39.9 94.5 31.6 40.7 18.2 47.0 33.2 87.6 43.7 25.5 55.4 17.9 31.5 43.3 14.8 35.4 47.3 44.7 16.4 39.7 20.3 17.7 15.4 39.1 17.0 38.3 0.0 0.5 0.6 0.8 0.7 0.4 0.3 0.9 0.8 0.7 2.0 0.9 0.3 0.0 0.1 4.0 0.9 1.5 0.2 64.6 67.2 62.1 86.8 64.4 64.6 65.6 65.3 66.9 64.2 64.8 65.4 51.3 12.8 10.7 9.1 18.0 131.2 101.7 25.4 82.0 46.0 38.8 75.7 25.2 22.8 11.2 35.0 18.8 78.8 21.5 72.2 74.3 35.2 1.6 36.1 28.6 32.0 29.3 11.2 9.8 37.4 63.4 25.9 33.6 34.1 2.5 26.8 22.9 17.4 39.9 48.8 10.6 26.5 4.1 11.7 38.4 7.9 17.1 21.3 64.0 10.3 12.8 50.8 11.3 4.0 12.3 48.2 30.9 23.0 26.5 61.2 30.8 54.6 20.0 37.6 32.9 20.3 40.3 5.4 21.4 118.1 145.9 78.1 22.0 18.8 26.2 106.4 IGSF22 "FLJ37794, IGFN2" ENSG00000179057 "Immunoglobulin superfamily member 22" Q8N9C0 11 18704312-18726230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.0" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Distal tubular cells: 21.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026459, HPA037851" Uncertain Approved Mitochondria NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "CAB026459: , HPA037851: " "unprognostic (4.05e-2)" "unprognostic (3.65e-2)" "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (8.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.24e-2)" "unprognostic (1.99e-4)" "unprognostic (9.35e-2)" "unprognostic (3.72e-4)" "unprognostic (2.87e-1)" "unprognostic (2.18e-1)" "unprognostic (3.43e-1)" "unprognostic (7.94e-3)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.3 0.2 0.6 0.0 0.5 0.3 2.9 2.4 4.7 1.4 0.6 1.3 7.5 5.3 1.7 0.0 3.1 23.9 0.0 0.0 1.0 1.5 21.5 3.3 1.4 5.3 1.2 0.9 3.6 0.0 3.2 4.3 0.0 0.7 2.0 5.8 2.5 0.7 0.4 0.4 1.5 1.7 1.7 5.8 8.2 0.3 1.0 4.6 1.5 0.6 0.0 0.0 0.7 0.5 2.1 1.5 0.3 9.5 2.6 0.7 0.3 4.0 0.3 2.2 6.1 0.9 0.0 0.5 1.0 0.0 0.4 0.7 1.7 0.0 2.9 3.1 2.8 8.4 IL12A "CLMF, IL-12A, NFSK, NKSF1, p35" ENSG00000168811 "Interleukin 12A" P29459 3 159988835-159996019 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 4.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 3.9;Ionocytes: 4.1;Oligodendrocyte precursor cells: 4.0;Respiratory ciliated cells: 6.1;Sertoli cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HDLM-2: 13.2;SK-BR-3: 17.6" "Region enhanced" "Detected in single" "cerebral cortex: 2.8" "Not detected" "Not detected" HPA001886 Uncertain "Secreted to blood" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA001886: AB_1079132" "unprognostic (6.23e-2)" "unprognostic (7.82e-5)" "unprognostic (1.25e-1)" "unprognostic (3.10e-2)" "unprognostic (4.22e-1)" "unprognostic (7.18e-2)" "unprognostic (4.18e-5)" "unprognostic (2.22e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (9.57e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (9.61e-2)" 0.3 0.4 0.9 0.6 0.9 1.5 0.7 0.9 2.0 0.2 0.3 0.8 0.5 0.3 0.1 4.1 2.1 0.2 0.8 0.8 0.8 0.4 0.1 2.1 0.8 0.9 1.1 0.5 0.5 0.0 0.5 0.1 1.0 0.3 0.4 0.1 0.3 0.1 0.2 0.1 0.8 0.2 0.7 1.2 0.5 0.3 0.9 0.4 0.2 0.7 0.5 0.7 0.6 1.1 3.1 0.3 0.4 2.6 0.0 0.2 0.2 3.3 2.1 3.9 8.1 1.2 0.1 0.0 0.2 0.5 4.5 0.3 0.8 0.5 3.6 13.2 4.1 0.1 0.2 0.9 2.5 0.7 6.1 0.6 1.0 6.9 2.7 2.7 1.2 0.3 0.0 2.1 2.4 0.1 0.1 0.0 0.4 0.1 1.8 2.4 0.0 0.4 0.4 0.2 0.1 1.2 0.0 17.6 0.5 0.6 0.9 1.4 0.9 0.8 0.8 2.3 6.3 1.4 0.0 0.0 1.5 5.9 0.8 0.0 0.0 0.5 0.3 0.1 0.5 0.5 0.1 0.6 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.9 0.9 0.9 2.0 0.8 0.8 0.9 1.1 1.0 0.7 0.9 1.1 1.0 0.0 0.6 1.0 3.4 0.1 2.1 1.0 1.2 0.0 1.6 2.2 0.4 0.0 1.1 0.0 0.0 0.1 0.7 0.3 0.0 1.5 0.0 3.9 0.2 1.4 2.4 0.8 0.1 0.0 0.0 0.4 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.9 4.1 0.3 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 4.0 1.3 0.4 0.2 0.0 2.1 2.9 0.1 0.0 6.1 0.0 6.6 1.5 0.3 0.4 2.9 2.6 0.1 0.0 0.7 0.1 0.5 1.3 INPP1 ENSG00000151689 "Inositol polyphosphate-1-phosphatase" P49441 2 190343570-190371665 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 727.4;Late spermatids: 836.0;Urothelial cells: 229.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 96.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 96.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036698, HPA036699" Supported Approved "Centriolar satellite,Cytosol" NA NA 31000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Centriolar satellite" Cytosol "HPA036698: AB_10672226, HPA036699: AB_2675260" "unprognostic (1.08e-3)" "unprognostic (4.50e-3)" "unprognostic (3.87e-2)" "unprognostic (2.70e-1)" "unprognostic (7.85e-2)" "unprognostic (3.67e-3)" "unprognostic (4.44e-2)" "unprognostic (1.17e-1)" "unprognostic (1.75e-1)" "unprognostic (2.96e-2)" "unprognostic (7.28e-2)" "unprognostic (2.41e-1)" "unprognostic (2.54e-1)" "unprognostic (3.74e-1)" "unprognostic (1.55e-1)" "prognostic favorable (1.12e-5)" "prognostic favorable (5.70e-4)" 24.0 35.0 35.6 11.4 41.2 14.8 20.7 36.5 47.5 27.4 24.5 22.3 36.7 18.1 12.5 71.9 18.9 23.5 30.9 36.2 42.0 19.6 33.1 27.9 9.3 37.5 37.0 11.8 26.6 41.6 29.6 13.4 37.6 18.2 21.0 17.0 17.0 13.4 21.2 37.4 25.3 19.6 34.7 25.8 18.2 52.9 38.1 23.7 19.0 35.7 20.9 42.1 35.8 54.0 26.7 7.4 13.9 0.0 15.0 31.8 0.3 30.9 41.5 28.8 37.5 28.8 16.5 0.2 36.3 30.5 9.3 35.8 5.4 19.9 35.0 32.8 11.7 19.5 22.1 17.5 31.5 15.2 6.0 21.6 30.6 32.9 18.6 20.7 54.7 0.3 48.6 16.3 51.3 0.1 1.1 14.3 4.2 42.3 40.4 0.7 11.2 0.3 22.6 62.2 20.6 7.8 21.7 1.4 31.7 14.4 0.1 21.0 51.0 18.4 13.2 33.3 18.5 3.1 3.5 0.3 5.7 6.0 14.9 26.2 8.3 96.0 6.9 8.1 6.3 3.3 4.3 4.7 8.7 4.4 2.4 3.6 3.9 16.2 4.7 0.2 20.3 5.1 35.6 41.2 36.5 47.5 36.2 42.0 37.5 37.0 37.6 34.7 38.1 54.0 63.0 3.2 5.5 44.1 8.0 86.4 155.4 33.2 50.7 15.0 9.9 14.6 20.9 38.6 27.5 11.0 6.2 6.9 9.7 50.4 7.9 33.4 727.4 18.8 16.0 59.6 31.1 1.7 30.3 85.4 2.6 30.7 29.6 26.9 8.8 3.8 88.5 21.9 8.8 16.8 36.7 23.7 20.3 10.7 27.3 836.0 26.8 14.0 26.6 17.8 12.2 73.2 14.4 29.7 125.6 53.1 40.8 23.7 12.9 90.7 50.6 20.8 13.0 11.9 26.3 26.0 19.4 18.1 11.4 170.2 97.3 4.0 10.4 37.8 35.4 229.0 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751677 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 24.0;salivary gland: 30.6;skin 1: 28.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 109.0;Alveolar cells type 2: 74.2;Basal keratinocytes: 202.1;Breast glandular cells: 147.4;Breast myoepithelial cells: 159.8;Suprabasal keratinocytes: 131.3" "Cancer enhanced" "Detected in many" "breast cancer: 14.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 93.2;BEWO: 56.4;HaCaT: 32.0;hTCEpi: 68.9;SK-BR-3: 39.1" "Group enriched" "Detected in many" 5 "midbrain: 26.5;pons and medulla: 20.9;thalamus: 11.2" "Region enhanced" "Detected in some" "pons: 5.1" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 30: Mammary glandular cells - Lactation" "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: AB_2682566" "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favorable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 3.8 0.1 2.0 0.0 2.7 0.0 24.0 4.9 1.0 0.6 0.4 0.7 0.0 0.0 3.1 4.5 0.2 0.0 1.5 0.8 2.8 21.5 0.0 18.1 0.2 20.7 8.2 0.0 2.0 2.9 1.6 5.6 22.3 3.6 0.3 1.1 30.6 0.9 0.3 28.2 0.0 0.0 4.2 0.0 15.7 2.1 4.7 0.5 1.8 0.6 0.2 0.2 2.0 4.2 10.7 0.0 93.2 0.0 5.4 3.9 56.4 5.4 3.4 5.0 4.0 11.8 0.0 0.0 0.0 11.5 0.0 32.0 0.1 24.6 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 68.9 2.4 20.1 0.0 0.0 0.0 0.0 0.0 3.6 19.1 0.0 0.1 10.2 25.7 0.0 0.0 5.7 0.0 22.7 0.0 3.5 0.0 18.6 39.1 0.0 14.3 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.7 4.9 1.0 0.8 2.8 20.7 8.2 22.3 4.2 4.7 4.2 5.5 109.0 74.2 0.0 0.2 202.1 17.6 33.1 31.9 1.4 147.4 159.8 2.7 0.0 23.9 7.3 0.0 27.8 1.2 3.0 27.4 0.1 5.0 0.1 0.4 2.9 0.0 0.0 0.0 0.0 18.6 15.0 15.3 0.0 1.3 0.1 0.0 0.0 3.3 0.0 0.0 2.5 14.2 0.0 15.4 10.4 0.0 0.7 19.6 0.0 0.0 0.3 0.0 1.5 0.0 0.3 2.9 0.0 0.1 23.5 0.2 0.6 13.0 2.5 0.0 3.6 14.6 9.4 9.4 20.1 131.3 15.2 0.9 0.0 2.8 8.3 ITGB4 CD104 ENSG00000132470 "Integrin subunit beta 4" P16144 17 75721328-75757818 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 200.6;skin 1: 205.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 173.6;Distal enterocytes: 133.3;Gastric mucus-secreting cells: 165.1;Pancreatic endocrine cells: 284.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 897.3;HaCaT: 345.1;HBEC3-KT: 768.6;hTCEpi: 256.9;RT4: 254.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 37.4" "CAB002422, CAB005258, HPA036348, HPA036349" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 980000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Cell Junctions" "CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078" "unprognostic (3.17e-3)" "unprognostic (3.52e-1)" "unprognostic (4.19e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" "prognostic unfavorable (6.39e-4)" "unprognostic (1.02e-1)" "unprognostic (2.23e-2)" "unprognostic (1.65e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" 39.2 5.3 82.8 12.4 87.8 1.6 66.6 74.9 91.8 58.4 76.4 87.5 56.9 24.0 3.6 101.2 43.8 20.0 22.7 80.5 86.9 18.2 5.6 18.4 4.5 104.6 104.8 8.5 24.5 2.8 21.1 35.4 82.6 85.3 15.7 8.7 200.6 18.5 6.8 205.9 75.5 6.4 102.4 76.9 79.9 4.9 82.0 4.1 17.6 6.0 7.2 58.4 98.8 99.6 172.7 148.5 0.3 2.1 0.4 1.3 199.2 0.7 0.6 0.5 0.9 16.1 897.3 0.1 31.5 0.3 1.3 345.1 1.0 768.6 0.5 0.7 0.6 0.9 39.6 17.0 1.2 0.2 1.8 1.1 256.9 0.6 159.2 18.0 5.5 0.6 0.5 15.7 0.1 95.8 2.0 2.0 1.0 92.8 127.8 2.7 4.4 2.2 204.8 254.9 0.2 1.9 4.9 15.2 2.2 5.3 63.9 1.5 16.9 4.6 7.8 0.7 1.9 5.6 2.1 0.7 2.0 0.8 2.7 0.0 0.2 0.0 0.4 0.4 1.1 0.7 0.1 0.5 0.0 2.0 0.4 0.3 0.7 0.0 0.0 4.6 0.8 0.4 82.8 87.8 74.9 91.8 80.5 86.9 104.6 104.8 82.6 102.4 82.0 99.6 26.9 12.8 2.2 50.3 1.4 49.5 45.1 173.6 67.2 0.3 21.2 36.6 7.5 25.8 38.9 23.9 2.1 89.8 1.8 133.3 1.9 33.3 0.4 61.3 5.7 26.8 9.6 0.8 0.7 28.8 20.2 5.2 165.1 60.2 2.5 1.1 17.9 0.4 9.4 0.0 0.7 59.2 18.3 0.3 5.4 0.4 3.7 1.9 12.4 1.9 0.1 34.4 0.0 1.5 0.7 284.4 68.4 1.5 2.6 17.1 94.0 2.6 53.3 1.0 0.0 1.2 5.0 1.1 8.2 28.1 13.1 111.1 1.8 0.5 60.1 42.0 KATNB1 ENSG00000140854 "Katanin regulatory subunit B1" Q9BVA0 16 57735739-57757244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041165, HPA041839" Enhanced Supported "Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" Microtubules "HPA041165: AB_10795584, HPA041839: AB_10795598" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "prognostic favorable (9.24e-4)" "unprognostic (2.54e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-1)" "prognostic favorable (8.44e-4)" "unprognostic (2.89e-2)" "unprognostic (1.03e-3)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (6.88e-2)" "unprognostic (1.54e-1)" 9.9 13.3 16.0 10.8 18.4 23.0 10.6 5.5 24.7 10.1 11.8 9.9 10.6 11.2 4.1 15.9 19.2 6.2 11.7 18.2 11.7 10.3 9.5 11.9 10.5 10.4 9.1 9.6 14.0 10.7 13.7 7.2 10.1 10.2 5.5 5.9 13.1 7.7 10.4 29.0 10.1 6.5 6.6 12.9 10.3 37.1 13.2 12.8 11.0 7.9 8.2 8.7 11.9 16.3 20.8 35.7 19.2 25.0 10.4 9.2 35.2 13.9 18.5 35.2 19.6 30.2 18.3 16.1 28.0 8.8 13.2 27.0 25.8 27.9 16.2 11.1 74.8 21.0 20.4 42.5 11.5 47.6 77.6 9.5 17.3 28.7 16.1 14.8 21.2 58.8 42.8 8.2 15.0 21.6 67.6 60.1 34.0 14.7 61.4 53.7 23.8 59.6 10.6 9.9 97.0 29.2 23.8 27.1 16.8 7.6 10.2 23.9 16.0 24.5 21.9 22.9 31.0 18.5 16.1 19.9 35.2 36.6 15.7 50.8 18.9 46.1 21.0 20.8 20.4 9.3 17.5 16.3 17.8 9.3 16.0 15.5 27.9 16.1 22.7 11.9 20.1 21.7 16.0 18.4 5.5 24.7 18.2 11.7 10.4 9.1 10.1 6.6 13.2 16.3 5.5 3.2 5.5 3.3 5.2 9.1 8.0 11.5 9.6 10.2 8.4 7.1 2.6 4.3 7.7 5.5 6.2 17.3 8.5 13.2 11.7 13.7 115.4 18.8 4.4 6.0 4.8 8.8 14.8 13.6 11.7 6.6 12.8 4.7 5.1 7.6 6.8 4.7 9.9 18.5 11.2 9.2 6.1 5.1 2.5 36.6 7.8 7.6 7.2 3.7 6.1 10.0 11.3 2.5 4.9 10.1 5.1 4.9 13.3 7.3 10.5 8.0 26.2 10.9 6.6 4.9 6.3 41.8 8.3 11.9 13.8 7.7 10.9 8.2 11.8 7.8 KCTD1 C18orf5 ENSG00000134504 "Potassium channel tetramerization domain containing 1" Q719H9 18 26454910-26657401 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 106.4;Distal tubular cells: 117.4;Excitatory neurons: 283.7;Squamous epithelial cells: 109.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 106.6;HaCaT: 113.5;hTCEpi: 100.6;RPTEC TERT1: 97.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057808, HPA062486" Approved "Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite" Yes NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nucleoli, Cytokinetic bridge, Centriolar satellite" "HPA057808: , HPA062486: " "unprognostic (1.15e-3)" "unprognostic (5.66e-2)" "unprognostic (2.35e-4)" "prognostic unfavorable (2.22e-4)" "unprognostic (3.65e-3)" "unprognostic (7.43e-2)" "unprognostic (2.03e-3)" "unprognostic (6.77e-2)" "unprognostic (2.74e-1)" "unprognostic (1.88e-3)" "unprognostic (5.68e-3)" "unprognostic (1.77e-2)" "prognostic favorable (4.60e-8)" "unprognostic (3.87e-3)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (8.02e-2)" 7.8 16.5 21.7 2.7 41.5 0.6 32.4 14.0 44.3 19.2 9.5 9.7 4.1 14.2 22.6 50.6 50.2 8.4 23.8 31.2 10.3 28.8 3.5 5.5 2.7 9.8 13.6 15.1 7.4 12.0 10.8 11.4 9.2 21.6 10.6 18.4 19.9 22.6 5.1 61.1 3.7 12.5 10.2 3.9 10.3 5.9 13.7 17.6 19.9 6.9 14.3 13.0 36.9 29.6 17.5 55.1 106.6 11.6 61.8 9.7 13.4 14.3 21.5 22.0 21.9 5.1 19.1 2.9 52.2 30.5 18.0 113.5 20.5 30.6 20.6 2.2 8.7 3.1 10.2 8.2 11.1 1.7 4.7 16.7 100.6 6.2 41.4 28.0 21.0 24.1 1.3 1.2 16.0 24.5 16.3 5.2 10.5 57.1 27.1 8.5 5.7 2.3 97.8 25.2 10.3 40.5 20.7 27.5 8.7 61.3 24.1 4.0 11.7 24.4 6.8 4.8 15.0 4.8 4.1 0.4 8.7 11.0 36.8 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 41.5 14.0 44.3 31.2 10.3 9.8 13.6 9.2 10.2 13.7 29.6 3.0 3.2 4.1 80.0 0.7 31.7 55.9 17.2 106.4 5.0 27.3 29.7 13.9 8.6 15.0 25.8 8.4 45.5 0.8 6.2 117.4 8.3 28.0 47.0 7.8 2.9 1.2 0.8 283.7 3.6 7.6 5.5 7.1 42.4 0.0 66.3 2.5 1.7 4.4 21.9 66.1 4.3 20.3 0.8 1.7 12.0 5.3 1.2 23.2 16.9 0.4 21.4 1.0 81.4 42.1 11.8 2.4 3.0 6.6 36.4 0.4 10.7 29.3 5.9 0.0 2.7 6.2 1.8 5.1 109.0 44.5 33.2 1.0 6.3 4.0 51.2 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Granulosa cells: 94.8;Hepatic stellate cells: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.8;eosinophil: 5.9;intermediate monocyte: 3.3;myeloid DC: 2.5;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.5;granulocytes: 5.9;monocytes: 4.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA050822: AB_2681250" "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 19.2 6.3 29.4 11.3 28.0 6.1 14.2 24.9 34.9 38.8 15.0 41.3 7.0 43.1 3.2 34.8 36.1 10.8 19.1 28.7 29.6 24.7 12.9 24.7 3.0 26.0 30.2 22.7 32.5 4.5 10.3 11.0 24.2 25.0 6.0 15.2 11.6 19.0 6.0 73.2 15.7 20.7 25.8 17.4 23.3 10.5 30.2 1.3 23.0 6.4 4.1 32.0 31.3 23.3 16.7 37.5 33.2 50.8 10.8 5.7 26.2 21.6 4.0 11.7 6.1 21.2 11.1 0.1 47.6 30.3 5.5 19.3 24.3 16.9 4.4 18.1 42.7 68.5 25.3 20.7 29.8 13.3 12.0 11.2 69.4 4.5 26.5 0.0 23.2 9.8 17.3 0.4 2.0 42.0 0.5 37.8 30.4 27.9 62.8 32.0 17.9 6.3 13.3 7.5 25.7 88.0 42.0 59.0 80.0 14.1 43.7 34.7 38.3 54.7 48.9 1.1 3.8 40.9 2.3 27.2 0.1 23.0 68.4 0.6 1.8 5.9 0.0 3.3 0.1 0.0 0.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.5 0.7 29.4 28.0 24.9 34.9 28.7 29.6 26.0 30.2 24.2 25.8 30.2 23.3 17.8 0.0 1.7 44.4 0.3 15.8 3.3 4.1 10.8 3.5 5.4 5.0 3.2 1.5 2.9 0.0 10.4 0.2 0.4 0.9 3.9 0.7 0.7 3.4 15.1 15.3 1.2 4.2 1.9 8.4 0.4 5.5 1.5 2.5 8.8 94.8 27.8 2.0 1.2 1.7 5.3 3.6 0.0 3.7 5.4 1.9 4.4 3.7 5.4 4.7 3.1 5.0 0.0 11.1 0.3 2.1 1.0 9.1 0.1 3.9 0.3 0.2 0.7 11.7 0.0 3.1 8.7 0.0 1.9 14.3 19.5 0.3 0.7 2.4 1.9 3.1 KIFC2 ENSG00000167702 "Kinesin family member C2" Q96AC6 8 144466043-144474202 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 113.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 59.8;Gastric mucus-secreting cells: 38.7;Inhibitory neurons: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029264 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "HPA029264: AB_10609999" "unprognostic (2.03e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-3)" "unprognostic (4.12e-3)" "unprognostic (4.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-2)" "unprognostic (2.12e-1)" "unprognostic (9.95e-2)" "unprognostic (2.39e-2)" "unprognostic (4.48e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" "unprognostic (8.13e-2)" "unprognostic (2.71e-2)" 12.3 17.2 68.7 6.2 78.3 7.2 14.0 58.3 113.7 24.5 33.2 26.5 11.9 11.4 6.7 45.0 15.3 6.1 10.1 74.7 42.9 32.9 20.6 17.2 7.3 54.9 41.1 13.0 24.9 9.6 45.0 3.2 54.6 31.5 6.3 3.8 19.1 8.0 4.2 75.0 24.4 2.5 35.7 27.6 19.7 25.8 46.4 5.4 24.2 1.7 4.8 22.2 31.8 63.9 13.5 12.7 6.1 13.2 8.7 5.2 13.2 5.3 6.4 4.7 4.6 4.9 18.1 11.6 3.6 5.0 7.9 24.2 6.1 8.1 2.0 10.2 3.7 8.6 34.5 6.6 11.1 2.6 23.4 6.7 28.3 4.7 6.1 21.8 3.0 14.7 7.0 15.9 3.6 25.4 10.3 7.1 0.9 16.5 15.2 24.1 0.3 8.8 19.9 23.1 18.4 16.4 6.2 19.3 6.9 4.3 50.4 5.0 7.6 9.0 22.9 9.4 7.7 6.3 2.9 3.9 17.6 12.3 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.7 78.3 58.3 113.7 74.7 42.9 54.9 41.1 54.6 35.7 46.4 63.9 3.7 9.6 11.3 35.3 4.9 6.0 3.0 2.1 6.2 16.2 7.9 5.8 0.8 7.2 5.2 14.7 6.2 2.0 12.1 29.1 1.9 3.5 13.2 6.8 4.4 2.0 23.4 3.2 59.8 1.4 2.0 2.0 38.7 13.8 8.2 3.3 2.5 8.7 2.7 15.2 39.7 12.2 0.0 5.3 9.1 8.0 7.8 6.4 3.6 12.2 3.5 7.5 3.1 8.5 6.9 2.2 18.5 3.0 7.0 3.4 11.3 5.1 4.5 4.6 0.0 1.8 2.9 7.3 7.5 10.6 11.4 3.0 8.0 6.6 18.0 3.3 KLK14 KLK-L6 ENSG00000129437 "Kallikrein related peptidase 14" Q9P0G3 19 51077495-51084245 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 9.7" "Cell type enhanced" "Detected in single" "Club cells: 2.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 26.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 10.7;HEK 293: 2.9;U-266/84: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" CAB026228 Uncertain "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "CAB026228: " "unprognostic (2.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.44e-2)" "unprognostic (2.60e-2)" "unprognostic (1.23e-1)" "unprognostic (6.12e-2)" "unprognostic (4.91e-2)" "unprognostic (5.79e-2)" "unprognostic (7.84e-2)" "unprognostic (1.38e-1)" "unprognostic (7.60e-2)" "unprognostic (8.87e-2)" "unprognostic (2.04e-8)" "unprognostic (1.93e-1)" "unprognostic (3.74e-3)" "unprognostic (1.94e-2)" "unprognostic (8.08e-2)" 0.5 0.3 2.1 0.2 2.2 0.1 1.6 2.3 3.3 4.2 1.9 0.4 1.3 0.5 0.6 0.9 0.7 0.3 0.8 2.2 1.7 0.5 0.3 0.4 0.3 2.1 1.9 1.1 0.7 0.0 0.6 0.0 2.2 0.8 0.3 0.6 0.8 0.5 0.3 9.7 0.7 0.1 1.6 0.6 0.6 0.9 2.0 0.3 0.4 0.1 0.5 0.6 3.9 2.3 1.4 0.5 0.1 0.6 0.4 0.4 0.6 0.1 0.0 0.0 0.1 1.2 1.4 0.6 0.4 0.2 0.3 10.7 0.1 0.2 0.0 0.3 2.9 0.2 0.9 0.0 0.1 0.2 0.2 0.2 0.3 0.4 0.4 0.1 0.1 0.4 0.2 0.3 0.0 0.9 0.2 0.5 0.6 1.2 1.1 0.1 0.1 0.6 0.0 0.6 0.1 0.0 0.2 1.0 0.3 0.2 0.4 0.0 0.0 0.1 0.4 0.6 0.2 2.6 5.5 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.2 2.3 3.3 2.2 1.7 2.1 1.9 2.2 1.6 2.0 2.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT72 "K6irs, K6IRS2, KRT6, KRT6IRS2" ENSG00000170486 "Keratin 72" Q14CN4 12 52585589-52601538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skin 1: 10.5;testis: 23.7" "Group enriched" "Detected in some" 4 "Early spermatids: 26.3;Late spermatids: 67.5;Spermatocytes: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065523 Enhanced NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA065523: AB_2685504" "unprognostic (3.36e-1)" "unprognostic (7.20e-2)" "unprognostic (3.41e-2)" "unprognostic (1.02e-1)" "unprognostic (6.97e-2)" "unprognostic (4.38e-3)" "unprognostic (4.82e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" 0.1 0.1 0.0 0.7 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.5 2.2 0.0 0.0 2.2 0.0 23.7 0.0 0.5 0.1 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 26.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.5 1.5 0.1 0.0 0.0 0.1 0.0 12.3 0.0 0.1 0.0 2.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.2 0.0 0.4 0.0 0.3 0.0 0.1 0.0 KRTAP21-2 KAP21.2 ENSG00000187026 "Keratin associated protein 21-2" Q3LI59 21 30746794-30747259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "skin 1: 1.4;testis: 1.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HEK 293: 1.7" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-7 "KRTAP5-3, KRTAP5.7" ENSG00000244411 "Keratin associated protein 5-7" Q6L8G8 11 71527267-71528669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 5.3;testis: 1.9" "Group enriched" "Detected in some" 4 "Early spermatids: 1.6;Late spermatids: 3.5;Spermatocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "RT4: 1.7" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (3.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (3.40e-2)" "unprognostic (7.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.83e-1)" "unprognostic (2.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.35e-1)" "unprognostic (5.68e-3)" 0.0 0.0 0.6 0.0 0.6 0.0 0.1 0.3 1.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.5 0.7 0.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.1 5.3 0.0 0.0 0.4 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.3 1.0 0.5 0.5 0.8 0.5 0.7 0.4 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.3 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 LAMTOR4 C7orf59 ENSG00000188186 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4" Q0VGL1 7 100148907-100155944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 3294.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020998 Enhanced Supported Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA020998: AB_1845762" "prognostic favorable (2.48e-4)" "prognostic favorable (6.08e-4)" "unprognostic (1.29e-2)" "unprognostic (1.14e-1)" "unprognostic (8.21e-3)" "unprognostic (6.11e-2)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (6.17e-2)" "unprognostic (1.57e-1)" "unprognostic (2.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.45e-1)" "unprognostic (1.68e-2)" 145.5 144.7 207.2 92.8 215.4 194.6 143.4 221.1 260.4 148.0 204.4 180.6 89.4 116.7 65.9 117.5 123.1 97.7 167.4 205.7 212.3 188.5 139.1 128.0 159.0 222.1 211.3 142.7 124.2 126.7 162.7 68.1 213.3 160.8 105.8 39.9 116.8 76.2 137.5 478.7 151.0 69.0 217.6 251.9 162.2 86.6 215.8 104.8 133.8 106.0 85.5 145.8 126.7 224.1 105.9 250.9 130.2 165.4 135.2 154.9 105.7 62.1 151.0 113.1 138.9 116.9 165.7 169.1 204.7 94.2 205.7 108.9 124.0 160.0 48.1 172.4 353.2 135.2 245.0 205.4 127.4 106.4 187.1 187.3 155.4 118.5 145.6 125.7 174.9 155.3 129.9 264.4 156.1 501.0 104.0 424.7 138.7 291.1 199.9 107.4 107.1 302.8 129.1 126.9 91.6 169.0 114.3 265.8 211.3 99.0 107.1 207.0 118.3 107.1 158.6 223.7 101.7 159.1 231.2 324.2 171.0 293.5 155.9 1033.3 843.2 3121.0 299.6 795.1 251.1 541.8 377.5 312.8 570.0 475.4 381.8 307.2 3294.2 310.1 756.2 482.6 453.0 893.6 207.2 215.4 221.1 260.4 205.7 212.3 222.1 211.3 213.3 217.6 215.8 224.1 181.8 93.0 150.7 18.9 195.8 274.9 194.0 282.0 167.9 65.3 240.8 277.2 176.6 143.0 172.9 218.8 12.5 258.4 199.9 819.7 534.1 167.3 40.0 152.9 125.8 186.7 299.3 99.3 12.0 326.2 196.5 175.6 146.3 131.4 183.2 120.9 239.1 246.3 531.1 58.9 13.6 423.9 252.3 497.4 351.7 46.6 146.3 365.2 434.0 13.1 411.0 229.9 298.6 11.6 26.2 204.2 867.4 120.4 133.0 169.5 511.6 557.5 194.8 67.0 144.7 142.1 196.9 88.1 101.2 151.3 662.9 201.4 195.9 150.8 511.8 219.0 LANCL3 FLJ42925 ENSG00000147036 "LanC like 3" Q6ZV70 X 37571569-37684463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 8.8;Inhibitory neurons: 20.4;Squamous epithelial cells: 10.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "basophil: 3.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "HEL: 11.8;HMC-1: 3.6;K-562: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005470, HPA076575" Approved Approved Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "HPA005470: AB_2134886, HPA076575: AB_2732315" "unprognostic (6.76e-2)" "unprognostic (4.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.85e-1)" "unprognostic (5.20e-2)" "unprognostic (5.26e-2)" "unprognostic (3.60e-1)" "unprognostic (1.21e-3)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.81e-2)" "unprognostic (2.88e-1)" "unprognostic (7.90e-5)" "unprognostic (4.01e-3)" "unprognostic (7.93e-3)" "unprognostic (1.11e-2)" "unprognostic (2.08e-2)" 0.2 0.2 0.1 0.1 0.4 0.2 0.1 2.6 1.0 0.4 0.0 1.0 0.1 0.2 0.0 1.5 0.1 0.1 0.1 0.6 3.7 0.2 0.0 0.3 0.1 1.0 1.6 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.5 0.6 0.4 0.2 0.2 0.7 0.2 0.1 0.5 0.1 0.6 0.2 2.5 0.1 0.1 0.1 0.2 0.3 1.1 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.7 1.5 0.2 0.0 0.0 0.2 11.8 1.1 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.2 0.0 3.0 0.0 0.6 0.0 0.1 0.2 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 1.1 0.5 0.0 0.0 1.8 0.0 0.3 3.8 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.3 0.3 0.1 0.4 2.6 1.0 0.6 3.7 1.0 1.6 1.0 0.5 2.5 0.5 1.3 3.2 4.1 2.9 0.1 8.8 1.2 1.8 6.8 0.8 0.6 0.4 0.9 0.0 1.2 0.0 0.0 0.0 3.0 6.6 0.0 0.0 0.1 0.3 0.6 1.1 1.8 0.8 3.1 0.2 0.2 0.4 4.1 0.7 1.3 0.1 0.0 0.2 0.1 3.3 20.4 0.4 2.0 0.3 0.5 0.0 0.3 0.2 0.0 1.0 0.2 0.5 4.1 1.0 2.0 2.1 1.4 1.5 0.2 0.7 1.6 0.2 0.0 1.4 0.0 1.8 0.9 0.7 3.1 10.1 4.4 0.1 1.4 0.2 1.0 2.5 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 92.4;Excitatory neurons: 68.6;Microglial cells: 104.9;Oligodendrocyte precursor cells: 308.6;Oligodendrocytes: 215.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 4.8;non-classical monocyte: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 63.7;RH-30: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 68: Oligodendrocytes - Mixed function" "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavorable (2.14e-5)" 10.9 4.5 9.9 4.7 13.9 1.4 18.6 20.8 10.6 7.7 6.3 3.4 2.0 8.5 3.2 6.7 5.8 4.8 4.0 9.7 12.4 4.4 1.6 3.8 3.6 22.0 16.8 11.2 3.8 1.3 5.1 2.3 18.5 11.2 2.1 1.1 20.6 4.1 5.6 13.7 3.5 5.4 15.8 2.1 3.7 3.5 14.8 3.5 3.3 3.0 3.6 5.8 6.8 19.3 11.5 10.7 32.3 19.7 25.2 27.5 24.7 6.5 5.8 14.3 12.7 8.0 7.0 0.0 4.8 7.1 21.4 5.7 10.0 14.6 19.9 1.0 21.1 36.5 6.6 2.3 33.2 8.0 4.0 33.1 63.7 6.5 56.0 5.8 24.3 0.0 9.6 1.3 26.7 6.4 0.0 1.8 13.3 1.2 18.4 0.0 60.3 3.5 2.5 1.6 11.0 24.8 11.3 12.2 36.6 12.5 16.9 10.6 24.7 17.0 15.3 1.4 21.8 0.7 0.0 0.0 8.6 9.6 31.3 1.4 4.8 0.5 0.0 4.5 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 6.4 0.2 0.0 1.8 9.9 13.9 20.8 10.6 9.7 12.4 22.0 16.8 18.5 15.8 14.8 19.3 3.5 0.0 3.2 92.4 0.5 15.4 7.4 3.6 10.8 0.4 31.1 12.1 0.6 0.0 1.7 0.0 0.0 2.6 0.7 0.2 0.0 3.8 13.0 1.2 10.8 15.4 0.0 2.5 68.6 1.1 13.1 9.1 0.5 0.9 0.0 11.4 25.4 0.6 4.0 0.0 8.4 0.0 0.0 15.4 4.9 22.6 9.6 9.5 7.2 104.9 6.2 0.9 0.0 308.6 215.5 1.2 0.1 24.8 0.1 20.3 0.0 1.8 0.8 0.1 13.1 21.3 9.9 0.4 3.0 19.3 26.0 1.4 1.1 9.8 0.5 3.4 LMX1B NPS1 ENSG00000136944 "LIM homeobox transcription factor 1 beta" O60663 9 126613928-126701032 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;salivary gland: 18.5" "Cell type enhanced" "Detected in some" "Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1" "Cancer enriched" "Detected in some" 14 "breast cancer: 12.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1" "Region enhanced" "Detected in some" "pons and medulla: 2.3" "Region enhanced" "Detected in many" "midbrain: 5.0" "HPA073716, HPA075656" Approved Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA073716: AB_2686630, HPA075656: " "unprognostic (4.17e-1)" "unprognostic (4.72e-2)" "unprognostic (2.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.73e-1)" "unprognostic (1.50e-4)" "unprognostic (1.86e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-1)" "unprognostic (2.26e-1)" "unprognostic (1.34e-2)" "unprognostic (3.51e-3)" "unprognostic (1.63e-5)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-6)" "unprognostic (1.13e-2)" 0.6 0.0 0.1 0.0 0.1 0.1 4.1 0.1 5.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 1.0 3.6 0.0 0.1 0.0 3.8 9.2 0.0 0.2 1.1 0.2 0.0 3.3 0.0 0.0 0.0 18.5 0.0 0.1 2.1 0.1 0.0 6.8 0.0 0.1 1.4 2.6 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.2 0.6 0.3 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.3 0.0 2.5 0.6 3.5 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 11.9 0.0 0.0 0.0 10.4 0.0 0.0 2.4 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.2 0.1 8.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 5.6 1.0 1.0 3.8 9.2 3.3 6.8 2.6 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 8.3 7.2 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 1.6 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 LPAR5 "GPR92, GPR93, KPG_010, LPA5" ENSG00000184574 "Lysophosphatidic acid receptor 5" Q9H1C0 12 6618835-6635960 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 20.9" "Cell type enhanced" "Detected in many" "B-cells: 26.5;Hofbauer cells: 38.0;Microglial cells: 33.7;Proximal enterocytes: 18.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 18.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 83.8;T-cells: 66.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.5;HEL: 19.6;HMC-1: 26.0;K-562: 14.8;OE19: 9.4;U-698: 13.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA013170 Approved NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" "HPA013170: AB_1849314" "unprognostic (1.94e-1)" "unprognostic (6.43e-2)" "unprognostic (1.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (1.37e-1)" "unprognostic (5.95e-2)" "unprognostic (3.45e-1)" "unprognostic (1.41e-2)" "unprognostic (3.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.27e-2)" "unprognostic (7.99e-3)" "unprognostic (5.43e-1)" "prognostic favorable (6.56e-5)" "unprognostic (7.43e-2)" 1.9 2.5 6.0 5.3 6.1 1.0 1.3 6.1 5.9 5.8 3.4 8.9 9.7 0.5 2.7 20.9 1.6 1.7 4.1 5.4 6.8 0.7 1.3 1.9 8.9 10.3 8.9 0.7 0.5 0.8 1.0 5.4 9.4 1.0 8.3 0.2 5.5 1.3 0.2 6.9 8.9 1.0 10.2 9.3 7.2 1.6 11.8 2.6 1.6 0.1 12.4 2.1 9.6 14.4 5.8 0.7 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 10.5 4.3 1.3 0.0 0.1 7.0 0.0 3.2 0.0 0.0 0.0 19.6 0.6 0.4 0.0 0.0 26.0 0.0 3.5 0.1 1.5 0.0 0.0 4.0 14.8 0.0 0.0 0.5 0.6 6.1 0.1 9.4 1.0 4.8 0.0 0.0 0.0 3.3 0.1 0.1 3.0 0.0 0.0 1.1 0.0 2.2 0.1 0.0 3.9 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 10.4 0.3 0.1 66.8 3.4 51.2 83.8 11.2 40.2 17.3 82.7 10.8 24.6 0.8 4.6 6.1 1.1 18.0 20.1 6.0 6.1 6.1 5.9 5.4 6.8 10.3 8.9 9.4 10.2 11.8 14.4 0.2 0.0 0.0 0.0 26.5 1.5 0.4 3.9 1.8 0.0 0.6 0.5 2.8 1.5 4.4 1.8 0.0 0.3 2.8 16.9 0.0 0.3 4.9 0.4 0.1 1.5 1.2 0.8 0.2 0.9 0.2 0.6 3.6 0.7 16.5 0.0 1.1 0.2 38.0 0.0 0.3 11.1 2.0 15.6 7.0 14.5 0.0 13.9 0.0 33.7 4.6 0.1 17.5 0.5 0.1 9.4 16.8 0.0 2.7 0.7 18.4 0.1 0.6 0.1 0.0 0.1 0.2 0.6 1.4 10.3 1.3 0.5 6.9 0.0 13.0 2.2 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818757-149864359 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 61.3;Respiratory ciliated cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017267 Approved "Vesicles,Plasma membrane" NA NA 1500000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" Vesicles "HPA017267: " "prognostic unfavorable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 14.5 18.0 25.2 5.3 25.8 1.4 11.8 18.7 31.5 17.2 13.8 13.1 11.7 11.4 16.4 28.6 22.3 11.3 10.8 26.7 23.3 20.3 10.0 13.6 2.9 23.6 24.9 16.5 19.8 42.8 17.6 12.5 25.0 25.5 12.3 13.5 20.1 13.0 5.2 20.6 9.1 12.0 19.7 4.1 16.3 8.0 26.0 2.4 22.9 4.8 5.9 18.0 20.8 25.0 26.5 22.9 17.2 15.0 37.8 67.2 3.5 27.7 52.1 18.5 22.4 7.3 52.9 0.2 36.7 43.3 79.4 69.4 19.2 47.1 13.3 43.7 19.4 13.3 74.3 30.4 22.6 13.2 0.8 42.8 93.1 23.0 46.5 52.5 28.9 11.8 26.8 11.0 22.3 45.4 0.5 1.3 10.4 52.0 19.6 14.5 25.5 6.4 33.9 53.8 22.4 15.6 86.7 46.3 17.0 8.5 38.8 26.4 21.1 22.6 4.8 48.4 21.3 0.1 8.7 6.3 40.9 12.9 13.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 25.2 25.8 18.7 31.5 26.7 23.3 23.6 24.9 25.0 19.7 26.0 25.0 7.3 6.4 2.8 17.6 0.5 11.3 14.3 17.9 5.7 12.2 10.2 6.0 8.8 12.8 18.3 20.2 2.1 2.1 0.5 7.7 5.9 6.5 27.0 61.3 6.4 7.4 29.4 5.5 42.5 22.7 1.8 20.5 15.3 16.5 0.0 12.4 9.3 9.5 3.6 8.4 44.3 5.0 16.2 1.9 6.2 31.7 16.4 1.7 14.2 11.2 0.1 6.0 0.0 17.6 40.1 19.7 4.2 14.7 0.6 22.2 4.0 7.0 107.7 5.5 0.0 10.0 11.7 14.7 10.4 14.9 14.3 5.6 1.8 15.7 13.2 23.6 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856717-46918642 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 46.7;skin 1: 31.6" "Cell type enhanced" "Detected in many" "Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3" "Group enriched" "Detected in all" 4 "colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 21.3;SuSa: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 0.7 1.4 23.3 0.9 30.5 0.0 1.5 19.1 21.3 2.3 0.0 4.8 3.4 1.6 0.9 1.8 1.4 2.0 6.9 24.2 16.0 0.7 0.2 2.9 0.1 46.7 23.0 4.6 2.2 5.6 2.6 2.6 19.8 2.1 3.4 7.9 1.7 2.3 4.4 31.6 4.9 1.5 21.3 3.9 7.8 1.1 30.9 1.5 2.4 7.7 0.3 0.9 1.4 25.6 0.1 9.6 21.3 6.5 13.4 3.7 4.9 1.0 1.9 2.8 3.2 2.8 0.0 0.0 1.4 11.4 3.1 3.9 12.0 7.5 2.2 0.0 10.3 1.0 3.8 6.8 2.8 0.1 1.9 4.5 4.2 4.4 1.1 2.5 2.5 2.6 0.9 0.0 1.6 0.8 0.2 0.3 11.9 0.0 0.9 1.6 7.3 0.0 0.3 2.8 0.1 14.2 1.2 0.0 3.4 16.2 0.3 0.5 0.2 5.7 3.5 6.5 2.1 0.0 0.0 0.4 4.3 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 30.5 19.1 21.3 24.2 16.0 46.7 23.0 19.8 21.3 30.9 25.6 0.2 0.0 1.9 123.1 0.0 8.2 2.7 2.4 10.8 0.5 0.3 1.9 6.2 0.0 1.9 1.8 41.7 2.6 0.0 31.1 1.9 0.0 0.5 1.0 4.7 1.0 0.0 0.0 19.7 0.4 0.4 5.0 3.1 4.4 5.1 1.6 1.8 0.4 0.2 0.0 18.6 2.8 0.0 0.0 0.4 0.0 1.8 0.2 1.8 15.0 0.6 9.3 0.0 137.2 31.3 0.3 3.0 1.2 0.0 1.0 8.0 0.3 1.1 2.7 0.0 12.4 0.9 0.2 0.8 2.3 10.9 1.4 0.2 8.4 3.3 0.8 LRRC69 ENSG00000214954 "Leucine rich repeat containing 69" Q6ZNQ3 8 91101832-91219236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.9" "Cell type enhanced" "Detected in many" "Early spermatids: 77.3;Late spermatids: 18.0;Microglial cells: 27.2;Oligodendrocytes: 27.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.3;SuSa: 5.2;U-266/70: 16.0;U-266/84: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046337 Uncertain Approved "Plasma membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Plasma membrane" "HPA046337: AB_2679626" "unprognostic (1.63e-2)" "unprognostic (1.02e-1)" "unprognostic (4.69e-1)" "unprognostic (3.28e-1)" "unprognostic (2.78e-1)" "unprognostic (3.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.47e-1)" "unprognostic (9.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-6)" "unprognostic (6.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" "unprognostic (8.68e-5)" 0.3 0.5 0.2 0.9 0.6 0.1 0.6 0.6 0.4 0.3 0.8 0.3 0.2 0.2 0.9 0.3 0.2 0.4 0.5 0.2 0.4 0.5 0.3 0.4 1.1 0.8 0.5 0.2 0.3 0.9 0.2 0.4 0.8 0.5 0.7 0.6 0.7 0.3 0.5 1.7 0.4 0.8 0.5 0.7 0.4 2.9 0.5 0.8 0.5 0.4 0.7 0.7 0.3 1.0 0.6 0.6 0.1 0.4 0.6 1.3 1.0 0.3 0.1 0.2 0.3 0.9 0.8 0.9 0.4 0.2 0.1 0.6 0.7 1.1 0.3 0.3 6.3 1.4 1.8 0.4 0.2 0.5 1.0 0.4 1.0 0.4 0.7 0.4 0.1 1.1 1.0 0.5 0.4 0.2 0.3 0.4 0.6 1.0 0.4 0.8 0.0 0.7 0.2 0.7 0.0 0.2 0.0 0.4 1.0 5.2 1.4 1.0 0.5 0.2 0.6 0.1 0.8 16.0 9.5 3.8 0.1 2.1 0.8 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.0 0.4 0.4 0.2 0.0 0.1 0.1 0.4 0.5 0.0 0.2 0.6 0.6 0.4 0.2 0.4 0.8 0.5 0.8 0.5 0.5 1.0 1.1 0.0 1.1 16.0 1.5 4.7 2.9 1.3 0.6 1.9 1.6 0.6 2.9 0.0 1.5 3.7 4.2 2.3 2.0 1.1 3.9 1.5 77.3 1.2 0.4 2.7 2.4 0.8 5.3 1.2 1.9 1.7 0.0 0.6 0.0 1.0 4.2 0.6 0.9 0.0 6.4 2.2 6.1 1.3 7.0 18.0 2.8 1.6 7.2 27.2 4.2 1.1 2.1 7.5 27.9 1.8 1.6 1.2 0.2 5.3 0.4 0.9 6.1 3.2 0.0 4.7 2.7 4.2 4.0 0.7 5.3 1.0 2.2 0.9 1.7 2.3 LRRC8A "FLJ10337, KIAA1437, LRRC8, SWELL1" ENSG00000136802 "Leucine rich repeat containing 8 VRAC subunit A" Q8IWT6 9 128882133-128918039 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 192.0;Prostatic glandular cells: 207.0;Urothelial cells: 328.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 163.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (6.33e-2)" "unprognostic (3.88e-2)" "unprognostic (1.88e-3)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "unprognostic (4.38e-3)" "unprognostic (4.29e-2)" "unprognostic (1.19e-3)" "unprognostic (2.44e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (3.53e-1)" "prognostic favorable (5.27e-5)" "unprognostic (3.69e-1)" "unprognostic (8.77e-2)" "unprognostic (3.93e-3)" "unprognostic (1.02e-2)" 31.4 17.4 68.2 16.2 69.4 17.3 27.3 69.4 77.1 30.8 44.6 31.4 9.7 36.3 7.3 71.7 23.5 23.3 32.0 57.2 67.9 18.2 28.9 42.4 9.3 76.7 77.2 18.8 21.2 32.4 13.7 23.1 67.9 29.3 8.5 13.4 28.1 25.5 13.9 35.2 17.3 29.1 63.9 16.2 25.0 11.8 82.6 9.9 25.6 18.4 10.1 32.7 44.2 52.4 35.1 54.2 32.0 27.5 73.6 28.3 40.4 39.8 26.2 24.1 17.1 24.1 73.2 12.8 43.6 43.3 30.1 163.8 19.9 87.5 11.3 13.1 16.4 11.5 33.4 29.2 49.8 13.8 20.3 22.1 60.9 42.7 50.8 48.6 84.1 17.5 25.8 12.4 31.8 30.3 15.6 13.2 95.9 58.3 58.4 21.4 37.0 20.6 37.9 17.3 19.2 39.9 44.4 27.3 15.8 23.9 19.9 10.2 149.4 69.9 30.2 29.9 58.8 14.4 36.5 15.5 38.7 10.3 41.3 0.7 0.7 1.9 3.9 1.1 1.8 1.2 1.9 2.5 1.0 0.9 1.9 1.8 1.4 3.5 0.3 1.6 3.5 1.0 68.2 69.4 69.4 77.1 57.2 67.9 76.7 77.2 67.9 63.9 82.6 52.4 98.8 16.0 15.6 57.1 7.5 105.7 192.0 91.6 113.3 13.1 38.3 29.2 31.3 17.2 73.6 7.3 6.2 13.8 17.4 31.9 0.0 28.9 6.9 22.0 50.5 57.4 16.1 13.7 11.8 21.2 17.6 27.5 24.5 47.0 6.3 35.1 55.6 16.5 6.1 25.2 14.2 28.7 24.4 5.0 17.4 4.5 23.0 9.9 26.6 12.2 5.1 41.3 36.0 8.5 9.7 78.1 23.0 44.4 13.5 207.0 10.9 8.1 33.2 10.2 65.7 38.2 35.2 3.2 8.6 91.6 145.1 20.8 15.5 9.6 14.5 328.5 LRSAM1 "CMT2P, FLJ31641, RIFLE, TAL" ENSG00000148356 "Leucine rich repeat and sterile alpha motif containing 1" Q6UWE0 9 127451489-127503499 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 32.0;Excitatory neurons: 28.6;Inhibitory neurons: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021403, HPA021844, CAB037304" Supported Approved Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368" "unprognostic (8.83e-2)" "unprognostic (3.13e-1)" "unprognostic (7.48e-3)" "unprognostic (4.15e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (1.64e-1)" "unprognostic (5.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.72e-2)" "prognostic favorable (6.78e-6)" "unprognostic (1.27e-1)" "prognostic favorable (5.72e-4)" "unprognostic (1.94e-2)" "unprognostic (3.26e-1)" "unprognostic (9.07e-2)" "unprognostic (3.33e-2)" 7.2 9.8 8.6 3.4 8.6 2.0 7.3 7.3 12.5 10.7 5.2 16.5 3.4 9.0 5.9 8.7 7.8 3.9 17.3 8.8 8.8 9.0 8.8 7.4 4.5 11.1 7.6 10.7 5.7 6.9 9.0 3.4 11.4 9.1 2.6 2.3 7.5 5.6 13.5 21.2 9.1 5.0 7.0 9.5 9.5 4.3 7.9 3.4 8.8 7.2 3.2 12.3 10.2 9.0 5.7 10.8 4.8 10.7 9.8 9.1 8.3 5.3 8.1 10.0 7.6 8.9 5.9 9.8 5.9 9.9 3.6 18.7 7.8 13.3 3.8 11.5 5.3 5.2 9.0 10.2 9.4 6.2 7.3 6.1 7.9 6.1 12.2 10.7 11.2 7.6 4.8 7.6 4.5 17.6 3.9 4.5 4.7 17.4 9.3 7.1 5.6 18.4 11.5 5.1 9.8 9.2 4.1 12.6 8.8 4.3 26.5 3.2 10.2 4.6 5.6 4.2 2.5 6.2 7.9 1.1 9.1 4.5 2.6 18.5 4.8 21.3 3.7 6.5 4.7 3.7 2.8 3.5 6.1 2.7 1.1 1.4 4.0 1.3 6.8 3.6 2.3 3.8 8.6 8.6 7.3 12.5 8.8 8.8 11.1 7.6 11.4 7.0 7.9 9.0 5.3 9.6 3.9 32.0 5.1 1.1 3.1 2.9 4.6 6.7 5.2 5.0 20.4 4.3 7.3 0.0 6.2 5.0 5.3 6.0 5.9 7.1 0.6 3.6 4.7 4.8 1.2 2.5 28.6 1.4 2.1 4.9 12.2 4.6 9.5 6.6 3.3 7.1 6.3 11.8 26.9 5.8 14.2 5.6 3.7 1.2 2.8 7.4 3.6 10.3 7.4 4.7 3.1 18.1 21.0 4.7 5.0 5.3 3.9 5.0 6.6 5.8 6.0 5.2 0.0 5.1 6.0 5.7 3.6 5.8 2.7 7.0 5.6 3.9 4.8 3.3 LY6G6F-LY6G6D "G6F-LY6G6D, MEGT-1, MEGT1" ENSG00000250641 "LY6G6F-LY6G6D readthrough" 6 31706904-31717918 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "skin 1: 5.4;testis: 2.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 9.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA008053 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "HPA008053: AB_1840160" "unprognostic (5.02e-2)" "unprognostic (1.31e-1)" "unprognostic (3.47e-1)" "unprognostic (5.90e-2)" "unprognostic (1.07e-2)" "unprognostic (2.66e-1)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAB21L3 "C1orf161, FLJ38716" ENSG00000173212 "Mab-21 like 3" Q8N8X9 1 116111755-116135240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;esophagus: 7.0;skin 1: 6.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Alveolar cells type 2: 48.3;Club cells: 18.5;granulocytes: 17.7;Oligodendrocytes: 31.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.6;EFO-21: 13.4;RT4: 14.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "cerebellum: 6.2" HPA039551 Approved Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA039551: AB_2676565" "unprognostic (9.25e-3)" "unprognostic (3.47e-3)" "unprognostic (1.44e-3)" "unprognostic (5.23e-5)" "unprognostic (2.22e-1)" "unprognostic (2.06e-2)" "unprognostic (5.36e-2)" "unprognostic (3.75e-3)" "unprognostic (1.21e-1)" "unprognostic (7.01e-2)" "unprognostic (2.49e-1)" "unprognostic (4.84e-2)" "unprognostic (1.16e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (4.61e-2)" 0.1 0.0 0.8 0.1 1.4 0.6 0.3 2.0 5.2 1.7 0.0 1.5 0.2 0.2 0.1 7.0 0.0 0.0 0.0 1.0 0.8 1.3 1.7 0.2 0.1 1.5 2.1 0.1 0.0 0.0 0.0 0.7 3.5 0.8 1.3 1.3 0.8 0.6 0.3 6.2 0.3 0.0 0.5 0.2 0.2 0.4 3.3 0.2 0.1 0.1 0.6 0.6 2.9 5.3 2.6 0.0 0.4 0.2 0.0 0.0 4.6 0.2 0.1 0.0 0.0 0.3 0.7 1.8 13.4 0.0 0.1 2.5 0.1 0.1 0.0 0.4 0.0 0.4 0.2 2.7 0.0 0.5 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.5 1.3 0.0 0.2 0.2 0.2 1.1 0.4 0.9 0.4 0.5 0.2 0.5 14.4 0.3 0.3 2.0 1.4 0.3 1.4 1.6 0.3 0.2 0.6 1.1 0.3 0.2 1.2 2.2 0.7 0.3 0.2 0.7 0.9 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.6 0.1 0.1 1.5 1.2 0.1 0.3 0.0 0.0 0.8 1.4 2.0 5.2 1.0 0.8 1.5 2.1 3.5 0.5 3.3 5.3 0.1 44.8 48.3 2.0 0.0 0.6 2.5 0.4 0.6 0.1 0.1 0.0 0.4 0.0 18.5 3.7 0.0 6.3 0.0 5.3 1.9 0.1 0.6 3.1 0.3 2.9 0.0 0.0 13.2 0.2 0.6 4.4 0.0 4.8 17.7 0.0 0.0 0.5 0.3 0.0 10.1 1.2 6.1 0.3 0.0 0.0 0.0 3.2 0.0 1.0 0.0 0.2 0.0 6.0 31.6 0.0 1.1 0.0 0.0 0.8 1.2 0.9 13.2 0.3 0.0 0.1 0.2 0.0 0.2 3.7 1.7 13.7 2.6 0.1 1.4 0.5 MAPKBP1 "KIAA0596, NPHP20" ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Cluster 46: Basophils - DNA binding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 6.2 10.5 10.9 4.6 12.4 4.4 7.7 31.1 13.7 11.1 10.1 10.2 9.6 9.9 4.5 18.6 10.4 4.6 6.4 9.9 8.5 7.1 4.1 6.0 3.9 9.0 8.0 15.1 5.5 4.2 12.7 5.4 9.0 8.9 3.6 9.0 7.5 5.9 5.1 24.2 9.9 9.0 5.3 8.0 9.3 34.4 9.1 6.3 13.4 3.7 6.8 12.2 12.0 10.2 7.4 3.8 10.0 9.5 10.9 10.8 6.9 10.1 25.5 9.1 6.6 7.6 2.7 1.8 8.1 8.3 12.5 17.2 9.8 28.5 6.5 6.7 2.7 7.3 12.8 2.6 4.7 4.7 14.5 5.6 22.3 14.3 25.9 14.8 13.4 11.9 4.6 3.4 12.9 1.5 4.0 4.2 1.1 4.3 7.6 4.3 7.2 0.7 5.3 8.1 11.3 6.3 5.7 5.9 4.5 10.2 7.1 3.7 10.6 13.0 6.2 12.4 10.0 7.3 12.7 4.3 8.7 6.3 11.0 1.1 0.4 0.3 0.8 0.1 0.6 0.4 0.4 0.3 0.5 0.4 0.6 0.5 0.1 0.6 0.5 0.1 0.2 0.5 10.9 12.4 31.1 13.7 9.9 8.5 9.0 8.0 9.0 5.3 9.1 10.2 7.1 6.4 10.3 33.0 3.5 54.7 10.0 8.6 36.5 14.5 5.4 8.9 3.4 2.8 7.3 3.7 204.3 6.8 5.6 4.0 0.0 3.0 15.7 10.9 7.1 9.5 4.8 0.8 62.2 3.7 4.4 5.8 9.2 8.9 1.3 12.2 5.3 2.6 3.9 15.2 55.1 1.7 4.1 2.5 6.1 27.1 7.2 5.0 8.8 33.7 4.2 4.4 3.1 34.7 51.9 4.6 1.8 7.9 5.1 12.5 8.1 0.5 13.0 8.9 13.1 7.8 5.7 12.7 4.2 27.7 53.6 5.3 5.8 8.0 2.5 15.2 MED19 LCMR1 ENSG00000156603 "Mediator complex subunit 19" A0JLT2 11 57703714-57712323 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039912, HPA040860" Uncertain Enhanced "Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" "HPA039912: AB_10795262, HPA040860: AB_10794153" "unprognostic (2.61e-1)" "unprognostic (1.62e-1)" "unprognostic (5.01e-2)" "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.40e-1)" "unprognostic (4.87e-3)" "prognostic favorable (1.76e-6)" "unprognostic (3.08e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (6.97e-2)" "unprognostic (4.91e-2)" "unprognostic (1.38e-2)" 11.3 18.1 22.7 6.2 23.7 6.8 11.6 20.7 41.5 11.0 21.0 10.0 9.6 11.6 13.4 15.5 9.2 6.1 11.3 23.4 22.6 14.7 13.2 8.9 7.5 21.4 22.9 9.6 11.6 9.8 16.0 10.2 22.2 12.5 7.8 12.0 12.1 8.9 10.6 15.5 9.7 8.1 22.2 10.8 11.1 22.8 26.0 8.2 13.6 9.2 9.4 10.1 11.9 23.7 30.3 19.1 22.7 21.0 23.6 21.4 27.0 25.4 19.7 23.9 24.0 13.6 23.0 16.6 38.5 24.4 21.0 22.6 17.1 16.1 21.0 21.8 18.6 14.3 11.3 12.7 35.5 15.7 16.4 17.5 28.9 23.8 46.6 16.7 31.1 13.3 15.9 16.1 29.1 14.5 22.3 29.2 19.8 21.4 37.7 21.1 32.2 20.2 15.9 12.6 17.6 24.7 20.5 20.7 47.2 19.1 43.8 16.0 25.7 20.7 24.8 49.2 22.6 19.9 20.5 15.7 28.3 11.5 22.1 27.9 25.8 31.3 29.2 37.2 31.6 45.0 32.8 31.4 25.6 39.4 34.0 32.0 16.4 24.6 39.2 36.9 33.9 26.0 22.7 23.7 20.7 41.5 23.4 22.6 21.4 22.9 22.2 22.2 26.0 23.7 40.7 9.6 27.1 4.6 32.5 87.6 60.9 72.0 62.0 38.6 37.4 39.8 14.7 30.0 40.2 51.5 35.5 58.2 32.2 36.2 39.2 44.1 12.2 33.3 37.8 39.3 23.3 21.4 9.2 45.4 48.6 38.1 20.9 34.0 22.2 39.2 36.0 26.3 29.3 37.0 8.3 38.3 54.9 17.6 31.4 15.4 28.3 18.6 37.4 2.8 26.3 37.4 24.7 5.5 7.2 40.6 33.2 29.7 22.9 53.6 32.9 47.2 42.1 59.7 19.7 31.3 50.5 111.7 97.9 42.7 82.3 73.1 35.8 37.5 31.8 52.8 MED31 "CGI-125, Soh1" ENSG00000108590 "Mediator complex subunit 31" Q9Y3C7 17 6643311-6651634 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035947 Uncertain Approved Nucleoplasm No No "Cluster 34: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA035947: AB_10696646" "unprognostic (1.42e-1)" "unprognostic (4.39e-1)" "unprognostic (6.87e-2)" "unprognostic (4.40e-3)" "unprognostic (1.71e-1)" "unprognostic (3.99e-1)" "unprognostic (6.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.03e-2)" "unprognostic (1.39e-2)" "unprognostic (5.79e-2)" "unprognostic (6.46e-3)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" 12.1 22.4 17.2 9.3 19.3 9.9 14.4 17.2 26.4 13.2 17.6 9.6 8.7 11.2 26.5 25.0 12.8 12.5 15.6 18.3 19.7 16.6 18.2 11.0 14.8 17.1 17.8 12.8 9.7 13.1 25.3 9.7 18.6 12.5 8.5 10.8 12.8 8.9 14.4 21.1 10.3 12.4 17.5 16.5 10.9 17.5 19.4 13.7 14.7 10.6 14.7 14.2 14.4 17.1 37.7 41.2 36.4 23.2 32.5 27.4 13.1 28.8 29.5 43.6 56.6 20.6 19.2 5.0 35.6 14.3 32.3 40.5 29.2 35.7 37.7 27.1 48.9 9.3 34.5 32.3 24.4 10.5 18.8 15.2 37.8 39.6 13.4 23.2 32.8 20.0 16.5 9.4 32.2 13.7 20.2 27.4 13.0 16.9 23.5 15.0 16.2 13.6 36.7 18.4 14.5 16.0 14.8 11.8 33.1 17.2 12.3 11.5 14.8 21.3 18.6 27.1 29.2 8.5 11.9 12.8 29.4 12.4 15.4 77.7 22.6 38.6 26.0 16.4 24.7 22.7 24.2 25.7 19.9 23.7 21.5 23.1 63.3 23.7 20.0 25.6 31.2 20.2 17.2 19.3 17.2 26.4 18.3 19.7 17.1 17.8 18.6 17.5 19.4 17.1 34.1 16.0 22.9 13.4 37.0 106.9 48.3 92.3 68.3 8.4 38.0 35.3 4.8 37.1 47.6 33.1 10.4 40.8 29.1 23.1 54.8 36.4 34.2 78.8 31.9 35.7 12.6 30.5 32.7 31.5 40.3 31.5 15.3 38.6 26.6 21.4 39.3 57.1 33.7 13.5 24.6 23.1 59.0 23.9 37.9 62.5 44.4 25.1 40.9 12.2 29.3 22.9 21.6 18.1 21.9 46.4 15.3 26.4 34.4 51.0 22.4 81.8 97.2 12.8 39.5 29.7 33.7 101.9 81.3 46.6 120.2 47.9 37.5 35.6 19.3 66.6 MFSD6 FLJ20160 ENSG00000151690 "Major facilitator superfamily domain containing 6" Q6ZSS7 2 190408355-190509205 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 110.6;Respiratory ciliated cells: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 79.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022274 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" "HPA022274: AB_2142776" "unprognostic (9.47e-2)" "unprognostic (7.01e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-2)" "unprognostic (2.49e-1)" "unprognostic (4.13e-3)" "unprognostic (1.78e-2)" "unprognostic (3.08e-2)" "unprognostic (3.92e-1)" "unprognostic (3.77e-1)" "unprognostic (9.54e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.05e-4)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" "unprognostic (9.14e-2)" "unprognostic (9.18e-2)" 20.8 40.3 29.1 12.7 31.7 7.6 21.3 37.0 40.3 21.8 0.0 31.8 19.8 10.5 32.8 40.6 19.5 15.8 17.9 35.5 27.6 10.8 2.3 26.4 14.8 45.8 48.3 4.1 16.8 64.5 35.4 8.6 52.4 23.0 28.9 14.9 30.8 32.3 6.4 29.8 24.6 14.4 28.6 20.9 32.1 7.9 38.3 19.9 38.9 14.2 20.6 22.9 21.5 51.2 25.1 15.2 0.5 5.2 10.6 13.6 20.4 12.7 25.3 8.4 10.5 5.6 31.1 39.1 5.8 26.4 15.6 41.5 7.4 22.1 9.5 79.7 11.6 20.9 14.2 2.9 4.2 8.3 6.4 2.1 39.3 12.5 8.1 27.1 3.0 30.5 5.4 42.2 2.2 9.7 38.8 1.8 3.4 27.1 16.1 8.6 1.2 34.1 15.9 45.1 47.5 12.2 17.9 41.7 24.9 1.7 13.6 9.5 12.6 1.4 2.9 16.6 19.7 19.3 8.6 13.8 13.5 16.9 6.9 4.6 1.1 0.4 1.4 0.3 1.5 1.6 1.8 2.0 1.5 0.7 0.9 1.9 0.1 2.1 0.5 0.7 3.5 0.8 29.1 31.7 37.0 40.3 35.5 27.6 45.8 48.3 52.4 28.6 38.3 51.2 48.6 32.1 20.0 7.2 7.6 6.4 11.5 11.7 10.8 9.7 16.8 9.8 21.4 5.7 30.3 23.9 8.4 0.2 14.9 25.1 0.0 13.2 46.8 27.9 5.9 26.7 35.4 7.8 55.7 20.5 0.2 8.9 31.1 22.5 24.0 8.7 16.1 0.8 4.0 28.6 47.9 42.7 12.2 4.0 8.0 13.7 5.6 12.3 8.8 11.2 9.7 6.8 3.1 41.7 110.6 24.9 20.8 5.3 14.9 13.5 13.6 1.0 88.5 7.9 0.0 16.7 7.2 1.0 1.4 28.8 18.3 0.0 17.0 18.6 21.1 22.7 MINDY1 "FAM63A, FLJ11280, MINDY-1" ENSG00000143409 "MINDY lysine 48 deubiquitinase 1" Q8N5J2 1 150996086-151008375 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Distal tubular cells: 39.2;Ductal cells: 11.6;Proximal tubular cells: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 98.4;eosinophil: 56.2;neutrophil: 85.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 98.4" "Cell line enhanced" "Detected in many" "T-47d: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028351, HPA028358, HPA061086" Approved Enhanced Nucleoplasm NA NA 220000 "Cluster 2: Granulocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425" "unprognostic (5.73e-2)" "unprognostic (2.86e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-1)" "unprognostic (3.39e-2)" "unprognostic (6.90e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.22e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.43e-8)" "unprognostic (2.30e-1)" "unprognostic (7.95e-2)" "unprognostic (2.50e-2)" "unprognostic (6.06e-2)" 13.8 13.0 24.9 8.2 49.9 7.2 15.0 42.7 33.7 19.0 30.9 18.4 16.8 18.1 7.0 37.1 17.4 14.0 33.5 22.2 30.7 30.4 19.0 12.9 6.4 58.7 43.9 21.7 47.6 30.1 15.1 6.8 53.4 14.3 17.2 13.3 29.6 13.7 16.7 20.6 14.8 15.6 33.3 15.1 25.9 23.6 43.1 3.6 47.3 18.0 8.7 15.0 20.1 75.6 11.3 7.3 7.7 10.8 13.4 11.1 6.4 3.6 9.1 5.0 7.9 15.6 26.3 0.7 8.4 4.7 1.5 5.5 6.1 6.8 2.2 8.6 9.2 11.0 13.8 13.5 3.0 3.3 4.3 9.1 5.9 9.0 2.5 16.8 12.9 3.8 7.0 27.5 5.3 17.4 0.6 7.4 3.5 3.5 2.5 8.3 1.4 34.8 23.4 22.1 13.1 9.7 6.9 12.4 7.4 3.6 49.5 11.1 12.0 4.3 5.5 2.2 3.1 10.1 9.9 37.5 10.2 7.2 20.4 98.4 9.3 56.2 0.4 4.1 0.3 0.8 3.5 1.0 11.5 1.5 5.8 2.0 85.4 4.7 2.8 1.7 4.8 9.9 24.9 49.9 42.7 33.7 22.2 30.7 58.7 43.9 53.4 33.3 43.1 75.6 4.5 9.6 5.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.8 5.8 0.0 0.0 3.7 3.7 0.0 3.8 1.4 0.0 39.2 11.6 0.0 3.4 3.7 3.7 0.0 0.0 0.0 7.0 0.8 2.9 0.0 4.5 3.8 6.4 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.0 12.0 2.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.6 0.8 5.0 0.0 0.0 MMP28 "EPILYSIN, MM28, MMP-25, MMP-28" ENSG00000271447 "Matrix metallopeptidase 28" Q9H239 17 35756249-35795707 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 47.7;Basal respiratory cells: 56.8;Distal enterocytes: 82.0;Paneth cells: 46.2;Proximal enterocytes: 47.2;Urothelial cells: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 6.3;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 7 "T-cells: 6.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.8;HaCaT: 86.9;hTCEpi: 38.3;OE19: 41.7;RT4: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057288, HPA057890" Approved "Nucleoplasm,Focal adhesion sites" "Secreted to extracellular matrix" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Focal adhesion sites" "HPA057288: , HPA057890: " "unprognostic (7.99e-3)" "unprognostic (3.27e-1)" "unprognostic (2.20e-1)" "unprognostic (1.01e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (6.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.28e-6)" "unprognostic (9.37e-2)" "unprognostic (1.31e-1)" "unprognostic (8.87e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" 14.7 2.0 18.7 0.5 18.1 0.2 8.3 12.1 18.8 4.1 11.9 17.5 1.8 5.2 2.1 13.5 6.1 1.4 3.8 16.2 15.6 1.9 0.3 14.1 0.2 15.2 17.8 1.1 0.8 0.1 1.3 2.0 12.9 5.0 10.5 3.0 2.5 3.5 1.8 23.7 10.2 4.1 14.4 1.1 8.8 22.3 19.3 0.3 5.9 2.4 3.2 16.3 7.6 13.9 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.1 1.5 0.0 0.1 86.9 0.0 0.2 0.0 0.0 0.7 0.0 0.2 0.0 4.3 0.0 0.0 1.2 38.3 0.0 3.1 0.7 0.3 0.3 0.0 0.2 0.0 0.3 0.1 0.3 0.0 41.7 0.1 0.8 0.0 0.0 0.0 15.7 0.2 0.7 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.6 0.2 1.0 0.0 0.4 6.3 3.7 0.0 0.9 0.2 0.9 0.0 0.4 18.7 18.1 12.1 18.8 16.2 15.6 15.2 17.8 12.9 14.4 19.3 13.9 31.5 28.9 26.5 47.7 0.4 38.5 5.3 56.8 21.1 2.7 1.0 1.5 1.3 7.2 15.2 7.3 0.0 0.0 0.2 82.0 0.0 1.2 6.7 0.1 0.0 16.8 3.6 0.4 2.8 0.4 0.0 4.4 12.2 0.1 0.0 0.0 17.9 0.0 0.1 1.7 4.8 32.9 2.0 0.0 1.8 13.4 1.2 0.5 3.6 10.3 0.4 9.4 1.0 1.0 0.6 16.7 46.2 3.0 0.1 8.6 47.2 0.8 4.5 0.5 6.6 0.7 5.5 1.1 3.7 34.9 33.1 0.0 1.0 0.1 21.5 43.9 MMS19 "CIAO4, hMMS19, MET18, MMS19L" ENSG00000155229 "MMS19 homolog, cytosolic iron-sulfur assembly component" Q96T76 10 97458324-97498794 "Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051936, HPA056299" Approved Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA051936: AB_2681668, HPA056299: AB_2683091" "unprognostic (8.57e-2)" "unprognostic (2.38e-3)" "unprognostic (9.34e-3)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (4.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.06e-3)" "unprognostic (6.79e-2)" "unprognostic (6.49e-2)" "unprognostic (4.06e-1)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.39e-4)" 25.9 23.3 45.1 14.9 47.1 16.4 27.0 45.7 66.4 27.7 45.3 26.1 14.2 24.6 18.3 32.8 24.8 13.1 39.3 47.6 44.0 37.3 24.0 25.1 22.3 44.7 44.2 30.3 30.6 17.1 35.7 20.6 45.2 23.5 17.5 28.8 26.7 15.8 38.0 44.4 28.4 17.8 43.4 33.4 27.9 47.2 45.8 25.8 23.5 29.2 22.7 25.6 30.3 44.9 39.1 36.5 43.3 61.1 41.4 49.9 26.3 30.7 61.6 45.8 53.5 48.9 49.7 59.9 32.5 42.1 30.4 43.5 71.5 82.7 43.1 26.3 54.5 32.0 30.5 51.8 31.3 42.7 29.9 41.5 35.7 40.7 86.3 88.8 78.2 44.7 45.5 32.8 45.1 35.1 40.5 77.3 24.6 39.0 29.8 32.1 33.0 27.1 55.0 27.9 17.8 29.5 17.8 23.4 48.3 53.7 47.9 37.8 45.0 21.1 26.0 14.2 35.6 29.5 35.0 34.6 31.5 62.3 17.3 10.5 6.1 4.6 5.4 6.6 9.3 6.0 7.2 6.8 8.5 5.0 8.7 7.1 1.2 5.7 5.2 6.3 7.2 6.3 45.1 47.1 45.7 66.4 47.6 44.0 44.7 44.2 45.2 43.4 45.8 44.9 9.4 22.4 16.0 21.2 10.0 10.5 6.2 11.3 12.5 10.6 9.2 11.2 18.0 12.8 8.2 5.5 18.8 13.7 13.4 8.7 11.7 11.1 9.6 5.6 12.1 13.0 10.2 11.6 32.8 8.1 18.8 9.9 16.8 9.0 3.8 12.8 15.4 14.4 12.4 10.1 29.7 14.6 4.1 12.6 9.6 7.4 15.5 9.0 14.2 7.5 15.6 6.4 6.2 27.6 38.6 9.7 4.1 11.3 10.7 6.1 9.1 6.7 7.6 22.2 13.1 9.1 8.8 22.2 28.5 12.7 11.5 8.8 9.7 9.7 13.1 4.9 MOV10 "fSAP113, gb110, MGC2948" ENSG00000155363 "Mov10 RISC complex RNA helicase" Q9HCE1 1 112673141-112700746 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031627 Approved Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA031627: AB_2673966" "unprognostic (1.44e-2)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" "unprognostic (6.82e-3)" "unprognostic (1.91e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.44e-4)" "unprognostic (9.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.58e-3)" "unprognostic (2.85e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.48e-11)" "unprognostic (4.01e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-3)" "unprognostic (1.21e-3)" 7.6 13.2 3.4 9.7 3.7 4.7 7.6 2.9 3.4 10.2 4.7 10.9 22.1 10.2 9.5 13.2 13.5 9.4 5.2 3.1 6.2 10.3 19.4 9.1 8.5 4.7 4.1 9.7 8.2 12.8 11.2 23.6 4.0 11.5 10.7 3.0 14.3 11.2 3.1 27.2 20.2 10.8 4.1 12.1 10.7 16.6 5.4 16.2 9.8 4.2 7.0 9.3 10.8 3.4 29.5 17.9 10.4 40.2 8.3 23.5 39.1 19.8 46.5 56.9 80.7 33.2 31.7 0.0 13.2 27.4 21.1 30.5 39.7 47.4 19.6 32.4 24.2 20.2 26.7 37.8 35.3 8.5 19.3 39.9 14.2 34.6 10.9 37.4 49.2 40.7 27.2 9.8 17.8 54.7 32.7 6.6 23.4 12.2 18.1 57.9 26.2 1.3 26.4 31.9 4.4 15.0 40.9 27.5 31.5 20.2 21.4 19.4 29.7 17.6 31.0 12.4 17.8 11.3 3.3 0.1 34.9 17.4 51.4 0.9 3.5 0.7 12.5 10.3 12.4 2.1 10.8 11.1 6.8 1.5 10.3 8.0 1.1 12.7 12.2 1.0 10.2 7.6 3.4 3.7 2.9 3.4 3.1 6.2 4.7 4.1 4.0 4.1 5.4 3.4 13.0 9.6 10.5 26.4 6.3 8.8 10.4 15.5 8.0 2.4 7.8 7.0 4.1 8.6 17.4 16.5 0.0 54.7 5.6 29.2 3.9 15.5 5.9 5.8 7.3 16.9 15.0 3.8 4.1 15.5 18.4 9.4 23.9 7.0 1.3 36.5 16.8 18.3 15.8 5.0 2.3 18.0 12.2 7.5 6.0 6.2 9.3 10.3 3.6 12.2 14.4 15.1 10.3 18.1 3.3 12.4 26.9 7.5 3.6 11.1 46.2 13.9 18.4 1.1 13.1 4.0 7.4 2.7 3.4 11.7 7.0 38.2 9.2 22.4 15.5 12.1 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170224 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavorable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favorable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 19.8 21.3 26.7 25.5 26.8 20.0 72.5 29.6 32.8 23.6 19.1 22.7 13.8 25.8 22.4 36.2 15.9 16.5 13.9 26.7 28.3 17.8 15.9 18.7 24.7 22.1 24.7 13.4 9.0 16.2 21.3 24.4 23.1 15.3 24.9 31.6 26.0 13.0 18.0 40.1 15.9 22.8 21.7 16.7 15.7 14.1 27.5 20.7 11.6 17.5 26.2 34.7 21.0 28.4 67.8 36.2 79.0 38.9 37.7 52.7 43.5 71.1 84.7 60.6 29.3 58.5 38.4 55.2 42.0 39.2 44.7 69.2 76.2 73.6 80.8 41.3 49.9 44.5 31.2 106.5 37.5 111.9 65.9 33.6 64.7 36.2 102.8 30.5 70.6 75.7 106.2 15.3 93.4 54.8 86.5 131.2 72.4 83.4 49.5 105.5 36.6 36.5 55.3 69.8 54.1 23.3 119.6 52.5 53.6 32.4 92.2 68.6 56.0 56.5 56.3 50.2 51.3 22.4 58.0 217.9 51.0 89.9 73.2 26.1 38.3 36.9 38.2 46.5 48.5 35.6 38.7 39.9 44.9 29.2 41.1 38.8 4.9 33.1 33.8 27.2 44.3 28.3 26.7 26.8 29.6 32.8 26.7 28.3 22.1 24.7 23.1 21.7 27.5 28.4 13.2 19.2 38.3 20.5 22.9 38.7 40.3 123.9 19.4 14.5 74.3 50.0 31.5 14.3 66.2 20.2 10.4 56.9 23.0 21.7 50.9 45.2 6.5 13.9 18.5 19.3 9.0 23.1 38.5 28.1 46.1 31.4 15.8 22.0 18.3 21.9 20.0 19.0 49.6 20.2 35.6 20.7 40.7 29.1 42.7 7.5 11.1 55.9 32.0 12.2 56.0 61.1 34.0 29.7 17.1 56.4 28.4 10.1 22.3 38.6 12.2 46.5 32.7 24.5 19.7 15.4 30.1 36.9 57.5 30.6 54.0 32.8 27.4 26.3 34.0 48.1 MYCBP2 "FLJ10106, KIAA0916, PAM, PHR1" ENSG00000005810 "MYC binding protein 2" O75592 13 77044657-77327094 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 425.4;Inhibitory neurons: 471.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 110.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058807 Supported Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Vesicles, Cytosol" "HPA058807: AB_2732627" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (8.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "prognostic favorable (5.01e-5)" "unprognostic (2.63e-1)" "unprognostic (9.84e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" 69.9 22.2 42.3 19.0 46.2 32.8 49.3 37.3 52.4 43.4 18.8 29.4 9.0 27.2 29.8 45.9 29.2 12.5 32.9 48.6 35.9 22.6 24.5 28.3 40.0 34.6 29.6 43.1 30.9 14.9 32.3 10.9 36.9 28.0 12.5 28.9 29.1 13.3 26.5 79.7 34.8 11.9 30.1 56.4 24.9 26.3 33.9 34.6 27.2 18.1 37.8 30.4 41.5 38.7 21.6 10.8 12.9 14.1 62.9 27.9 7.5 13.4 19.8 11.5 14.7 9.7 11.0 61.4 8.3 26.6 11.2 19.5 22.4 24.7 15.5 24.5 22.2 52.2 22.2 20.1 21.4 110.8 17.7 31.5 20.2 10.6 20.8 11.4 26.5 22.3 11.3 18.8 20.7 13.1 30.5 74.3 6.8 28.7 13.6 34.2 13.1 15.0 19.6 21.1 20.2 9.4 16.2 23.1 12.8 13.0 8.6 83.8 35.0 10.9 9.1 7.3 13.0 20.3 15.0 42.7 22.1 89.2 11.3 1.4 2.0 2.0 3.2 2.1 2.8 4.9 3.6 2.8 1.9 4.3 4.1 3.2 1.8 2.8 1.6 2.7 4.5 1.4 42.3 46.2 37.3 52.4 48.6 35.9 34.6 29.6 36.9 30.1 33.9 38.7 92.2 38.5 52.2 158.7 170.3 82.3 39.9 32.6 63.7 229.3 36.8 38.4 69.7 25.8 30.9 35.0 104.3 46.1 109.2 14.2 1.9 26.1 56.0 50.9 61.1 83.8 32.6 46.9 425.4 33.1 31.5 80.6 38.2 66.6 48.2 34.0 44.6 52.4 41.8 218.7 471.3 19.7 26.4 106.9 48.2 23.4 65.9 100.4 32.0 282.9 116.7 121.5 120.5 338.8 212.5 30.2 15.8 96.3 121.9 53.7 15.2 13.2 19.5 94.8 105.2 76.7 76.0 81.5 71.6 129.1 150.7 43.9 121.5 67.4 28.1 42.4 NDRG1 "CAP43, DRG1, NDR1, RTP, TDD5" ENSG00000104419 "N-myc downstream regulated 1" Q92597 8 133237175-133302022 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 613.9" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 571.9;Distal enterocytes: 405.4;Horizontal cells: 588.9;Suprabasal keratinocytes: 667.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 606.9;hTERT-HME1: 1226.9;U-87 MG: 772.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006881 Approved Supported Microtubules,Cytosol NA NA 200000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 28: Keratinocytes - Keratinization" Cytosol Microtubules "HPA006881: AB_1078392" "unprognostic (6.96e-3)" "unprognostic (3.31e-3)" "unprognostic (8.53e-2)" "unprognostic (1.41e-3)" "unprognostic (1.54e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.04e-3)" "unprognostic (5.33e-2)" "unprognostic (4.29e-2)" "unprognostic (9.09e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (4.13e-4)" "unprognostic (7.27e-2)" "unprognostic (1.91e-1)" "unprognostic (2.47e-3)" "unprognostic (4.28e-2)" 161.2 72.9 299.1 55.9 523.6 130.0 107.6 413.5 300.2 169.4 132.8 130.0 242.2 92.9 34.3 343.1 106.4 87.8 99.8 254.5 316.6 192.4 49.6 116.6 38.7 523.2 500.0 126.1 52.8 69.1 82.2 110.8 476.8 354.3 77.8 86.0 130.8 60.0 28.2 262.6 258.1 61.9 333.7 39.4 154.0 28.1 423.1 55.1 80.5 44.6 88.1 105.5 273.8 613.9 191.6 24.0 1.7 0.8 116.3 86.8 26.0 13.7 103.0 9.8 52.5 12.5 27.6 1.5 133.0 58.0 21.9 62.4 1.7 316.8 18.0 13.3 226.8 1.9 55.6 14.7 46.3 7.0 4.6 79.2 606.9 51.2 1226.9 124.2 45.2 27.9 2.0 138.3 17.2 11.0 19.1 20.8 3.0 69.8 155.8 1.7 19.4 86.2 29.7 28.0 13.8 13.0 31.0 312.1 73.3 48.6 1.3 20.0 58.5 84.4 43.6 40.7 10.4 96.3 280.3 0.8 772.5 69.5 161.5 10.9 4.3 0.0 5.8 3.4 9.1 1.6 5.3 6.9 6.0 1.4 3.9 3.1 4.0 1.5 4.2 13.0 8.1 3.7 299.1 523.6 413.5 300.2 254.5 316.6 523.2 500.0 476.8 333.7 423.1 613.9 123.0 144.2 47.4 14.4 23.6 571.9 141.3 207.3 42.1 68.8 28.6 31.2 20.6 80.1 102.9 187.6 2.1 12.8 68.1 405.4 33.2 33.2 5.3 57.4 59.0 217.7 22.1 17.4 7.7 13.7 138.2 90.5 151.4 167.7 22.2 41.0 112.8 64.0 16.5 588.9 5.7 140.9 83.4 31.1 109.5 5.9 49.0 42.7 101.4 28.1 25.7 81.2 14.4 20.6 136.2 62.9 155.9 44.0 23.5 264.3 402.5 87.5 38.7 40.3 46.0 65.2 44.3 1.2 7.1 113.0 667.4 43.4 45.7 32.6 124.7 280.8 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.4;esophagus: 2.3;retina: 2.1;skin 1: 3.3" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 14.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 7.9;Spermatocytes: 5.1;Squamous epithelial cells: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 58.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 37: Myocytes - Muscle contraction" "Nuclear bodies" Nucleoplasm "HPA055238: AB_2682752" "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.0 0.0 2.0 0.0 1.4 0.0 0.1 5.9 2.1 0.3 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 3.2 4.0 0.0 0.0 0.2 0.0 3.8 5.1 0.0 0.0 0.0 0.2 0.0 7.4 0.2 0.0 2.1 0.4 0.1 0.2 3.3 0.0 0.0 2.5 0.0 0.2 0.4 6.7 0.0 0.0 0.0 0.0 0.0 0.7 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.4 5.9 2.1 3.2 4.0 3.8 5.1 7.4 2.5 6.7 3.0 0.0 0.0 0.0 0.3 0.0 2.8 2.8 3.3 14.8 3.9 0.0 0.6 3.4 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 1.8 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 4.5 7.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.4 0.0 3.5 0.3 5.1 3.4 7.0 2.3 0.0 0.0 0.0 0.0 0.4 NHP2 "FLJ20479, NOLA2" ENSG00000145912 "NHP2 ribonucleoprotein" Q9NX24 5 178149463-178153894 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 1398.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044171, HPA050400" Enhanced NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA044171: AB_2678844, HPA050400: AB_2681113" "unprognostic (1.19e-1)" "unprognostic (1.59e-1)" "unprognostic (3.71e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (4.05e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (5.24e-4)" "unprognostic (8.87e-2)" "unprognostic (9.12e-2)" "unprognostic (1.78e-2)" "unprognostic (4.20e-2)" "unprognostic (6.72e-2)" "unprognostic (1.67e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (4.04e-2)" "unprognostic (8.63e-2)" 101.1 106.0 100.4 76.2 108.4 111.6 102.0 106.0 129.1 102.7 86.8 91.8 56.9 99.8 40.8 185.4 89.0 41.6 110.2 105.7 105.4 109.4 107.4 70.4 96.8 101.3 101.5 107.6 114.6 52.7 79.0 51.1 101.7 89.9 45.1 31.0 90.0 51.1 133.2 129.8 68.3 49.5 105.4 77.1 89.6 64.2 104.1 64.8 78.3 58.1 68.3 104.9 111.0 109.1 288.3 474.1 148.2 417.3 99.9 133.1 499.8 216.1 119.0 260.4 222.5 290.8 252.4 413.6 396.3 133.4 233.8 185.3 225.7 514.8 131.8 778.2 789.2 216.4 343.0 319.3 168.1 371.8 229.6 162.3 240.5 199.6 176.9 96.7 243.6 294.0 226.5 273.5 143.6 1398.1 529.0 280.1 215.9 271.9 739.0 362.6 190.9 641.5 192.3 195.5 375.2 407.7 167.9 470.0 426.5 89.7 227.1 274.6 222.4 253.3 274.0 207.6 513.3 316.8 679.2 494.1 250.1 519.9 284.6 58.3 218.3 32.8 188.4 254.5 265.5 335.5 232.7 218.7 310.1 347.2 238.9 245.3 16.8 260.1 188.2 507.4 245.0 363.7 100.4 108.4 106.0 129.1 105.7 105.4 101.3 101.5 101.7 105.4 104.1 109.1 94.4 60.9 67.3 9.4 123.7 193.2 226.4 222.9 155.4 46.8 228.2 309.9 11.6 131.5 139.5 126.9 18.8 233.7 85.4 88.0 358.1 230.6 59.2 75.2 165.5 116.6 126.6 100.7 9.2 302.4 359.6 113.8 76.5 83.2 79.3 133.0 84.3 172.3 172.6 30.3 9.1 151.8 97.6 78.4 131.8 114.0 134.8 81.3 145.9 5.6 117.2 78.3 93.7 9.0 14.0 231.0 71.2 97.4 128.7 389.5 54.5 320.7 73.1 36.7 59.2 100.0 139.4 107.5 129.2 343.9 242.9 166.9 87.0 183.3 207.7 289.4 NIPAL4 ICHYN ENSG00000172548 "NIPA like domain containing 4" Q0D2K0 5 157460213-157474722 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" Receptor "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7;skin 1: 61.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 29.7;Basal prostatic cells: 9.8;Oligodendrocytes: 21.0;Squamous epithelial cells: 9.8;Suprabasal keratinocytes: 42.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.0;urothelial cancer: 11.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 1.6;naive B-cell: 4.8" "Lineage enriched" "Detected in single" 37 "B-cells: 4.8" "Group enriched" "Detected in some" 8 "hTCEpi: 31.7;RT4: 108.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038259 Approved NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 28: Keratinocytes - Keratinization" "HPA038259: AB_10672510" "unprognostic (6.74e-4)" "unprognostic (9.54e-2)" "unprognostic (2.63e-2)" "unprognostic (1.49e-1)" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (3.55e-2)" "unprognostic (5.20e-2)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (5.28e-9)" "unprognostic (3.12e-2)" "unprognostic (8.66e-3)" "unprognostic (1.18e-2)" "prognostic favorable (6.82e-4)" 0.4 0.0 3.5 2.0 9.7 3.4 2.2 8.5 7.1 5.9 1.1 3.7 0.3 1.2 0.1 15.1 0.1 0.5 1.5 3.9 6.2 0.0 0.0 0.7 0.4 12.4 8.7 0.0 0.0 0.0 0.5 0.6 10.5 1.5 0.6 0.1 1.9 1.4 0.2 61.2 0.9 1.1 7.6 0.2 2.5 0.1 8.0 0.4 0.3 0.0 5.8 11.5 15.1 18.7 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.4 0.1 1.1 0.0 0.0 0.7 0.4 0.0 6.3 0.3 2.7 0.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.3 31.7 0.0 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 108.1 0.0 0.4 0.0 0.0 0.0 8.5 1.6 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 9.7 8.5 7.1 3.9 6.2 12.4 8.7 10.5 7.6 8.0 18.7 0.0 0.0 0.5 0.0 2.4 29.7 9.8 0.6 2.2 0.6 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.7 0.3 0.0 1.1 1.8 0.0 0.0 0.0 0.0 0.0 21.0 0.1 0.0 0.0 0.3 3.8 0.0 0.0 0.1 1.1 0.0 5.2 0.3 0.0 0.1 9.8 42.1 0.0 0.2 0.0 0.0 4.4 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019837-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3;skin 1: 7.7" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 16.7;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 28.3" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 9.9;Daudi: 10.2;HEK 293: 11.1;HMC-1: 9.0;NB-4: 18.1;U-266/84: 11.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA043364: , HPA072259: AB_2686500" "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.9 0.4 3.1 0.3 1.8 0.2 0.7 0.3 6.3 0.4 1.9 0.4 0.0 0.1 0.0 1.0 0.6 0.0 1.1 5.4 2.8 1.7 0.6 0.4 0.5 2.9 2.5 0.2 0.6 0.0 1.3 0.1 4.3 0.4 0.0 0.5 0.4 0.0 0.1 7.7 0.4 0.1 0.7 2.8 2.7 0.6 1.5 0.1 0.5 0.0 0.3 0.4 0.7 2.0 0.2 2.4 0.3 0.5 0.2 0.2 0.0 9.9 0.3 0.1 0.4 0.7 0.5 10.2 2.2 8.1 0.4 0.2 2.1 0.2 0.1 0.7 11.1 0.8 1.2 2.5 0.0 5.5 9.0 0.9 0.4 0.0 0.1 0.6 0.2 1.3 3.5 0.8 1.3 0.9 0.4 18.1 2.4 0.4 1.7 0.9 0.4 0.8 0.6 0.6 0.7 0.6 0.8 0.3 2.4 0.8 2.1 1.7 0.1 0.2 0.9 0.1 0.2 5.4 11.5 2.2 1.2 1.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.8 0.3 6.3 5.4 2.8 2.9 2.5 4.3 0.7 1.5 2.0 0.1 0.0 0.6 1.6 1.1 0.8 1.4 1.1 1.8 0.7 2.2 2.5 1.1 0.0 1.1 0.0 16.7 0.0 0.1 0.3 0.0 0.6 0.1 0.4 0.2 0.2 1.2 2.7 5.7 0.4 0.1 0.5 27.0 0.4 0.0 0.7 0.0 0.1 0.3 0.0 28.3 1.4 2.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 5.4 0.0 2.0 1.2 1.0 0.2 0.0 2.6 1.5 0.0 0.9 2.0 5.4 0.0 0.1 1.1 0.4 2.1 2.2 2.3 0.0 1.2 0.1 0.6 1.2 NPIPB11 ENSG00000254206 "Nuclear pore complex interacting protein family member B11" E5RHQ5 16 29381354-29404029 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Early spermatids: 17.5;Intestinal goblet cells: 9.4;Undifferentiated cells: 9.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (6.82e-2)" "unprognostic (2.99e-1)" "unprognostic (1.93e-3)" "unprognostic (1.42e-1)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "unprognostic (3.06e-1)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (5.57e-4)" "unprognostic (7.41e-2)" "unprognostic (2.94e-6)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "unprognostic (5.96e-3)" "unprognostic (4.79e-5)" 2.8 1.6 6.0 2.8 5.4 4.7 2.5 7.2 8.4 2.9 6.3 2.7 2.0 2.1 3.2 2.1 3.1 1.8 2.3 5.6 6.7 3.3 4.2 2.5 6.0 5.5 4.6 3.3 2.0 0.9 2.6 1.2 5.4 2.8 1.7 5.8 2.2 0.6 4.4 6.7 3.7 0.9 3.4 4.4 2.7 4.9 5.8 2.0 3.2 0.9 1.1 2.3 2.5 6.6 1.5 1.2 2.2 3.2 1.6 1.2 2.9 1.4 0.6 1.2 0.5 1.7 2.9 9.0 2.1 0.7 0.5 2.6 1.8 2.1 1.2 2.2 2.4 2.1 4.4 2.8 0.8 2.6 4.9 0.7 1.6 1.3 1.8 2.5 0.6 2.4 2.7 2.6 1.1 3.5 2.2 8.3 3.8 0.9 2.7 3.3 0.9 3.0 1.3 1.1 2.9 1.4 0.4 2.0 1.1 6.8 1.1 3.3 3.0 3.0 1.3 2.1 1.9 2.5 1.7 7.3 1.7 3.3 2.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.5 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 6.0 5.4 7.2 8.4 5.6 6.7 5.5 4.6 5.4 3.4 5.8 6.6 1.4 9.6 5.6 3.6 4.2 0.0 0.1 0.3 0.6 0.2 1.5 0.9 2.5 1.5 2.6 0.0 0.0 0.3 3.7 8.8 0.0 1.2 17.5 0.6 0.5 2.6 7.2 1.3 4.6 0.8 0.2 1.8 3.6 0.6 5.1 0.4 0.4 0.2 0.3 5.0 5.4 9.4 0.0 0.0 0.0 5.9 0.3 1.6 0.0 1.0 1.5 0.1 5.2 2.5 4.2 1.9 5.9 0.7 2.7 0.1 3.7 0.3 2.3 0.3 0.0 0.5 1.0 0.8 0.1 0.5 0.0 0.4 4.4 0.3 9.8 0.0 NPIPB12 ENSG00000169203 "Nuclear pore complex interacting protein family member B12" F8W0I5 16 29483642-29505999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 198.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 29.3" "Group enriched" "Detected in all" 4 "B-cells: 8.4;granulocytes: 29.3;NK-cells: 14.2" "Cell line enhanced" "Detected in all" "NB-4: 166.4" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.83e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "unprognostic (7.92e-2)" "unprognostic (1.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.20e-2)" "unprognostic (2.42e-1)" "unprognostic (6.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.28e-7)" "unprognostic (3.32e-2)" "unprognostic (4.11e-2)" "unprognostic (2.33e-1)" "unprognostic (2.14e-4)" 25.4 21.7 135.6 40.5 135.5 63.7 21.9 136.7 198.1 30.8 109.8 27.5 24.0 24.0 38.5 24.8 27.5 24.8 29.2 127.2 143.6 31.8 58.2 27.5 57.0 128.7 140.4 26.9 24.2 15.1 26.3 20.4 128.8 33.3 25.6 32.2 34.5 20.0 44.3 108.9 33.6 19.7 105.7 51.2 23.5 29.1 137.3 28.1 28.8 15.5 29.8 26.7 24.2 131.2 26.2 26.7 20.6 52.8 24.7 14.7 40.0 15.7 4.4 7.8 6.7 23.1 52.5 43.8 27.4 13.1 15.4 34.5 35.2 25.3 10.7 28.1 25.6 33.3 36.0 46.5 22.2 36.1 61.5 23.0 19.5 17.6 18.5 19.9 9.0 24.3 34.5 37.2 12.7 42.6 26.6 166.4 31.5 17.6 19.3 61.6 9.1 42.7 19.1 18.6 21.9 15.4 8.9 36.5 22.5 9.2 18.7 43.4 22.4 49.9 19.2 34.9 30.2 19.5 21.3 42.7 20.3 63.9 23.9 29.3 3.5 1.4 3.9 1.2 1.0 3.7 2.3 2.7 2.4 8.4 3.1 2.1 9.5 14.2 3.0 2.6 1.8 1.3 135.6 135.5 136.7 198.1 127.2 143.6 128.7 140.4 128.8 105.7 137.3 131.2 0.0 3.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 NR2C2AP TRA16 ENSG00000184162 "Nuclear receptor 2C2 associated protein" Q86WQ0 19 19201409-19203414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042054, HPA055653" Approved Supported Nucleoplasm NA NA "Cluster 30: Non-specific - Translation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" Nucleoplasm "HPA042054: AB_10965022, HPA055653: AB_2682877" "unprognostic (9.54e-2)" "unprognostic (2.93e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.36e-2)" "unprognostic (6.81e-2)" "unprognostic (6.26e-3)" "prognostic unfavorable (5.63e-5)" "unprognostic (1.60e-2)" "unprognostic (1.53e-1)" "unprognostic (8.77e-2)" "unprognostic (3.65e-3)" "unprognostic (5.89e-2)" "unprognostic (7.62e-3)" "unprognostic (1.17e-2)" "unprognostic (5.99e-2)" "prognostic favorable (1.65e-4)" "unprognostic (2.10e-2)" 14.5 10.0 13.8 12.5 14.2 7.6 15.6 14.3 14.2 14.6 12.6 15.0 8.2 14.8 13.7 17.0 14.9 6.7 10.7 14.2 13.8 16.2 10.6 9.5 13.6 14.4 14.1 16.4 15.3 7.8 8.2 7.6 14.4 14.8 11.0 3.5 13.3 10.6 12.6 21.0 12.4 11.4 14.5 13.4 13.4 5.5 14.1 10.2 11.1 7.8 13.6 17.8 14.6 15.6 50.7 29.2 13.6 28.9 11.1 11.1 52.7 28.3 16.0 37.9 35.8 19.7 60.4 27.3 77.2 15.0 26.5 44.2 36.0 37.3 23.1 24.3 39.0 15.6 18.0 21.9 12.9 30.5 23.2 11.3 45.1 26.3 35.4 10.7 15.2 31.0 28.4 35.0 22.8 130.0 51.2 27.6 24.4 72.9 58.8 36.3 22.0 53.3 23.5 26.4 45.2 20.7 24.3 47.1 37.0 16.5 25.6 18.9 12.2 24.5 23.3 61.7 54.7 20.7 32.4 36.3 28.5 51.3 33.2 2.6 14.9 1.5 31.4 21.5 41.2 43.6 40.7 30.4 12.6 42.8 42.3 39.7 2.7 27.4 17.4 24.7 37.7 26.3 13.8 14.2 14.3 14.2 14.2 13.8 14.4 14.1 14.4 14.5 14.1 15.6 14.7 0.0 9.4 2.3 19.2 31.7 41.3 19.8 38.1 3.8 26.8 31.8 2.5 5.7 12.3 7.3 0.0 24.8 17.2 10.3 7.9 20.8 0.7 8.9 7.8 13.5 4.8 8.8 2.9 16.2 34.3 12.1 6.6 11.4 14.0 14.0 5.3 4.5 18.5 8.4 1.7 12.8 10.2 5.0 11.0 1.2 16.4 9.3 10.6 1.0 15.2 5.5 11.3 2.0 2.4 19.0 5.4 13.5 8.0 67.8 7.6 10.9 9.2 3.9 0.0 11.7 10.9 4.6 16.7 26.3 25.1 12.6 16.3 8.7 17.9 36.0 NSG1 "D4S234E, NEEP21, P21" ENSG00000168824 "Neuronal vesicle trafficking associated 1" P42857 4 4348140-4419058 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.7;pituitary gland: 135.1;skin 1: 120.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 222.4;Cytotrophoblasts: 120.2;Granulosa cells: 128.8;Melanocytes: 291.7;Suprabasal keratinocytes: 178.2" "Cancer enriched" "Detected in many" 4 "melanoma: 61.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 45.2;MAIT T-cell: 61.9;memory CD4 T-cell: 42.2;memory CD8 T-cell: 37.1;naive CD8 T-cell: 27.6" "Lineage enriched" "Detected in many" 57 "T-cells: 61.9" "Cell line enhanced" "Detected in many" "HAP1: 84.7;SCLC-21H: 168.6;SH-SY5Y: 82.5;SK-MEL-30: 80.9;TIME: 204.6;U-698: 75.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "unprognostic (3.21e-3)" "unprognostic (2.33e-1)" "unprognostic (5.29e-3)" "unprognostic (7.60e-2)" "unprognostic (8.06e-2)" "unprognostic (1.49e-1)" "unprognostic (1.32e-3)" "unprognostic (3.47e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-3)" "prognostic favorable (9.49e-4)" "unprognostic (2.50e-1)" "unprognostic (6.85e-2)" "unprognostic (4.21e-2)" "unprognostic (7.33e-2)" "unprognostic (2.85e-1)" "unprognostic (7.41e-2)" 5.0 25.3 29.0 4.2 33.1 1.0 6.0 59.6 50.7 17.1 5.3 7.9 6.8 7.8 2.1 30.7 20.1 1.3 5.9 18.4 95.7 4.4 0.5 1.5 3.2 57.1 64.8 46.3 1.8 0.1 135.1 18.3 58.8 22.8 7.1 32.3 6.7 18.2 0.7 120.9 5.8 6.9 24.2 2.2 8.0 16.0 45.4 9.5 0.5 3.0 3.5 13.3 30.1 24.2 0.2 0.1 0.8 0.5 0.0 0.0 14.6 0.3 0.0 0.2 0.0 1.3 0.4 0.0 10.4 0.5 3.3 2.4 84.7 5.5 0.4 0.0 3.0 0.0 0.2 0.0 4.1 0.0 0.0 0.1 12.0 0.0 2.3 0.0 14.6 22.3 0.0 0.1 1.3 0.0 6.8 0.5 10.1 0.1 0.4 0.1 0.0 0.4 0.0 4.8 168.6 82.5 0.6 0.2 80.9 7.0 0.9 0.3 204.6 0.0 13.0 0.2 0.3 0.1 0.4 75.9 0.1 0.2 0.4 0.2 0.1 0.1 45.2 0.1 61.9 0.1 42.2 37.1 0.1 0.1 10.4 27.6 1.0 0.9 0.2 0.1 4.5 15.7 29.0 33.1 59.6 50.7 18.4 95.7 57.1 64.8 58.8 24.2 45.4 24.2 1.6 9.6 0.0 5.9 0.4 86.8 83.4 47.9 31.3 222.4 0.7 24.3 0.0 0.0 13.2 0.0 4.2 120.2 6.0 0.0 0.0 0.0 31.2 10.3 1.4 2.1 2.4 0.0 16.6 0.0 15.2 24.9 0.0 16.4 1.3 128.8 1.8 0.0 8.2 8.4 32.2 0.0 4.1 0.0 13.6 44.2 3.1 1.3 291.7 6.5 0.4 6.4 20.6 1.5 4.0 0.1 0.2 5.7 0.7 19.9 0.0 20.4 1.7 24.3 0.0 0.2 10.8 2.9 14.4 44.8 178.2 76.8 17.0 96.0 0.3 77.0 NXPH4 NPH4 ENSG00000182379 "Neurexophilin 4" O95158 12 57216794-57226449 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4;skin 1: 19.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 14.5;Cytotrophoblasts: 29.0;Muller glia cells: 18.5;Suprabasal keratinocytes: 10.4;Syncytiotrophoblasts: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 76.8;RH-30: 62.3;RPMI-8226: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "unprognostic (1.08e-2)" "unprognostic (4.84e-2)" "unprognostic (2.70e-3)" "prognostic unfavorable (6.21e-4)" "prognostic unfavorable (5.42e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (3.07e-1)" "unprognostic (1.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (7.83e-2)" "unprognostic (2.73e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-3)" 2.5 0.6 6.3 0.3 4.1 0.4 0.7 8.3 3.6 2.3 0.6 0.1 0.0 0.0 0.2 3.0 0.1 0.0 2.7 8.3 13.8 0.7 0.8 0.3 0.5 13.3 7.1 0.0 1.5 1.7 0.3 2.7 18.4 4.4 0.0 5.0 4.0 0.0 0.2 19.4 0.2 0.1 7.5 0.4 0.1 1.2 7.1 0.1 0.4 0.0 0.3 0.1 2.8 5.0 18.1 1.4 0.4 76.8 8.6 2.2 7.1 4.9 11.5 2.1 2.7 5.0 0.9 19.4 7.6 5.1 3.2 16.2 10.3 2.4 0.6 3.4 20.6 0.1 0.6 0.3 7.4 0.7 2.5 2.0 4.0 2.0 3.2 2.5 0.0 1.2 0.8 20.0 1.5 18.6 0.0 0.0 0.7 0.4 13.5 1.0 62.3 43.1 0.0 3.2 12.3 0.7 11.0 22.5 23.2 0.2 22.4 0.6 0.0 5.4 17.8 2.3 5.8 10.8 2.3 6.9 3.5 9.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 4.1 8.3 3.6 8.3 13.8 13.3 7.1 18.4 7.5 7.1 5.0 0.8 0.0 0.0 0.7 8.0 14.5 0.4 1.1 3.4 4.7 0.7 0.9 0.8 0.0 0.7 0.0 8.4 29.0 0.3 0.1 0.0 0.8 0.0 0.1 0.4 0.5 7.2 0.0 0.7 0.0 1.9 1.1 0.5 0.1 0.0 1.1 0.0 0.1 2.0 1.7 1.4 0.0 2.0 0.0 0.8 0.0 0.0 0.4 3.6 0.0 0.0 18.5 0.0 0.0 0.1 0.6 0.0 0.4 0.3 3.3 0.0 0.0 1.0 0.5 0.0 2.4 3.6 0.7 4.5 1.8 10.4 29.3 0.4 0.0 0.0 0.4 OBP2B "hOBPIIb, LCN14" ENSG00000171102 "Odorant binding protein 2B" Q9NPH6 9 133205277-133209250 "Predicted secreted proteins" "Olfaction, Sensory transduction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.7;testis: 10.0" "Group enriched" "Detected in some" 9 "Breast glandular cells: 17.7;Breast myoepithelial cells: 29.1" "Group enriched" "Detected in many" 8 "breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: Glandular cells - Unknown function" "unprognostic (1.40e-1)" "unprognostic (5.70e-2)" "unprognostic (9.45e-3)" "unprognostic (6.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.30e-1)" "unprognostic (7.03e-2)" "unprognostic (6.82e-6)" "unprognostic (2.00e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.4 0.3 0.0 0.0 0.0 17.7 29.1 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.5 1.2 0.1 1.8 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.2 1.2 0.1 0.1 OLFM2 "NOE2, OlfC" ENSG00000105088 "Olfactomedin 2" O95897 19 9853718-9936552 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 202.6;skin 1: 94.8" "Cell type enhanced" "Detected in many" "Astrocytes: 108.4;Basal keratinocytes: 125.0;Muller glia cells: 91.1;Oligodendrocyte precursor cells: 124.7;Suprabasal keratinocytes: 118.1" "Cancer enhanced" "Detected in all" "glioma: 96.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 49.7" "Group enriched" "Detected in many" 26 "granulocytes: 49.7;T-cells: 17.0" "Cell line enhanced" "Detected in many" "AN3-CA: 25.6;ASC diff: 23.4;BJ hTERT+: 18.5;SH-SY5Y: 24.3;U-2 OS: 28.7;WM-115: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049961, HPA057771" Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA 2700000 "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 28: Keratinocytes - Keratinization" Nucleoplasm "HPA049961: AB_2680972, HPA057771: AB_2683524" "unprognostic (1.42e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.99e-2)" "unprognostic (5.91e-2)" "unprognostic (3.39e-2)" "unprognostic (8.78e-2)" "unprognostic (4.47e-2)" "unprognostic (8.04e-2)" "unprognostic (4.03e-2)" "unprognostic (1.41e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.23e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" 36.8 30.7 130.8 3.4 134.5 0.2 25.0 118.5 202.6 17.2 80.7 4.8 2.1 16.7 4.5 5.6 11.1 6.7 10.1 134.0 127.3 9.2 41.9 10.1 7.9 152.5 168.8 9.7 11.2 9.6 19.1 7.1 162.0 10.1 1.1 24.6 10.0 13.4 1.8 94.8 3.8 6.7 130.0 2.5 2.2 10.7 123.2 16.5 13.2 1.0 4.8 3.0 14.1 120.7 0.0 3.7 3.0 25.6 23.4 14.3 1.7 5.6 18.5 1.2 1.5 0.3 2.4 0.1 2.3 4.2 2.1 1.5 9.8 1.7 0.1 0.1 2.1 0.0 0.2 0.3 0.1 0.0 4.3 7.5 1.5 0.1 0.2 0.7 0.1 4.8 0.3 0.3 0.0 8.2 0.3 0.2 15.8 2.5 0.0 0.1 0.0 0.0 0.0 0.9 0.1 24.3 0.9 0.1 5.2 9.7 0.9 0.0 0.3 10.5 28.7 0.1 0.1 0.0 0.0 0.0 0.3 0.0 25.6 21.2 0.0 49.7 6.2 0.0 6.6 0.0 7.0 5.5 0.0 0.0 13.5 8.9 0.5 1.2 0.0 0.1 17.0 2.9 130.8 134.5 118.5 202.6 134.0 127.3 152.5 168.8 162.0 130.0 123.2 120.7 12.9 0.0 0.0 108.4 0.3 125.0 4.7 5.9 8.6 4.9 6.9 13.8 0.8 7.2 0.4 7.3 0.0 0.1 1.0 0.1 1.9 0.9 8.6 0.9 2.2 4.3 1.2 0.4 27.3 2.4 0.0 17.2 0.0 1.0 4.5 6.5 1.4 24.7 0.3 1.7 51.0 0.2 2.0 0.3 32.6 52.8 13.7 0.6 17.8 15.0 0.4 91.1 7.2 124.7 3.5 4.1 0.0 9.8 0.5 7.9 0.0 0.2 0.2 3.7 0.0 7.4 24.3 3.0 10.4 1.4 118.1 0.1 7.7 0.6 0.1 2.9 OSBPL2 "DFNA67, KIAA0772, ORP-2" ENSG00000130703 "Oxysterol binding protein like 2" Q9H1P3 20 62231922-62296213 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Lipid transport, Transport" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 94.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 94.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041127, HPA042659" Uncertain Approved Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA041127: AB_10962008, HPA042659: AB_10960683" "unprognostic (1.00e-3)" "unprognostic (7.20e-3)" "unprognostic (1.31e-1)" "unprognostic (6.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.73e-3)" "unprognostic (3.79e-2)" "unprognostic (9.60e-2)" "unprognostic (6.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.73e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.20e-5)" "unprognostic (3.86e-2)" "unprognostic (8.13e-2)" "unprognostic (4.00e-1)" "unprognostic (3.32e-2)" 14.6 15.2 21.1 13.4 21.2 32.9 18.9 38.9 21.4 21.9 20.0 24.3 22.8 14.0 15.8 40.7 15.6 20.0 25.4 16.6 20.3 20.8 18.0 16.2 14.3 23.7 24.0 15.8 39.7 26.4 26.4 13.7 22.3 19.8 22.7 14.5 24.9 18.8 18.0 43.5 21.6 17.4 19.4 24.9 27.9 14.9 29.8 17.2 21.9 11.9 20.4 23.1 29.8 19.4 23.9 17.0 19.6 18.3 19.4 19.1 18.5 14.2 27.9 46.6 32.1 61.0 24.1 11.5 37.1 28.4 41.8 40.7 18.9 42.4 25.7 13.7 17.7 30.6 21.5 31.2 19.0 11.8 26.6 17.7 61.0 20.8 23.3 22.1 19.1 29.4 20.3 21.2 13.5 19.4 17.2 19.8 6.4 43.5 15.0 15.9 23.5 15.3 23.6 48.2 25.6 16.7 25.7 48.2 24.3 25.9 32.1 21.0 13.2 23.2 17.0 24.7 17.3 24.5 37.4 17.5 25.7 8.4 14.9 16.1 9.2 34.5 13.0 11.7 11.4 13.7 10.5 13.7 9.9 10.9 9.5 11.4 94.6 16.8 9.9 7.1 17.5 10.9 21.1 21.2 38.9 21.4 16.6 20.3 23.7 24.0 22.3 19.4 29.8 19.4 27.1 16.0 18.3 17.3 16.5 20.1 24.8 24.4 14.2 18.9 24.7 16.6 61.2 15.7 28.2 11.0 6.2 13.4 21.6 44.5 31.3 22.7 33.0 22.6 12.0 18.1 16.3 24.2 13.9 20.1 14.8 17.8 42.8 34.2 10.8 19.2 12.8 14.1 12.3 18.5 21.7 29.6 22.4 11.1 8.0 17.4 17.4 14.3 8.8 10.3 16.8 18.2 27.8 9.0 15.5 39.8 37.0 13.2 21.9 38.8 30.2 14.1 34.3 15.9 13.1 14.8 13.1 22.8 11.1 25.2 27.8 37.1 18.5 12.0 25.7 58.7 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol NA NA 500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 44.8 57.0 69.9 43.0 78.0 63.5 47.3 53.0 93.4 54.1 39.7 51.9 42.0 49.0 37.4 85.4 55.8 35.9 62.4 79.3 62.5 61.3 47.0 47.1 59.8 65.0 58.0 44.5 43.9 47.1 48.6 49.3 66.1 53.5 39.3 25.6 54.3 42.6 70.2 78.1 51.9 38.0 51.2 58.6 54.0 57.1 65.0 56.0 51.9 48.4 57.1 52.5 56.7 67.7 113.4 198.9 107.2 95.7 70.7 77.8 83.0 66.0 97.1 143.6 105.1 138.1 104.5 59.3 122.0 106.6 124.4 138.1 140.4 165.4 88.1 69.9 111.7 99.3 114.1 172.9 98.8 99.2 104.3 83.4 106.4 110.2 69.8 74.4 137.2 54.6 71.2 65.3 97.9 237.2 109.2 133.0 126.5 95.4 94.1 88.3 41.8 102.5 151.1 162.1 81.5 117.5 74.6 114.1 123.3 72.9 178.2 86.3 100.1 75.8 74.2 103.3 88.4 76.2 51.7 86.4 98.4 64.0 74.5 228.8 186.8 189.9 165.5 244.2 131.2 149.6 152.1 153.6 203.1 139.3 117.1 130.4 184.6 161.8 218.9 140.7 224.7 313.4 69.9 78.0 53.0 93.4 79.3 62.5 65.0 58.0 66.1 51.2 65.0 67.7 37.0 19.2 56.5 15.0 67.2 48.3 70.9 137.8 83.6 44.4 42.5 48.8 31.9 37.1 82.5 46.0 39.6 146.2 56.5 104.7 74.3 80.7 72.6 55.4 36.2 43.4 87.8 35.5 17.8 85.5 109.2 50.0 71.9 44.3 48.7 54.6 35.7 33.2 90.4 30.3 16.9 70.8 101.7 57.4 65.9 87.1 34.2 61.0 51.6 8.4 98.0 43.2 78.2 12.5 18.8 90.1 92.0 25.6 80.8 51.8 90.8 85.2 89.2 55.7 26.3 28.1 62.0 48.0 71.4 77.7 52.6 194.8 73.7 51.7 62.7 71.6 OTUB2 "C14orf137, FLJ21916, MGC3102" ENSG00000089723 "OTU deubiquitinase, ubiquitin aldehyde binding 2" Q96DC9 14 94026340-94048930 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 7.3;testis: 14.4" "Group enriched" "Detected in many" 8 "Early spermatids: 641.1;Late spermatids: 1415.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 16.5;Karpas-707: 18.0;OE19: 18.1;RPTEC TERT1: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002329, HPA075090" Enhanced NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "HPA002329: AB_1079537, HPA075090: AB_2686734" "unprognostic (6.80e-3)" "unprognostic (1.39e-3)" "unprognostic (3.68e-3)" "unprognostic (4.82e-3)" "unprognostic (1.66e-1)" "unprognostic (2.20e-1)" "unprognostic (2.30e-3)" "unprognostic (1.18e-2)" "unprognostic (2.55e-1)" "unprognostic (3.09e-3)" "unprognostic (2.80e-2)" "unprognostic (1.16e-2)" "unprognostic (6.25e-3)" "unprognostic (1.15e-1)" "unprognostic (2.06e-2)" "unprognostic (1.02e-4)" "unprognostic (3.16e-1)" 0.3 0.6 1.2 0.2 1.1 0.2 0.8 1.3 1.3 1.3 0.1 0.5 0.3 0.8 0.3 3.8 0.6 0.4 0.1 1.0 0.8 0.6 0.8 0.4 0.3 0.1 1.3 0.7 0.7 1.9 0.2 1.8 0.1 0.6 0.8 0.6 0.7 0.2 0.1 7.3 0.3 0.3 0.1 0.2 0.5 14.4 2.5 0.1 0.2 0.0 0.8 0.9 1.5 0.5 1.3 3.7 2.4 2.3 0.9 0.7 2.6 0.5 0.3 1.4 2.1 0.8 5.9 0.3 2.2 0.6 16.5 0.3 3.2 1.7 1.1 0.9 1.5 0.1 0.4 3.9 1.3 0.0 0.6 0.6 2.1 0.5 0.9 1.8 1.6 3.3 0.1 18.0 0.7 1.3 0.1 0.4 0.7 18.1 3.1 0.1 0.2 1.0 11.2 1.7 1.8 1.3 0.7 0.8 1.9 1.6 6.3 0.8 1.7 0.9 2.8 0.7 1.0 3.0 2.2 0.0 1.7 0.9 1.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 1.2 1.1 1.3 1.3 1.0 0.8 0.1 1.3 0.1 0.1 2.5 0.5 0.5 0.0 0.5 0.7 0.2 0.1 0.7 4.0 0.6 1.5 1.1 1.1 0.5 0.0 2.4 0.0 0.0 4.2 0.1 1.9 1.9 4.3 641.1 6.4 2.8 0.9 0.0 2.7 1.9 1.6 1.5 0.6 4.6 24.8 0.0 2.2 0.4 0.9 1.4 0.0 1.3 1.4 2.0 1.2 1.3 1415.3 6.8 2.4 0.0 0.0 0.4 0.5 0.0 0.5 0.6 5.2 1.3 3.4 0.1 0.3 0.5 1.5 1.8 1.4 6.6 0.6 0.6 9.2 4.3 2.0 2.3 117.5 1.0 2.2 1.0 2.4 OTX1 ENSG00000115507 "Orthodenticle homeobox 1" P32242 2 63050057-63057836 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "salivary gland: 18.0;skin 1: 8.4" "Cell type enhanced" "Detected in some" "Astrocytes: 9.8;Basal respiratory cells: 6.3;Club cells: 4.1;Ionocytes: 6.1;Respiratory ciliated cells: 6.8;Suprabasal keratinocytes: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 95 "neutrophil: 9.4" "Lineage enriched" "Detected in single" 95 "granulocytes: 9.4" "Cell line enriched" "Detected in many" 9 "THP-1: 54.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052122 Uncertain Approved Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA052122: AB_2681736" "unprognostic (2.25e-2)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-3)" "unprognostic (2.32e-1)" "unprognostic (1.67e-2)" "unprognostic (6.92e-3)" "unprognostic (3.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (2.26e-3)" "unprognostic (1.71e-1)" "unprognostic (0.00e+0)" "unprognostic (4.64e-2)" "unprognostic (2.31e-1)" "unprognostic (3.80e-4)" "unprognostic (3.67e-3)" 0.1 0.0 2.1 0.0 1.7 0.0 0.2 0.1 2.5 0.0 3.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.9 1.4 0.0 0.0 0.1 0.0 0.2 2.5 0.0 0.2 0.0 0.0 0.0 0.7 0.7 0.0 0.0 18.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.2 0.3 2.8 0.0 0.0 0.0 0.5 0.0 0.1 1.8 2.3 1.3 4.2 2.5 0.0 0.1 5.9 0.0 0.3 0.3 0.4 4.4 2.2 0.1 0.8 0.0 1.1 3.0 2.7 1.9 0.5 1.1 2.5 2.7 2.2 5.0 0.0 1.9 2.0 0.0 0.7 0.0 0.7 0.8 0.0 2.6 2.4 0.0 0.2 2.1 2.6 4.6 0.0 2.2 1.6 2.3 3.6 0.7 1.2 0.8 0.4 0.5 1.8 0.2 1.5 0.0 1.0 54.1 0.1 0.9 1.7 0.0 0.9 1.5 1.1 4.0 0.3 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 2.1 1.7 0.1 2.5 1.9 1.4 0.2 2.5 0.7 0.0 2.8 1.8 0.2 0.0 0.0 9.8 0.1 1.7 0.0 6.3 0.6 0.0 0.8 1.0 0.8 0.0 4.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.2 0.6 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.7 0.3 0.3 0.5 1.1 2.6 0.1 0.0 0.1 0.2 0.1 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 13 "Extravillous trophoblasts: 49.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "myeloid DC: 1.2;plasmacytoid DC: 2.1" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.1" "Cell line enhanced" "Detected in some" "RT4: 3.3;SK-BR-3: 1.4;U-2 OS: 1.6" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane" "HPA067673: AB_2685883" "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 1.3 0.0 1.0 1.3 0.8 0.1 4.2 0.5 1.5 1.0 0.5 2.0 0.2 0.5 2.5 2.1 1.6 0.1 0.2 0.8 2.1 4.0 0.0 0.4 0.1 1.2 1.3 0.1 0.5 0.3 0.3 0.9 1.0 0.5 1.6 0.0 3.0 0.4 0.2 2.6 0.4 0.5 0.7 0.4 0.2 0.1 2.6 0.3 0.5 0.3 0.8 1.7 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.1 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 1.0 0.8 0.5 1.5 0.8 2.1 1.2 1.3 1.0 0.7 2.6 1.3 0.8 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.7 1.4 0.2 0.0 0.0 0.0 0.0 2.4 0.1 0.2 1.9 0.0 0.2 0.7 0.1 0.8 1.2 0.0 0.6 0.0 49.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.5 0.0 0.0 0.4 0.1 0.0 0.3 3.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 2.2 0.0 3.7 0.0 0.0 1.2 0.0 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40217428-40277487 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 25.6;skin 1: 28.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.2 8.2 11.6 0.4 15.9 0.9 2.1 8.5 16.6 4.5 0.0 1.3 1.5 0.9 1.0 25.6 4.3 1.1 8.3 17.6 3.0 4.7 0.3 2.5 0.9 1.4 1.1 0.6 8.0 8.0 12.1 7.6 1.9 4.4 1.1 0.8 6.1 3.8 4.5 28.2 1.5 0.3 1.8 0.9 3.9 17.7 3.0 0.5 7.5 1.3 1.9 3.5 9.4 5.4 3.9 0.0 0.2 0.0 0.0 0.0 6.0 0.0 0.2 0.7 0.7 26.5 2.9 0.1 3.6 0.0 1.3 32.2 4.5 6.9 0.3 0.2 1.0 0.0 3.0 0.2 0.0 0.1 0.3 0.0 19.4 0.3 4.5 0.2 0.0 5.5 1.8 0.3 0.0 4.5 0.0 0.5 0.5 3.9 2.9 0.2 0.2 2.9 1.5 8.4 7.3 2.0 2.6 10.9 0.3 1.7 1.7 10.3 0.0 0.3 0.6 0.0 0.3 0.1 0.3 0.1 0.7 0.6 0.2 1.2 0.1 1.2 2.3 0.1 0.8 0.6 0.1 1.9 0.3 0.1 0.1 0.4 0.5 0.9 0.1 0.1 0.0 0.6 11.6 15.9 8.5 16.6 17.6 3.0 1.4 1.1 1.9 1.8 3.0 5.4 0.0 0.0 4.2 0.7 0.3 9.8 9.6 4.8 8.6 3.5 2.8 2.9 0.0 4.3 5.4 5.5 0.0 52.7 2.1 0.3 13.7 4.4 8.6 3.3 0.4 0.3 4.9 0.0 8.9 4.3 3.0 0.7 0.5 5.1 0.0 0.7 0.0 0.0 4.1 0.0 7.3 1.1 2.0 0.6 0.9 5.8 1.8 0.3 1.8 1.0 0.0 1.3 16.5 0.5 0.3 2.5 1.0 1.9 0.1 5.2 0.2 0.2 3.9 0.2 0.0 0.3 0.4 1.9 3.3 13.9 19.0 9.0 1.0 0.8 2.0 11.3 PAPSS1 "ATPSK1, PAPSS" ENSG00000138801 "3'-phosphoadenosine 5'-phosphosulfate synthase 1" O43252 4 107590276-107720234 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 444.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 321.8;eosinophil: 359.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 359.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049781 Approved Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No 13000 "Cluster 2: Granulocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA049781: AB_2680879" "unprognostic (1.36e-2)" "unprognostic (5.03e-2)" "prognostic favorable (9.14e-4)" "prognostic favorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.70e-5)" "unprognostic (1.58e-2)" "unprognostic (1.05e-1)" "unprognostic (8.92e-2)" "unprognostic (1.42e-1)" "unprognostic (5.76e-2)" "unprognostic (6.23e-3)" "unprognostic (1.29e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-2)" "unprognostic (1.38e-1)" 26.3 14.2 36.8 30.8 43.9 26.0 49.9 46.4 50.0 49.6 26.5 20.4 16.0 47.1 43.0 36.2 48.4 26.4 15.9 41.9 40.8 31.7 10.3 44.4 32.9 53.2 41.4 29.2 49.3 26.9 15.8 17.2 51.8 41.1 24.7 22.3 66.0 25.9 6.1 49.7 15.8 33.6 51.1 17.4 62.8 17.0 41.8 35.4 20.3 9.9 51.7 31.7 23.7 66.3 33.6 29.7 49.1 62.1 59.1 74.0 39.6 42.4 77.2 39.4 53.1 45.7 46.7 51.3 26.0 76.1 30.4 40.7 46.8 81.6 50.5 124.2 35.5 60.4 62.6 103.0 32.3 93.0 99.8 61.7 41.2 45.7 37.1 95.2 88.7 63.9 13.6 97.0 111.6 50.7 77.3 28.2 52.6 35.3 33.1 62.4 78.0 15.0 59.6 45.6 55.5 81.4 42.9 63.3 51.9 61.9 37.9 14.1 52.9 49.3 51.0 33.6 35.4 76.9 57.2 48.7 60.1 69.3 79.2 321.8 49.9 359.8 15.6 56.2 18.8 44.8 21.2 18.0 51.4 26.4 13.2 14.9 55.5 27.6 60.8 9.8 39.9 36.7 36.8 43.9 46.4 50.0 41.9 40.8 53.2 41.4 51.8 51.1 41.8 66.3 19.7 96.1 20.2 41.4 25.4 32.0 36.3 73.2 33.6 19.9 48.4 41.5 7.4 50.1 92.3 57.0 10.4 20.6 7.0 10.5 17.6 36.8 6.2 124.2 84.6 25.1 23.4 15.3 112.2 44.7 48.7 35.2 62.2 444.3 42.5 25.0 20.3 10.2 55.1 30.3 64.7 17.5 32.6 46.5 27.8 6.7 18.0 53.5 60.5 29.0 37.4 35.0 10.3 100.0 150.3 33.6 9.1 25.6 86.4 29.1 6.9 28.8 110.0 13.3 26.3 45.2 29.1 19.6 14.7 62.9 40.9 8.9 22.2 19.2 14.8 29.4 PAX3 "HUP2, WS1" ENSG00000135903 "Paired box 3" P23760 2 222199887-222298998 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Deafness, Disease variant, Proto-oncogene, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5;salivary gland: 4.8;skeletal muscle: 3.6;skin 1: 2.9" "Group enriched" "Detected in some" 4 "Early spermatids: 14.4;Late spermatids: 34.8;Melanocytes: 33.8;Skeletal myocytes: 12.8" "Cancer enriched" "Detected in some" 24 "melanoma: 20.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 9.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;HBF TERT88: 8.0;RH-30: 17.5;SK-MEL-30: 29.1" "Group enriched" "Detected in some" 7 "cerebellum: 3.4;midbrain: 1.4;pons and medulla: 1.3" "Region enhanced" "Detected in many" "midbrain: 7.7" "HPA063659, HPA069000" Enhanced Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA063659: AB_2685080, HPA069000: AB_2686067" "unprognostic (2.57e-2)" "unprognostic (1.48e-2)" "unprognostic (1.27e-2)" "unprognostic (1.65e-1)" "unprognostic (2.61e-2)" "unprognostic (3.70e-1)" "unprognostic (6.18e-2)" "unprognostic (1.41e-1)" "unprognostic (2.26e-1)" "unprognostic (9.70e-2)" 0.5 0.0 0.4 0.0 0.1 0.0 1.0 4.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.3 1.9 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 4.8 0.0 3.6 2.9 0.0 0.0 2.0 0.0 0.0 1.1 1.2 0.0 0.0 0.8 0.1 0.0 0.1 5.5 0.0 0.0 4.9 0.0 0.0 0.0 0.0 6.0 6.5 9.0 10.6 0.0 0.7 0.0 0.0 4.4 0.2 0.0 0.0 0.0 8.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 6.9 0.1 0.0 0.0 0.0 17.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 29.1 7.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.5 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 4.6 0.1 0.0 0.1 3.3 1.9 2.8 2.0 1.2 5.5 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 34.8 0.9 0.1 33.8 1.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.4 5.6 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 PDCD6 "ALG-2, PEF1B" ENSG00000249915 "Programmed cell death 6" O75340 5 271621-314974 "Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047221 Supported Nucleoplasm,Cytosol No No 1800000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol Nucleoplasm "HPA047221: " "unprognostic (1.32e-1)" "unprognostic (5.01e-2)" "unprognostic (2.10e-2)" "unprognostic (4.41e-3)" "unprognostic (4.94e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.47e-5)" "unprognostic (1.56e-1)" "unprognostic (1.27e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (7.97e-2)" "unprognostic (1.48e-1)" "unprognostic (2.67e-1)" "prognostic favorable (2.19e-4)" 63.3 108.3 89.0 48.7 90.4 42.1 74.8 95.4 102.6 73.4 88.1 83.0 71.6 63.4 98.2 134.8 64.8 48.4 53.5 91.1 92.9 114.6 85.0 53.1 59.9 92.2 88.9 61.7 65.5 77.3 76.4 61.4 90.5 64.3 85.4 29.6 73.9 54.4 42.3 72.7 71.8 52.8 94.9 77.0 69.0 50.3 90.3 81.2 72.8 27.3 74.5 72.7 86.9 100.1 151.8 208.6 88.4 133.5 156.1 141.9 185.6 115.5 151.9 144.2 134.6 147.3 186.4 119.6 283.2 155.4 187.2 112.9 137.3 288.2 116.0 409.9 170.9 105.9 508.7 194.0 193.3 155.7 129.5 128.1 175.0 117.4 208.9 148.3 137.9 81.2 136.8 90.3 130.7 237.7 125.7 270.1 95.6 183.8 295.1 102.0 83.8 171.5 344.7 192.6 86.3 117.5 297.2 309.4 224.7 91.9 215.1 210.7 108.5 94.0 76.9 82.8 100.0 121.4 163.4 141.8 138.9 198.9 128.9 172.8 209.7 284.4 158.2 206.0 199.7 251.9 196.4 179.6 229.3 224.6 217.8 175.5 231.0 260.7 206.6 183.2 236.7 356.2 89.0 90.4 95.4 102.6 91.1 92.9 92.2 88.9 90.5 94.9 90.3 100.1 134.6 64.1 57.4 9.4 99.5 82.1 129.6 250.6 85.4 47.9 140.1 182.1 50.4 78.6 146.7 103.0 37.5 239.1 104.4 146.4 252.4 172.0 55.4 130.9 91.6 110.7 79.7 83.9 10.7 129.1 321.6 104.3 68.8 99.9 82.5 101.3 69.9 77.7 140.4 63.9 11.3 187.5 219.7 84.1 75.5 55.5 117.4 90.0 124.5 10.3 175.3 136.8 137.0 5.5 11.0 164.0 136.7 116.6 57.7 170.7 175.6 205.1 181.9 42.0 85.5 85.3 109.5 100.8 137.8 123.8 92.5 356.7 92.6 173.3 192.3 176.6 PGAM1 "PGAM-B, PGAMA" ENSG00000171314 "Phosphoglycerate mutase 1" P18669 10 97426191-97433444 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 791.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042528, HPA060483" Approved Supported Nucleoplasm NA NA 120000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.64e-1)" "unprognostic (5.64e-2)" "unprognostic (1.16e-1)" "unprognostic (9.47e-3)" "unprognostic (7.60e-3)" "unprognostic (1.74e-3)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "unprognostic (2.48e-2)" "unprognostic (1.48e-1)" "unprognostic (5.74e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-1)" "unprognostic (2.61e-3)" 149.0 294.7 228.7 153.6 249.7 180.0 122.1 252.9 265.0 184.3 275.1 162.9 151.5 153.7 98.6 436.7 117.2 106.6 275.7 256.1 266.0 167.6 182.5 121.7 165.7 241.7 242.7 133.3 81.8 191.3 150.8 156.6 280.9 107.3 141.9 420.7 164.7 156.5 56.5 206.9 141.4 177.9 228.3 139.6 133.2 87.5 278.8 124.9 86.9 70.2 229.7 186.6 233.3 224.7 1160.6 538.9 364.0 697.9 336.7 307.7 494.1 722.4 938.4 830.2 1148.3 589.4 335.4 609.1 482.7 619.2 333.4 706.8 639.8 1051.4 998.1 567.2 611.7 393.6 386.4 667.5 248.4 570.0 503.9 303.2 422.5 552.7 408.7 1118.9 610.8 447.2 262.0 334.0 884.8 478.3 514.7 697.8 559.0 331.8 637.8 384.2 333.6 484.0 646.0 431.1 79.1 370.1 388.6 229.2 381.2 564.9 625.0 472.9 463.8 441.5 385.2 394.8 844.0 499.0 593.1 556.1 1023.3 937.5 209.3 242.5 433.5 572.7 217.0 366.6 192.3 134.8 183.8 216.9 309.7 114.7 117.5 164.9 312.6 149.4 422.7 110.5 265.6 580.2 228.7 249.7 252.9 265.0 256.1 266.0 241.7 242.7 280.9 228.3 278.8 224.7 92.9 44.8 44.4 23.8 122.2 187.0 173.1 394.2 124.1 403.5 77.8 76.7 22.9 85.8 140.8 106.7 77.2 495.8 122.3 233.9 358.1 321.8 15.1 50.2 113.7 145.9 48.1 71.1 29.4 205.8 791.9 146.0 68.8 72.0 103.4 109.5 96.8 193.7 395.1 387.0 35.7 116.7 152.5 170.0 129.1 27.0 149.5 174.6 131.6 16.9 376.9 404.4 174.0 14.1 19.9 295.7 132.9 234.3 254.9 175.2 283.0 274.8 72.1 300.5 203.8 73.1 199.9 38.0 114.7 253.3 204.7 372.6 138.0 257.8 176.4 269.6 PIR ENSG00000087842 Pirin O00625 X 15384799-15493564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 96.1;Syncytiotrophoblasts: 85.6" "Cancer enhanced" "Detected in all" "melanoma: 48.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 292.4;HUVEC TERT2: 683.9;SK-MEL-30: 267.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000697 Approved Supported Cytosol NA NA 35000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA000697: AB_1079621" "unprognostic (3.46e-3)" "prognostic favorable (2.78e-4)" "unprognostic (4.26e-2)" "unprognostic (5.62e-3)" "unprognostic (4.16e-3)" "unprognostic (2.09e-2)" "unprognostic (6.70e-3)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic favorable (4.94e-4)" "unprognostic (3.78e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (6.11e-7)" "unprognostic (1.99e-2)" "unprognostic (8.90e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" 19.1 19.9 20.2 5.2 23.7 5.7 15.4 23.5 24.3 12.4 21.2 10.0 6.5 11.7 15.3 29.6 13.3 11.4 17.3 18.7 22.9 11.4 21.0 15.4 2.7 23.0 22.6 13.1 3.3 4.9 11.3 10.5 22.8 10.1 6.7 7.9 10.3 14.2 14.7 11.9 8.6 10.4 22.5 20.1 11.9 6.2 22.5 6.2 15.7 6.4 7.1 30.4 17.4 25.7 14.3 76.6 45.0 66.3 26.1 29.0 14.4 4.2 26.5 11.0 24.5 21.5 118.9 0.0 147.2 12.3 292.4 96.7 52.8 21.3 4.0 0.0 11.6 8.4 80.7 63.9 33.4 4.4 29.8 8.3 72.3 41.9 14.4 19.2 683.9 0.0 6.4 19.2 9.4 29.8 3.3 4.1 48.4 62.1 47.7 0.0 8.9 37.9 22.2 136.0 17.2 47.5 36.7 20.5 267.9 76.8 42.4 26.7 43.2 5.9 11.0 28.5 8.7 9.1 39.6 0.3 28.6 15.8 59.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 20.2 23.7 23.5 24.3 18.7 22.9 23.0 22.6 22.8 22.5 22.5 25.7 24.5 0.0 4.1 0.0 1.1 8.7 24.3 48.4 10.8 2.8 4.2 4.8 5.8 10.0 19.4 1.8 0.0 96.1 0.0 4.8 9.8 5.9 0.6 59.6 3.8 40.3 11.3 11.6 0.2 2.5 12.8 15.6 15.8 20.0 0.0 21.7 22.9 24.0 22.0 20.2 0.2 3.4 38.7 6.4 3.4 4.0 37.6 4.1 40.9 0.0 11.9 30.8 0.0 0.0 0.0 3.4 1.7 28.6 3.6 18.1 5.9 12.0 38.0 4.8 13.1 8.4 11.3 0.6 3.5 34.5 12.6 85.6 0.6 56.2 4.3 50.9 PLCD1 ENSG00000187091 "Phospholipase C delta 1" P51178 3 38007496-38029642 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 89.5;Theca cells: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009913, HPA020107, HPA021677" Approved Approved Microtubules NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" Microtubules "CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319" "unprognostic (1.75e-3)" "unprognostic (1.01e-2)" "unprognostic (4.29e-2)" "unprognostic (1.45e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-3)" "unprognostic (1.55e-1)" "unprognostic (7.25e-3)" "unprognostic (3.95e-1)" "unprognostic (1.45e-1)" "unprognostic (2.80e-1)" "unprognostic (2.24e-1)" "prognostic favorable (9.25e-11)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (2.93e-1)" "unprognostic (7.88e-2)" 14.8 12.9 14.3 4.6 16.1 4.3 10.6 15.4 15.6 15.9 9.7 15.7 4.9 11.5 4.2 26.2 9.8 5.6 7.2 12.8 19.0 10.1 5.4 11.3 6.6 20.3 18.5 12.7 6.0 3.9 9.3 3.8 19.6 9.1 10.1 2.8 13.0 8.8 2.9 18.5 8.3 5.6 19.4 7.2 8.3 32.6 16.9 9.1 8.3 4.1 6.6 15.7 19.0 21.9 1.0 2.7 9.4 2.6 25.3 22.2 2.8 2.8 11.1 4.2 6.4 1.0 2.3 0.6 1.4 26.3 2.9 15.0 4.8 3.0 1.3 3.9 1.2 0.5 1.7 4.7 14.7 0.0 1.6 18.0 31.6 12.9 1.7 9.4 8.2 2.2 16.3 1.3 9.6 1.2 2.2 1.1 2.4 5.5 2.7 0.9 1.3 3.6 5.1 5.0 0.1 2.6 0.8 12.4 3.2 3.1 2.7 1.2 4.4 2.5 6.3 6.7 0.1 5.2 2.2 0.6 6.4 0.1 1.3 14.6 2.7 0.2 13.0 3.7 15.2 1.3 16.9 12.8 3.8 0.6 10.1 7.9 9.9 5.9 2.2 2.0 16.6 7.4 14.3 16.1 15.4 15.6 12.8 19.0 20.3 18.5 19.6 19.4 16.9 21.9 5.2 3.2 7.5 22.9 3.6 2.8 12.4 9.6 8.0 0.9 5.4 6.1 4.7 8.6 7.3 9.2 2.1 1.8 4.2 89.5 3.9 11.4 1.7 3.3 11.3 8.1 4.9 3.6 1.9 3.0 5.1 10.2 6.6 3.8 4.5 3.6 20.0 4.1 4.0 3.3 2.3 28.3 10.2 3.8 14.5 3.6 12.8 4.3 1.8 3.7 3.4 13.3 1.0 7.1 2.2 4.1 34.7 14.3 5.9 13.2 10.0 5.8 6.2 1.7 6.6 5.4 7.2 3.1 3.7 12.6 5.8 0.8 7.4 53.4 11.3 14.7 PLD2 ENSG00000129219 "Phospholipase D2" O14939 17 4807152-4823434 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013397 Approved NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA013397: AB_1855328" "unprognostic (1.87e-1)" "unprognostic (3.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (2.90e-2)" "unprognostic (3.85e-3)" "unprognostic (3.64e-1)" "unprognostic (6.15e-3)" "unprognostic (2.58e-3)" "unprognostic (1.25e-1)" "unprognostic (8.10e-3)" "unprognostic (1.08e-1)" "unprognostic (2.95e-1)" "unprognostic (1.91e-1)" "unprognostic (1.85e-1)" "unprognostic (5.48e-2)" 17.4 8.1 19.9 10.0 22.8 2.6 17.9 21.5 21.3 32.3 16.0 11.2 6.9 15.2 6.9 63.3 14.5 14.3 10.2 19.4 21.9 11.7 12.1 16.1 9.5 30.4 24.3 21.5 14.0 8.9 10.4 14.2 22.3 19.0 9.0 4.9 22.6 14.5 5.1 33.5 10.7 13.4 24.7 12.6 11.3 4.3 24.5 12.9 11.9 6.7 18.0 15.0 37.1 23.5 13.0 20.2 17.4 18.8 15.0 19.9 20.0 8.2 17.2 14.2 11.3 21.7 15.1 5.6 9.4 21.3 5.3 30.2 13.9 18.3 12.8 7.3 7.0 1.8 15.7 13.2 10.8 0.1 13.3 29.4 27.0 12.8 12.1 20.0 33.2 3.9 2.1 5.2 12.0 9.9 0.7 2.4 9.2 10.7 8.7 6.3 11.2 1.4 12.9 20.9 5.9 10.2 15.5 18.1 11.6 14.1 13.0 3.0 26.1 9.4 9.5 21.6 12.8 4.6 2.3 1.2 14.4 2.6 5.6 4.0 4.8 1.2 1.2 4.9 0.9 1.6 1.3 0.9 3.6 0.9 0.3 0.4 0.3 0.8 5.4 1.6 2.3 2.4 19.9 22.8 21.5 21.3 19.4 21.9 30.4 24.3 22.3 24.7 24.5 23.5 10.9 0.0 1.1 26.8 2.8 12.6 9.8 11.2 14.8 1.2 11.6 10.3 2.8 7.2 8.9 1.8 0.0 21.8 2.6 7.1 1.9 8.7 0.0 2.5 4.6 12.0 1.2 0.0 1.6 11.5 14.8 7.7 10.7 5.4 5.7 12.0 12.8 2.9 12.9 0.0 2.7 7.0 6.1 8.1 13.8 0.5 9.6 10.7 7.2 5.6 19.9 7.8 1.0 3.5 5.8 10.4 10.2 8.6 1.4 14.0 3.8 4.2 9.2 1.7 0.0 4.1 5.0 0.2 2.7 9.8 12.1 17.4 3.1 7.2 5.7 10.5 PLEKHA1 TAPP1 ENSG00000107679 "Pleckstrin homology domain containing A1" Q9HB21 10 122374696-122442602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 203.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002043, HPA064795" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA002043: AB_1079632, HPA064795: AB_2685354" "unprognostic (1.79e-2)" "unprognostic (3.18e-2)" "unprognostic (2.70e-1)" "unprognostic (5.44e-3)" "unprognostic (7.41e-2)" "unprognostic (1.69e-1)" "unprognostic (5.50e-2)" "unprognostic (4.07e-2)" "unprognostic (3.88e-1)" "unprognostic (2.69e-1)" "unprognostic (7.98e-2)" "unprognostic (7.63e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (7.42e-2)" "unprognostic (4.31e-2)" "unprognostic (5.23e-2)" 18.0 10.4 21.2 13.9 25.5 4.4 19.6 10.7 42.0 18.6 5.0 21.4 25.9 25.9 20.5 39.4 12.7 24.0 29.2 25.9 14.8 39.1 38.7 36.6 14.9 12.4 14.9 19.2 27.3 27.6 21.8 37.3 13.3 17.9 20.1 19.8 25.2 18.8 31.8 66.5 25.1 23.6 13.2 13.7 21.2 40.7 13.7 15.6 27.3 57.4 18.0 24.9 21.7 36.9 25.9 23.5 23.3 16.1 33.1 37.5 28.0 28.2 49.1 16.8 18.0 20.0 31.8 16.1 13.3 25.6 17.0 55.4 22.3 86.1 15.4 11.4 21.8 0.0 22.6 23.6 21.8 2.9 7.3 20.5 69.7 13.9 58.3 27.5 56.8 33.2 24.3 0.1 15.6 9.9 14.8 2.5 18.1 39.3 15.5 4.0 33.1 3.2 203.2 28.3 31.6 15.5 36.4 26.8 28.9 32.7 14.9 0.3 54.6 14.1 11.5 15.4 14.3 0.1 0.0 5.4 21.6 0.1 8.8 0.3 2.7 2.3 27.1 2.4 17.5 5.1 16.3 21.9 3.2 10.3 25.4 21.9 0.8 21.3 2.9 1.6 11.9 11.6 21.2 25.5 10.7 42.0 25.9 14.8 12.4 14.9 13.3 13.2 13.7 36.9 48.6 144.2 42.0 19.9 28.0 72.8 54.7 51.6 97.9 46.5 25.6 19.2 55.9 55.8 46.0 57.0 75.0 58.4 47.6 39.1 41.1 63.1 202.0 50.2 30.6 70.8 22.3 6.9 133.8 85.3 53.9 34.3 28.1 83.7 5.1 20.8 32.5 45.1 37.2 26.9 92.9 19.6 22.4 23.7 23.6 336.5 44.1 20.4 24.9 35.6 28.5 20.2 147.2 35.2 161.9 71.4 26.9 36.1 7.4 91.4 64.4 118.1 29.1 49.5 26.3 32.2 28.9 119.4 86.1 71.6 84.8 39.7 39.7 14.7 27.5 83.5 PNPLA5 "dJ388M5.4, GS2L" ENSG00000100341 "Patatin like phospholipase domain containing 5" Q7Z6Z6 22 43879678-43892013 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;epididymis: 1.7;skin 1: 3.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.2;Inhibitory neurons: 2.1;Late spermatids: 2.1" "Cancer enriched" "Detected in single" 4 "thyroid cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;RPMI-8226: 2.7" "Not detected" "Not detected" "HPA050409, HPA054211" Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA050409: AB_2681118, HPA054211: AB_2682418" "unprognostic (6.69e-5)" "unprognostic (3.53e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (3.33e-3)" "unprognostic (1.05e-1)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" 0.0 0.0 0.8 0.1 3.4 0.3 0.3 0.2 2.3 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.1 0.0 1.4 0.5 0.0 0.9 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.8 3.4 0.2 2.3 1.4 0.5 1.2 0.6 0.4 0.1 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POLR1C "AC40, RPA39, RPA40, RPA5, RPAC1, RPC40" ENSG00000171453 "RNA polymerase I and III subunit C" O15160 6 43509702-43562419 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 306.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031010 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli fibrillar center" "HPA031010: AB_10603131" "unprognostic (2.84e-1)" "unprognostic (1.67e-1)" "unprognostic (3.15e-1)" "unprognostic (6.57e-2)" "unprognostic (7.01e-2)" "unprognostic (3.59e-1)" "unprognostic (6.69e-3)" "unprognostic (1.09e-3)" "unprognostic (2.00e-3)" "unprognostic (1.90e-2)" "unprognostic (2.05e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (1.20e-2)" "unprognostic (4.69e-2)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" 15.5 19.2 16.0 12.3 16.0 7.7 20.3 15.7 20.9 15.3 19.8 18.4 13.1 15.1 15.7 21.3 21.0 9.5 13.3 16.0 16.4 17.6 17.7 11.0 13.9 15.9 15.9 14.4 15.5 17.1 13.8 12.2 16.2 14.4 15.5 6.6 15.8 12.0 15.3 20.5 10.9 14.8 16.0 12.7 14.6 20.1 16.3 12.5 16.1 13.4 20.8 23.4 15.5 17.1 76.0 61.7 26.6 72.3 40.0 43.0 42.1 45.3 33.5 49.7 42.2 82.5 25.2 85.2 48.3 44.2 42.5 45.2 64.7 57.6 57.6 45.4 67.7 58.3 57.2 115.7 50.1 90.0 39.1 38.7 54.8 67.9 85.4 29.4 39.6 35.4 136.9 24.5 44.0 106.4 47.4 65.0 49.2 306.8 52.9 31.9 41.8 57.6 60.7 104.1 49.0 32.8 39.6 34.1 62.2 19.4 36.9 77.9 47.6 35.3 48.1 38.4 72.3 35.1 85.0 146.0 24.1 60.9 40.0 5.7 30.0 4.6 34.1 24.0 46.5 51.1 40.4 34.1 42.4 55.0 55.1 49.6 2.7 41.7 20.5 38.6 32.7 34.0 16.0 16.0 15.7 20.9 16.0 16.4 15.9 15.9 16.2 16.0 16.3 17.1 13.0 12.8 17.7 9.8 24.9 61.8 50.6 34.3 42.1 8.2 24.0 23.6 5.2 17.2 30.4 5.5 6.2 29.7 15.3 11.3 15.6 26.7 13.5 23.4 15.9 18.6 13.1 12.8 13.6 24.4 18.9 21.5 25.0 14.2 14.0 14.4 15.7 11.9 13.3 5.0 12.3 17.4 28.5 5.2 17.0 8.3 11.5 8.5 21.4 11.2 8.3 7.1 14.4 14.1 10.2 21.0 11.5 11.7 13.1 29.2 5.0 27.5 48.5 15.4 6.6 29.1 45.6 34.4 43.3 26.4 40.9 13.5 17.4 21.5 19.9 37.0 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38043829-38046793 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 10.3;skin 1: 32.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8" "Group enriched" "Detected in many" 4 "cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055980, HPA073824" Enhanced Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055980: AB_2682995, HPA073824: AB_2686635" "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.2 1.5 2.3 0.2 7.0 0.0 0.3 0.9 10.3 0.2 0.1 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.1 9.7 1.9 0.0 0.0 0.0 1.0 1.4 2.6 0.1 0.1 0.2 0.0 0.0 1.3 0.2 0.0 0.3 0.3 0.1 0.9 32.6 0.0 0.0 0.6 0.1 0.1 0.8 2.0 0.3 0.0 0.5 1.0 0.8 0.3 2.5 0.0 0.0 24.1 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 23.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 1.4 5.7 0.0 0.1 0.0 28.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.0 0.9 10.3 9.7 1.9 1.4 2.6 1.3 0.6 2.0 2.5 12.2 0.0 0.0 2.3 8.3 27.3 2.9 1.4 20.5 7.8 9.9 39.1 5.2 0.0 0.2 0.0 22.9 0.2 13.4 13.8 0.0 0.0 0.2 0.5 2.3 1.9 1.8 2.7 6.4 0.0 0.1 5.2 7.1 1.4 0.0 0.5 0.0 0.0 0.3 1.7 1.1 11.0 0.0 0.0 1.3 0.0 0.3 4.3 7.2 1.0 0.0 14.0 0.0 0.5 0.2 0.0 0.1 0.0 2.7 0.7 0.3 0.1 0.0 21.1 0.0 8.5 7.2 0.2 4.1 20.2 55.8 0.1 5.2 8.3 5.7 3.2 PPARD "FAAR, NR1C2, NUC1, NUCII" ENSG00000112033 "Peroxisome proliferator activated receptor delta" Q03181 6 35342558-35428191 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 67.7;Pancreatic endocrine cells: 102.5;Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017635 Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "CAB017635: AB_1128605" "unprognostic (3.70e-2)" "unprognostic (8.75e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (8.68e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (4.59e-3)" "unprognostic (4.34e-1)" "unprognostic (1.45e-1)" "unprognostic (1.05e-1)" "unprognostic (1.51e-3)" "unprognostic (7.27e-3)" "unprognostic (1.43e-1)" "unprognostic (9.42e-2)" "unprognostic (5.95e-2)" "unprognostic (2.00e-2)" 21.0 20.6 31.9 18.7 30.2 9.1 18.4 27.4 35.3 25.3 22.2 24.2 11.6 19.1 18.4 45.9 19.7 14.9 23.0 35.9 26.5 29.9 31.8 31.5 15.5 31.3 31.5 32.0 12.2 14.2 24.6 28.3 31.2 28.2 12.3 10.9 20.5 17.2 29.4 28.9 27.4 11.3 29.1 30.7 29.8 14.1 36.1 7.6 40.9 13.4 13.8 23.5 33.7 27.8 51.0 8.9 13.7 29.3 20.0 34.9 74.3 40.6 36.1 34.2 28.4 12.0 9.4 8.1 11.6 29.1 19.4 17.8 13.0 39.4 23.8 11.8 11.8 7.7 12.2 17.9 35.0 1.9 8.3 59.7 13.0 50.7 25.9 39.0 16.2 9.9 8.1 8.9 29.1 16.1 5.6 8.2 6.7 19.1 23.9 7.9 23.5 8.2 8.5 44.7 7.7 21.4 16.3 27.9 34.5 9.4 10.4 28.1 35.1 46.3 17.5 28.1 49.1 7.5 11.2 8.7 15.2 16.3 21.2 0.5 1.5 3.3 1.2 1.3 0.9 1.3 1.3 1.2 1.3 1.7 2.2 2.1 2.3 1.0 0.9 0.8 1.4 1.1 31.9 30.2 27.4 35.3 35.9 26.5 31.3 31.5 31.2 29.1 36.1 27.8 14.8 9.6 7.8 11.8 8.8 18.7 19.5 7.5 5.7 7.6 6.6 6.2 11.0 10.0 11.6 1.8 2.1 35.6 3.2 67.7 3.9 30.9 3.0 9.7 8.5 11.9 6.6 1.7 24.4 24.1 32.1 8.0 31.6 18.3 22.9 5.5 6.1 5.6 14.9 5.0 18.7 9.2 10.2 6.6 18.3 3.6 5.9 17.0 12.4 59.0 4.3 8.0 6.2 23.1 42.8 102.5 38.6 8.2 6.1 18.5 22.6 6.3 5.1 7.5 13.1 9.6 10.2 6.2 7.7 7.2 12.8 98.1 7.1 18.8 8.1 51.4 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119544-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 45.0;skin 1: 42.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 40.8;Horizontal cells: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 23.1;PC-3: 36.1;SK-BR-3: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "Nucleoli fibrillar center, Vesicles" "HPA043567: AB_2678558, HPA050340: AB_2681096" "prognostic unfavorable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favorable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favorable (6.46e-7)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 2.0 4.5 16.4 0.8 18.8 0.2 2.7 11.7 28.6 4.6 0.0 6.6 3.0 2.2 0.3 14.1 1.9 0.6 3.1 18.2 11.4 3.1 2.7 2.9 0.8 10.1 8.7 1.3 4.7 2.1 45.0 0.4 9.9 5.6 1.0 3.7 5.3 0.6 1.4 42.3 3.7 0.4 3.5 2.2 2.4 4.2 11.7 2.4 2.8 0.2 1.1 1.4 8.1 16.6 3.3 3.3 3.3 8.0 0.1 0.0 6.0 0.4 0.4 1.5 2.2 2.2 1.3 7.3 4.3 0.4 2.4 1.7 5.0 0.7 0.4 7.9 10.8 4.6 3.5 1.7 0.4 1.9 11.4 0.4 1.8 1.0 0.5 0.7 0.0 12.1 9.0 11.2 0.1 14.2 2.3 3.2 1.4 23.1 36.1 7.6 6.5 3.6 0.5 1.6 7.2 9.5 1.3 29.7 3.3 0.0 16.5 4.4 0.7 1.7 6.1 1.1 0.2 21.0 18.2 5.4 1.7 7.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 18.8 11.7 28.6 18.2 11.4 10.1 8.7 9.9 3.5 11.7 16.6 15.7 0.0 0.6 8.5 0.8 7.1 8.0 3.5 11.4 40.8 10.4 6.1 4.2 8.6 3.0 5.5 14.6 0.5 3.6 19.3 19.6 2.7 1.2 1.3 3.6 15.2 26.5 2.7 19.9 4.4 2.1 3.4 3.6 2.4 0.0 2.7 23.2 8.6 2.5 43.7 21.5 26.3 8.2 2.2 2.4 1.7 5.6 2.7 16.0 2.8 0.0 16.2 0.0 10.6 2.7 1.9 13.7 3.8 1.2 18.2 15.0 4.6 0.9 17.9 0.0 0.6 5.5 2.5 5.9 8.7 11.8 0.5 0.7 13.2 20.4 6.3 PPP2R2C "B55gamma, IMYPNO, MGC33570, PR52, PR55G" ENSG00000074211 "Protein phosphatase 2 regulatory subunit Bgamma" Q9Y2T4 4 6320578-6563600 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 106.2" "Group enriched" "Detected in many" 5 "Astrocytes: 61.0;Early spermatids: 67.4;Excitatory neurons: 203.3;Inhibitory neurons: 82.8;Late spermatids: 182.5;Oligodendrocytes: 94.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 31.4;A549: 46.1;CAPAN-2: 28.2;GAMG: 68.4;MCF7: 36.2;PC-3: 38.9;SCLC-21H: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, HPA060473" Approved Approved Cytosol NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291" "unprognostic (9.39e-2)" "unprognostic (7.10e-2)" "unprognostic (9.12e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (5.91e-2)" "unprognostic (2.70e-4)" "prognostic unfavorable (4.94e-4)" "unprognostic (1.77e-1)" "unprognostic (3.90e-1)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (1.36e-13)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.66e-3)" "unprognostic (9.90e-3)" 0.8 6.2 72.9 0.6 86.7 0.0 1.4 42.1 106.2 18.0 0.0 1.1 0.8 27.0 7.4 35.9 9.9 0.4 2.5 85.7 44.5 0.3 0.1 0.1 0.3 52.5 52.7 0.6 0.7 1.5 22.6 0.1 55.1 5.0 0.3 10.9 5.3 14.5 0.8 34.0 1.2 11.9 62.3 0.3 0.8 7.3 66.9 2.7 0.1 0.9 3.1 0.9 11.5 91.2 31.4 46.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 28.2 0.0 19.0 0.0 68.4 13.7 20.0 0.7 0.0 0.0 2.4 0.0 3.2 3.7 0.7 0.0 0.1 6.6 11.4 0.0 0.0 0.0 0.1 4.2 0.0 0.1 6.6 36.2 0.0 0.1 2.2 0.6 38.9 0.0 0.0 1.2 0.0 0.1 39.1 7.5 1.5 0.1 0.0 1.1 18.9 0.1 0.0 0.2 22.7 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.9 86.7 42.1 106.2 85.7 44.5 52.5 52.7 55.1 62.3 66.9 91.2 0.2 0.0 0.0 61.0 0.0 14.7 0.4 0.8 4.6 11.0 1.9 0.4 4.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 67.4 0.8 5.7 0.6 0.0 0.0 203.3 0.2 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.1 3.3 82.8 0.0 0.0 0.0 1.1 182.5 6.8 0.0 0.0 4.7 0.0 6.5 0.0 14.1 94.6 2.4 0.0 4.5 0.0 1.3 0.0 0.2 0.0 3.1 0.0 0.0 2.5 2.3 1.6 6.5 22.0 0.0 0.2 0.1 0.0 0.2 PRDX1 "NKEFA, PAGA" ENSG00000117450 "Peroxiredoxin 1" Q06830 1 45510914-45542732 "Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 2690.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004682, HPA007730" Approved Approved Mitochondria NA NA 110000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria "CAB004682: AB_437046, HPA007730: AB_1855204" "unprognostic (1.28e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-2)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.68e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.39e-2)" "unprognostic (5.99e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.89e-4)" 277.8 362.9 642.4 290.2 667.1 86.7 454.3 700.7 747.3 314.1 627.0 326.7 501.4 255.3 459.4 945.8 306.3 297.4 542.9 613.0 700.8 785.5 841.2 340.2 371.4 712.1 706.3 255.5 122.7 214.6 210.0 353.3 711.6 256.0 327.1 347.3 348.6 307.2 571.4 296.5 402.1 329.3 713.5 265.8 355.5 143.7 671.4 262.8 802.3 477.7 603.3 393.2 375.3 766.6 1028.1 1743.7 735.2 942.9 828.4 701.9 1459.3 1134.8 1144.1 1183.0 964.3 932.3 429.2 899.1 1125.9 1237.6 1448.6 967.6 1640.2 1101.3 1193.0 696.9 1266.4 678.6 2042.8 2484.7 361.0 793.6 848.9 610.4 813.6 1201.7 283.8 657.7 1409.7 1044.0 1271.8 292.7 1225.2 829.4 1053.7 772.5 2339.8 2241.0 1867.3 1863.6 934.0 1177.7 2211.5 872.4 987.5 495.1 1035.3 2524.2 73.3 2157.3 760.6 631.1 1208.1 474.8 1071.9 1034.4 1541.5 206.1 1220.5 1678.2 791.4 537.9 278.7 469.3 325.6 111.6 155.7 367.1 205.4 253.8 246.8 209.3 293.9 221.6 150.3 166.6 12.1 123.8 407.5 195.9 438.2 416.3 642.4 667.1 700.7 747.3 613.0 700.8 712.1 706.3 711.6 713.5 671.4 766.6 530.7 522.4 259.0 48.3 330.1 607.3 1115.3 1161.1 745.0 161.3 387.0 510.9 54.9 397.5 685.2 617.9 104.3 1258.6 151.5 339.3 946.9 1015.7 19.7 662.7 281.2 437.8 174.5 304.2 15.5 442.8 1773.2 462.0 500.0 435.5 325.3 463.2 326.3 875.2 1467.4 206.9 17.1 295.0 545.3 366.9 980.7 44.2 498.6 534.8 581.7 12.2 545.7 416.4 62.8 24.1 90.5 804.4 384.9 410.7 612.8 1100.9 995.0 2690.9 919.1 402.2 309.0 279.0 982.6 84.5 329.2 1346.9 528.6 1114.9 270.9 499.4 398.8 1462.7 PRSS36 FLJ90661 ENSG00000178226 "Serine protease 36" Q5K4E3 16 31138926-31150083 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 2.6" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 11.7;Distal enterocytes: 13.2;Hofbauer cells: 18.7;Paneth cells: 15.4;Proximal enterocytes: 46.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "HeLa: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA036079 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 45: Enterocytes - Digestion" "HPA036079: AB_10602290" "unprognostic (3.74e-2)" "prognostic favorable (2.97e-7)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (4.26e-3)" "unprognostic (1.31e-5)" "unprognostic (4.18e-2)" "unprognostic (5.05e-2)" "unprognostic (2.65e-2)" "unprognostic (8.03e-2)" "unprognostic (2.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (9.86e-2)" "unprognostic (1.23e-1)" "unprognostic (3.13e-1)" 1.4 0.8 0.4 0.3 0.6 0.4 0.5 0.4 0.8 0.2 0.3 0.7 1.0 0.1 0.0 0.3 0.3 0.1 0.3 0.5 0.5 0.2 0.3 0.7 0.1 0.5 0.4 0.1 0.2 0.1 2.6 0.7 0.5 0.1 0.2 0.0 0.5 0.1 0.2 1.0 0.7 0.3 0.4 0.1 0.3 0.4 0.6 0.8 0.3 0.0 0.2 0.4 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.8 2.6 0.4 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.0 0.1 0.0 0.2 0.0 0.0 0.4 0.6 0.4 0.8 0.5 0.5 0.5 0.4 0.5 0.4 0.6 0.5 0.3 0.0 1.1 0.7 0.2 1.9 2.6 8.9 1.8 0.5 5.9 11.7 1.1 2.8 3.5 0.0 0.0 0.8 1.2 13.2 0.0 1.7 1.7 0.9 0.6 0.6 0.0 0.4 0.6 2.8 1.2 1.3 1.1 0.9 0.0 0.5 3.3 3.3 18.7 0.0 0.8 4.1 2.0 3.2 3.8 0.9 2.8 4.2 0.0 0.0 5.4 0.6 4.1 0.0 0.1 1.8 15.4 2.6 0.0 1.7 46.9 1.9 1.2 0.0 0.0 0.4 0.4 0.6 4.4 1.5 2.6 0.5 0.5 1.1 3.9 1.9 PSMG3 "C7orf48, MGC10911, PAC3" ENSG00000157778 "Proteasome assembly chaperone 3" Q9BT73 7 1567332-1571005 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023876 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA023876: AB_1844356" "unprognostic (3.08e-1)" "unprognostic (9.21e-2)" "unprognostic (4.40e-3)" "unprognostic (5.02e-2)" "unprognostic (3.10e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.12e-1)" "unprognostic (4.82e-1)" "unprognostic (1.65e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (5.13e-1)" "unprognostic (2.82e-1)" "unprognostic (1.84e-1)" 26.2 27.6 41.0 15.4 40.6 46.1 25.7 40.4 45.3 26.0 40.1 29.7 22.8 22.6 16.4 52.9 28.9 15.0 24.4 41.5 40.3 37.5 33.1 22.5 25.7 40.4 40.8 19.2 27.8 14.8 29.9 15.8 41.0 28.2 17.4 13.4 30.8 18.4 27.6 57.6 31.3 12.2 38.5 38.3 30.9 18.3 41.5 25.9 23.8 13.8 20.7 25.7 33.3 41.2 130.1 81.6 58.7 57.1 44.8 51.8 57.7 29.2 51.8 72.8 61.7 75.8 82.7 41.1 34.0 49.4 102.3 99.5 75.0 77.2 33.1 39.1 131.1 44.0 176.9 66.5 70.4 58.2 39.6 44.2 93.1 55.2 62.5 31.9 29.7 98.6 121.0 61.4 54.3 220.5 38.0 189.4 117.3 89.3 150.3 63.1 31.4 91.8 59.7 64.6 87.6 75.1 35.8 127.3 80.8 14.6 90.1 108.2 20.6 67.1 97.9 83.9 86.8 69.2 69.4 110.8 39.7 183.3 143.0 54.9 47.6 51.3 40.0 50.2 47.7 41.2 40.5 36.4 47.6 33.4 38.8 38.8 12.3 36.3 54.6 71.1 35.5 38.4 41.0 40.6 40.4 45.3 41.5 40.3 40.4 40.8 41.0 38.5 41.5 41.2 28.5 19.2 15.1 2.3 23.9 53.3 26.4 46.1 48.9 17.5 36.8 40.9 11.4 34.3 30.4 35.0 4.2 49.2 28.7 42.9 84.1 49.5 7.1 62.3 30.0 29.3 28.8 65.0 9.7 51.4 88.2 30.8 30.1 38.5 15.2 25.1 24.3 36.0 56.3 6.7 8.6 64.0 38.7 26.8 31.6 5.8 36.1 24.0 39.2 4.7 37.5 28.0 36.0 7.5 8.2 61.8 40.4 25.9 31.2 41.0 44.1 85.3 50.0 18.6 26.3 22.4 29.7 24.8 36.3 56.9 58.4 39.4 26.4 31.9 48.2 29.0 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 88.4;skin 1: 31.9" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 2714.3" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" NA NA 3400000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavorable (9.36e-4)" 1.6 1.6 66.0 1.2 64.2 0.0 4.0 57.2 88.4 1.8 21.5 4.4 0.6 0.1 0.8 7.9 0.3 0.7 1.3 64.0 64.1 0.1 0.1 1.2 0.0 60.9 62.9 0.7 2.7 0.0 2.3 0.2 62.4 1.0 1.1 19.0 3.4 0.7 0.1 31.9 1.0 1.3 63.7 1.0 13.8 0.3 58.6 0.2 0.1 0.3 2.6 0.9 2.3 72.4 0.1 0.0 425.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 27.7 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 126.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 5.4 15.2 0.1 0.0 0.0 0.1 0.0 0.0 0.7 10.9 5.6 0.0 0.6 0.0 193.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 66.0 64.2 57.2 88.4 64.0 64.1 60.9 62.9 62.4 63.7 58.6 72.4 0.1 0.0 1.5 625.2 0.2 25.2 8.6 82.2 44.9 18.3 5.6 12.2 1.3 0.0 39.7 0.0 4.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 37.7 0.7 0.1 1.3 9.2 0.0 0.0 10.1 0.0 0.0 0.1 65.6 72.0 0.0 0.0 0.0 1.6 0.7 0.3 0.1 19.6 22.5 0.0 90.4 0.0 2714.3 3.6 0.9 0.3 0.0 1.2 1.8 0.0 0.1 16.9 6.6 0.0 1.2 1.7 0.1 1.6 14.8 21.5 0.3 0.2 0.5 0.0 7.8 PYDC1 "ASC2, POP1" ENSG00000169900 "Pyrin domain containing 1" Q8WXC3 16 31215962-31217135 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 8.1;skin 1: 14.5" "Group enriched" "Detected in some" 5 "Breast glandular cells: 3.2;Breast myoepithelial cells: 2.5;Suprabasal keratinocytes: 6.3" "Cancer enriched" "Detected in some" 8 "breast cancer: 8.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: Glandular cells - Unknown function" "unprognostic (9.72e-3)" "unprognostic (1.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.61e-1)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (2.62e-1)" "unprognostic (5.34e-2)" "unprognostic (3.15e-2)" "unprognostic (2.60e-10)" "unprognostic (3.62e-1)" "unprognostic (1.74e-1)" "unprognostic (1.70e-1)" "unprognostic (9.47e-2)" 0.0 0.0 5.9 0.0 4.7 0.0 0.4 7.6 8.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 4.4 0.0 0.0 0.0 0.0 2.9 3.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 1.1 14.5 0.0 0.0 1.8 0.0 0.1 0.0 4.8 0.4 0.0 0.0 0.2 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.9 4.7 7.6 8.1 5.4 4.4 2.9 3.1 2.9 1.8 4.8 2.8 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.0 3.2 2.5 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 6.3 0.0 0.1 0.1 0.0 0.1 RAB22A ENSG00000124209 "RAB22A, member RAS oncogene family" Q9UL26 20 58309715-58367507 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066920 Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "HPA066920: AB_2685749" "unprognostic (4.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.68e-1)" "unprognostic (8.34e-3)" "unprognostic (6.20e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.12e-1)" "unprognostic (2.00e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (7.01e-3)" 6.4 10.2 8.7 5.3 10.4 4.7 6.4 5.9 11.0 6.9 0.7 6.9 7.1 6.2 7.8 11.6 4.7 5.6 4.2 11.3 9.9 7.5 7.4 6.0 5.8 8.4 8.3 5.6 5.5 11.6 6.1 4.8 9.7 5.2 6.8 5.4 6.4 5.6 4.5 7.5 6.9 5.8 8.0 6.1 7.0 5.4 10.1 6.3 8.5 5.0 7.2 7.0 7.7 8.7 17.5 7.1 8.8 5.7 17.9 16.7 5.2 12.9 14.9 17.4 10.4 11.9 11.8 9.6 15.7 18.2 19.5 13.7 4.5 20.4 19.7 6.5 4.4 6.8 10.0 9.5 13.8 8.5 11.5 11.4 24.4 12.4 12.7 12.3 11.0 7.5 6.0 13.4 18.4 25.1 10.0 8.0 2.2 15.3 17.4 5.2 8.6 8.3 10.9 11.1 6.7 9.1 18.2 34.0 15.6 4.6 12.6 11.5 17.6 28.7 11.9 18.0 15.6 11.5 17.0 6.3 29.5 8.0 10.0 1.5 1.0 0.8 2.2 1.3 2.1 1.5 1.7 1.9 1.4 1.4 1.5 1.8 2.0 2.2 2.1 1.1 1.5 0.8 8.7 10.4 5.9 11.0 11.3 9.9 8.4 8.3 9.7 8.0 10.1 8.7 34.2 22.4 16.2 25.1 34.2 56.0 68.9 21.3 32.5 14.6 32.7 22.5 18.6 32.9 20.9 20.2 8.4 16.6 39.7 39.9 50.9 37.0 6.4 30.1 32.8 29.9 19.2 22.3 27.8 36.0 24.7 39.3 31.1 33.7 11.4 19.9 26.0 25.3 28.0 11.8 26.5 23.5 22.4 23.0 69.7 9.2 31.4 33.6 24.9 35.6 23.0 27.9 34.0 24.6 32.1 75.2 26.2 20.7 29.3 75.4 24.5 44.1 22.4 12.6 13.1 42.4 39.7 22.2 39.7 47.6 68.9 35.4 40.6 30.1 22.5 124.3 RALBP1 "RIP, RIP1, RLIP76" ENSG00000017797 "RalA binding protein 1" Q15311 18 9475009-9538114 "Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transport "GTPase activation, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Collecting duct cells: 480.1;Extravillous trophoblasts: 518.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 10 "neutrophil: 195.6" "Lineage enriched" "Detected in all" 10 "granulocytes: 195.6" "Cell line enhanced" "Detected in all" "OE19: 239.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046010, HPA046651" Approved Approved "Nuclear membrane,Vesicles,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "Nuclear membrane, Vesicles" "CAB046010: AB_11126824, HPA046651: AB_2679738" "unprognostic (1.23e-1)" "unprognostic (5.84e-3)" "unprognostic (1.58e-1)" "unprognostic (1.74e-2)" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (5.72e-2)" "unprognostic (9.90e-2)" "unprognostic (1.53e-1)" "prognostic favorable (8.47e-4)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "prognostic favorable (5.39e-6)" "unprognostic (1.28e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-1)" 29.7 20.4 42.7 23.4 44.1 30.7 27.8 45.8 82.2 26.8 38.6 34.1 18.7 22.1 23.5 50.3 24.8 20.3 28.5 40.7 45.1 42.7 19.9 22.6 24.0 44.1 48.0 26.3 15.4 47.9 16.8 31.4 44.4 32.6 25.4 13.5 25.0 48.2 38.5 75.9 20.4 21.1 43.6 26.5 25.7 13.0 45.3 29.3 22.9 32.5 25.4 33.8 33.3 45.1 58.9 37.6 34.2 39.0 38.3 60.7 43.3 67.7 38.1 35.6 38.0 42.6 57.5 70.5 47.0 64.8 50.2 32.8 48.1 52.7 44.2 71.4 38.5 38.5 34.6 32.7 31.2 114.8 43.0 42.0 52.2 49.6 48.7 47.7 60.6 64.6 53.7 67.7 56.2 46.3 70.7 50.9 25.4 239.5 31.9 93.6 59.4 54.2 48.4 80.7 44.7 34.8 58.2 52.8 30.9 52.3 32.9 53.8 67.4 105.0 76.9 72.3 81.9 38.7 42.9 77.9 45.6 53.4 40.5 13.0 9.6 15.7 10.3 10.6 8.7 9.9 8.7 8.8 8.7 7.5 7.3 9.4 195.6 14.8 17.8 19.8 6.4 4.5 42.7 44.1 45.8 82.2 40.7 45.1 44.1 48.0 44.4 43.6 45.3 45.1 101.8 57.7 35.7 15.3 48.0 156.4 80.9 59.9 112.7 42.6 96.0 102.2 64.8 88.6 64.6 480.1 29.2 104.2 70.9 122.6 123.3 119.4 16.1 99.1 82.6 86.9 74.2 175.7 25.4 90.7 518.6 71.6 56.1 179.4 40.5 85.8 78.9 88.3 70.1 52.2 26.7 87.7 109.9 92.8 69.7 9.5 72.7 78.4 58.7 20.6 99.6 47.6 83.4 17.1 25.3 166.3 78.2 87.3 63.2 174.4 61.0 115.0 38.6 37.3 65.7 76.8 105.6 66.7 80.0 149.6 242.5 44.6 62.6 128.4 90.1 216.4 RALGDS "RalGEF, RGDS, RGF" ENSG00000160271 "Ral guanine nucleotide dissociation stimulator" Q12967 9 133097720-133149334 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Urothelial cells: 116.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 24.0;MAIT T-cell: 9.7;memory CD4 T-cell: 10.9;memory CD8 T-cell: 17.6;naive CD8 T-cell: 9.1;NK-cell: 9.0;T-reg: 20.8" "Group enriched" "Detected in many" 7 "NK-cells: 9.0;T-cells: 24.0" "Cell line enhanced" "Detected in all" "HDLM-2: 152.4;SH-SY5Y: 92.0" "HPA025961, CAB032582" Approved Uncertain Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB032582: AB_2238105, HPA025961: AB_2671795" "unprognostic (1.01e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.35e-2)" "unprognostic (7.92e-3)" "unprognostic (8.20e-2)" "unprognostic (7.95e-2)" "unprognostic (5.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.91e-2)" "unprognostic (2.88e-1)" "unprognostic (2.69e-3)" "unprognostic (5.03e-2)" "unprognostic (9.54e-3)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" 36.8 29.7 68.3 20.2 88.1 41.8 35.5 76.3 75.8 22.2 34.7 28.2 17.3 19.0 12.8 40.5 23.9 31.3 26.8 66.8 66.5 14.8 13.4 35.7 27.6 91.3 87.5 33.0 22.9 16.6 68.5 10.9 84.4 25.0 10.1 7.3 31.8 20.3 32.5 62.3 25.2 13.6 73.5 22.2 21.4 6.1 86.1 15.8 23.5 16.3 16.9 38.8 29.6 117.9 7.5 10.9 22.2 27.8 8.3 12.1 18.7 8.8 13.0 8.8 5.7 9.5 16.1 11.3 8.0 15.1 13.4 33.8 22.7 16.1 2.9 152.4 16.3 9.6 22.0 13.8 10.8 15.6 16.9 14.2 22.1 4.7 9.7 23.7 18.2 21.7 19.3 68.4 8.3 24.6 22.2 15.0 15.3 33.3 27.6 22.2 5.4 18.9 10.8 13.0 70.1 92.0 10.5 15.4 14.0 8.6 16.0 15.9 9.5 9.8 10.3 7.4 6.1 3.2 9.2 14.0 8.6 17.4 11.2 2.3 0.6 0.9 24.0 0.3 9.7 1.7 10.9 17.6 0.8 0.5 2.4 9.1 0.4 9.0 0.3 0.8 20.8 6.1 68.3 88.1 76.3 75.8 66.8 66.5 91.3 87.5 84.4 73.5 86.1 117.9 83.9 32.1 11.3 43.4 17.2 55.4 46.3 19.5 40.5 16.6 55.5 40.5 7.2 12.8 21.4 9.2 12.5 5.5 45.7 40.6 3.9 11.4 0.6 100.2 11.7 54.1 37.0 14.3 34.1 6.7 4.5 21.8 26.0 93.1 15.8 26.9 36.4 3.8 12.5 62.2 29.8 14.4 22.4 9.8 51.1 1.8 13.4 33.6 23.2 12.2 4.9 16.3 46.4 32.2 86.4 11.5 31.5 9.1 26.5 43.9 26.7 2.5 34.5 9.3 0.0 43.7 15.4 2.5 5.1 47.6 101.4 5.9 41.6 19.6 17.6 116.6 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41244779-41286187 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Late spermatids: 1717.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" Yes Yes 75000 "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favorable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 27.5 72.9 78.2 26.0 86.0 48.1 29.6 70.8 102.3 34.4 47.7 29.2 18.1 24.9 12.0 79.8 23.6 17.2 45.1 79.5 85.2 43.9 88.0 41.6 30.6 102.7 77.9 32.5 60.9 12.7 57.4 22.8 105.1 39.3 13.2 32.7 38.0 17.6 43.0 96.9 30.6 17.5 68.7 42.3 39.6 178.1 82.0 40.4 34.4 14.2 31.8 34.7 45.4 109.1 228.0 112.2 75.9 77.3 38.8 31.4 85.9 194.5 103.8 182.8 98.4 135.9 71.9 118.0 154.0 137.4 94.8 203.0 135.5 145.4 125.2 95.7 199.2 103.3 115.0 107.9 46.7 171.6 72.5 30.0 69.5 132.2 123.4 67.6 102.1 45.0 127.7 83.3 111.9 186.1 96.3 130.0 84.5 217.6 127.6 118.8 73.4 126.0 72.5 123.7 66.6 44.1 139.1 117.7 71.7 74.6 72.2 64.4 146.5 141.7 138.5 78.6 154.6 60.1 92.8 124.2 99.3 119.3 82.0 2.7 7.6 6.9 8.1 9.0 9.5 5.9 8.2 7.8 5.6 6.4 7.4 5.9 2.0 5.9 12.9 5.9 9.5 8.2 78.2 86.0 70.8 102.3 79.5 85.2 102.7 77.9 105.1 68.7 82.0 109.1 10.9 3.2 20.9 8.5 15.0 23.1 22.2 10.9 18.2 16.0 22.4 16.9 19.6 25.8 9.6 9.2 14.6 22.7 20.3 22.9 3.9 33.3 270.7 21.0 14.7 16.1 25.0 16.6 28.3 20.3 35.3 13.3 25.5 25.1 6.3 74.4 8.9 21.8 16.6 15.2 20.8 19.1 16.2 13.9 20.9 1717.0 14.9 16.8 12.4 5.6 8.9 10.1 14.4 6.0 32.2 39.8 5.7 12.0 25.8 37.4 7.1 13.1 11.4 26.4 0.0 6.8 18.2 25.6 17.7 38.8 31.0 23.7 24.3 42.5 24.8 23.3 RCE1 "FACE-2, FACE2, hRCE1, RCE1A, RCE1B" ENSG00000173653 "Ras converting CAAX endopeptidase 1" Q9Y256 11 66842835-66846552 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074124 Approved NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "HPA074124: " "unprognostic (1.11e-1)" "unprognostic (7.23e-2)" "unprognostic (1.15e-1)" "unprognostic (8.16e-3)" "unprognostic (3.11e-1)" "unprognostic (6.40e-3)" "unprognostic (1.98e-3)" "unprognostic (7.69e-3)" "unprognostic (1.39e-1)" "unprognostic (9.14e-3)" "unprognostic (2.35e-3)" "unprognostic (5.31e-3)" "unprognostic (1.06e-1)" "unprognostic (4.48e-3)" "unprognostic (2.17e-2)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" 10.1 10.9 14.9 7.2 15.1 20.9 9.3 17.9 18.2 10.7 13.7 13.3 10.1 8.4 5.9 19.9 8.9 8.6 7.3 14.7 14.9 25.7 7.9 8.9 9.9 14.0 14.1 10.8 15.5 9.5 13.9 11.8 14.2 12.0 8.2 10.0 12.6 6.1 4.4 19.9 12.4 5.9 13.5 12.0 12.0 13.5 15.5 9.5 7.0 4.2 6.1 11.9 12.9 14.6 22.7 24.5 14.7 13.8 9.0 7.8 32.3 11.6 11.2 17.7 15.8 46.6 47.2 17.2 21.8 11.1 29.3 39.6 17.1 17.4 10.2 20.7 19.3 15.5 17.0 18.0 31.7 20.3 22.0 12.6 32.7 19.9 17.6 13.7 14.6 23.5 21.7 26.0 9.0 42.8 28.2 38.3 43.5 43.1 24.0 22.9 11.0 34.1 19.5 12.0 18.3 16.5 16.8 22.3 74.1 14.3 26.2 16.3 9.7 24.2 18.7 26.4 18.5 14.6 15.2 19.6 16.4 20.8 18.4 23.1 21.1 14.6 17.1 24.0 15.6 15.3 14.7 22.1 18.9 12.0 11.8 17.8 7.2 14.3 21.5 29.1 6.7 17.8 14.9 15.1 17.9 18.2 14.7 14.9 14.0 14.1 14.2 13.5 15.5 14.6 12.5 0.0 4.8 4.2 16.9 31.2 26.6 46.2 14.2 9.2 16.4 20.6 1.8 10.0 20.3 16.5 29.2 54.6 24.9 12.4 3.9 24.3 10.1 11.3 12.5 12.2 10.7 10.7 7.7 27.4 65.0 12.0 11.7 17.1 8.2 13.3 8.2 3.0 22.8 3.3 6.2 16.0 26.4 8.9 15.1 20.2 6.8 13.3 14.2 3.7 12.9 6.4 9.2 6.0 4.0 30.0 18.0 6.4 14.5 19.6 23.2 7.4 8.9 18.0 13.1 5.6 32.1 9.7 25.7 17.1 24.9 58.6 19.1 10.3 16.2 23.9 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 8.4 6.5 13.6 2.9 46.6 2.3 8.7 10.2 20.5 16.1 10.5 8.3 4.8 8.6 4.7 30.4 9.9 3.9 6.7 12.9 8.5 11.1 17.3 10.6 3.5 9.5 8.5 12.5 4.9 3.3 13.8 3.7 8.2 16.6 1.9 3.8 9.4 4.7 12.3 20.7 6.2 2.6 7.8 6.0 6.7 10.3 8.7 3.6 8.0 4.6 3.3 10.4 20.2 10.5 4.8 6.0 11.9 8.6 3.9 3.1 4.9 5.1 4.1 5.2 3.8 4.9 2.8 1.1 3.1 4.5 7.6 4.6 2.3 16.3 1.7 0.1 1.9 0.5 3.6 12.0 3.5 0.3 6.5 2.6 10.9 2.7 3.6 4.6 11.5 4.2 5.6 0.2 4.8 4.1 0.8 13.1 5.6 2.7 5.7 12.3 4.6 4.0 2.7 14.1 13.3 13.8 3.2 2.2 11.4 2.9 5.4 8.2 8.7 10.0 6.5 2.0 5.5 5.9 4.9 2.7 5.9 7.2 7.3 0.4 0.3 0.0 0.2 1.1 0.0 0.0 0.2 0.1 0.4 0.2 0.3 0.1 0.4 0.0 1.1 0.2 0.2 0.2 13.6 46.6 10.2 20.5 12.9 8.5 9.5 8.5 8.2 7.8 8.7 10.5 16.1 6.4 6.4 66.9 2.6 84.4 142.0 69.3 71.2 17.3 11.0 14.9 8.6 8.6 28.6 5.5 29.2 6.2 1.3 6.4 3.9 10.4 5.0 22.8 13.3 26.6 14.9 4.8 44.3 10.4 1.3 14.6 7.7 11.8 14.0 57.7 27.8 28.8 20.8 10.1 170.1 10.8 8.2 12.4 11.3 5.5 14.9 21.7 17.8 47.8 7.8 29.3 2.1 71.4 25.5 14.7 2.7 7.9 0.8 53.9 6.0 23.9 34.6 18.9 0.0 12.5 12.7 24.0 15.3 84.4 110.0 6.7 4.3 11.8 9.0 153.8 RHBDL2 FLJ20435 ENSG00000158315 "Rhomboid like 2" Q9NX52 1 38885807-38941830 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 24.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 74.6;Club cells: 44.8;Distal enterocytes: 52.2;Ionocytes: 46.8;Oligodendrocytes: 53.9;Pancreatic endocrine cells: 53.0;Urothelial cells: 49.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 12.7;CAPAN-2: 41.7;HaCaT: 21.7;RT4: 40.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043807 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA043807: AB_10961118" "unprognostic (3.34e-2)" "unprognostic (2.96e-1)" "unprognostic (4.57e-2)" "unprognostic (2.56e-1)" "unprognostic (7.26e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (5.81e-2)" "unprognostic (2.36e-1)" "unprognostic (2.87e-1)" "unprognostic (4.07e-3)" "unprognostic (1.23e-1)" "unprognostic (7.47e-9)" "unprognostic (1.11e-2)" "unprognostic (2.46e-1)" "unprognostic (4.12e-2)" "unprognostic (4.20e-2)" 2.2 0.4 4.1 1.7 8.8 0.4 2.0 5.6 7.1 4.3 0.3 18.0 1.3 0.6 0.2 24.4 1.1 3.4 7.7 4.0 4.9 0.9 0.4 1.0 0.8 10.0 9.5 0.3 0.6 0.3 1.3 1.1 7.3 1.8 18.0 1.1 7.8 0.5 0.5 16.6 0.8 1.1 4.1 0.4 15.7 7.3 7.4 0.7 0.7 0.0 7.1 9.7 12.8 11.4 12.7 4.3 0.4 0.2 0.2 1.2 1.2 0.7 0.1 0.9 0.1 0.9 41.7 0.3 3.0 6.3 4.2 21.7 0.0 7.1 0.6 0.3 0.2 0.2 2.9 2.5 0.5 0.1 0.5 0.9 1.0 6.0 0.1 4.0 1.0 0.4 0.0 0.4 0.9 0.0 0.1 0.3 0.2 1.3 1.2 0.2 0.2 0.0 0.0 40.4 0.4 0.3 5.0 11.4 0.4 0.6 5.6 0.4 0.9 4.4 0.5 0.3 0.3 0.4 0.5 0.5 4.1 0.8 0.2 1.5 0.6 0.4 0.2 0.4 0.1 0.7 0.2 0.1 0.7 0.3 0.2 0.2 1.7 0.3 0.2 0.7 0.3 0.3 4.1 8.8 5.6 7.1 4.0 4.9 10.0 9.5 7.3 4.1 7.4 11.4 1.3 0.0 0.5 11.1 0.7 17.7 8.0 74.6 5.2 2.7 3.9 2.4 0.4 5.7 44.8 3.7 0.0 0.4 0.2 52.2 0.0 12.4 3.9 4.7 3.4 1.4 2.4 0.0 19.0 15.8 0.3 2.1 27.5 8.4 4.5 1.6 1.8 0.0 0.2 1.7 21.9 17.3 46.8 0.0 2.7 1.0 0.6 0.4 1.8 4.7 0.6 1.3 0.0 10.6 53.9 53.0 22.3 0.0 0.2 13.4 0.2 0.3 33.2 1.8 6.6 1.2 4.0 0.3 0.1 19.0 28.4 0.7 0.5 0.2 30.2 49.9 RTN4RL1 "DKFZp547J144, NgR3, NGRH2" ENSG00000185924 "Reticulon 4 receptor like 1" Q86UN2 17 1934677-2025334 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 20.6;Cone photoreceptor cells: 37.5;Excitatory neurons: 43.5;Horizontal cells: 33.7;Inhibitory neurons: 18.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 12.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.9;HaCaT: 10.8;hTCEpi: 10.1;T-47d: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044428 Uncertain Approved "Nucleoplasm,Plasma membrane,Actin filaments,Midbody" "Intracellular and membrane" Yes NA 35000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Actin filaments" "Nucleoplasm, Plasma membrane, Midbody" "HPA044428: AB_10963229" "unprognostic (5.23e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-2)" "unprognostic (7.25e-2)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (8.97e-3)" "unprognostic (6.21e-2)" "unprognostic (2.55e-3)" "unprognostic (6.32e-3)" "prognostic unfavorable (7.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (3.15e-2)" 4.0 3.1 4.6 0.3 4.0 0.0 6.4 0.0 9.2 2.1 0.0 0.4 0.1 0.8 0.2 1.3 1.5 0.6 2.3 12.3 0.3 1.6 2.6 1.6 0.1 0.0 0.5 0.9 1.8 1.3 5.9 0.3 0.0 3.4 0.1 8.5 4.4 2.0 1.8 9.6 0.5 0.3 0.0 1.1 0.7 0.8 1.9 0.2 1.4 0.4 0.1 1.5 2.2 0.0 1.4 1.6 1.8 2.5 2.0 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.0 0.0 0.1 10.9 0.2 10.8 4.6 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.1 0.0 3.6 0.0 0.0 2.5 0.1 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.3 0.8 0.3 1.2 0.0 0.0 2.2 0.0 0.3 0.8 1.7 0.2 13.3 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.0 0.0 9.2 12.3 0.3 0.0 0.5 0.0 0.0 1.9 0.0 1.0 0.0 2.2 1.6 0.1 2.7 0.2 0.0 1.8 20.6 5.4 4.3 3.0 1.5 1.3 3.7 37.5 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.7 0.0 0.0 43.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.1 3.3 1.8 33.7 18.6 0.0 0.0 0.3 0.4 1.1 0.0 0.1 3.6 7.5 0.0 1.8 0.0 8.5 1.7 0.1 0.0 0.0 0.1 0.9 0.0 0.1 1.5 10.0 0.0 0.0 0.6 0.0 0.2 0.5 2.8 0.0 0.2 0.0 0.0 0.3 S1PR5 "Edg-8, EDG8" ENSG00000180739 "Sphingosine-1-phosphate receptor 5" Q9H228 19 10512742-10517931 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;brain: 60.2" "Cell type enhanced" "Detected in some" "dendritic cells: 93.9;NK-cells: 164.8;Oligodendrocytes: 26.6;T-cells: 33.1" "Group enriched" "Detected in many" 5 "cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 299.4;MAIT T-cell: 184.9;memory CD8 T-cell: 144.9;naive CD8 T-cell: 109.3" "Lineage enriched" "Detected in many" 7 "T-cells: 299.4" "Cell line enhanced" "Detected in many" "HaCaT: 28.5;HBEC3-KT: 10.9;RT4: 18.7;T-47d: 11.6;U-2 OS: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029683 Enhanced NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "HPA029683: AB_10603237" "unprognostic (9.07e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-2)" "unprognostic (5.55e-4)" "unprognostic (4.21e-1)" "unprognostic (4.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.55e-1)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (2.46e-2)" "unprognostic (2.90e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-1)" 0.8 0.4 21.1 0.8 35.7 19.7 0.6 32.4 44.7 5.4 8.6 0.3 0.2 0.3 4.4 12.8 0.2 0.2 0.6 19.7 23.2 0.8 1.6 3.0 1.0 39.0 34.0 0.2 1.4 0.1 0.4 1.7 35.8 2.5 0.1 0.0 2.4 0.5 0.6 18.7 0.3 0.2 26.0 11.1 0.3 0.7 30.1 0.9 0.5 0.2 2.1 2.2 10.9 60.2 1.9 2.8 0.6 0.0 0.0 0.1 0.2 0.6 0.5 0.9 0.5 0.3 0.1 0.0 7.6 0.3 1.2 28.5 1.8 10.9 2.0 0.0 1.8 0.2 2.3 0.0 0.1 0.0 0.1 0.0 5.0 3.0 0.6 0.2 0.0 0.0 0.2 0.0 0.0 3.7 1.1 0.0 4.5 0.6 0.5 0.0 2.1 0.0 0.0 18.7 0.0 0.0 4.7 0.0 0.5 1.9 11.6 3.3 0.0 1.5 10.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.5 0.5 1.2 299.4 0.2 184.9 0.6 36.3 144.9 0.6 0.5 10.8 109.3 3.9 44.5 1.1 0.8 0.6 64.2 21.1 35.7 32.4 44.7 19.7 23.2 39.0 34.0 35.8 26.0 30.1 60.2 1.0 3.2 1.9 0.0 0.6 3.6 2.2 10.9 7.4 0.0 0.1 0.9 0.9 1.5 0.9 0.0 0.0 0.1 93.9 0.0 0.0 0.0 6.2 0.1 0.2 0.6 0.0 0.8 0.1 0.2 0.3 1.7 0.5 0.0 2.5 0.0 1.8 0.3 0.2 0.0 0.1 0.0 0.0 0.8 0.3 2.3 0.0 0.6 0.0 2.8 1.2 0.0 164.8 0.0 26.6 0.2 0.0 0.0 14.7 0.2 0.0 0.1 0.4 0.0 0.0 0.1 1.9 0.0 0.2 4.8 5.1 0.1 33.1 0.0 0.0 0.4 SALL3 ZNF796 ENSG00000256463 "Spalt like transcription factor 3" Q9BXA9 18 78980275-79002677 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.4;prostate: 6.0;vagina: 8.0" "Cell type enhanced" "Detected in some" "Astrocytes: 25.5;Bipolar cells: 14.7;Cone photoreceptor cells: 47.9;Horizontal cells: 25.2;Oligodendrocyte precursor cells: 21.1" "Cancer enriched" "Detected in some" 6 "glioma: 6.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.7;HEK 293: 2.7;NTERA-2: 9.5;SuSa: 1.6" "Region enriched" "Detected in many" 4 "olfactory bulb: 12.5" "Low region specificity" "Detected in many" HPA016656 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 62: Horizontal cells - Visual perception" "HPA016656: AB_1856546" "unprognostic (3.96e-2)" "unprognostic (3.41e-3)" "unprognostic (8.16e-2)" "unprognostic (1.87e-2)" "unprognostic (2.37e-1)" "unprognostic (4.23e-1)" "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-1)" "unprognostic (5.86e-3)" 0.0 0.0 5.7 0.0 6.2 0.0 0.0 5.8 5.7 1.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 5.2 8.2 3.3 0.0 0.0 0.0 9.0 6.5 0.0 0.0 0.0 1.2 0.0 7.2 6.0 0.0 1.8 0.7 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 1.3 6.3 0.0 0.0 0.0 0.0 0.4 8.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 6.2 5.8 5.7 5.2 8.2 9.0 6.5 7.2 9.4 6.3 7.5 0.2 0.0 0.0 25.5 0.0 0.0 7.4 0.0 0.0 14.7 0.0 0.1 1.8 0.0 0.0 1.8 47.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 25.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 4.8 0.0 0.0 0.0 0.0 8.4 0.0 0.1 0.0 1.8 6.6 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 SAMD10 C20orf136 ENSG00000130590 "Sterile alpha motif domain containing 10" Q9BYL1 20 63974116-63980008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.6;T-cells: 3.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040973 Approved Approved Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA040973: AB_10794258" "unprognostic (5.89e-3)" "unprognostic (1.16e-3)" "unprognostic (6.27e-2)" "unprognostic (3.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.84e-3)" "prognostic unfavorable (4.60e-4)" "unprognostic (2.69e-2)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.96e-2)" "unprognostic (1.08e-1)" "unprognostic (5.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.20e-1)" "unprognostic (1.28e-1)" "unprognostic (6.94e-3)" 1.6 3.4 6.8 4.0 9.4 2.4 2.9 11.6 10.0 2.9 4.2 3.9 4.3 0.8 1.6 13.8 3.3 2.2 4.5 6.4 5.3 8.9 5.7 2.7 6.6 5.0 4.9 0.4 5.2 3.0 3.5 1.9 5.1 5.5 2.1 3.1 5.6 1.6 1.1 7.7 5.4 0.8 4.3 6.5 6.2 3.5 6.7 4.2 3.7 1.0 6.2 3.7 5.9 5.9 8.2 0.0 2.6 0.2 0.6 0.8 0.1 2.6 2.1 5.2 2.4 7.8 15.5 0.5 5.3 1.3 0.3 11.0 2.6 3.2 2.6 16.6 5.4 2.7 8.8 11.8 1.1 13.8 21.3 0.7 5.8 2.8 0.5 3.7 2.4 5.7 6.7 6.5 1.0 6.3 6.2 12.8 4.2 11.7 12.3 8.7 0.1 14.6 8.6 14.1 2.9 6.2 1.8 14.9 3.4 1.1 10.1 6.8 2.3 1.6 3.7 0.1 0.4 1.3 1.0 4.7 5.0 11.0 1.5 0.0 0.1 0.3 2.7 0.1 1.4 1.6 1.7 1.6 0.3 0.6 3.1 3.4 0.0 0.6 0.3 0.5 1.4 1.1 6.8 9.4 11.6 10.0 6.4 5.3 5.0 4.9 5.1 4.3 6.7 5.9 1.9 3.2 0.0 5.2 3.5 1.0 2.3 3.9 0.0 5.7 4.9 4.3 2.4 0.0 3.6 9.2 2.1 3.0 5.1 2.5 1.9 3.2 0.0 2.3 0.4 1.9 4.9 2.1 5.1 3.4 0.5 0.3 5.1 3.3 0.0 3.3 2.5 1.1 1.2 0.0 5.8 4.4 4.1 1.0 0.4 0.2 0.0 0.9 1.8 0.0 2.1 2.9 8.2 1.5 0.0 8.4 1.8 0.0 0.5 3.0 4.1 3.5 3.0 3.3 0.0 0.1 0.9 0.5 1.3 6.4 1.8 2.7 4.7 0.4 2.5 3.9 SAMD12 FLJ39458 ENSG00000177570 "Sterile alpha motif domain containing 12" Q8N8I0 8 118189455-118622112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Excitatory neurons: 537.6;Inhibitory neurons: 531.7;Oligodendrocytes: 1158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 34.6;U-266/70: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024634 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Cytosol" "HPA024634: AB_1856549" "unprognostic (6.96e-2)" "unprognostic (9.35e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (4.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-1)" "prognostic favorable (1.52e-6)" "unprognostic (3.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (6.35e-3)" 0.7 1.4 2.4 1.1 4.9 0.4 3.0 0.7 8.8 2.3 0.0 4.0 3.7 1.1 4.0 4.1 5.3 3.6 6.9 7.5 0.8 5.2 1.6 4.2 0.7 1.4 0.5 0.9 1.9 9.6 3.3 0.1 2.6 3.7 4.7 5.9 2.4 5.0 0.8 0.8 2.0 0.7 0.9 2.6 5.7 1.3 2.1 1.0 10.2 0.1 2.0 4.4 1.1 8.4 10.2 0.7 0.9 0.0 0.0 0.0 2.1 3.4 10.4 7.8 4.3 1.1 12.1 3.4 0.8 8.2 1.6 1.9 2.0 4.7 11.9 0.1 1.1 0.0 5.7 0.0 0.0 0.0 0.2 0.0 2.3 4.6 0.4 2.8 0.2 5.9 0.0 6.0 6.0 2.0 1.6 0.0 0.8 13.2 1.3 0.0 0.0 9.7 5.4 13.5 4.0 0.0 2.8 34.6 0.0 2.1 0.5 0.0 0.0 0.1 3.8 1.4 1.2 14.9 10.2 0.4 1.8 0.0 1.1 0.1 0.0 0.0 0.1 0.0 1.0 1.5 0.8 0.5 0.0 1.0 1.0 0.6 0.1 0.6 0.0 0.3 0.8 0.2 2.4 4.9 0.7 8.8 7.5 0.8 1.4 0.5 2.6 0.9 2.1 8.4 4.7 112.2 95.0 53.5 8.0 1.7 10.1 10.3 13.1 16.8 10.9 5.1 12.1 12.8 57.5 29.5 43.8 0.0 3.3 10.5 19.6 12.9 5.2 12.1 1.5 13.0 14.3 2.1 537.6 12.4 0.1 9.1 26.5 16.4 56.8 4.4 7.5 5.2 0.1 30.3 531.7 11.2 14.2 0.3 0.0 6.1 0.3 6.5 7.2 163.0 0.7 4.5 4.1 122.6 1158.0 13.0 3.5 0.4 16.9 5.0 8.6 17.4 68.0 26.9 0.0 0.5 0.9 0.5 2.4 15.9 1.7 0.0 8.9 4.5 11.9 13.6 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062127-137070557 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.1;esophagus: 8.5;skin 1: 6.2" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 122.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 0.5 0.3 6.9 2.4 5.1 2.0 1.3 4.7 5.4 1.2 1.3 3.7 4.3 0.4 0.0 8.5 0.3 0.2 0.2 5.4 4.5 1.2 0.2 0.5 2.7 7.1 6.8 0.1 0.4 0.0 0.5 0.9 5.7 3.1 1.8 0.1 4.1 0.1 0.1 6.2 4.3 0.4 5.0 2.2 2.4 0.5 6.8 2.3 0.3 0.0 2.5 0.4 2.3 7.0 52.1 27.5 10.7 32.0 0.3 0.7 57.1 8.4 5.7 8.8 4.1 52.5 23.2 53.8 26.5 4.1 8.2 72.3 33.6 9.7 2.0 37.4 38.9 23.6 32.7 59.6 0.2 27.0 39.2 0.1 1.5 3.0 5.8 2.3 14.4 27.1 33.1 23.7 2.6 122.1 7.8 72.7 19.9 119.2 61.9 82.9 40.7 60.1 10.9 14.8 55.2 32.7 32.2 89.1 12.2 2.4 71.9 51.1 9.4 7.9 26.6 24.0 41.9 8.2 25.5 26.3 18.4 31.8 25.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 5.1 4.7 5.4 5.4 4.5 7.1 6.8 5.7 5.0 6.8 7.0 0.5 0.0 0.0 0.7 1.9 4.2 0.7 0.5 0.6 0.2 5.0 5.2 1.3 0.0 1.1 0.0 0.0 2.8 1.6 5.4 1.9 0.3 0.0 1.6 0.8 0.9 0.0 3.6 0.2 0.0 3.5 1.1 6.1 6.0 0.0 3.3 1.4 0.0 3.1 0.0 0.2 10.8 0.0 2.8 1.5 0.1 0.0 2.2 0.0 0.0 1.5 0.5 0.0 29.7 5.6 0.6 4.0 0.0 1.8 2.1 0.5 0.0 0.1 0.6 0.0 0.2 1.0 0.0 1.4 5.8 2.7 0.5 1.3 0.6 12.1 1.1 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905372-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favorable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 23.2 27.4 31.1 15.5 39.9 11.4 25.4 41.3 33.3 28.1 33.6 23.3 19.8 26.0 17.5 39.9 38.3 19.5 15.5 28.9 33.1 34.4 28.3 25.5 15.6 51.5 42.9 27.1 36.5 15.8 31.8 18.8 47.7 31.7 9.8 7.4 43.9 20.4 13.9 36.3 20.3 12.3 39.7 25.1 26.4 22.0 40.6 8.3 32.7 5.8 9.4 22.0 25.0 53.5 53.6 53.9 25.7 56.8 50.7 31.7 29.6 35.5 33.1 39.3 46.7 44.9 51.1 22.5 32.1 30.7 23.1 63.7 24.7 38.2 14.5 34.8 21.7 15.8 19.0 44.3 65.6 16.9 23.2 48.8 24.2 34.8 21.2 32.9 27.2 25.2 35.7 25.3 23.3 67.8 21.5 31.6 38.8 31.1 18.6 25.9 18.1 34.6 49.8 47.5 33.8 45.0 23.9 49.9 31.4 18.1 50.6 41.5 29.6 44.8 30.5 81.1 35.7 57.8 62.6 21.0 59.1 26.9 30.1 1.7 4.4 1.9 3.9 4.9 2.0 5.1 2.7 2.6 4.8 3.4 1.5 2.9 2.1 5.8 4.5 12.0 2.3 3.7 31.1 39.9 41.3 33.3 28.9 33.1 51.5 42.9 47.7 39.7 40.6 53.5 16.9 9.6 7.3 12.1 22.9 17.1 25.0 20.8 33.0 19.7 40.0 23.5 3.0 21.5 14.1 49.7 75.0 40.0 59.6 53.0 7.9 20.8 0.8 63.2 23.2 17.8 18.7 11.6 8.3 12.5 38.1 18.2 43.3 42.1 17.2 27.8 15.7 13.4 38.0 21.9 8.0 36.1 20.3 20.1 24.9 1.9 21.8 24.2 21.4 5.6 21.0 29.6 33.0 16.6 18.9 16.1 25.3 17.3 16.0 30.0 47.6 10.1 33.2 52.2 0.0 15.8 15.7 19.0 26.1 30.8 20.2 59.0 20.4 26.9 31.1 28.1 SEMA4A "CORD10, FLJ12287, SEMAB, SemB" ENSG00000196189 "Semaphorin 4A" Q9H3S1 1 156147366-156177752 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Angiogenesis, Differentiation, Immunity, Neurogenesis" "Developmental protein" "Cone-rod dystrophy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 51.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 63.7;Plasma cells: 61.2;Skeletal myocytes: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 123.9;eosinophil: 120.2;intermediate monocyte: 132.7;myeloid DC: 183.0;neutrophil: 210.7;non-classical monocyte: 76.1" "Group enriched" "Detected in all" 13 "dendritic cells: 183.0;granulocytes: 210.7;monocytes: 132.7" "Cell line enhanced" "Detected in many" "Karpas-707: 151.8;U-698: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069136 Supported NA NA 3300000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA069136: AB_2686093" "unprognostic (1.90e-1)" "unprognostic (2.39e-2)" "unprognostic (4.24e-1)" "unprognostic (5.20e-2)" "unprognostic (8.04e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (3.51e-1)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (8.20e-4)" "unprognostic (8.77e-2)" "unprognostic (4.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.28e-2)" 6.1 1.0 22.7 24.8 21.5 37.5 9.1 6.1 23.2 10.8 4.7 6.9 3.6 3.0 51.3 32.5 7.9 8.8 3.0 25.3 23.0 18.1 2.1 15.2 31.5 12.2 15.5 5.2 4.0 1.5 3.6 1.8 15.3 16.3 6.1 2.0 19.2 12.5 3.1 32.3 4.8 3.6 11.4 26.9 10.6 4.1 29.0 8.1 23.1 2.2 33.1 10.8 17.4 13.1 12.6 0.0 0.5 0.0 0.0 0.9 0.3 0.2 0.4 0.1 0.2 0.1 0.3 8.1 0.3 0.6 0.1 11.7 0.9 10.0 0.4 3.5 0.0 0.4 0.2 0.4 0.4 18.5 1.1 0.6 9.2 0.2 0.4 2.3 0.9 2.8 1.3 151.8 0.5 15.2 0.1 6.5 3.6 12.4 0.0 0.6 0.3 5.4 17.9 24.1 0.1 0.3 0.0 19.2 1.0 1.7 22.3 23.3 0.9 0.0 0.1 0.0 0.0 29.3 3.0 67.6 0.5 17.5 0.4 16.0 123.9 120.2 4.0 132.7 8.5 13.2 1.3 8.0 183.0 10.9 0.2 1.3 210.7 4.3 76.1 25.7 1.4 66.4 22.7 21.5 6.1 23.2 25.3 23.0 12.2 15.5 15.3 11.4 29.0 13.1 13.6 19.2 63.7 25.8 13.9 23.5 22.5 25.8 24.5 1.9 28.3 27.6 5.9 14.3 13.8 40.5 0.0 0.9 9.8 6.5 1.9 6.1 6.4 12.9 21.6 9.5 3.6 1.3 7.5 0.7 0.4 20.9 22.4 33.5 17.7 0.6 9.3 0.6 15.4 0.0 5.2 24.1 8.2 22.8 42.1 4.3 1.8 37.8 16.0 1.0 32.6 6.3 2.1 1.0 1.0 1.1 7.2 1.2 61.2 14.2 0.8 0.7 9.6 0.4 0.0 100.1 11.3 3.1 0.7 39.0 27.6 1.8 10.0 1.4 17.6 15.6 SEPTIN5 "H5, HCDCREL-1, PNUTL1, SEPT5" ENSG00000184702 "Septin 5" Q99719 22 19714503-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 321.9" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 3.4;Smooth muscle cells: 2.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 32 "eosinophil: 15.4;neutrophil: 5.8" "Lineage enriched" "Detected in single" 47 "granulocytes: 15.4" "Cell line enhanced" "Detected in many" "K-562: 281.6;THP-1: 75.9" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 860000 "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Actin filaments, Cytosol" "CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141" "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 17.7 17.7 152.8 5.7 215.6 41.0 16.4 49.2 321.9 54.1 61.9 19.8 5.2 28.1 46.2 62.1 38.8 14.7 165.4 233.6 49.3 12.7 5.2 17.4 8.4 40.9 45.2 29.3 17.0 127.3 82.7 12.0 39.4 20.1 6.3 30.3 15.9 9.9 10.8 126.5 8.8 17.3 24.7 14.3 16.3 29.1 73.1 15.9 33.4 16.2 8.1 13.5 42.8 168.6 0.4 10.6 42.0 64.0 3.9 13.1 0.3 15.8 20.1 17.9 10.5 0.7 5.6 1.5 6.1 35.8 26.0 6.0 30.2 6.0 8.8 9.6 3.4 0.7 2.4 0.2 16.2 0.8 47.2 17.4 7.4 6.0 2.5 5.1 7.5 23.1 281.6 0.6 28.2 4.2 4.6 31.2 5.4 1.0 10.4 41.4 1.3 7.2 1.3 1.4 62.3 49.2 2.4 3.5 2.8 10.2 17.3 75.9 3.0 46.4 55.6 2.0 3.2 4.5 0.0 0.4 5.8 2.2 15.2 0.0 0.1 15.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.8 0.0 0.0 0.3 0.0 6.0 152.8 215.6 49.2 321.9 233.6 49.3 40.9 45.2 39.4 24.7 73.1 168.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SETD4 "C21orf18, C21orf27" ENSG00000185917 "SET domain containing 4" Q9NVD3 21 36034541-36079389 "Predicted intracellular proteins" "Inflammatory response" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 54.3;Spermatocytes: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024073, HPA035405" Approved Approved "Nuclear speckles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA024073: AB_1856755, HPA035405: AB_2674612" "unprognostic (4.23e-1)" "unprognostic (5.67e-2)" "unprognostic (6.98e-2)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (8.05e-3)" "unprognostic (7.86e-2)" "unprognostic (2.13e-3)" "unprognostic (2.17e-2)" "unprognostic (5.81e-2)" "unprognostic (1.33e-1)" "unprognostic (4.60e-3)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "unprognostic (8.09e-3)" "unprognostic (3.30e-2)" "unprognostic (1.28e-2)" 8.8 9.3 9.1 6.9 9.9 8.4 9.1 9.4 10.4 10.2 15.8 9.5 11.4 9.7 11.1 10.9 10.8 7.8 10.1 9.4 10.5 9.7 7.2 8.4 8.7 9.0 8.3 9.7 7.8 10.0 8.9 9.0 9.5 10.2 9.4 9.6 10.0 7.9 9.8 13.6 9.3 10.9 8.4 8.5 9.9 23.1 9.9 11.1 10.1 8.8 10.9 9.9 10.7 12.1 13.3 9.2 13.6 17.3 6.5 7.9 21.9 17.1 15.0 17.3 11.5 19.2 11.5 7.1 11.9 7.8 13.3 9.7 10.3 10.2 15.0 12.7 12.4 19.2 16.2 12.6 15.9 18.3 10.7 8.3 17.2 11.7 15.0 9.8 13.1 9.6 25.5 12.7 10.7 14.3 12.3 26.3 28.2 11.3 11.6 18.2 10.0 17.3 18.9 9.3 11.2 17.9 17.4 18.5 17.6 11.7 16.3 15.2 11.0 15.0 5.6 9.4 15.9 20.3 31.7 11.2 15.6 24.9 13.2 5.9 12.5 11.3 8.1 10.0 9.0 16.2 10.3 8.8 14.6 13.2 7.3 8.6 9.5 11.0 10.2 15.6 13.0 7.7 9.1 9.9 9.4 10.4 9.4 10.5 9.0 8.3 9.5 8.4 9.9 12.1 9.7 9.6 7.0 11.1 10.8 12.1 11.3 18.6 15.4 13.3 9.0 8.9 9.2 7.2 13.7 9.2 31.3 16.3 13.4 7.9 5.9 12.7 54.3 16.8 10.9 9.3 3.6 7.2 17.4 8.2 9.6 10.4 8.6 8.7 11.4 17.0 7.5 5.5 10.6 3.3 19.2 13.4 26.4 6.9 5.1 10.4 9.6 5.0 10.6 4.7 8.0 7.6 14.4 19.6 19.8 10.0 9.4 10.1 6.2 11.2 20.7 10.3 23.8 21.0 6.6 8.9 9.0 63.1 20.8 13.2 9.1 9.4 8.1 14.8 11.3 11.3 SGPP2 "FLJ39004, SPP2" ENSG00000163082 "Sphingosine-1-phosphate phosphatase 2" Q8IWX5 2 222424543-222562621 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 33.0;Excitatory neurons: 43.5;Glandular and luminal cells: 54.2;Microglial cells: 48.7;Urothelial cells: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.2;EFO-21: 13.0;hTCEpi: 52.6;RPTEC TERT1: 59.0;SCLC-21H: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.56e-3)" "unprognostic (1.79e-1)" "unprognostic (8.50e-2)" "unprognostic (2.97e-2)" "unprognostic (1.24e-3)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.31e-2)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "prognostic favorable (1.28e-4)" "unprognostic (3.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.74e-2)" "unprognostic (2.69e-2)" 2.8 6.1 11.1 4.0 12.8 1.4 5.3 15.0 15.3 13.3 2.1 17.3 17.3 2.7 3.8 21.4 13.2 11.5 5.2 11.0 13.7 16.4 0.4 8.0 3.9 17.9 10.9 0.5 3.1 26.8 5.9 0.1 17.6 1.5 18.1 3.6 7.9 7.6 0.8 22.4 18.2 1.4 9.7 1.0 25.1 1.6 15.2 5.3 21.2 0.0 15.2 22.3 10.0 9.8 1.4 1.1 0.4 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 16.2 0.6 13.0 0.0 0.2 0.3 0.2 0.1 0.0 0.3 4.6 1.0 0.4 0.0 0.0 1.7 0.8 0.0 52.6 0.0 0.2 0.0 0.0 0.7 0.3 0.6 0.0 0.8 0.4 1.2 0.5 10.6 0.4 0.7 0.4 0.6 59.0 3.7 16.5 0.6 0.0 1.9 0.1 0.8 0.2 0.1 0.0 0.2 0.5 0.6 0.5 0.5 0.4 1.0 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 11.1 12.8 15.0 15.3 11.0 13.7 17.9 10.9 17.6 9.7 15.2 9.8 0.1 3.2 11.5 1.3 2.2 3.7 4.4 29.1 4.6 5.3 1.6 1.5 6.9 7.2 26.2 12.9 6.2 0.1 0.6 20.2 1.9 14.5 9.7 33.0 4.8 1.5 1.2 0.0 43.5 1.8 0.3 1.4 25.5 54.2 0.0 0.4 0.0 0.1 0.2 1.7 15.8 5.5 14.2 0.0 1.1 3.7 0.6 0.8 0.0 48.7 0.1 0.7 1.0 2.5 1.1 9.3 16.3 0.4 2.3 7.5 13.1 0.5 20.4 5.9 0.0 2.1 1.7 3.1 1.0 26.3 14.3 2.5 2.5 0.3 9.9 39.4 SH3GLB2 KIAA1848 ENSG00000148341 "SH3 domain containing GRB2 like, endophilin B2" Q9NR46 9 129007036-129028331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 127.9;Syncytiotrophoblasts: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 234.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021438, HPA024734" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol Nucleoplasm "HPA021438: AB_1856820, HPA024734: AB_1856821" "unprognostic (2.59e-1)" "prognostic favorable (1.56e-6)" "unprognostic (1.88e-1)" "unprognostic (7.51e-2)" "unprognostic (2.94e-1)" "unprognostic (1.09e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (5.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.81e-2)" "unprognostic (6.25e-2)" "prognostic favorable (2.32e-4)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-3)" "prognostic favorable (4.28e-4)" 32.7 49.1 86.7 19.2 93.6 59.4 46.0 69.4 127.6 60.5 63.5 56.3 42.1 47.9 17.1 101.4 52.7 22.0 32.4 95.0 74.5 63.9 25.3 35.4 24.9 81.3 71.1 45.2 71.5 69.1 88.4 37.7 82.2 71.8 16.1 11.7 60.8 50.2 50.0 116.7 47.9 18.5 68.8 42.1 71.2 24.4 78.0 37.2 45.9 19.0 22.6 72.6 66.8 93.1 49.7 41.2 19.9 27.1 11.7 14.8 59.2 17.0 37.8 33.0 30.0 25.8 83.2 51.9 13.3 30.1 25.5 119.2 6.3 36.7 9.3 34.0 27.5 13.2 70.5 22.9 24.4 11.9 30.7 10.6 41.1 16.8 14.9 36.2 28.0 66.8 17.8 67.2 16.9 121.5 68.4 31.5 17.8 83.2 28.7 136.3 37.2 234.3 36.7 59.1 62.0 50.3 24.7 62.6 26.3 16.4 90.5 17.5 25.8 15.3 26.1 39.3 37.7 65.6 34.0 33.8 35.6 14.7 8.3 2.1 1.6 3.5 1.9 0.8 2.3 3.5 2.2 1.8 1.3 2.0 1.6 1.3 1.3 2.6 2.5 3.7 2.0 1.5 86.7 93.6 69.4 127.6 95.0 74.5 81.3 71.1 82.2 68.8 78.0 93.1 36.3 16.0 28.4 28.1 20.3 20.8 27.5 11.6 9.6 26.9 59.7 62.9 10.6 18.6 19.8 47.8 8.4 127.9 29.4 58.2 15.6 14.5 11.2 36.3 19.6 15.6 25.3 29.5 24.4 26.0 19.2 23.3 84.6 63.6 6.3 29.9 12.1 9.9 20.7 47.1 14.2 35.9 12.2 11.9 11.6 24.4 19.0 14.3 14.2 17.8 6.9 36.0 6.2 23.6 95.6 24.6 50.3 20.3 25.9 23.0 39.4 7.6 21.5 20.6 13.1 32.0 39.7 8.6 6.6 27.6 53.6 149.5 16.3 18.3 34.6 58.3 SLC16A14 "FLJ30794, MCT14" ENSG00000163053 "Solute carrier family 16 member 14" Q7RTX9 2 230034982-230068993 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 18.6" "Cell type enhanced" "Detected in many" "Adipocytes: 17.0;Excitatory neurons: 18.5;Inhibitory neurons: 21.1;Microglial cells: 45.0;Oligodendrocyte precursor cells: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 24 "eosinophil: 11.3" "Lineage enriched" "Detected in single" 24 "granulocytes: 11.3" "Cell line enhanced" "Detected in many" "HL-60: 24.2;Karpas-707: 15.2;REH: 19.5;RPMI-8226: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040518 Uncertain Approved "Endoplasmic reticulum" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Endoplasmic reticulum" "HPA040518: AB_10794877" "unprognostic (2.99e-1)" "unprognostic (1.74e-1)" "unprognostic (2.63e-1)" "unprognostic (1.74e-3)" "unprognostic (2.20e-3)" "unprognostic (2.01e-1)" "unprognostic (4.96e-2)" "unprognostic (1.95e-1)" "unprognostic (3.15e-1)" "unprognostic (5.70e-3)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.03e-3)" "unprognostic (3.51e-1)" "unprognostic (2.39e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" 4.6 3.9 7.9 1.7 7.2 5.6 3.2 8.9 7.7 5.0 2.4 3.7 1.0 3.9 2.3 4.0 3.1 2.8 2.4 7.1 7.2 2.3 2.0 1.9 1.3 5.2 6.1 7.3 0.8 7.0 1.4 1.2 4.7 4.5 4.0 2.5 18.6 3.6 1.0 11.0 1.3 3.8 3.8 5.9 1.4 1.2 9.4 2.2 1.5 2.0 1.5 2.0 2.7 4.7 2.9 1.6 1.3 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.4 0.0 0.5 0.0 0.3 0.1 0.0 0.5 5.1 1.4 0.1 0.0 9.7 0.2 3.1 0.0 0.3 24.2 0.0 0.5 3.6 0.0 0.0 3.9 0.2 4.7 0.0 15.2 0.3 0.0 2.4 2.7 1.0 0.3 2.7 19.5 0.0 17.3 5.6 2.6 6.3 2.3 4.9 0.0 0.1 0.1 7.7 1.9 0.0 0.0 1.3 3.3 2.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 11.3 0.4 0.0 0.3 0.3 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.9 7.2 8.9 7.7 7.1 7.2 5.2 6.1 4.7 3.8 9.4 4.7 17.0 0.0 0.0 2.3 1.5 2.5 0.5 1.9 3.4 3.3 1.2 0.8 3.9 0.0 3.5 0.0 2.1 0.0 0.1 1.8 0.0 0.8 0.0 0.5 2.6 10.8 3.6 0.0 18.5 0.6 0.0 2.3 0.0 0.3 0.0 0.2 4.2 2.1 0.1 3.3 21.1 0.3 4.1 0.3 0.6 0.0 1.2 0.1 1.8 45.0 0.0 1.9 0.0 13.6 1.8 0.8 1.0 3.0 8.4 0.9 0.0 0.3 1.6 1.6 0.0 0.5 1.4 0.2 0.2 6.8 4.7 0.3 1.4 8.4 1.3 0.3 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925353-42958893 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease variant, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 98.7;skin 1: 79.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 833.8;Erythroid cells: 520.4;Extravillous trophoblasts: 536.4;Syncytiotrophoblasts: 2482.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 241.0;CACO-2: 219.9;Hep G2: 157.4" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" No No 2000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane" "CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734" "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavorable (3.65e-8)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.05e-4)" 6.9 3.6 24.1 2.5 26.1 41.6 7.8 33.7 27.7 28.6 43.6 6.1 0.4 5.1 1.4 54.1 8.2 1.7 10.0 20.6 28.5 14.2 1.7 3.3 1.0 31.9 29.3 5.5 2.1 4.5 4.8 98.7 34.5 6.0 1.0 24.6 17.6 5.1 2.0 79.8 4.6 0.4 24.7 7.5 8.4 2.1 41.2 1.0 3.0 1.5 2.1 19.3 54.2 29.4 60.5 52.9 66.3 6.2 3.5 1.2 241.0 47.8 36.9 15.5 27.8 219.9 96.3 22.2 138.9 6.0 26.5 43.6 12.5 52.3 14.8 16.4 10.3 29.8 20.9 157.4 12.9 16.8 8.1 3.3 21.3 18.3 20.5 96.7 2.9 12.8 81.2 1.5 11.7 46.6 7.4 11.7 35.1 22.1 17.9 8.4 20.6 23.3 21.7 17.9 27.0 23.8 47.7 95.6 11.0 70.0 3.8 16.9 14.9 25.6 28.6 6.1 83.8 5.3 6.5 11.5 57.1 8.2 25.5 0.5 0.1 1.2 10.6 0.3 8.5 10.9 5.1 6.7 3.7 8.3 3.8 4.8 0.2 4.3 0.1 18.4 6.2 4.0 24.1 26.1 33.7 27.7 20.6 28.5 31.9 29.3 34.5 24.7 41.2 29.4 3.1 0.0 1.8 12.7 25.4 286.1 48.8 286.3 66.0 15.8 41.4 21.8 26.7 20.0 159.3 27.6 66.7 833.8 33.5 53.1 5.9 53.2 4.0 112.1 46.0 100.5 18.4 520.4 2.8 11.7 536.4 25.9 11.7 118.9 6.3 6.8 2.2 2.1 84.8 5.0 3.2 22.4 65.1 1.6 34.2 0.3 7.8 5.0 21.4 71.2 36.0 350.1 18.6 8.0 9.9 120.3 51.9 14.7 11.6 31.2 1.9 2.2 118.1 32.1 0.0 9.8 32.1 0.1 2.4 99.1 238.3 2482.5 20.8 5.5 11.8 105.8 SLC44A5 "CTL5, MGC34032" ENSG00000137968 "Solute carrier family 44 member 5" Q8NCS7 1 75202131-75611116 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 10.7" "Group enriched" "Detected in many" 4 "Excitatory neurons: 274.5;Inhibitory neurons: 563.3;Oligodendrocyte precursor cells: 265.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 7.7;RPTEC TERT1: 7.4;SH-SY5Y: 11.5;SuSa: 11.7;TIME: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047455, HPA051011" Uncertain Approved Cytosol NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA047455: AB_2680054, HPA051011: AB_2681309" "unprognostic (9.00e-2)" "unprognostic (1.91e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-3)" "unprognostic (4.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (5.78e-3)" "unprognostic (6.41e-2)" "unprognostic (9.19e-2)" "prognostic unfavorable (6.52e-4)" "unprognostic (1.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" "unprognostic (4.30e-1)" 0.3 0.7 1.5 0.5 1.9 0.3 5.5 0.0 3.4 1.1 0.0 2.1 1.2 0.7 0.4 6.6 3.6 1.0 2.5 2.3 1.7 2.0 1.0 0.6 0.5 2.6 1.6 1.1 1.7 3.7 3.1 3.8 2.8 0.8 2.7 2.5 1.4 0.2 1.6 10.7 1.4 0.2 2.0 0.8 1.5 4.5 2.3 2.5 0.7 1.5 2.1 1.6 2.0 1.2 0.2 0.2 4.6 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.7 0.0 0.0 2.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.7 0.6 1.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.4 2.7 2.7 0.0 0.0 1.9 0.0 4.7 3.2 0.6 0.0 0.0 2.3 7.4 5.2 1.1 11.5 0.0 4.8 0.0 11.7 0.2 0.0 14.7 0.4 1.3 0.0 1.5 2.1 2.1 3.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.5 1.9 0.0 3.4 2.3 1.7 2.6 1.6 2.8 2.0 2.3 1.2 0.1 0.0 1.1 12.4 0.4 1.9 1.0 0.4 0.0 4.0 2.9 1.7 0.8 0.0 1.0 0.0 0.0 9.1 0.0 2.0 0.0 0.1 86.9 1.0 0.1 0.6 2.4 0.0 274.5 0.9 3.9 0.4 0.0 0.3 0.0 20.1 7.5 0.0 1.1 0.0 563.3 1.0 0.0 0.0 0.2 35.2 0.9 0.1 0.0 6.5 0.0 0.0 0.0 265.4 10.1 0.2 0.2 0.0 0.1 1.1 0.0 0.1 2.5 0.8 0.0 0.6 0.2 0.4 0.4 0.9 6.7 3.8 0.1 0.5 1.2 3.6 SLC45A2 "AIM-1, MATP, OCA4" ENSG00000164175 "Solute carrier family 45 member 2" Q9UMX9 5 33944623-33984693 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Sensory transduction, Vision" "Albinism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 1.2;skin 1: 1.0;testis: 1.0" "Cell type enhanced" "Detected in some" "Early spermatids: 3.1;Excitatory neurons: 4.1;Inhibitory neurons: 5.4;Late spermatids: 5.1;Melanocytes: 12.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 4.7" "Cancer enriched" "Detected in some" 18 "melanoma: 47.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 28 "SK-MEL-30: 60.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.97e-1)" "unprognostic (3.99e-2)" "unprognostic (3.55e-1)" "unprognostic (2.39e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (8.45e-2)" "unprognostic (5.34e-3)" "unprognostic (4.06e-2)" "unprognostic (8.45e-2)" "unprognostic (7.39e-4)" "unprognostic (1.40e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.39e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.2 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 60.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.2 0.4 0.1 0.0 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.6 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.1 0.3 0.1 0.3 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.4 5.1 0.0 0.0 12.4 0.0 0.0 0.1 0.0 2.5 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.1 0.0 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.4;skin 1: 46.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3" "Cancer enhanced" "Detected in all" "glioma: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 62.3;hTCEpi: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 3.9 31.0 21.7 4.9 45.5 10.8 4.6 53.2 24.2 12.1 6.3 11.0 2.3 7.4 1.1 23.1 9.5 4.8 2.1 16.1 31.3 4.3 2.3 11.6 1.1 66.3 43.5 2.9 8.2 2.8 1.7 1.4 63.6 3.9 6.3 17.2 11.5 5.5 1.1 46.6 6.0 9.1 45.6 1.9 7.4 1.1 45.9 1.4 5.3 0.6 4.3 12.3 25.1 72.4 19.7 13.7 7.1 18.0 11.2 3.7 15.6 14.7 41.0 24.3 30.1 4.8 7.5 0.3 1.6 42.9 0.0 62.3 11.0 12.5 5.0 0.1 1.8 17.1 33.9 5.8 50.3 3.8 0.7 11.3 106.6 11.9 28.5 15.3 0.6 12.3 13.0 48.5 1.0 10.4 2.9 0.1 5.4 7.4 19.1 2.2 0.0 22.9 2.3 2.2 4.4 4.2 7.4 35.3 7.0 1.7 9.1 10.3 0.2 2.8 11.0 2.4 8.0 53.1 39.2 4.4 9.2 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 45.5 53.2 24.2 16.1 31.3 66.3 43.5 63.6 45.6 45.9 72.4 1.5 0.0 2.0 5.9 1.1 7.5 0.9 3.2 8.0 30.7 2.2 0.9 0.7 4.3 2.2 1.8 16.7 0.5 0.5 17.8 0.0 3.7 5.9 4.8 0.4 0.7 0.0 33.1 2.2 8.9 1.0 0.9 1.5 2.7 0.0 0.0 0.0 0.3 0.3 1.7 1.5 2.7 20.3 0.0 1.0 0.8 1.5 0.1 3.6 0.0 1.0 1.2 0.0 3.0 16.4 4.2 3.0 1.5 1.3 2.0 9.1 1.1 12.5 11.1 6.6 0.1 10.0 0.1 0.4 8.9 12.9 0.5 0.3 1.2 2.6 3.2 SLC7A1 "ATRC1, CAT-1, ERR, HCAT1, REC1L" ENSG00000139514 "Solute carrier family 7 member 1" P30825 13 29509414-29595688 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 235.6;Microglial cells: 162.1;Squamous epithelial cells: 175.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039721, HPA077838" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA039721: AB_10672893, HPA077838: " "unprognostic (1.85e-1)" "unprognostic (1.04e-3)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (1.36e-3)" "unprognostic (2.02e-3)" "unprognostic (4.98e-2)" "unprognostic (1.23e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.20e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (7.37e-3)" 6.2 6.0 34.8 10.7 21.9 11.3 7.7 28.6 31.1 8.5 24.4 10.1 10.2 8.4 10.2 55.1 7.4 4.5 7.5 31.0 25.9 6.6 2.0 4.9 8.6 40.5 27.6 2.8 30.5 4.5 7.5 3.0 41.4 7.7 7.4 9.0 16.1 9.2 2.1 17.7 14.8 9.1 33.9 5.9 11.3 6.9 39.5 7.8 9.6 1.7 10.4 11.0 11.1 27.6 42.2 33.2 28.7 58.0 14.5 28.6 32.6 87.8 58.3 74.2 55.0 68.0 72.1 82.9 23.3 134.5 82.8 188.0 50.4 62.2 97.1 78.3 30.1 62.1 36.3 37.0 75.0 91.6 39.4 36.6 129.4 82.6 96.9 17.4 37.1 92.8 40.5 37.6 31.5 56.5 67.2 24.6 27.5 74.2 22.1 45.7 59.1 48.3 47.2 27.5 97.3 46.3 50.0 48.3 79.4 17.9 21.3 76.6 35.1 58.2 40.6 51.6 63.6 42.1 33.1 93.8 46.4 36.3 60.1 0.0 0.4 0.1 1.0 0.4 0.8 0.6 0.7 0.8 0.6 0.4 0.5 0.9 0.0 0.2 1.0 1.2 0.6 0.7 34.8 21.9 28.6 31.1 31.0 25.9 40.5 27.6 41.4 33.9 39.5 27.6 12.1 0.0 5.0 7.2 14.4 49.8 53.9 33.0 235.6 15.6 21.4 12.8 10.2 12.8 16.2 71.7 16.7 1.1 10.3 14.7 1.9 19.9 0.2 32.5 10.0 29.2 31.1 54.7 28.9 56.9 40.0 10.3 26.5 69.2 7.0 8.0 5.7 0.4 6.1 25.2 27.0 34.5 26.4 5.7 18.2 0.8 6.2 8.6 8.8 162.1 5.7 3.1 3.1 23.6 13.1 56.5 21.1 3.8 36.8 55.2 20.7 0.3 10.1 18.6 6.6 28.1 9.0 4.5 2.1 175.1 34.9 4.0 11.3 10.8 33.5 41.6 SLC9C1 "NHE, SLC9A10" ENSG00000172139 "Solute carrier family 9 member C1" Q4G0N8 3 112140898-112294227 "Predicted membrane proteins, Transporters" "Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "skin 1: 2.1;testis: 8.1" "Cell type enhanced" "Detected in some" "Adipocytes: 4.1;Early spermatids: 3.3;Excitatory neurons: 4.3;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 5.1;Spermatocytes: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (4.79e-2)" "unprognostic (2.92e-1)" "unprognostic (1.57e-3)" "unprognostic (9.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.98e-2)" "unprognostic (1.65e-2)" "unprognostic (8.32e-2)" "unprognostic (5.89e-2)" "unprognostic (9.62e-3)" "unprognostic (3.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 3.3 1.0 0.1 2.5 0.0 0.0 4.3 0.0 0.3 0.2 1.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 5.0 5.1 0.1 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 15.2 0.4 0.0 0.0 0.4 0.0 0.4 0.1 0.1 SMCO2 "C12orf70, LOC341346" ENSG00000165935 "Single-pass membrane protein with coiled-coil domains 2" A6NFE2 12 27466810-27502185 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Cell type enhanced" "Detected in some" "Early spermatids: 14.8;Excitatory neurons: 9.4;Inhibitory neurons: 3.7;Late spermatids: 5.7;Prostatic glandular cells: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.4;HDLM-2: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA014366 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA014366: AB_1845544" "unprognostic (2.64e-2)" "unprognostic (3.11e-1)" "unprognostic (1.33e-2)" "unprognostic (4.10e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (7.86e-3)" "unprognostic (5.44e-3)" "unprognostic (2.81e-1)" "unprognostic (8.86e-2)" "unprognostic (9.21e-5)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (5.48e-2)" "unprognostic (3.01e-1)" "unprognostic (3.65e-1)" "unprognostic (1.69e-1)" 0.1 0.1 0.9 0.4 0.9 0.0 0.1 0.6 1.1 0.1 0.6 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.8 0.7 0.0 0.2 0.1 0.1 0.7 1.3 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.3 0.9 1.5 0.1 0.0 0.0 0.4 0.2 0.2 1.0 0.9 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.6 0.0 1.4 0.0 0.3 0.0 0.5 0.2 0.1 0.2 0.4 2.2 0.0 0.0 0.5 0.0 0.0 0.8 0.1 0.4 0.2 0.3 1.2 0.3 0.7 0.3 0.0 0.6 0.0 0.1 0.3 0.9 0.3 0.6 0.7 0.3 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.6 0.3 0.7 1.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.6 1.1 0.8 0.7 0.7 1.3 0.7 0.5 1.5 1.0 0.2 0.0 0.0 0.3 0.0 0.3 0.6 0.4 0.0 0.0 0.1 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 14.8 0.2 0.0 0.2 0.0 0.0 9.4 0.8 0.1 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 1.1 5.7 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.4 0.0 4.4 0.2 0.4 0.3 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 2.3 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.0;breast: 14.2;skin 1: 32.2" "Group enriched" "Detected in some" 22 "Breast glandular cells: 367.0;Breast myoepithelial cells: 324.9" "Cancer enhanced" "Detected in many" "liver cancer: 7.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 20 "basophil: 2.8" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.8" "Cell line enriched" "Detected in some" 13 "Hep G2: 59.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052824 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 35: Glandular cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA052824: AB_2681964" "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.3 0.9 6.7 0.2 14.1 0.5 14.2 21.2 8.5 0.7 0.2 3.3 0.9 0.7 0.5 1.0 1.2 0.0 0.8 11.9 23.5 1.3 7.4 0.8 0.6 37.8 14.8 0.7 1.7 0.3 1.6 0.2 28.3 1.5 0.3 0.6 4.7 0.1 1.0 32.2 1.7 0.1 38.2 1.1 0.8 8.1 14.2 0.1 0.6 0.0 0.0 0.9 0.8 55.0 0.9 0.0 0.3 1.4 1.0 1.6 2.4 0.3 0.0 0.3 0.7 0.0 0.2 0.0 0.7 0.1 0.5 0.5 0.0 0.0 0.0 0.6 2.1 0.5 0.4 59.6 0.8 0.1 1.7 0.0 1.3 0.4 0.8 0.7 1.6 0.6 0.1 0.2 0.2 0.2 0.2 0.5 0.0 0.0 2.2 0.4 0.6 0.4 0.1 0.9 0.2 0.8 0.4 0.0 2.2 1.0 0.1 2.6 0.9 0.2 0.8 0.8 0.8 3.8 4.7 0.2 0.1 1.4 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 14.1 21.2 8.5 11.9 23.5 37.8 14.8 28.3 38.2 14.2 55.0 3.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 367.0 324.9 0.0 0.0 0.0 1.8 0.0 0.1 10.1 0.0 5.9 0.5 0.0 3.8 0.4 6.3 0.0 0.0 0.0 0.8 0.1 2.9 0.0 2.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 2.3 0.9 0.0 0.0 SNX24 SBBI31 ENSG00000064652 "Sorting nexin 24" Q9Y343 5 122843439-123029354 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044566, HPA073934" Approved Approved Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 4: Macrophages - Innate immune response" Vesicles "HPA044566: AB_10797034, HPA073934: AB_2686644" "unprognostic (2.63e-1)" "unprognostic (2.50e-1)" "unprognostic (2.73e-1)" "prognostic unfavorable (7.93e-6)" "unprognostic (2.31e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (8.88e-4)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (3.42e-1)" "unprognostic (5.77e-2)" "unprognostic (3.69e-2)" "prognostic favorable (1.28e-4)" "unprognostic (2.03e-1)" "unprognostic (1.10e-1)" "unprognostic (6.94e-2)" "unprognostic (1.50e-2)" 8.1 8.1 12.3 5.5 15.1 4.5 7.5 19.0 15.5 9.5 13.1 11.1 15.2 6.5 11.8 36.8 7.6 10.5 12.3 11.4 15.6 20.6 14.1 17.3 6.5 19.3 15.6 5.9 10.6 25.6 7.8 25.3 18.6 6.1 12.5 12.5 12.3 6.5 9.5 16.8 11.5 11.0 16.9 7.7 16.4 8.7 17.1 2.5 18.5 14.0 8.8 9.2 14.2 23.9 33.2 14.7 23.5 15.8 8.5 21.7 47.2 28.7 26.7 32.9 42.1 20.8 30.0 0.0 24.0 28.3 31.9 6.7 15.2 36.8 50.3 17.8 9.3 4.7 13.4 29.8 43.4 0.2 5.4 18.3 53.4 16.6 64.4 28.5 16.0 5.7 6.1 26.3 25.1 29.5 0.8 1.3 9.6 6.0 9.3 4.2 37.3 16.3 47.8 19.8 14.4 17.2 27.1 19.7 31.2 30.4 35.5 10.4 13.9 35.4 27.3 14.0 46.6 9.1 12.9 5.0 30.3 0.6 73.4 0.0 1.4 0.0 0.6 2.8 0.3 0.3 0.6 0.5 0.7 0.2 0.2 0.1 0.0 1.3 3.2 0.1 1.4 0.5 12.3 15.1 19.0 15.5 11.4 15.6 19.3 15.6 18.6 16.9 17.1 23.9 7.8 44.8 24.6 45.4 1.1 10.5 7.5 10.6 3.4 18.3 8.7 5.8 14.9 14.3 6.3 20.2 6.2 45.1 3.7 17.7 35.2 15.6 75.8 18.6 11.1 6.5 1.2 4.0 51.8 11.8 57.1 12.6 7.1 15.0 0.0 19.1 8.6 12.9 66.1 11.8 52.1 6.7 6.1 51.9 4.7 95.9 9.0 21.0 3.6 60.9 16.0 12.4 4.1 46.8 63.5 21.9 4.4 9.4 2.7 16.2 35.2 39.9 12.0 18.0 13.1 7.0 9.1 5.0 9.6 19.5 16.8 39.7 3.9 39.2 8.9 11.8 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box transcription factor 15" O60248 17 7588178-7590094 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 87.4;skin 1: 48.2" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 6.7;non-classical monocyte: 10.6" "Lineage enriched" "Detected in many" 5 "monocytes: 10.6" "Group enriched" "Detected in many" 8 "A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6" "Not detected" "Not detected" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Yes NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: AB_2685802, HPA074049: AB_2686656" "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 2.2 0.9 15.0 0.8 14.6 2.7 3.4 17.4 23.3 21.1 11.8 12.4 0.7 8.2 1.7 87.4 11.0 1.0 8.6 14.5 15.3 1.7 1.3 1.5 0.5 14.3 15.0 15.3 1.0 0.2 7.9 0.3 14.1 12.1 0.5 5.0 14.6 7.1 2.3 48.2 3.5 1.3 14.5 1.1 4.7 2.6 14.7 1.0 2.3 1.8 2.8 10.4 32.7 15.0 130.6 3.2 1.8 1.0 0.1 0.3 9.6 1.4 0.5 1.1 1.7 2.5 0.8 0.4 1.2 0.1 0.4 142.1 0.1 57.8 0.4 3.3 3.9 0.5 1.7 0.5 0.2 0.3 2.6 0.0 56.6 0.7 11.9 3.6 0.0 2.6 2.9 0.8 0.2 0.9 0.6 1.5 3.6 0.3 0.7 1.6 1.8 1.0 2.7 0.7 0.8 2.2 1.5 0.5 0.7 5.5 1.1 1.0 1.6 1.3 2.3 1.6 4.4 0.9 1.5 1.6 4.4 1.7 3.2 0.1 2.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 10.6 1.0 0.0 0.4 15.0 14.6 17.4 23.3 14.5 15.3 14.3 15.0 14.1 14.5 14.7 15.0 0.8 0.0 0.0 2.6 0.1 209.2 51.8 72.7 447.3 13.6 6.3 13.0 4.7 0.0 20.6 1.8 14.6 1.7 0.7 0.5 1.9 0.1 0.2 0.4 4.9 3.1 1.2 0.0 8.1 0.5 2.0 10.4 0.0 0.4 0.0 1.3 1.4 0.0 0.4 10.1 7.7 0.4 10.2 1.2 19.3 1.1 31.4 0.9 26.6 1.0 1.2 50.0 0.0 4.0 2.4 0.5 0.1 36.9 4.9 21.2 0.3 0.2 16.2 9.4 32.9 7.8 7.1 0.7 10.9 388.1 169.9 1.1 1.1 0.6 0.8 73.8 SOX2 ENSG00000181449 "SRY-box transcription factor 2" P48431 3 181711925-181714436 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;esophagus: 24.5" "Group enriched" "Detected in some" 6 "Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 0.3 0.9 58.0 0.5 58.5 0.0 0.2 47.1 56.6 2.1 8.6 5.5 0.4 0.1 0.2 24.5 3.1 0.2 0.5 46.5 59.0 0.0 0.1 1.8 0.0 50.5 58.9 0.3 0.1 0.0 13.6 0.0 45.2 2.5 0.4 15.0 18.4 0.3 0.1 0.6 1.4 0.2 59.8 0.0 7.9 1.9 59.2 0.4 0.1 0.1 5.3 1.3 4.8 62.2 0.1 9.0 277.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.3 0.0 0.1 0.0 0.2 0.7 118.6 3.2 0.0 0.1 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 226.2 12.4 0.5 0.0 0.6 0.0 31.0 0.4 0.5 1.2 0.0 0.0 0.1 45.7 1.7 0.1 0.0 0.0 4.2 0.0 54.0 0.0 0.0 0.0 0.2 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 58.5 47.1 56.6 46.5 59.0 50.5 58.9 45.2 59.8 59.2 62.2 0.2 0.0 6.0 0.0 0.0 0.3 35.5 28.5 362.0 4.9 0.2 0.4 0.5 0.0 48.4 3.7 0.0 0.2 0.0 1.1 0.0 0.0 0.9 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.1 1.6 19.4 0.0 1.3 0.2 0.7 0.1 0.1 0.0 0.0 0.5 38.7 0.0 0.4 0.4 0.6 0.8 3.6 0.0 0.0 383.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 5.8 0.0 0.1 52.8 13.1 0.0 0.2 1.6 3.9 0.4 229.1 0.4 0.3 0.6 0.2 0.0 7.5 SOX21 SOX25 ENSG00000125285 "SRY-box transcription factor 21" Q9Y651 13 94709622-94712545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 9.8;esophagus: 10.3;skin 1: 15.9;stomach 1: 35.1" "Cell type enhanced" "Detected in some" "Astrocytes: 24.5;Basal squamous epithelial cells: 11.4;Gastric mucus-secreting cells: 55.5;Oligodendrocyte precursor cells: 17.1;Squamous epithelial cells: 57.1" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 79.7;NTERA-2: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048337, HPA064084" Approved Approved Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA048337: AB_2732547, HPA064084: AB_2685187" "unprognostic (3.33e-1)" "prognostic favorable (7.60e-4)" "unprognostic (7.96e-2)" "prognostic favorable (8.79e-5)" "unprognostic (1.54e-2)" "unprognostic (3.87e-1)" "unprognostic (9.02e-2)" "unprognostic (2.11e-1)" "unprognostic (1.50e-1)" "unprognostic (2.90e-2)" "unprognostic (1.93e-1)" "unprognostic (6.05e-2)" "unprognostic (1.11e-1)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" 0.0 0.0 9.6 0.0 9.7 0.0 0.6 7.3 9.4 0.9 2.7 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 8.6 8.7 0.0 0.0 0.1 0.0 8.1 9.8 0.0 0.0 0.0 0.2 0.0 6.8 0.5 0.0 0.0 1.4 0.0 0.0 15.9 0.0 0.0 8.7 0.0 35.1 0.1 9.8 0.0 0.0 0.0 3.3 0.3 2.2 7.8 0.0 2.4 79.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 6.4 12.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 9.7 7.3 9.4 8.6 8.7 8.1 9.8 6.8 8.7 9.8 7.8 0.0 0.0 0.0 24.5 0.0 5.4 1.1 6.6 11.4 0.0 0.0 0.0 1.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 17.1 0.3 0.0 0.0 0.0 0.1 1.6 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.1 0.4 57.1 9.1 0.0 0.0 0.0 0.0 0.9 SPNS2 SLC62A2 ENSG00000183018 "Sphingolipid transporter 2" Q8IVW8 17 4498881-4539035 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.0" "Cell type enhanced" "Detected in many" "Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068717 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA068717: AB_2686021" "unprognostic (3.03e-2)" "unprognostic (4.76e-2)" "unprognostic (8.08e-2)" "unprognostic (3.53e-2)" "unprognostic (2.78e-1)" "unprognostic (6.30e-3)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.99e-2)" "unprognostic (2.98e-2)" "unprognostic (4.48e-2)" "unprognostic (2.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.19e-2)" "unprognostic (6.89e-2)" 17.3 2.6 13.1 5.2 14.0 7.9 14.7 13.1 18.2 14.6 0.1 6.5 12.2 8.6 0.6 51.0 7.8 12.1 10.7 14.1 12.1 28.6 3.8 28.3 4.9 26.4 16.2 1.8 10.0 1.1 2.1 7.9 28.9 5.3 2.1 0.6 16.5 2.0 4.4 24.8 10.8 4.8 13.9 11.4 21.0 1.3 15.5 1.7 8.5 3.9 13.3 6.6 22.6 25.1 9.7 1.2 0.0 0.2 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.5 8.1 0.5 11.8 0.0 0.1 0.5 0.0 0.7 0.0 0.1 0.2 0.6 0.2 0.0 0.1 3.0 0.0 0.0 0.2 0.0 0.0 0.0 4.2 4.7 0.0 0.0 0.0 3.8 0.2 17.0 0.1 17.6 0.3 0.8 0.0 0.3 161.7 0.5 5.4 0.2 0.0 76.7 0.0 5.1 2.7 7.5 0.2 0.2 0.7 0.3 0.1 0.3 0.3 0.1 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.1 14.0 13.1 18.2 14.1 12.1 26.4 16.2 28.9 13.9 15.5 25.1 32.7 6.4 10.6 1.6 0.2 1.8 0.4 2.1 0.0 1.2 4.3 3.6 1.2 22.8 16.2 22.0 0.0 1.3 0.2 2.8 1.9 16.7 0.2 0.5 1.0 34.5 0.0 3.2 23.4 3.0 30.5 1.7 26.0 2.8 0.0 0.0 12.5 6.7 1.1 6.7 26.2 12.7 2.0 0.3 1.6 0.2 0.6 1.9 1.8 37.5 0.0 0.4 0.0 3.5 97.8 18.6 0.0 0.4 1.2 11.7 1.9 24.3 16.9 1.1 0.0 1.4 3.1 0.6 0.5 0.6 2.4 1.9 1.6 0.1 1.1 39.8 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904358 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Plasma membrane" "HPA004194: AB_2667171, HPA059958: AB_2684179" "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavorable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 20.9 14.9 25.3 11.9 28.1 20.9 24.2 29.0 27.5 30.0 13.1 26.7 18.2 26.3 15.7 44.3 28.6 18.7 18.1 25.4 30.6 22.8 19.3 20.4 15.9 25.0 26.0 31.4 21.3 49.6 13.9 28.4 26.1 20.6 27.2 15.5 20.2 27.0 15.7 56.5 18.8 29.6 24.1 24.3 15.2 39.0 26.4 32.7 31.2 19.6 27.8 28.6 34.2 31.4 30.0 29.2 43.4 27.4 56.2 37.7 30.5 22.5 66.6 47.4 37.9 30.5 29.9 27.4 0.1 39.4 42.0 35.6 44.8 48.4 48.9 21.9 27.5 23.6 16.2 23.4 59.2 27.4 29.3 38.1 75.9 40.7 38.1 56.0 47.1 41.5 26.5 13.4 41.2 26.3 36.7 22.0 29.2 27.8 20.6 21.6 36.6 19.7 36.8 83.8 29.7 31.9 42.8 19.6 34.7 46.1 58.9 18.7 35.4 21.9 29.5 13.6 17.1 30.9 60.3 26.4 32.5 22.3 36.9 4.8 1.2 1.1 1.3 1.2 1.8 1.3 1.6 1.7 2.1 1.6 1.5 1.7 2.2 1.3 1.1 2.7 1.4 0.7 25.3 28.1 29.0 27.5 25.4 30.6 25.0 26.0 26.1 24.1 26.4 31.4 35.2 19.2 20.8 79.3 25.3 55.1 32.3 29.4 43.3 37.8 35.2 24.1 21.2 20.0 19.8 40.5 27.1 42.0 21.2 47.2 1.9 19.3 8.6 20.9 26.9 33.0 27.1 14.5 97.2 24.7 29.0 33.2 25.0 29.7 4.5 68.7 37.5 33.1 38.3 37.0 112.6 33.7 22.4 38.1 39.3 8.0 28.6 34.5 26.6 79.6 26.6 23.0 16.5 141.3 192.3 22.8 34.9 35.0 22.0 33.4 34.0 18.1 18.1 22.4 13.1 32.3 27.4 55.6 41.1 76.9 84.7 64.6 22.4 35.0 35.4 37.6 SPTBN2 SCA5 ENSG00000173898 "Spectrin beta, non-erythrocytic 2" O15020 11 66682497-66729226 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.6;skin 1: 85.5" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009844, HPA039293, HPA043529" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" Vesicles "CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531" "unprognostic (9.34e-2)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (3.41e-3)" "unprognostic (4.91e-1)" "unprognostic (6.05e-3)" "unprognostic (4.45e-2)" "unprognostic (1.38e-2)" "unprognostic (7.25e-2)" "unprognostic (1.67e-2)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" "unprognostic (3.99e-2)" "unprognostic (1.00e-3)" 1.3 14.4 26.8 1.0 32.6 2.3 7.7 29.7 73.6 14.3 0.0 0.9 0.9 1.7 1.2 39.8 3.7 1.7 1.4 38.8 0.3 37.5 23.3 1.1 0.2 4.8 0.9 0.9 16.7 13.1 16.4 0.4 3.2 12.4 0.7 14.7 29.6 4.7 0.5 85.5 1.0 1.1 0.0 0.9 2.9 52.8 4.6 1.0 0.3 0.1 6.7 1.6 16.5 24.2 20.5 7.4 3.4 0.3 0.1 0.0 0.6 0.3 0.1 0.1 0.0 4.8 28.2 0.2 3.7 0.0 0.7 16.9 25.2 2.4 0.0 0.1 10.4 0.1 45.6 3.0 0.8 7.3 0.6 0.2 11.5 0.0 7.4 4.2 6.3 5.2 7.3 0.1 0.1 35.2 6.3 3.5 49.1 28.7 21.1 23.8 2.8 14.7 9.6 4.8 49.9 29.4 14.0 52.3 3.2 2.7 67.2 2.4 1.4 0.1 8.6 1.3 11.5 0.7 3.0 14.7 0.1 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 26.8 32.6 29.7 73.6 38.8 0.3 4.8 0.9 3.2 0.0 4.6 24.2 0.7 3.2 1.1 4.9 0.3 3.7 2.7 3.2 2.8 11.0 4.7 4.6 1.8 1.5 4.6 86.5 104.3 0.9 0.0 0.6 0.0 2.6 30.9 3.6 1.8 1.1 3.0 7.2 29.3 10.0 0.3 0.8 1.5 3.6 0.0 1.4 1.4 24.7 0.1 0.0 20.7 1.6 0.0 0.3 0.7 77.6 1.8 0.1 0.0 2.8 0.6 1.6 0.0 7.5 4.6 7.5 0.2 1.5 0.8 3.2 0.2 1.3 3.5 21.3 0.0 0.2 0.5 8.5 9.4 14.6 12.5 0.3 0.2 0.1 0.8 1.7 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346213-55373100 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 79.6" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favorable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 12.5 12.0 10.4 2.5 11.5 3.7 12.2 11.0 12.4 12.9 9.2 7.3 3.8 6.8 4.2 26.1 5.6 10.3 9.3 10.7 10.1 9.6 14.5 10.5 2.5 11.0 11.2 3.1 20.2 7.0 5.9 4.0 10.8 7.4 4.1 1.5 16.4 2.9 6.3 15.4 7.0 2.6 10.9 6.8 9.7 3.3 10.9 6.0 7.6 5.4 6.0 10.0 14.7 12.7 9.7 4.3 10.3 10.1 29.4 20.4 5.6 10.4 9.3 2.4 5.4 6.5 19.5 21.2 11.7 11.0 11.1 7.0 5.3 7.9 3.9 6.6 17.1 12.3 5.2 15.8 9.2 23.7 6.1 17.6 14.5 5.4 5.3 7.8 14.4 38.5 21.2 47.7 21.1 10.8 36.0 10.3 13.0 53.2 9.3 11.4 3.3 14.0 12.8 7.9 16.0 9.1 10.7 79.6 8.3 9.0 9.4 17.9 8.3 25.0 4.7 2.0 8.1 28.6 15.8 7.9 34.1 29.5 25.9 25.6 35.8 11.7 16.1 56.5 18.6 12.5 12.0 15.2 30.2 12.7 10.2 14.4 1.8 8.6 59.5 61.7 12.5 23.1 10.4 11.5 11.0 12.4 10.7 10.1 11.0 11.2 10.8 10.9 10.9 12.7 25.4 9.6 15.9 4.6 7.8 13.6 13.3 245.5 5.2 4.9 43.8 29.3 5.3 34.3 245.2 5.5 4.2 27.0 21.2 12.2 3.9 93.4 3.2 51.2 31.0 19.6 12.0 14.9 11.1 105.4 106.0 16.2 13.3 105.9 14.0 6.7 17.5 18.6 63.4 10.1 17.1 22.6 57.0 32.4 34.1 0.5 1.8 27.6 24.9 4.7 31.3 21.9 18.6 8.5 23.4 155.5 10.0 5.7 16.8 17.5 9.4 18.4 195.0 3.9 13.1 13.3 28.2 3.5 20.1 32.7 29.7 7.5 7.2 15.4 23.3 108.6 SREBF2 "bHLHd2, SREBP2" ENSG00000198911 "Sterol regulatory element binding transcription factor 2" Q12772 22 41833079-41907307 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031962, HPA031963" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 27: Brain & Skin - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "HPA031962: AB_10601266, HPA031963: AB_2674090" "unprognostic (6.53e-2)" "unprognostic (6.07e-2)" "unprognostic (1.75e-2)" "unprognostic (1.50e-3)" "unprognostic (3.41e-3)" "unprognostic (9.08e-2)" "unprognostic (5.04e-2)" "unprognostic (1.31e-1)" "unprognostic (4.78e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (9.85e-2)" "prognostic favorable (1.37e-4)" "unprognostic (4.68e-2)" "unprognostic (1.92e-2)" "unprognostic (3.22e-1)" "unprognostic (7.93e-3)" 22.8 80.7 50.1 31.1 58.7 32.3 24.5 22.3 60.5 26.5 2.5 47.1 40.8 34.4 60.5 82.0 27.4 25.3 53.8 51.8 32.3 33.3 36.2 43.2 35.2 38.5 37.8 35.8 45.8 51.4 30.5 24.5 38.3 33.5 31.6 21.0 49.1 22.9 34.1 58.4 35.9 30.1 16.1 26.1 53.8 20.4 37.8 25.0 23.3 33.5 36.2 29.7 39.0 45.1 65.5 45.8 119.4 111.6 68.4 90.9 66.7 21.4 71.1 24.8 50.5 54.3 84.2 115.8 29.7 52.6 91.1 109.6 68.7 141.8 17.5 32.9 75.0 58.0 79.7 54.6 113.8 85.7 37.9 85.8 78.7 65.1 80.6 56.7 49.2 64.2 60.6 135.9 26.4 83.1 62.5 64.5 75.7 81.2 34.9 71.3 68.1 189.0 103.3 67.6 48.2 36.3 49.1 89.3 91.7 69.5 56.3 150.2 53.0 33.2 61.0 15.9 25.8 98.3 54.3 91.7 32.4 64.0 51.9 0.0 4.7 1.6 4.6 3.6 3.1 7.0 2.5 3.3 5.0 4.8 2.2 2.6 0.7 1.4 3.1 6.3 1.5 4.8 50.1 58.7 22.3 60.5 51.8 32.3 38.5 37.8 38.3 16.1 37.8 45.1 14.5 44.8 43.3 100.6 35.4 16.3 13.5 52.2 30.7 41.0 36.3 23.1 30.3 37.1 38.0 58.8 10.4 25.4 23.5 67.0 3.9 20.3 15.9 25.2 10.5 16.8 49.1 14.1 72.6 44.3 22.6 16.3 42.8 59.2 12.7 43.2 8.2 34.3 14.8 57.2 75.1 39.4 52.9 10.3 14.8 7.0 31.4 16.3 7.2 67.5 18.1 18.6 20.6 90.5 129.5 38.4 30.5 27.4 29.2 27.9 26.3 4.8 30.0 18.7 19.7 13.7 20.5 8.4 13.8 55.7 28.1 36.5 19.0 43.0 40.3 30.2 SRY TDF ENSG00000184895 "Sex determining region Y" Q05066 Y 2786855-2787682 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Activator, Calmodulin-binding, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 1.8;testis: 2.3" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.8;Muller glia cells: 2.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 5: Muller glia cells - Visual perception" "unprognostic (1.34e-1)" "unprognostic (5.53e-4)" "unprognostic (1.61e-1)" 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 STK11IP "KIAA1898, LIP1, LKB1IP, STK11IP1" ENSG00000144589 "Serine/threonine kinase 11 interacting protein" Q8N1F8 2 219597857-219616451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 15.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036837, HPA036838, HPA053192" Approved Enhanced Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075" "unprognostic (3.37e-1)" "unprognostic (1.33e-1)" "unprognostic (3.51e-1)" "unprognostic (1.97e-1)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (1.22e-3)" "unprognostic (8.36e-2)" "unprognostic (9.36e-2)" "unprognostic (1.87e-2)" "prognostic favorable (1.63e-4)" "unprognostic (9.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-3)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" 7.6 10.0 12.0 9.5 12.4 19.5 7.1 11.3 13.8 9.2 12.6 9.8 9.2 9.2 15.0 9.6 10.4 9.5 8.0 12.4 10.6 11.2 5.9 9.3 14.0 12.0 11.9 24.5 9.5 7.5 21.5 8.2 12.3 9.9 7.8 12.3 8.1 6.5 5.8 18.4 10.0 8.3 10.0 15.1 8.6 31.2 12.0 19.5 11.1 4.3 11.1 9.0 8.3 11.8 10.1 15.4 16.1 11.0 5.6 9.9 16.5 8.7 7.6 13.9 11.7 14.3 16.7 5.8 8.7 8.4 12.6 24.4 7.7 18.7 10.3 8.7 11.7 15.1 17.2 11.6 7.4 15.9 38.2 9.6 16.5 11.7 5.9 14.2 8.6 9.7 11.4 8.5 7.9 19.7 9.3 19.6 16.2 4.8 8.4 17.5 5.9 4.5 13.8 15.8 10.6 16.8 5.7 13.8 12.0 12.9 8.8 15.3 6.5 15.0 12.6 14.5 8.6 9.4 4.5 10.8 11.4 8.7 9.5 1.5 4.3 5.3 2.6 5.8 2.1 1.7 1.2 2.1 7.7 1.2 1.0 1.0 1.4 3.7 6.5 15.1 2.1 2.6 12.0 12.4 11.3 13.8 12.4 10.6 12.0 11.9 12.3 10.0 12.0 11.8 3.5 6.4 6.7 12.4 3.9 2.3 2.1 6.3 1.2 7.8 5.1 5.5 3.6 1.5 7.8 7.3 18.8 10.0 10.3 14.6 1.9 5.0 14.0 11.9 4.0 4.6 13.1 6.9 10.7 6.5 5.6 5.3 17.3 5.8 12.7 29.7 4.2 3.3 8.4 11.8 8.0 8.8 6.1 8.6 5.7 30.9 25.4 8.9 3.6 8.4 7.0 4.9 4.1 8.5 7.4 4.2 3.3 14.7 2.8 1.7 5.4 2.7 19.9 12.6 13.1 3.2 4.9 18.5 13.8 3.5 2.7 16.1 4.5 5.4 8.8 2.8 STX6 ENSG00000135823 "Syntaxin 6" O43752 1 180972712-181023121 "Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038557, HPA038558" Approved Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" Nucleoplasm "HPA038557: AB_2676082, HPA038558: AB_10672716" "unprognostic (1.11e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.09e-3)" "unprognostic (2.23e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.12e-1)" "unprognostic (6.12e-2)" "unprognostic (4.48e-3)" "unprognostic (4.18e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.93e-8)" "unprognostic (2.59e-1)" "unprognostic (1.59e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" 9.5 7.4 13.7 11.2 14.9 2.7 9.2 15.9 17.9 9.5 11.6 7.9 7.5 8.2 7.7 17.5 7.4 7.1 5.8 15.6 13.5 8.7 4.8 11.3 10.9 13.8 13.7 8.2 4.1 7.4 4.5 11.5 12.6 7.2 8.1 8.1 8.0 6.7 4.0 12.8 7.6 8.7 13.2 9.3 7.9 5.6 14.1 17.2 11.4 4.9 14.1 14.2 11.2 16.6 16.9 18.6 18.0 24.1 18.5 21.7 30.3 21.2 27.3 16.4 13.9 17.4 16.5 17.0 28.7 23.4 10.2 29.4 16.5 37.4 19.0 12.3 12.1 11.4 14.2 17.2 18.4 16.4 14.1 19.9 33.6 27.6 28.3 29.3 33.6 15.7 21.3 11.8 22.0 24.2 15.9 15.4 28.2 21.0 9.2 13.7 22.0 24.7 19.6 41.7 25.5 27.0 22.2 42.3 23.9 30.7 25.8 14.9 28.0 22.4 11.8 21.2 17.3 19.8 11.8 12.3 11.0 15.8 13.5 2.6 1.6 2.1 0.7 1.3 0.8 0.7 1.1 1.1 2.2 0.7 1.4 0.9 1.4 0.2 1.1 0.7 1.4 0.6 13.7 14.9 15.9 17.9 15.6 13.5 13.8 13.7 12.6 13.2 14.1 16.6 13.9 16.0 18.6 32.3 11.8 48.9 21.3 19.0 41.5 12.8 16.0 11.7 6.4 2.8 13.7 18.4 6.2 25.7 15.8 10.5 11.7 10.7 8.9 19.4 16.6 23.0 23.4 16.0 54.7 9.8 24.9 12.7 19.4 22.7 12.0 12.7 14.6 4.8 26.4 8.4 38.0 11.1 16.2 26.1 28.0 11.8 8.4 31.9 7.2 23.4 25.2 6.7 15.5 50.3 30.7 14.9 13.9 13.2 10.0 22.2 10.2 11.5 13.3 11.4 6.6 8.2 12.2 5.6 15.4 47.8 37.6 20.5 14.0 16.4 10.6 22.8 STYXL1 "DUSP24, MK-STYX" ENSG00000127952 "Serine/threonine/tyrosine interacting like 1" Q9Y6J8 7 75996338-76048004 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050261 Uncertain NA No "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" "HPA050261: AB_2681066" "unprognostic (6.24e-2)" "unprognostic (1.12e-1)" "unprognostic (7.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.88e-3)" "unprognostic (9.33e-2)" "unprognostic (1.50e-3)" "unprognostic (4.77e-2)" "unprognostic (8.01e-2)" "unprognostic (4.02e-2)" "unprognostic (4.47e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "unprognostic (5.45e-2)" "unprognostic (3.17e-2)" "unprognostic (2.28e-1)" "prognostic favorable (8.22e-4)" 8.7 15.4 21.9 11.5 22.5 15.1 17.4 21.3 26.5 15.3 24.6 15.9 11.2 10.5 20.7 18.9 28.7 9.8 11.5 21.7 19.7 16.8 19.4 11.9 16.1 21.0 20.8 15.2 22.5 16.3 11.9 17.3 22.0 16.5 20.4 13.1 16.2 10.1 10.5 20.4 9.1 14.4 20.2 14.4 14.8 21.9 21.3 13.2 14.8 9.6 21.6 14.2 13.4 23.8 50.3 26.2 20.3 27.2 31.4 33.6 21.1 22.1 31.3 35.1 34.7 30.6 44.2 11.7 10.9 29.4 55.6 21.6 33.3 44.3 50.5 37.4 14.5 14.2 12.2 27.5 44.3 19.9 24.7 33.2 51.0 42.1 104.8 45.0 34.5 17.4 46.4 34.1 31.8 40.8 7.9 84.6 17.1 48.2 62.5 30.1 16.9 31.1 45.2 32.2 26.5 27.6 20.7 46.7 57.6 50.4 51.5 38.0 17.3 29.9 12.6 33.3 31.8 36.6 24.9 39.5 26.7 37.5 47.8 70.8 52.9 50.0 23.8 48.2 26.3 36.3 22.5 26.6 42.1 29.7 19.8 22.2 44.9 49.7 47.0 28.1 41.4 34.1 21.9 22.5 21.3 26.5 21.7 19.7 21.0 20.8 22.0 20.2 21.3 23.8 7.7 22.4 13.2 16.6 10.7 7.4 14.8 24.2 13.1 6.7 17.9 18.5 18.1 10.0 31.4 11.0 0.0 34.8 7.3 24.6 39.2 15.6 91.4 42.7 10.2 11.1 20.3 9.0 18.8 25.6 24.5 9.4 18.3 19.7 10.8 13.9 11.7 18.2 30.9 3.3 11.6 29.1 24.4 21.0 9.6 62.1 11.5 19.7 3.6 11.2 31.1 20.2 9.2 8.0 15.8 23.9 40.3 10.1 23.0 17.0 14.6 25.2 60.7 10.4 6.6 7.6 9.0 39.3 12.6 13.0 9.9 45.0 10.8 9.5 18.8 17.9 SUFU "PRO1280, SUFUH, SUFUXL" ENSG00000107882 "SUFU negative regulator of hedgehog signaling" Q9UMX1 10 102503972-102633535 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Ciliopathy, Disease variant, Joubert syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 129.2;Late spermatids: 115.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008700 Supported Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA008700: AB_1080125" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-1)" "unprognostic (4.69e-2)" "unprognostic (5.68e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "unprognostic (1.64e-1)" "unprognostic (3.15e-3)" "unprognostic (9.60e-2)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.82e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-2)" "unprognostic (3.82e-3)" 6.6 7.2 8.8 7.1 8.5 2.0 6.1 8.9 8.0 8.6 5.5 6.8 3.9 7.4 4.9 9.2 7.1 6.6 6.3 7.8 7.3 6.1 6.2 5.8 7.2 8.3 8.2 8.9 4.1 11.1 4.3 7.4 7.8 8.5 4.4 4.6 7.1 5.2 8.6 14.4 5.7 7.3 6.7 7.4 4.6 11.5 8.0 7.8 3.4 7.3 8.1 8.8 9.2 7.3 8.7 9.1 14.4 20.8 14.5 12.1 7.0 8.8 17.0 12.5 11.3 8.5 6.3 8.9 24.5 9.9 5.0 6.0 17.8 9.8 8.2 5.5 13.8 21.2 5.2 8.0 6.9 7.7 14.6 13.9 7.5 9.3 7.5 22.9 16.3 8.5 4.8 7.9 7.8 7.2 14.8 11.6 4.1 5.6 6.7 15.8 15.5 4.7 8.3 12.8 4.8 7.8 7.0 6.4 8.1 13.1 14.2 5.0 18.1 5.5 7.8 6.0 9.8 6.4 4.5 6.4 6.9 14.9 3.8 2.0 2.0 2.9 1.0 2.4 0.8 0.9 1.2 1.1 1.9 0.8 0.8 1.0 0.4 1.1 2.5 1.1 0.8 1.4 8.8 8.5 8.9 8.0 7.8 7.3 8.3 8.2 7.8 6.7 8.0 7.3 3.3 0.0 3.7 28.7 4.9 3.1 2.1 2.9 6.8 4.2 3.5 3.0 4.0 1.5 4.6 3.7 8.4 7.8 3.1 3.5 1.9 4.4 129.2 4.5 6.2 5.1 1.2 2.5 25.9 3.0 3.5 6.0 4.6 8.5 3.8 3.8 10.8 5.4 12.4 1.7 22.2 2.2 0.0 9.4 6.3 115.9 5.0 8.7 0.0 32.8 7.8 2.7 4.1 17.6 16.8 4.1 1.3 6.8 4.0 2.0 5.7 5.8 5.7 4.8 0.0 3.0 4.5 8.7 5.3 8.9 6.5 7.0 7.1 7.6 3.0 1.3 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364233 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.0;esophagus: 51.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 83.7;Inhibitory neurons: 89.7;Oligodendrocyte precursor cells: 101.6;Squamous epithelial cells: 68.3;Theca cells: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 6.8;naive CD4 T-cell: 10.2" "Lineage enriched" "Detected in single" 40 "T-cells: 10.2" "Cell line enhanced" "Detected in some" "HaCaT: 9.7;RPTEC TERT1: 11.1;SCLC-21H: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA058296: AB_2683672" "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.4 6.0 28.4 0.8 21.7 0.4 8.7 5.4 63.7 9.5 0.0 1.3 1.0 0.3 25.1 51.1 3.5 0.7 23.0 69.0 26.8 19.5 3.8 2.8 1.6 9.4 10.4 45.3 10.7 14.9 26.0 0.5 15.9 6.0 0.2 12.2 17.0 4.3 3.5 7.8 0.6 0.4 5.0 0.4 11.0 6.6 21.4 3.4 1.0 2.2 15.0 3.6 25.3 16.2 5.9 0.5 0.2 0.0 0.0 0.0 0.1 0.8 0.4 1.0 0.5 5.8 1.8 0.0 1.8 0.2 0.0 9.7 0.2 1.5 0.9 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.2 0.0 6.6 0.5 0.0 0.5 3.9 3.8 0.0 0.2 3.0 1.3 0.0 0.2 0.1 11.1 2.8 36.3 0.4 0.0 3.2 0.0 0.8 2.1 0.2 0.0 1.7 6.2 0.0 2.9 0.7 0.1 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.3 0.1 5.5 0.0 6.8 1.7 0.0 0.0 10.2 1.9 0.0 0.2 0.0 0.0 0.9 1.4 28.4 21.7 5.4 63.7 69.0 26.8 9.4 10.4 15.9 5.0 21.4 16.2 0.2 0.0 4.8 6.2 0.0 0.6 8.6 8.4 10.2 17.9 9.7 5.0 9.5 5.7 14.8 16.5 10.4 0.1 0.3 0.1 31.3 0.6 3.1 4.0 0.4 0.6 1.2 0.0 83.7 6.9 0.0 3.8 2.6 6.1 0.0 9.1 0.4 1.8 2.8 21.9 89.7 0.1 2.0 0.6 0.3 3.4 20.5 0.3 5.4 8.4 0.0 1.6 0.0 101.6 2.5 2.6 0.0 12.4 0.1 4.6 0.0 0.3 5.4 6.2 0.0 1.4 2.8 1.3 10.7 68.3 1.7 0.0 1.7 65.5 0.3 25.7 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 54.5;Alveolar cells type 2: 49.5;Endothelial cells: 20.4;Hepatic stellate cells: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-BR-3: 14.6" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 3.7 2.3 3.5 3.4 3.8 0.8 3.2 1.9 9.3 4.5 0.0 1.6 1.8 2.9 3.9 3.3 4.5 2.7 4.1 7.6 1.8 2.1 1.4 9.6 5.4 6.9 1.7 2.6 4.8 2.3 0.9 5.1 6.7 2.5 2.1 3.4 3.6 3.5 2.2 11.6 1.5 3.7 0.2 3.5 1.2 1.5 4.3 1.8 2.6 4.1 4.0 2.9 3.4 3.9 2.8 2.9 1.5 0.7 1.7 1.6 2.1 2.9 5.3 2.2 2.5 6.8 5.2 0.6 2.2 2.5 2.1 9.4 0.0 0.8 2.9 1.4 3.2 1.7 2.8 4.5 4.4 3.0 2.1 3.2 0.9 1.4 4.2 2.7 1.2 2.2 0.7 1.7 1.0 4.6 1.5 4.7 1.2 0.5 1.2 1.9 0.0 1.9 3.3 1.3 0.9 1.4 2.4 14.6 1.3 1.4 4.3 1.3 3.8 0.8 3.3 2.0 2.1 2.6 2.9 2.3 1.8 1.9 0.6 0.0 0.6 0.3 0.7 1.4 0.6 0.4 0.6 0.3 0.6 0.2 0.4 0.5 0.0 0.5 1.1 0.4 0.1 0.3 3.5 3.8 1.9 9.3 7.6 1.8 6.9 1.7 6.7 0.2 4.3 3.9 8.0 54.5 49.5 0.7 0.3 6.1 2.2 2.0 0.6 2.2 2.8 1.5 3.6 0.0 3.0 1.8 2.1 1.1 0.6 0.9 1.9 2.0 0.4 0.8 1.2 20.4 1.2 2.7 0.7 5.8 1.4 2.7 0.0 1.0 2.5 1.1 26.4 1.5 0.1 0.0 0.8 1.6 0.0 2.2 3.5 0.6 3.7 0.6 3.6 1.9 0.5 0.6 1.0 1.0 1.1 4.5 0.9 3.8 0.4 5.6 1.1 2.5 1.5 1.8 6.6 3.6 2.7 1.3 1.4 0.5 5.5 1.2 0.8 0.4 1.4 2.4 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98199011-98255649 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Oligodendrocytes: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 27.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 77.0;HaCaT: 98.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030871, HPA076521" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Plasma membrane, Cytosol" "HPA030871: AB_10670046, HPA076521: " "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 8.8 5.3 11.1 5.7 16.0 13.1 7.8 12.3 26.0 10.8 8.5 8.6 12.6 4.4 1.5 37.4 5.5 4.0 3.7 10.6 12.9 6.4 19.8 32.0 3.8 14.9 14.9 2.9 3.0 3.5 4.4 7.2 16.4 12.0 4.4 3.4 14.7 6.1 4.3 24.3 10.1 2.8 11.4 9.4 7.0 3.4 23.3 3.0 8.1 1.4 4.9 11.7 17.3 23.9 77.0 10.8 0.5 2.5 8.2 15.9 24.3 33.2 18.4 23.8 19.6 6.9 32.8 1.3 24.7 19.6 5.2 98.1 0.7 36.8 8.3 2.6 1.4 0.7 38.0 5.4 37.6 1.7 2.9 21.7 59.8 23.6 58.7 41.5 8.6 2.1 2.4 1.0 19.0 9.9 0.4 4.6 1.6 7.4 6.2 1.2 4.8 0.2 36.0 46.7 0.9 1.4 11.3 24.4 3.4 1.7 8.1 2.6 51.7 28.8 8.6 4.8 13.6 1.6 1.5 0.6 29.0 2.9 3.2 2.1 27.5 8.4 2.5 15.3 1.8 1.2 3.8 2.2 10.0 0.8 1.6 1.9 11.9 1.2 12.3 1.3 5.5 10.8 11.1 16.0 12.3 26.0 10.6 12.9 14.9 14.9 16.4 11.4 23.3 23.9 2.9 57.7 12.5 5.2 2.4 8.3 18.5 30.4 21.6 3.3 2.7 5.6 0.7 4.3 23.3 3.7 0.0 21.5 0.9 16.2 3.9 3.3 1.8 4.6 3.7 5.0 7.7 0.4 4.6 3.2 10.9 2.4 6.1 10.3 0.0 0.6 1.1 6.1 32.0 1.7 5.4 12.6 18.3 16.2 1.8 1.2 1.8 18.3 3.6 4.7 7.5 4.4 3.1 12.1 64.9 14.4 10.7 0.7 1.7 9.2 16.4 3.2 10.8 2.4 0.0 1.8 3.4 2.1 3.0 29.8 10.9 17.4 2.4 0.7 5.7 17.1 TBX6 ENSG00000149922 "T-box transcription factor 6" O95947 16 30085793-30091924 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4;Urothelial cells: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 4.1;RT4: 6.9;U-266/70: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062498 Approved Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA062498: AB_2732686" "unprognostic (2.47e-1)" "unprognostic (1.32e-3)" "unprognostic (5.62e-5)" "unprognostic (1.49e-1)" "unprognostic (4.76e-2)" "unprognostic (2.35e-2)" "unprognostic (3.35e-1)" "unprognostic (5.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (3.87e-1)" "unprognostic (2.76e-2)" "unprognostic (2.95e-1)" "unprognostic (4.21e-2)" "unprognostic (5.05e-3)" "unprognostic (4.26e-2)" 1.1 1.9 3.3 0.7 3.9 0.5 1.4 3.1 4.1 3.6 2.4 1.8 1.2 1.1 0.7 13.8 1.7 0.8 1.3 3.1 3.3 3.2 1.9 1.4 0.8 3.7 3.7 1.8 4.3 1.0 1.9 0.3 3.9 3.3 0.3 1.7 2.8 1.2 2.0 3.5 1.7 0.4 3.4 2.4 4.7 1.8 4.0 0.9 2.8 0.5 1.5 4.4 7.3 4.5 0.6 0.7 0.4 0.7 1.0 0.5 0.5 0.2 0.1 0.0 0.1 0.9 2.9 1.2 1.5 0.1 0.1 0.8 0.3 0.5 0.0 0.9 0.5 0.8 1.4 0.7 0.7 0.1 1.7 0.2 0.8 0.1 0.3 0.6 0.4 2.7 0.1 2.9 0.0 2.6 0.5 0.3 0.6 4.1 0.6 2.0 0.0 2.1 0.0 6.9 0.9 1.3 0.1 0.5 0.8 0.3 1.2 1.2 0.3 0.8 0.4 0.4 0.0 6.9 1.7 0.2 0.8 1.2 0.2 1.2 0.6 0.2 0.4 0.6 0.3 0.3 0.2 0.3 0.3 1.2 0.4 0.4 0.8 0.3 0.2 0.2 0.5 0.3 3.3 3.9 3.1 4.1 3.1 3.3 3.7 3.7 3.9 3.4 4.0 4.5 1.0 0.0 0.6 2.6 2.7 1.1 3.4 4.2 4.0 1.9 1.2 1.4 0.5 0.0 3.7 1.8 8.4 1.7 0.5 0.7 0.0 0.8 0.1 0.9 0.8 1.9 0.0 3.2 0.2 1.2 0.8 1.1 3.6 1.0 0.0 1.1 0.4 0.4 0.5 0.0 0.4 1.2 4.1 0.8 1.7 0.2 0.9 1.2 0.0 1.9 0.6 1.9 2.1 0.0 2.7 3.5 1.6 1.2 0.2 3.2 2.6 0.7 3.0 3.4 6.6 2.7 1.4 2.6 3.9 6.2 1.0 2.3 0.8 0.5 1.6 9.4 TCHP "MGC10854, TpMs" ENSG00000139437 "Trichoplein keratin filament binding" Q9BT92 12 109900264-109983841 "Predicted intracellular proteins" "Apoptosis, Cilium biogenesis/degradation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038638, HPA061543" Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Centrosome, Cytosol" "HPA038638: AB_10670785, HPA061543: AB_2684556" "unprognostic (2.21e-1)" "unprognostic (1.51e-2)" "unprognostic (2.58e-1)" "unprognostic (1.04e-1)" "unprognostic (2.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.59e-2)" "unprognostic (9.75e-2)" "unprognostic (1.15e-3)" "unprognostic (4.63e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.52e-4)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" 6.5 7.3 9.7 8.9 10.6 6.8 6.6 10.9 11.3 10.1 8.1 10.4 7.3 9.1 7.5 15.4 7.6 5.9 8.1 9.4 10.5 7.8 5.6 7.3 11.7 10.4 10.5 8.9 10.9 7.4 6.4 7.6 10.5 8.6 6.8 9.2 10.5 7.9 9.1 27.4 8.2 7.6 9.2 11.8 8.2 9.3 10.7 10.4 8.6 7.0 11.6 9.3 13.8 11.0 27.6 24.0 12.7 15.3 11.0 11.9 17.3 25.6 13.4 21.8 12.1 15.2 9.4 38.2 7.2 14.9 11.8 22.5 14.0 16.0 19.5 20.7 13.8 27.6 15.3 15.0 13.3 38.0 20.4 9.8 19.1 22.9 17.1 13.7 19.7 23.8 30.5 7.5 18.2 18.9 35.0 38.4 15.3 6.6 24.2 31.7 24.9 32.4 9.9 24.2 18.8 19.8 18.5 19.8 18.2 9.0 17.9 27.2 21.8 22.2 15.5 14.3 32.7 21.8 29.5 27.0 23.5 31.0 23.7 0.0 2.7 2.3 3.6 1.7 2.6 2.0 3.2 4.5 2.1 1.3 3.2 2.5 2.7 5.9 3.7 1.5 4.7 3.1 9.7 10.6 10.9 11.3 9.4 10.5 10.4 10.5 10.5 9.2 10.7 11.0 11.7 19.2 21.4 18.9 10.4 9.8 7.7 9.5 8.0 28.9 11.3 11.4 13.2 17.2 12.0 7.3 18.8 11.2 14.3 12.8 9.8 20.7 32.5 23.0 19.1 15.2 14.8 15.4 8.3 15.1 8.4 11.4 10.2 13.2 13.3 15.7 7.9 7.4 11.6 25.2 12.3 10.7 10.2 13.0 7.8 47.6 11.1 11.4 7.2 1.9 14.3 13.9 35.0 10.1 19.4 18.8 14.4 27.8 15.0 9.1 14.2 6.6 33.6 24.0 13.1 19.6 12.6 25.1 33.2 14.8 24.7 7.0 15.9 30.9 12.2 30.7 TGFA ENSG00000163235 "Transforming growth factor alpha" P01135 2 70447284-70554193 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 59.3;Pancreatic endocrine cells: 74.5;Urothelial cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 11.3;eosinophil: 23.8;neutrophil: 23.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 23.8" "Cell line enhanced" "Detected in many" "A-431: 72.5;CAPAN-2: 82.5;HBEC3-KT: 72.3;OE19: 54.6;RPTEC TERT1: 72.6;U-87 MG: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042297 Approved Approved Vesicles "Secreted to blood" No No 57900 "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Vesicles "HPA042297: AB_10793878" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (3.57e-3)" "unprognostic (6.39e-2)" "unprognostic (1.41e-1)" "unprognostic (8.49e-3)" "unprognostic (1.52e-1)" "unprognostic (3.00e-3)" "unprognostic (6.69e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (7.74e-2)" "unprognostic (3.70e-2)" "unprognostic (1.60e-1)" "unprognostic (9.21e-2)" "prognostic favorable (1.52e-4)" "unprognostic (9.19e-2)" 2.2 0.5 9.2 5.0 16.8 1.6 6.9 15.0 12.2 6.1 5.2 10.7 8.5 1.3 2.9 25.5 6.1 14.1 0.7 10.4 11.7 13.4 4.5 3.9 4.1 21.0 15.8 0.1 7.5 3.0 0.5 1.9 18.5 2.4 7.9 7.4 6.4 1.2 0.1 12.2 10.0 1.4 16.6 5.8 8.5 2.5 13.2 1.0 8.1 0.3 9.0 10.0 12.8 27.3 72.5 11.3 0.1 0.2 0.0 0.0 0.0 11.0 0.0 0.3 0.1 0.2 82.5 0.0 43.2 0.4 11.2 37.1 0.6 72.3 0.1 0.1 1.6 0.0 1.8 6.0 0.0 0.9 0.1 0.0 29.1 0.1 27.8 3.4 0.0 5.6 0.0 0.4 0.0 2.6 0.1 1.4 1.1 54.6 22.9 0.0 0.5 19.8 72.6 27.2 0.6 0.1 5.8 0.0 0.1 0.2 9.8 0.7 0.6 0.3 4.9 0.1 15.7 0.4 0.6 0.1 69.0 2.4 25.6 11.3 0.8 23.8 1.7 0.2 4.4 0.0 1.0 1.0 1.0 0.0 0.5 0.4 23.8 0.3 0.0 0.0 0.0 0.7 9.2 16.8 15.0 12.2 10.4 11.7 21.0 15.8 18.5 16.6 13.2 27.3 0.4 6.4 2.7 0.3 0.2 16.2 12.3 16.9 10.8 1.4 9.8 12.1 2.3 24.3 21.8 25.8 0.0 0.0 2.2 19.8 1.9 37.3 21.3 8.1 0.7 1.7 1.2 0.0 0.8 10.0 0.0 0.6 13.7 10.5 5.7 0.0 0.0 3.0 3.9 0.0 3.6 6.2 12.2 3.2 2.4 1.9 0.3 4.1 0.0 6.5 18.2 7.9 2.1 59.3 36.1 74.5 9.0 0.0 0.7 16.8 21.1 6.6 20.4 0.7 0.0 0.1 1.1 0.6 0.2 12.2 24.9 0.0 1.9 0.0 5.6 63.6 THSD8 ENSG00000284491 "Thrombospondin type 1 domain containing 8" A0A1W2PP97 19 12802031-12813581 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Cell type enhanced" "Detected in single" "Breast myoepithelial cells: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: Non-specific - Mitochondria" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TLCD1 ENSG00000160606 "TLC domain containing 1" Q96CP7 17 28724348-28727935 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 36.4;Syncytiotrophoblasts: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "plasmacytoid DC: 21.7" "Lineage enriched" "Detected in many" 11 "dendritic cells: 21.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 116.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042366 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA042366: AB_10794419" "unprognostic (1.23e-1)" "unprognostic (3.78e-2)" "unprognostic (8.52e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.47e-3)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (9.05e-5)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (1.86e-2)" "unprognostic (3.93e-2)" 2.6 5.4 14.5 3.2 14.9 1.4 5.2 16.6 21.5 4.4 13.1 8.1 8.1 1.8 13.8 13.1 14.5 2.3 2.3 14.7 14.9 25.9 15.0 7.4 3.2 14.7 15.7 1.1 11.9 3.4 3.9 4.5 14.1 6.5 8.2 1.6 12.9 3.7 0.8 20.6 4.0 1.0 14.7 1.3 8.8 13.1 15.1 4.5 5.3 0.1 9.8 13.8 5.7 13.9 12.4 55.8 14.9 12.7 10.2 18.5 34.6 10.1 17.8 4.7 6.7 31.1 21.3 3.9 15.3 12.1 21.4 19.4 16.6 31.6 7.2 3.1 15.8 6.6 33.4 38.2 10.9 14.0 1.0 12.5 25.4 17.1 30.0 7.3 4.1 1.2 24.3 0.6 8.1 43.5 1.6 5.9 17.0 42.4 10.0 4.6 6.3 23.7 38.9 22.2 28.1 5.6 20.6 116.2 11.3 22.1 57.1 4.9 4.2 4.8 16.2 8.9 16.4 4.0 4.9 9.0 9.1 8.0 16.2 1.9 0.9 0.2 0.2 1.1 0.5 1.4 0.5 0.3 0.9 0.6 0.2 0.3 0.6 0.4 0.7 21.7 0.4 0.4 14.5 14.9 16.6 21.5 14.7 14.9 14.7 15.7 14.1 14.7 15.1 13.9 2.1 0.0 8.4 4.2 2.5 2.4 11.8 23.9 2.2 0.2 19.0 17.1 0.9 7.2 16.6 12.9 0.0 18.3 1.0 7.8 0.0 9.0 17.0 24.1 4.6 1.7 4.8 1.3 0.0 8.3 36.4 4.2 7.1 23.6 0.0 0.9 1.1 18.6 3.5 1.7 0.0 8.8 14.2 0.8 3.7 15.6 1.2 1.5 3.6 0.0 2.1 5.3 0.0 1.0 0.0 10.5 4.5 0.4 1.8 23.7 8.5 6.9 31.0 0.7 0.0 2.0 8.8 20.2 7.2 8.4 2.0 32.3 2.2 3.0 8.0 23.1 TMEM91 "DSPC3, FLJ27310, IFITMD6" ENSG00000142046 "Transmembrane protein 91" Q6ZNR0 19 41350911-41384083 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 212.0;Late spermatids: 451.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 193.3" "Group enriched" "Detected in all" 8 "granulocytes: 193.3;monocytes: 51.9" "Cell line enhanced" "Detected in many" "HEL: 20.1;HSkMC: 20.5;TIME: 19.8" "Low region specificity" "Detected in all" HPA053240 Uncertain NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 25: Spermatids - Spermatogenesis" "HPA053240: AB_2682085" "unprognostic (3.02e-3)" "unprognostic (1.92e-2)" "unprognostic (5.13e-3)" "unprognostic (2.97e-2)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (4.70e-2)" "unprognostic (2.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.69e-3)" "prognostic favorable (3.54e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.06e-2)" 24.0 12.8 32.3 6.9 43.1 36.2 19.7 19.5 35.2 39.1 27.7 26.6 3.5 18.6 10.2 22.6 30.2 8.2 16.4 29.3 49.0 20.3 9.6 23.3 6.5 29.2 33.3 20.1 17.7 4.1 26.2 9.4 28.4 23.0 3.9 9.2 11.4 8.6 5.4 66.3 14.3 8.7 23.3 37.5 12.3 37.8 52.7 5.7 20.5 7.3 7.6 29.8 31.3 24.2 3.3 7.0 5.4 2.7 6.4 13.6 5.0 2.6 3.4 1.3 2.1 0.5 2.9 1.5 2.4 3.0 2.1 0.9 1.3 2.4 3.0 2.3 3.6 20.1 5.7 11.1 12.3 3.4 5.2 20.5 12.6 4.0 9.8 14.8 9.2 3.7 3.8 6.2 2.1 6.3 2.5 6.6 2.3 0.9 4.2 4.2 1.2 1.4 3.4 1.6 1.4 3.3 5.0 1.0 4.1 3.8 1.3 9.9 19.8 3.1 3.0 2.9 2.7 3.8 0.6 1.1 6.5 4.6 1.2 36.8 51.9 4.0 5.9 12.3 7.4 0.7 3.4 3.1 9.5 1.4 8.0 3.9 193.3 1.5 9.1 14.6 4.7 41.2 32.3 43.1 19.5 35.2 29.3 49.0 29.2 33.3 28.4 23.3 52.7 24.2 20.2 3.2 22.4 23.8 3.5 17.8 22.9 59.8 7.4 8.3 10.7 15.9 5.3 2.8 25.0 7.3 6.2 2.7 10.6 0.7 1.9 5.3 212.0 12.0 12.1 13.7 14.4 4.8 11.7 3.2 84.3 21.7 1.1 4.8 34.2 13.0 20.0 3.8 15.7 8.4 18.9 1.6 10.2 67.6 8.4 451.5 14.0 51.6 8.8 7.5 30.7 4.1 20.6 5.0 5.8 3.8 18.5 7.2 1.7 6.5 2.3 2.5 13.5 6.4 6.6 4.8 8.6 4.9 9.0 9.7 21.3 8.6 7.8 3.7 1.7 10.4 TNFSF9 "4-1BB-L, 4-1BBL" ENSG00000125657 "TNF superfamily member 9" P41273 19 6531026-6535924 "Plasma proteins, Predicted intracellular proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 9.8;esophagus: 9.8;vagina: 9.5" "Cell type enhanced" "Detected in many" "B-cells: 57.5;dendritic cells: 51.6;Gastric mucus-secreting cells: 23.0;Macrophages: 22.5;T-cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 85.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA059857 Approved "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA059857: AB_2684144" "unprognostic (2.21e-1)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "unprognostic (7.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-1)" "unprognostic (2.93e-2)" "unprognostic (2.41e-3)" "unprognostic (4.88e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (8.07e-3)" 1.8 0.6 3.5 1.0 3.0 3.7 0.8 3.7 7.6 9.8 2.3 1.2 0.3 0.3 0.3 9.8 1.1 1.0 0.6 3.9 3.3 0.9 0.4 4.9 1.1 3.6 2.9 0.5 0.3 0.5 0.3 0.9 3.4 0.3 1.8 0.3 1.5 0.1 0.7 1.4 1.2 0.4 3.1 2.2 0.6 3.3 3.1 0.5 0.4 0.3 0.7 0.7 9.5 6.3 10.7 13.4 0.2 4.8 2.5 6.0 0.4 1.5 4.8 3.6 17.1 0.3 18.0 11.3 6.8 3.0 0.0 19.2 5.4 2.3 0.9 0.0 2.6 1.8 18.4 4.4 0.4 0.3 85.8 1.0 10.1 20.1 5.5 2.6 0.6 1.6 10.9 0.2 1.3 1.5 0.9 1.8 1.8 0.7 9.5 1.2 0.0 2.8 22.9 0.4 0.0 0.0 29.8 1.7 5.0 0.6 1.2 16.4 6.2 0.0 9.6 26.0 0.0 26.9 10.2 20.9 10.2 5.9 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.5 3.0 3.7 7.6 3.9 3.3 3.6 2.9 3.4 3.1 3.1 6.3 11.3 0.0 4.5 0.0 57.5 2.7 0.3 4.3 6.2 0.2 4.0 3.8 8.1 0.0 1.6 0.0 0.0 0.1 51.6 4.3 0.0 0.3 0.1 5.7 3.9 6.8 14.2 0.0 2.2 0.2 0.0 12.6 23.0 9.2 8.9 0.6 1.8 0.0 4.5 0.0 2.5 3.4 2.0 1.9 15.9 0.0 0.0 22.5 3.6 0.0 1.6 0.8 0.0 1.5 2.9 0.8 4.9 0.0 17.2 0.9 0.2 0.1 0.9 0.2 0.0 2.5 7.5 0.1 0.4 12.7 1.3 0.1 31.5 0.9 5.7 0.3 TNPO2 "FLJ12155, IPO3, KPNB2B, TRN2" ENSG00000105576 "Transportin 2" O14787 19 12699194-12724011 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046446, HPA071498" Approved Approved Nucleoplasm,Nucleoli Yes No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli" "CAB046446: AB_10603392, HPA071498: AB_2686405" "unprognostic (1.88e-1)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.16e-5)" "unprognostic (2.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.63e-2)" "prognostic favorable (8.18e-4)" "unprognostic (2.76e-3)" "unprognostic (6.00e-2)" "unprognostic (3.50e-3)" "unprognostic (7.63e-2)" 28.3 33.0 50.3 21.7 54.4 26.8 24.8 36.7 57.3 30.9 28.2 28.4 17.3 33.3 25.5 31.3 30.3 20.5 26.6 54.6 44.1 22.5 18.4 23.0 23.4 51.3 45.4 40.3 20.6 32.3 33.6 20.9 50.9 26.6 19.8 33.0 22.2 23.9 25.7 48.1 23.4 28.1 39.5 26.3 23.5 32.7 51.5 27.8 26.8 20.1 23.9 28.6 27.6 51.2 54.4 40.5 61.0 78.3 36.3 47.6 39.5 61.0 40.1 86.5 60.6 55.9 28.5 36.6 46.5 51.7 24.1 70.5 109.2 60.3 47.9 45.6 87.6 56.5 72.1 68.4 40.9 100.6 52.0 42.9 46.8 57.5 60.4 55.8 41.0 72.7 89.4 33.9 48.5 93.4 84.8 68.8 71.0 39.8 120.8 80.7 47.6 67.0 51.2 38.9 148.6 73.8 49.6 62.2 30.7 41.2 43.5 35.2 41.5 131.5 34.9 71.3 91.2 66.8 70.4 62.3 39.2 89.9 47.9 0.2 0.2 0.1 0.6 0.3 0.9 0.4 0.4 0.5 0.4 0.4 0.8 1.0 0.8 0.1 0.4 1.5 0.2 0.2 50.3 54.4 36.7 57.3 54.6 44.1 51.3 45.4 50.9 39.5 51.5 51.2 13.2 6.4 17.9 24.2 10.7 31.0 8.9 10.6 14.8 42.4 22.8 17.1 17.6 11.5 10.0 22.0 100.1 10.9 11.0 14.1 5.9 9.7 12.2 16.2 20.6 17.0 22.9 14.9 22.3 8.5 6.6 18.0 10.2 12.9 3.8 20.7 19.2 17.8 10.5 57.2 26.6 17.7 8.2 13.0 14.9 19.5 31.1 8.7 8.8 22.5 11.1 24.6 6.2 19.6 24.7 15.2 9.1 32.4 8.7 19.3 11.9 16.7 11.3 33.6 6.6 23.8 15.3 23.8 11.3 21.9 41.5 14.5 9.5 16.5 16.6 9.3 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652516-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971" "unprognostic (5.71e-3)" "prognostic favorable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favorable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favorable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.0 0.0 0.7 0.7 0.5 0.5 0.8 4.2 0.5 1.4 8.0 0.2 0.0 0.1 0.1 3.7 6.7 0.0 0.1 0.8 0.7 0.1 0.2 0.9 1.0 2.4 2.9 0.1 0.8 0.1 0.3 0.0 1.4 2.6 0.1 0.2 2.9 0.3 0.2 6.6 0.2 0.0 1.4 0.7 0.3 0.7 0.7 1.6 0.2 0.0 1.4 0.1 2.9 1.0 2.6 0.1 0.3 7.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.9 4.0 2.6 2.0 0.0 0.9 4.3 2.7 0.9 0.0 0.8 8.7 0.2 3.9 2.6 0.0 0.0 2.9 0.0 1.7 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.8 1.9 15.0 2.0 0.5 0.0 0.1 0.0 11.6 0.1 0.3 3.8 18.0 8.4 0.4 0.0 0.8 0.0 10.9 9.2 0.0 2.9 7.5 0.0 5.8 3.3 0.7 18.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 4.2 0.5 0.8 0.7 2.4 2.9 1.4 1.4 0.7 1.0 0.0 0.0 1.5 0.0 1.2 3.1 3.8 13.0 16.5 0.5 0.2 2.5 1.5 0.0 7.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 21.8 31.0 0.3 0.3 2.4 3.2 0.1 0.2 0.4 0.4 0.0 0.7 0.0 0.1 0.4 0.2 0.3 0.0 0.1 0.5 2.0 0.0 1.3 15.7 0.6 0.1 1.8 0.0 0.0 0.2 0.0 2.5 0.1 0.2 0.0 0.0 6.8 0.2 0.0 0.1 35.8 0.1 0.0 0.0 2.6 0.1 0.4 1.6 2.3 0.3 0.4 0.1 0.3 0.2 TPD52L1 "D53, hD53, TPD53" ENSG00000111907 "TPD52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 258.3;salivary gland: 298.3" "Cell type enhanced" "Detected in many" "Astrocytes: 390.1;Squamous epithelial cells: 272.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favorable (3.97e-4)" "prognostic unfavorable (5.34e-4)" 44.7 258.3 83.9 10.1 96.2 0.8 67.0 72.6 97.4 35.8 103.4 36.2 9.7 15.2 68.8 152.4 34.6 27.3 71.4 78.4 81.3 40.6 58.4 10.9 6.6 81.4 76.8 20.7 47.1 67.3 24.8 8.9 78.8 41.0 13.0 1.9 298.3 79.1 111.9 47.9 10.6 12.3 68.5 2.0 43.1 5.1 81.5 3.4 60.7 126.2 12.3 59.6 60.8 76.6 37.7 42.0 0.5 269.1 2.4 0.6 63.3 6.2 5.9 0.0 0.7 67.3 46.9 0.1 136.2 31.2 9.1 83.8 8.4 58.2 0.2 0.8 58.0 0.8 58.0 0.5 5.7 0.2 0.1 7.4 234.3 0.1 30.7 82.5 0.0 0.0 30.5 0.6 4.7 365.5 0.0 0.7 4.4 36.8 22.7 0.4 0.1 0.0 271.4 9.8 9.1 0.2 70.5 189.4 4.6 9.6 162.3 0.8 0.2 1.8 5.9 0.5 2.0 0.1 0.1 0.2 1.0 0.3 0.7 1.8 0.5 0.3 0.3 0.2 0.3 0.3 0.6 0.2 0.2 0.4 0.7 0.5 2.7 2.6 0.1 0.4 0.2 0.4 83.9 96.2 72.6 97.4 78.4 81.3 81.4 76.8 78.8 68.5 81.5 76.6 141.6 0.0 28.3 390.1 2.2 19.6 44.6 70.2 128.1 3.8 164.4 154.9 45.8 25.8 51.7 125.0 4.2 32.7 3.2 3.9 176.1 30.7 6.9 71.7 21.1 87.2 16.2 0.0 16.4 110.8 140.2 18.8 13.7 184.5 2.5 29.5 15.4 59.9 10.9 0.0 48.2 11.3 83.4 2.1 5.2 4.9 17.4 3.4 131.6 28.1 0.6 3.9 1.0 11.6 2.9 35.3 2.3 36.5 2.6 37.1 10.9 45.4 15.7 1.3 0.0 177.1 10.1 5.7 9.2 272.2 37.2 14.4 3.5 53.8 17.8 19.2 TRIM35 "HLS5, KIAA1098, MAIR" ENSG00000104228 "Tripartite motif containing 35" Q9UPQ4 8 27284886-27311272 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 68.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019647 Approved Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "HPA019647: AB_1858291" "unprognostic (7.67e-3)" "unprognostic (6.53e-2)" "unprognostic (1.61e-2)" "unprognostic (9.64e-3)" "unprognostic (9.35e-2)" "prognostic favorable (1.38e-4)" "unprognostic (8.79e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (4.86e-2)" "prognostic favorable (5.59e-7)" "unprognostic (1.74e-2)" "unprognostic (1.69e-1)" "unprognostic (3.99e-2)" "unprognostic (1.92e-1)" 9.4 6.1 6.5 5.9 8.2 7.2 8.4 8.1 9.2 8.9 13.7 7.9 5.5 8.8 4.5 10.7 7.4 3.6 5.5 8.9 6.8 6.3 11.9 5.9 6.9 10.0 7.7 6.1 5.9 4.6 4.2 5.3 9.7 7.3 3.9 4.1 16.3 9.0 5.0 32.2 6.2 7.2 6.7 6.2 5.9 6.4 9.8 8.1 4.6 4.6 7.0 8.2 10.4 11.7 17.4 12.3 7.0 9.0 68.4 16.9 16.1 10.3 8.1 9.4 10.0 17.6 3.4 15.3 10.3 11.5 8.3 17.0 10.1 19.9 7.1 8.7 7.6 15.1 10.3 15.1 17.8 8.3 12.4 24.6 44.2 13.3 26.1 5.0 9.4 14.5 10.8 16.4 7.7 9.0 27.8 11.3 12.3 11.1 9.8 13.8 9.0 13.3 6.4 13.5 11.9 11.4 8.6 8.1 14.3 6.7 5.2 13.2 10.9 8.5 17.7 27.1 10.2 7.5 8.5 11.1 12.1 12.0 8.5 11.9 3.0 4.0 8.6 3.0 9.7 5.3 11.2 9.7 3.8 3.8 7.5 11.2 1.1 8.9 3.4 6.4 14.5 5.3 6.5 8.2 8.1 9.2 8.9 6.8 10.0 7.7 9.7 6.7 9.8 11.7 9.4 3.2 4.5 5.2 4.4 20.9 6.0 4.6 40.9 3.5 3.6 2.7 5.0 8.6 3.8 12.9 6.2 3.5 3.2 3.6 0.0 3.7 1.0 4.0 3.7 6.7 2.4 8.6 8.3 5.1 2.8 6.6 6.1 4.6 5.7 3.8 23.9 20.3 2.9 5.0 5.3 2.7 6.1 8.9 6.2 0.6 12.8 6.9 7.2 3.7 5.2 3.5 3.1 4.5 16.8 4.7 2.0 10.9 4.8 3.6 4.5 6.1 0.9 3.5 0.0 3.4 5.5 1.3 3.9 15.0 22.3 1.5 6.9 2.4 3.5 2.5 TRIM62 "DEAR1, FLJ10759" ENSG00000116525 "Tripartite motif containing 62" Q9BVG3 1 33145399-33182059 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.0" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "AF22: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050061 Approved "Vesicles,Focal adhesion sites" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 68: Oligodendrocytes - Mixed function" "Vesicles, Focal adhesion sites" "HPA050061: AB_2681001" "unprognostic (1.57e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (2.62e-2)" "unprognostic (1.14e-2)" "unprognostic (5.80e-2)" "unprognostic (5.10e-5)" "unprognostic (2.05e-2)" "unprognostic (1.14e-1)" "unprognostic (4.32e-2)" "unprognostic (3.55e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (2.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" 3.1 6.6 8.7 2.9 13.1 4.8 3.6 10.0 11.9 3.2 2.3 3.2 2.4 3.1 2.6 5.1 3.0 2.0 3.5 8.5 10.4 3.5 1.8 3.1 4.6 10.7 11.3 3.7 3.1 2.9 6.4 3.4 12.1 5.1 2.1 2.1 5.2 2.9 4.9 12.5 4.2 2.8 7.4 5.1 4.3 2.3 12.4 5.2 3.9 2.5 4.5 4.8 4.4 21.0 3.7 2.7 23.9 3.9 5.7 2.5 7.6 3.4 9.9 6.3 5.5 3.0 3.7 5.9 3.8 3.0 3.2 7.2 5.0 4.3 5.6 5.8 3.8 6.5 3.2 2.5 5.7 2.2 16.2 5.2 3.9 8.7 2.0 9.9 6.3 5.0 1.1 3.8 6.1 9.9 6.8 2.0 6.0 4.3 3.5 8.6 12.8 2.7 3.8 9.6 6.0 3.7 3.8 14.5 16.8 12.6 4.1 1.4 6.3 2.7 3.8 8.1 2.8 6.9 3.3 2.7 5.1 3.9 3.5 1.2 1.0 3.4 1.3 1.8 2.3 1.1 1.9 1.8 0.9 1.4 1.3 1.2 2.3 1.0 1.1 0.4 4.7 1.1 8.7 13.1 10.0 11.9 8.5 10.4 10.7 11.3 12.1 7.4 12.4 21.0 2.0 3.2 2.2 2.6 1.8 2.7 0.8 1.7 2.8 3.4 3.5 1.9 0.9 0.0 1.2 1.8 0.0 1.1 2.5 1.5 0.0 1.4 0.5 0.6 1.1 1.4 1.8 0.4 1.9 1.9 1.8 2.1 4.1 1.3 1.3 1.7 1.1 0.7 1.2 10.1 10.2 1.5 4.1 1.2 1.6 0.5 2.5 1.3 0.0 10.3 1.4 1.5 3.1 50.8 26.0 2.6 0.6 4.9 2.6 2.1 1.2 1.0 0.4 1.0 6.6 2.0 2.1 1.3 0.6 2.8 4.7 1.4 3.0 3.4 0.9 2.0 TTC39B "C9orf52, FLJ33868" ENSG00000155158 "Tetratricopeptide repeat domain 39B" Q5VTQ0 9 15163622-15307360 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 64.4;Paneth cells: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 2.0;gdT-cell: 2.9;MAIT T-cell: 3.9;memory CD4 T-cell: 4.0;memory CD8 T-cell: 4.6;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.9;NK-cell: 6.3;T-reg: 3.8" "Group enriched" "Detected in many" 6 "granulocytes: 2.0;NK-cells: 6.3;T-cells: 4.7" "Cell line enhanced" "Detected in many" "HEL: 40.9;RT4: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063162 Approved "Endoplasmic reticulum" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Endoplasmic reticulum" "HPA063162: AB_2684952" "unprognostic (1.64e-1)" "unprognostic (9.32e-3)" "unprognostic (1.47e-2)" "unprognostic (7.89e-2)" "unprognostic (7.47e-2)" "unprognostic (1.06e-1)" "unprognostic (4.12e-2)" "prognostic favorable (9.64e-6)" "unprognostic (5.99e-2)" "unprognostic (4.77e-2)" "unprognostic (1.59e-1)" "unprognostic (6.89e-2)" "prognostic favorable (4.08e-7)" "unprognostic (3.31e-3)" "unprognostic (2.12e-2)" "unprognostic (5.19e-2)" "unprognostic (1.48e-1)" 1.9 2.6 2.9 4.0 2.5 1.5 4.8 10.8 7.0 4.3 1.8 6.7 5.7 3.5 1.9 8.8 3.3 6.9 1.3 1.5 4.6 9.0 5.4 4.6 6.1 7.0 2.9 2.9 3.9 1.9 3.9 1.2 7.2 2.3 5.6 2.9 3.0 1.9 1.8 9.6 5.6 4.2 2.5 3.8 5.5 5.7 4.7 3.4 2.6 1.3 6.0 3.6 4.7 2.9 3.9 0.8 1.2 5.6 5.3 9.9 1.2 5.0 9.1 3.9 9.3 0.8 1.6 0.0 0.6 6.3 4.6 3.4 0.9 6.2 3.3 4.5 0.8 40.9 1.7 7.3 8.8 0.0 0.8 9.7 4.7 8.1 9.0 2.8 5.6 3.3 0.1 9.1 10.0 1.3 2.2 0.2 1.6 12.3 1.2 0.4 3.0 1.9 8.3 23.0 2.9 0.5 1.2 2.9 0.9 1.8 12.7 2.5 4.2 2.2 1.8 3.1 1.4 0.1 0.1 0.0 2.1 0.5 1.1 2.0 0.7 0.9 2.9 0.5 3.9 0.2 4.0 4.6 0.4 0.6 4.7 2.9 0.4 6.3 0.7 0.1 3.8 2.5 2.9 2.5 10.8 7.0 1.5 4.6 7.0 2.9 7.2 2.5 4.7 2.9 7.5 12.8 19.8 10.4 7.0 17.3 7.8 19.1 10.8 25.5 9.0 4.4 4.1 10.0 15.8 7.3 0.0 3.2 18.0 40.6 17.6 6.6 43.2 11.8 10.1 7.4 12.7 0.4 44.0 21.8 1.1 10.0 22.4 7.7 29.1 3.6 7.5 11.6 4.1 13.5 64.4 16.1 24.4 3.1 9.2 33.2 7.2 16.7 7.2 12.2 2.9 14.9 11.3 24.6 2.3 10.5 65.0 12.8 5.5 11.5 30.3 35.5 25.3 4.3 0.0 9.4 12.4 4.7 3.0 8.6 21.5 4.1 22.3 6.8 17.3 14.4 TUBB2A "dJ40E16.7, TUBB, TUBB2" ENSG00000137267 "Tubulin beta 2A class IIa" Q13885 6 3153497-3157544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 364.3" "Cell type enhanced" "Detected in many" "Horizontal cells: 516.5;Suprabasal keratinocytes: 368.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.2;monocytes: 1.6;T-cells: 3.2" "Cell line enhanced" "Detected in all" "AF22: 241.1;CACO-2: 247.6;SuSa: 365.5;WM-115: 280.1" "Low region specificity" "Detected in all" "CAB015339, HPA043640, HPA046280" Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 61: Squamous epithelial cells - Keratinization" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.57e-1)" "unprognostic (9.86e-3)" "unprognostic (5.90e-3)" "unprognostic (7.98e-3)" "unprognostic (4.02e-3)" "unprognostic (1.67e-1)" "unprognostic (1.82e-3)" "unprognostic (7.53e-2)" "unprognostic (1.48e-3)" "unprognostic (9.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.42e-2)" "prognostic favorable (4.65e-4)" "unprognostic (2.39e-2)" "unprognostic (1.79e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (1.61e-4)" 58.8 17.8 266.1 19.3 251.1 67.5 47.8 130.1 287.5 32.7 10.0 78.0 24.2 50.8 28.0 90.6 23.5 21.5 29.4 248.3 364.3 31.1 67.0 16.4 11.0 292.6 212.2 15.5 39.4 2.2 56.3 23.9 334.3 17.5 8.2 49.9 52.2 15.6 22.3 151.4 34.9 41.7 131.6 7.7 41.0 9.5 204.4 6.4 10.0 11.8 9.6 23.6 51.2 169.4 55.9 45.3 241.1 53.6 30.6 34.0 14.5 119.8 44.7 80.6 115.7 247.6 18.4 27.4 72.9 115.5 80.2 26.0 86.6 26.8 28.0 134.1 57.7 9.4 11.4 77.0 31.6 1.5 8.4 35.1 31.1 85.1 5.3 28.9 37.3 10.6 33.7 8.8 74.2 25.1 14.9 2.8 207.2 16.0 58.3 12.4 22.6 18.9 28.0 27.4 57.6 52.9 30.5 8.5 179.7 365.5 19.1 2.0 76.0 53.9 56.7 117.3 65.8 3.2 4.6 18.8 19.7 7.0 280.1 0.0 1.1 0.0 2.2 1.6 2.4 3.2 2.1 3.1 0.5 0.6 1.0 2.0 0.3 0.4 1.3 0.2 3.2 1.2 266.1 251.1 130.1 287.5 248.3 364.3 292.6 212.2 334.3 131.6 204.4 169.4 125.3 16.0 13.1 43.1 31.6 311.4 63.3 87.0 132.6 105.6 32.0 134.6 20.4 42.9 62.7 12.9 16.7 6.0 53.4 87.0 217.2 54.0 60.9 46.7 29.6 40.6 73.1 322.3 59.9 182.4 50.4 96.2 185.0 57.9 34.9 10.1 12.5 55.6 50.8 516.5 73.0 103.9 73.2 6.3 164.4 32.9 20.8 36.7 129.9 24.4 72.7 261.0 0.0 18.1 23.0 103.4 181.8 15.4 15.8 34.9 126.3 40.4 50.3 86.2 6.6 95.6 87.9 32.4 14.9 140.6 368.5 6.2 58.9 6.4 60.0 54.7 UBTD1 FLJ11807 ENSG00000165886 "Ubiquitin domain containing 1" Q9HAC8 10 97498924-97571206 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 53.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 6.4;neutrophil: 6.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034825 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Plasma membrane, Cytosol" "HPA034825: AB_10602254" "unprognostic (1.52e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (2.43e-1)" "unprognostic (1.78e-1)" "unprognostic (3.90e-2)" "unprognostic (3.63e-3)" "unprognostic (1.43e-2)" "unprognostic (1.66e-3)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "unprognostic (4.78e-1)" "unprognostic (6.62e-3)" "unprognostic (8.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-3)" "unprognostic (3.50e-3)" 18.8 11.1 14.9 5.7 15.2 8.8 14.7 16.8 17.0 16.5 12.6 10.3 1.8 13.5 4.0 9.5 13.6 7.0 35.1 13.5 15.8 29.2 18.6 29.8 3.1 17.7 17.1 8.7 9.6 3.6 15.9 3.8 16.2 13.4 0.6 6.0 11.2 7.5 34.2 49.5 5.5 3.6 16.1 11.0 9.4 60.3 18.9 1.6 14.6 11.2 1.1 12.4 16.3 14.6 18.1 17.7 4.6 23.0 18.9 17.8 5.4 20.3 29.4 21.3 16.3 12.0 15.4 2.2 24.1 13.8 13.4 21.4 4.6 27.2 3.0 5.6 9.1 2.2 5.5 15.2 27.2 2.0 5.9 24.6 9.0 23.3 5.7 32.8 34.3 4.7 1.2 3.3 13.9 8.6 0.9 18.5 7.5 3.4 32.1 1.8 8.1 2.1 16.7 6.7 1.5 4.8 9.2 5.6 27.1 4.0 20.8 13.6 37.5 26.9 16.4 28.4 26.8 4.2 5.1 0.9 22.7 12.3 14.3 1.0 2.6 6.4 0.1 0.7 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 6.6 0.0 0.7 0.9 0.3 0.5 14.9 15.2 16.8 17.0 13.5 15.8 17.7 17.1 16.2 16.1 18.9 14.6 5.0 41.7 28.6 13.1 1.1 26.0 8.8 32.2 19.4 3.8 10.0 4.8 15.5 8.6 21.2 7.3 4.2 3.5 0.6 1.5 11.7 18.9 53.5 8.2 8.7 23.8 0.0 0.4 5.6 12.8 12.8 11.6 2.6 4.0 0.0 0.8 7.9 7.0 25.8 6.7 5.9 0.2 10.2 10.1 18.9 33.8 12.8 10.3 10.6 12.2 8.4 16.5 2.1 2.0 14.5 22.1 0.1 9.4 3.0 14.0 0.0 10.4 19.1 18.6 13.1 8.5 10.3 7.5 7.9 8.2 29.7 2.9 1.9 1.5 0.4 7.6 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942014-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 6.1" "Cell type enhanced" "Detected in many" "Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 12.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enriched" "Detected in single" 6 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "SiHa: 66.7;U-2197: 47.4" "CAB018974, HPA066741" Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 27: Brain & Skin - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Plasma membrane" "CAB018974: , HPA066741: " "unprognostic (2.09e-5)" "prognostic unfavorable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 1.5 0.7 1.3 0.6 1.6 1.8 0.7 1.6 2.6 0.9 0.7 0.2 0.2 0.1 0.1 6.1 0.2 0.5 2.0 3.0 1.0 2.1 0.5 3.4 0.3 1.8 1.2 0.0 0.4 0.6 0.5 1.6 1.8 0.2 0.1 0.2 0.7 0.1 0.3 0.5 0.2 0.7 0.8 0.2 0.3 1.5 1.1 0.7 1.2 0.7 0.8 1.4 1.6 1.7 19.9 1.8 0.5 6.1 1.1 5.6 3.3 20.1 11.8 20.6 16.8 7.4 11.0 0.0 29.9 23.0 29.6 13.9 7.6 18.4 11.8 9.1 3.9 1.1 2.8 0.0 7.1 0.0 1.5 2.7 13.9 18.3 8.0 16.7 11.9 16.6 2.5 0.0 15.4 13.9 1.8 0.0 0.0 3.6 10.2 3.0 4.5 0.0 29.0 5.7 0.6 0.0 66.7 1.4 1.9 3.2 1.8 8.5 18.8 13.5 17.1 47.4 23.5 0.0 0.1 0.9 19.2 10.7 9.9 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.8 1.5 0.0 0.0 0.3 1.8 0.0 0.4 0.0 0.0 1.7 0.5 1.3 1.6 1.6 2.6 3.0 1.0 1.8 1.2 1.8 0.8 1.1 1.7 28.9 0.0 1.3 0.0 1.2 3.7 6.5 17.9 7.4 0.0 1.3 4.4 0.3 0.0 9.4 1.8 0.0 0.0 12.1 0.5 0.0 7.5 7.0 0.3 0.5 9.1 0.0 0.0 3.0 8.8 0.5 3.0 1.1 0.2 0.0 0.1 7.1 0.2 2.2 0.0 0.7 0.3 2.0 0.8 2.1 8.0 0.0 3.1 1.8 0.0 0.0 0.4 4.1 0.5 0.3 4.5 0.0 0.0 1.4 1.4 0.0 0.1 1.4 0.0 0.0 1.0 4.2 3.1 7.0 11.8 2.8 0.0 11.0 0.6 0.4 5.2 ULK3 "DKFZP434C131, FLJ90566" ENSG00000140474 "Unc-51 like kinase 3" Q6PHR2 15 74836118-74843346 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 89.7;Horizontal cells: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040474 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "HPA040474: AB_2677003" "unprognostic (3.67e-2)" "unprognostic (8.90e-3)" "unprognostic (2.65e-3)" "unprognostic (1.59e-2)" "unprognostic (1.70e-1)" "unprognostic (2.07e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (1.47e-2)" "unprognostic (4.18e-2)" "prognostic favorable (7.47e-4)" "unprognostic (1.97e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-2)" "unprognostic (1.63e-1)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" 7.1 15.2 29.5 6.4 31.5 2.2 6.1 28.1 32.2 13.6 23.0 12.1 5.0 4.4 3.5 35.7 5.5 4.5 15.9 29.4 27.3 17.6 13.8 8.3 5.8 34.0 26.6 5.7 12.0 16.2 12.5 3.5 35.8 9.9 9.4 15.4 11.5 3.1 21.0 24.7 15.7 4.4 26.1 13.1 10.6 7.1 27.8 6.3 7.6 19.0 7.8 9.4 15.4 30.4 6.7 17.7 7.4 14.4 9.3 6.7 6.0 5.1 7.3 10.1 11.1 7.0 15.4 13.0 8.8 6.2 10.8 4.7 23.1 7.6 4.4 26.1 26.1 30.3 25.0 7.4 14.8 10.3 22.5 9.4 14.0 8.2 7.1 3.5 15.8 16.8 10.3 11.9 7.0 9.4 7.3 6.6 10.0 10.6 8.7 18.6 10.3 23.0 6.0 7.4 16.7 22.3 8.6 9.8 25.6 9.1 11.0 26.8 9.4 16.0 8.9 12.7 10.3 20.7 19.7 9.3 7.4 29.5 12.4 5.2 3.5 1.4 10.9 7.3 8.7 3.3 6.4 9.0 3.7 2.8 7.1 4.8 0.8 5.8 6.1 4.0 9.2 5.1 29.5 31.5 28.1 32.2 29.4 27.3 34.0 26.6 35.8 26.1 27.8 30.4 16.5 9.6 15.3 37.2 11.4 10.1 7.5 6.0 10.2 89.7 18.1 13.6 17.1 14.3 6.7 12.9 16.7 9.2 23.3 46.4 19.6 11.0 1.0 8.9 8.8 10.7 11.4 14.1 64.7 11.7 2.5 9.2 23.4 11.9 21.0 6.2 13.2 13.3 16.1 89.2 56.5 17.5 4.1 7.9 8.2 2.2 13.1 11.2 5.4 18.7 13.2 18.4 29.9 16.6 15.3 12.3 17.9 11.7 8.6 10.4 68.5 16.5 8.0 54.5 0.0 12.9 8.8 9.5 17.3 19.7 21.7 5.7 19.7 12.3 27.9 8.9 UNC5B "p53RDL1, UNC5H2" ENSG00000107731 "Unc-5 netrin receptor B" Q8IZJ1 10 71212570-71302864 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell type enhanced" "Detected in many" "Horizontal cells: 112.7;Muller glia cells: 54.1;Oligodendrocytes: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 46.2;HHSteC: 146.3;hTCEpi: 132.1;SH-SY5Y: 123.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076687 Approved NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 62: Horizontal cells - Visual perception" "HPA076687: " "unprognostic (3.98e-2)" "unprognostic (3.14e-2)" "unprognostic (9.28e-2)" "unprognostic (2.71e-1)" "unprognostic (5.64e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.01e-5)" "unprognostic (8.82e-3)" "unprognostic (6.79e-3)" "prognostic unfavorable (3.80e-5)" "unprognostic (7.70e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.17e-2)" "unprognostic (4.62e-2)" "unprognostic (9.89e-3)" "unprognostic (2.25e-1)" 3.2 10.2 17.5 4.0 28.4 0.1 2.3 26.8 19.2 6.0 15.4 7.2 2.6 5.9 6.0 18.6 7.4 8.8 15.6 15.1 17.3 7.9 2.4 9.5 3.5 34.1 28.8 3.6 4.3 2.2 5.8 5.0 25.3 9.8 4.9 7.8 5.3 27.0 2.6 8.0 5.2 4.4 19.1 7.8 8.7 5.6 32.3 2.9 3.7 4.1 2.9 9.0 12.2 48.3 0.0 0.2 0.8 3.9 11.6 18.9 0.3 6.6 19.3 0.2 0.6 3.8 17.9 0.0 6.7 41.6 0.4 46.2 1.4 2.7 0.0 0.1 4.3 10.7 0.7 0.2 146.3 0.2 1.1 16.4 132.1 1.6 8.4 1.7 2.8 0.2 0.4 0.1 0.2 1.5 0.0 0.0 10.3 9.6 0.3 0.0 4.5 0.1 0.1 20.5 20.3 123.7 1.4 1.6 1.0 18.2 1.9 0.6 8.0 1.4 5.9 2.5 2.7 0.0 0.0 0.0 42.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 28.4 26.8 19.2 15.1 17.3 34.1 28.8 25.3 19.1 32.3 48.3 18.6 0.0 3.3 5.5 0.0 3.1 19.3 21.8 2.8 13.1 1.6 3.0 7.6 0.0 11.3 5.5 0.0 0.4 0.0 34.3 0.0 5.7 0.4 12.7 4.8 22.7 3.0 0.0 8.9 1.6 0.4 6.5 12.2 25.8 22.9 27.0 7.5 0.0 1.2 112.7 11.3 6.3 32.6 8.5 2.4 1.0 0.6 5.9 1.8 29.0 0.6 54.1 0.0 11.6 89.0 12.1 20.1 0.7 0.0 14.7 8.1 0.2 14.4 3.5 0.0 2.7 12.7 0.8 5.4 20.3 4.3 0.3 0.8 0.7 4.7 44.8 VANGL2 "KIAA1215, LPP1, LTAP, MGC119403, MGC119404, STB1, STBM, STBM1" ENSG00000162738 "VANGL planar cell polarity protein 2" Q9ULK5 1 160400564-160428670 "Disease related genes, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Intestinal goblet cells: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 106.3;AN3-CA: 26.4;NTERA-2: 43.1;SH-SY5Y: 28.9;SuSa: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027043 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA027043: AB_10601709" "unprognostic (4.32e-3)" "unprognostic (1.86e-1)" "unprognostic (1.59e-2)" "unprognostic (1.07e-3)" "unprognostic (3.05e-1)" "unprognostic (2.55e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-1)" "unprognostic (1.84e-3)" "unprognostic (9.83e-2)" "unprognostic (3.84e-1)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-2)" 1.6 1.5 8.3 2.5 7.9 0.2 5.7 9.1 6.8 10.1 5.3 7.2 5.2 7.1 6.3 13.1 6.1 3.1 4.9 8.5 11.5 3.9 0.4 5.7 4.8 12.8 14.7 8.3 6.1 5.5 4.4 6.1 11.2 10.7 5.6 4.3 13.3 8.2 1.9 37.6 5.4 3.7 12.8 2.0 4.9 1.9 13.5 8.3 8.2 1.3 7.0 6.1 14.0 11.2 1.2 1.6 106.3 26.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 10.0 0.1 13.5 0.0 0.2 6.2 17.8 0.9 0.0 0.0 1.3 5.4 0.0 0.0 0.1 0.0 0.0 0.2 3.7 0.0 0.0 0.3 0.0 4.1 8.4 0.0 0.7 0.0 7.2 0.3 43.1 0.5 0.0 14.5 5.6 0.1 0.0 0.2 9.8 28.9 0.0 0.0 9.6 36.7 0.0 1.4 0.0 0.0 16.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 7.9 9.1 6.8 8.5 11.5 12.8 14.7 11.2 12.8 13.5 11.2 1.3 0.0 0.5 14.0 0.0 15.8 2.8 7.1 6.2 4.3 11.0 9.5 3.8 4.3 4.3 0.0 33.3 0.0 1.3 1.9 0.0 3.9 1.2 1.9 7.8 2.6 16.8 0.0 0.8 1.6 0.0 5.0 3.1 4.1 0.0 5.0 2.5 0.0 0.1 10.1 2.5 18.4 8.2 0.0 0.4 1.4 3.7 0.2 7.2 0.0 0.0 4.3 0.0 13.0 3.5 4.3 2.2 7.2 0.1 7.1 1.3 0.4 3.9 0.4 0.0 3.5 3.7 0.5 3.0 13.1 17.0 0.0 0.2 1.5 6.4 5.6 VPS13D "FLJ10619, KIAA0453" ENSG00000048707 "Vacuolar protein sorting 13 homolog D" Q5THJ4 1 12230030-12512047 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 181.4;Inhibitory neurons: 149.2;Late spermatids: 208.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027332, HPA051621" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" Cytosol "HPA027332: AB_2672223, HPA051621: AB_2681555" "unprognostic (2.97e-1)" "unprognostic (8.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.75e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-3)" "unprognostic (3.33e-1)" "unprognostic (2.00e-2)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "prognostic favorable (7.42e-12)" "unprognostic (5.13e-1)" "unprognostic (1.72e-1)" "unprognostic (4.04e-2)" "unprognostic (8.31e-2)" 10.9 6.9 14.3 4.4 17.2 5.0 10.3 14.5 17.9 13.7 18.1 12.2 3.8 8.1 8.7 12.6 8.9 5.3 21.9 15.8 14.5 10.5 10.4 8.8 6.4 14.6 16.5 8.9 10.9 13.4 7.7 5.3 14.3 17.4 6.4 14.1 10.8 9.3 18.1 24.7 8.7 6.0 13.4 9.3 11.1 6.1 17.8 6.6 15.5 15.3 6.2 9.6 10.6 16.6 9.3 5.2 5.8 4.4 15.1 11.9 2.7 4.4 7.7 7.4 7.0 3.5 6.4 8.7 5.4 12.6 6.2 8.3 10.1 8.7 10.3 4.7 3.4 7.4 8.1 2.8 6.3 10.8 3.7 10.1 11.9 9.5 9.3 9.2 12.0 8.2 15.5 4.3 6.9 4.3 6.4 4.2 2.3 5.0 6.5 5.5 6.9 2.6 5.3 5.4 2.8 3.8 12.9 9.4 9.0 5.4 8.1 3.6 13.1 4.6 4.7 12.0 3.7 3.8 3.3 13.4 5.2 7.5 7.1 3.2 0.7 0.5 1.1 0.7 1.2 0.9 1.2 0.8 0.6 1.6 1.1 0.9 0.9 0.7 0.5 1.5 0.6 0.3 14.3 17.2 14.5 17.9 15.8 14.5 14.6 16.5 14.3 13.4 17.8 16.6 28.9 19.2 23.4 111.0 19.8 21.7 45.1 23.2 19.9 38.1 18.8 12.8 68.0 14.3 35.7 18.4 73.0 8.4 20.3 24.7 3.9 9.1 83.1 20.6 23.5 23.0 14.4 9.4 181.4 14.4 7.2 19.4 28.1 48.1 12.6 26.3 17.9 21.2 11.5 47.1 149.2 15.1 18.3 17.3 15.5 208.7 23.0 17.5 12.4 79.6 16.7 23.0 17.5 78.4 107.4 17.0 11.2 21.8 11.8 32.0 18.2 9.8 32.0 34.1 46.0 23.4 46.5 18.8 12.3 38.2 31.4 14.8 21.4 20.3 15.5 37.3 VPS26B "MGC10485, Pep8b" ENSG00000151502 "VPS26, retromer complex component B" Q4G0F5 11 134224671-134247788 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038172 Uncertain NA NA 8800 "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 25: Spermatids - Spermatogenesis" "HPA038172: AB_10675630" "unprognostic (1.55e-2)" "unprognostic (6.56e-2)" "unprognostic (7.02e-3)" "unprognostic (2.52e-3)" "unprognostic (1.52e-1)" "unprognostic (5.76e-2)" "unprognostic (5.29e-2)" "unprognostic (1.71e-1)" "unprognostic (3.54e-1)" "unprognostic (7.77e-2)" "unprognostic (6.97e-3)" "unprognostic (1.66e-1)" "unprognostic (3.42e-3)" "unprognostic (3.15e-2)" "unprognostic (7.05e-3)" "unprognostic (2.44e-1)" "unprognostic (2.13e-1)" 17.7 21.2 37.8 13.5 40.8 30.4 16.3 33.1 42.4 18.2 28.6 23.5 20.5 20.5 31.5 19.8 20.4 15.3 23.7 42.4 36.4 14.2 29.5 15.8 14.0 31.4 33.1 19.1 25.8 17.5 21.4 13.4 33.3 21.0 17.2 24.7 21.6 18.8 17.1 35.3 21.4 20.5 30.8 18.5 20.1 16.9 35.9 30.2 17.7 16.1 12.8 18.9 16.7 35.4 25.1 27.8 22.8 70.0 50.2 44.2 19.1 26.3 31.5 23.4 17.4 46.4 43.3 15.8 52.0 46.1 27.4 35.8 30.5 43.6 17.5 37.4 21.9 69.5 16.1 30.3 36.6 41.3 42.9 42.1 28.0 22.4 41.3 32.9 41.9 60.1 34.3 27.1 33.3 30.4 89.8 47.0 13.0 78.3 45.1 20.5 18.4 22.5 29.2 39.6 38.0 38.3 30.0 53.9 17.3 24.0 99.8 31.9 34.7 29.5 16.5 37.7 18.8 34.0 20.0 6.4 19.2 64.1 22.3 3.9 3.3 8.3 5.4 4.1 4.8 0.9 4.6 5.8 3.0 0.4 2.9 5.3 4.9 5.5 3.6 3.4 5.1 2.9 37.8 40.8 33.1 42.4 42.4 36.4 31.4 33.1 33.3 30.8 35.9 35.4 14.3 12.8 6.4 14.7 9.4 17.7 12.7 7.1 25.0 30.0 21.9 22.1 29.1 17.2 6.9 20.2 8.4 18.8 36.2 31.4 21.5 8.6 26.5 12.9 16.7 14.0 28.4 24.8 24.8 14.8 27.1 19.2 29.0 11.5 1.3 22.5 14.6 34.7 23.9 30.3 18.8 30.3 10.2 32.7 16.4 67.9 18.0 27.5 12.4 11.2 21.7 23.8 48.4 13.6 19.9 11.2 32.4 30.9 26.8 11.7 63.8 22.7 7.7 22.8 6.6 14.6 19.7 13.4 21.3 24.4 24.0 12.4 26.6 20.0 25.7 12.0 VPS33B FLJ14848 ENSG00000184056 "VPS33B late endosome and lysosome associated" Q9H267 15 90998673-91022603 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040415 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA040415: AB_10795419" "unprognostic (7.49e-2)" "unprognostic (1.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.55e-2)" "unprognostic (3.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (1.30e-1)" "unprognostic (2.84e-3)" "unprognostic (2.78e-2)" "unprognostic (7.94e-2)" "unprognostic (3.70e-1)" "unprognostic (6.75e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-2)" "unprognostic (1.00e-2)" 5.7 5.4 5.9 5.1 7.2 2.8 6.1 6.3 7.6 6.6 6.7 6.7 5.8 6.3 7.0 6.8 8.1 4.7 3.8 6.6 7.1 5.9 4.3 5.6 6.9 6.3 6.3 6.8 6.9 8.1 5.3 6.8 6.4 6.6 6.4 5.8 6.7 6.7 4.1 11.0 6.9 6.2 6.3 6.9 7.9 6.1 7.2 5.4 5.5 4.3 6.5 6.1 6.4 7.7 5.6 16.4 3.4 6.0 8.9 15.1 17.7 6.8 12.7 10.7 10.9 7.0 11.0 7.1 9.4 11.9 9.6 10.0 4.7 10.3 5.6 3.8 4.9 7.7 6.6 10.3 10.9 9.6 10.3 17.0 10.7 8.0 9.5 9.3 15.2 8.6 12.6 1.7 7.9 11.9 6.5 6.8 8.3 14.8 5.8 4.9 8.9 8.7 12.2 12.3 5.2 9.6 10.0 7.9 17.5 8.1 8.1 12.6 10.4 7.0 7.8 5.0 5.2 3.6 12.9 2.7 14.7 9.3 6.4 12.5 7.1 12.1 7.7 11.8 8.9 5.6 6.8 6.9 9.5 7.8 7.8 11.0 3.2 7.9 13.4 4.7 5.9 6.4 5.9 7.2 6.3 7.6 6.6 7.1 6.3 6.3 6.4 6.3 7.2 7.7 2.2 0.0 7.3 5.5 5.3 2.2 3.0 3.5 1.8 9.2 2.6 1.8 4.8 2.8 4.4 3.7 2.1 16.8 5.0 6.9 5.9 9.0 3.1 3.0 2.7 4.7 2.4 5.7 11.4 9.4 10.8 2.9 7.7 2.9 8.2 6.7 5.7 4.9 8.0 8.4 11.3 5.1 4.1 6.0 4.1 4.0 3.7 4.5 8.8 3.7 7.7 6.3 3.1 7.5 9.7 9.3 5.0 5.3 4.9 4.1 7.9 4.3 7.9 7.0 6.6 2.7 3.5 11.0 8.2 2.3 2.6 12.3 5.0 3.6 4.3 3.0 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647085-67674820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206" "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favorable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 53.8 26.9 55.5 20.4 56.8 22.3 39.8 54.4 102.1 22.7 49.8 42.9 28.3 18.4 53.5 44.3 18.5 28.7 60.1 56.6 58.1 53.0 41.6 26.8 23.8 55.1 56.6 21.0 44.0 23.9 17.1 21.3 56.8 22.3 35.2 23.0 30.1 13.6 46.5 31.0 24.1 22.4 56.0 26.5 40.0 30.8 56.3 12.1 34.0 28.2 27.0 33.3 23.4 56.9 111.7 54.8 31.4 18.1 61.9 37.2 45.4 48.1 30.5 23.8 23.7 27.3 38.5 32.9 40.2 54.5 27.5 30.6 36.8 36.6 37.7 34.3 22.6 33.4 32.5 34.8 26.6 20.9 22.9 36.3 39.6 25.6 26.1 60.5 27.2 23.1 22.2 25.4 34.5 131.1 26.6 77.7 20.3 76.6 88.0 31.8 35.6 12.2 35.1 65.0 17.4 35.5 33.8 45.5 71.4 23.7 41.9 58.0 38.5 62.6 93.8 51.4 45.6 23.8 27.8 53.2 52.9 38.9 29.0 88.8 61.5 143.8 49.4 80.4 42.4 49.0 43.1 51.1 59.6 43.0 40.5 50.3 27.2 56.4 70.2 38.6 60.2 58.3 55.5 56.8 54.4 102.1 56.6 58.1 55.1 56.6 56.8 56.0 56.3 56.9 47.6 25.6 35.0 13.1 48.7 42.3 61.4 91.7 33.0 23.2 82.2 65.4 30.5 67.2 64.4 66.2 22.9 107.4 47.5 138.2 217.2 109.1 141.7 58.5 43.2 51.5 46.6 102.7 15.8 131.4 167.9 51.6 40.8 49.5 64.0 43.6 73.9 95.3 131.4 15.2 18.2 96.0 50.8 99.8 49.2 493.5 41.7 80.9 71.2 11.2 121.6 65.4 78.2 13.6 17.1 130.7 119.4 39.9 51.0 120.5 165.4 268.6 55.3 44.8 19.7 36.5 58.2 104.5 57.2 58.2 52.8 125.9 46.8 35.5 91.9 124.6 WDFY2 ZFYVE22 ENSG00000139668 "WD repeat and FYVE domain containing 2" Q96P53 13 51584455-51767709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050094 Supported Vesicles NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA050094: " "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-3)" "unprognostic (1.59e-1)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (9.58e-2)" "unprognostic (2.28e-1)" "unprognostic (2.59e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (7.49e-4)" "unprognostic (1.47e-1)" "unprognostic (7.04e-2)" "unprognostic (6.36e-2)" "unprognostic (2.48e-1)" 6.7 11.2 8.9 4.5 12.1 15.0 7.6 9.0 8.8 8.4 4.8 3.9 1.9 5.1 5.5 9.5 6.5 2.9 3.8 8.9 10.4 4.5 6.4 5.4 4.7 11.5 9.9 8.1 17.5 15.0 5.2 5.4 12.4 5.1 2.3 6.0 5.6 4.9 1.6 17.7 4.3 3.6 10.0 7.5 6.5 6.5 10.2 4.4 5.9 3.0 5.1 4.3 8.6 15.4 1.4 2.6 11.3 4.6 5.4 11.2 3.6 11.0 7.0 5.6 4.4 1.7 1.5 4.5 1.0 7.6 3.6 5.0 6.3 19.7 10.6 3.7 3.5 9.6 3.8 13.6 4.3 6.5 4.4 9.1 9.3 12.5 14.2 9.1 2.5 4.8 2.7 2.3 9.3 3.1 4.5 14.8 13.4 3.2 3.7 5.9 4.5 3.0 7.2 3.8 3.1 7.5 3.3 4.9 5.0 9.3 2.3 15.5 9.4 10.6 2.0 5.2 7.8 1.5 2.6 3.2 12.1 6.6 13.3 6.1 7.8 4.0 2.2 8.6 3.1 3.8 2.4 1.9 13.0 4.2 2.1 2.7 5.2 4.0 9.5 11.9 3.5 3.5 8.9 12.1 9.0 8.8 8.9 10.4 11.5 9.9 12.4 10.0 10.2 15.4 16.3 16.0 21.9 118.2 36.9 23.3 20.0 10.2 45.5 35.2 25.7 24.0 7.1 8.6 17.5 29.5 127.2 28.5 41.2 7.0 27.4 19.8 46.3 19.3 23.6 13.0 13.8 17.1 47.1 23.5 33.7 20.7 14.8 20.2 29.7 35.3 27.1 18.1 28.1 37.0 47.1 9.2 8.2 63.8 30.8 19.9 39.4 41.3 12.4 96.5 45.9 26.4 16.5 106.6 301.8 15.0 4.5 21.8 17.1 12.2 9.2 6.4 14.9 52.5 26.3 45.1 27.1 32.3 16.5 46.4 27.1 14.0 27.3 41.7 10.0 16.2 WFDC3 "dJ447F3.3, WAP14" ENSG00000124116 "WAP four-disulfide core domain 3" Q8IUB2 20 45747944-45791932 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "skin 1: 16.7;testis: 20.0" "Group enriched" "Detected in many" 5 "Early spermatids: 115.9;Late spermatids: 222.8;Spermatocytes: 108.1" "Cancer enhanced" "Detected in many" "lung cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (7.47e-2)" "unprognostic (1.94e-1)" "unprognostic (2.64e-1)" "unprognostic (2.39e-2)" "unprognostic (1.06e-1)" "unprognostic (5.75e-2)" "unprognostic (9.30e-4)" "unprognostic (6.63e-3)" "unprognostic (4.02e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-3)" "unprognostic (1.79e-1)" "unprognostic (1.36e-8)" "unprognostic (8.53e-2)" "unprognostic (2.45e-1)" "unprognostic (5.27e-3)" "unprognostic (3.03e-2)" 0.3 0.0 0.5 0.1 0.6 0.0 1.2 0.6 0.5 0.0 0.4 0.2 0.3 0.1 0.8 0.0 0.6 0.0 0.0 0.5 0.5 0.2 0.0 0.1 0.0 0.6 0.9 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.1 0.3 0.0 0.2 0.0 16.7 0.0 0.9 0.8 0.0 0.0 20.0 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.5 0.5 0.5 0.6 0.9 0.6 0.8 0.6 0.6 0.5 0.0 2.6 0.7 0.1 1.1 5.9 2.7 0.0 1.2 2.4 1.8 0.8 0.0 12.3 3.7 6.2 0.4 0.0 5.7 11.7 2.5 115.9 17.6 0.7 0.2 3.6 0.0 0.6 10.0 1.8 2.1 3.1 3.4 1.3 1.7 2.9 0.9 1.1 0.0 0.6 12.1 24.4 0.6 0.8 222.8 1.5 1.3 0.0 0.0 0.3 2.2 0.0 1.0 0.8 13.1 2.0 2.6 0.0 6.2 5.8 5.9 9.0 28.7 0.0 0.5 1.5 108.1 2.6 1.5 3.1 0.0 0.4 0.4 1.1 14.3 WNT7B ENSG00000188064 "Wnt family member 7B" P56706 22 45920366-45977162 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.4;skin 1: 17.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 33.6;Basal prostatic cells: 26.4;Basal squamous epithelial cells: 42.1;Club cells: 23.9;Pancreatic endocrine cells: 43.3;Prostatic glandular cells: 26.2;Urothelial cells: 46.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 119.4;HeLa: 103.7;RPTEC TERT1: 41.4;SK-BR-3: 51.0;U-87 MG: 93.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (2.02e-3)" "unprognostic (7.83e-3)" "unprognostic (8.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-1)" "unprognostic (4.05e-2)" "unprognostic (3.85e-3)" "unprognostic (1.69e-2)" "unprognostic (8.58e-4)" "unprognostic (1.90e-1)" "unprognostic (6.73e-2)" "unprognostic (1.36e-1)" "unprognostic (1.22e-2)" 0.0 0.0 4.6 0.0 3.4 0.0 1.1 1.8 5.1 3.5 0.4 0.0 0.0 0.1 0.1 12.4 1.2 2.9 0.0 4.9 4.5 6.3 0.1 3.1 0.0 2.7 2.3 0.0 0.5 0.1 0.5 0.4 4.3 4.4 0.0 0.0 2.2 1.9 0.0 17.9 0.0 0.0 1.7 0.0 0.0 0.3 5.4 0.7 0.3 0.0 1.0 9.1 8.3 1.9 23.2 119.4 0.3 0.0 0.0 0.0 15.2 0.4 1.3 0.0 0.0 0.5 15.5 0.1 3.7 0.2 1.3 25.8 0.9 15.1 0.0 0.1 1.0 0.0 103.7 0.6 0.0 0.0 0.1 0.0 10.2 0.1 3.0 0.4 0.0 0.0 0.0 0.2 0.0 33.1 0.0 0.0 0.1 9.7 22.4 0.0 0.0 1.3 41.4 33.9 4.3 0.0 10.3 51.0 0.0 0.2 8.5 13.6 0.0 2.1 1.8 0.0 1.0 0.0 0.0 0.0 93.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 3.4 1.8 5.1 4.9 4.5 2.7 2.3 4.3 1.7 5.4 1.9 0.3 6.4 15.6 3.9 0.5 33.6 26.4 16.3 42.1 0.5 4.0 0.6 1.6 8.6 23.9 12.9 4.2 3.5 0.1 0.1 0.0 5.9 0.3 1.7 0.4 0.7 0.0 0.0 0.3 0.5 0.3 1.7 0.0 4.3 2.5 0.2 0.4 0.1 0.1 0.0 1.2 0.0 0.0 0.0 3.7 0.2 0.3 0.3 0.0 1.0 1.0 0.2 0.0 7.5 0.1 43.3 0.0 0.4 1.5 26.2 0.0 0.1 13.8 1.1 0.0 0.8 1.9 0.2 1.8 21.0 20.5 0.7 0.5 0.0 0.0 46.6 ZNF18 "HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38" ENSG00000154957 "Zinc finger protein 18" P17022 17 11977439-11997475 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 23.0;Late spermatids: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006144 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA006144: AB_1080683" "unprognostic (2.99e-3)" "prognostic favorable (6.32e-4)" "unprognostic (2.32e-1)" "unprognostic (2.50e-2)" "unprognostic (4.91e-2)" "unprognostic (2.72e-3)" "unprognostic (2.28e-2)" "unprognostic (5.93e-3)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "prognostic favorable (5.12e-6)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (1.52e-2)" "unprognostic (9.31e-2)" "unprognostic (3.34e-2)" "unprognostic (3.53e-3)" 7.2 5.7 7.9 5.8 8.6 13.7 6.1 7.7 11.2 6.7 7.4 6.0 5.0 5.3 6.3 7.5 5.7 5.5 5.9 7.9 8.3 5.8 12.4 5.1 8.8 8.4 8.0 5.7 6.0 4.3 7.7 4.0 8.8 8.4 6.7 4.9 5.2 5.1 7.3 9.7 6.6 5.8 7.6 10.2 5.3 14.1 8.1 8.5 6.2 4.6 8.0 6.3 6.6 9.8 3.0 6.1 6.4 9.7 11.9 10.5 3.4 4.3 7.5 5.5 5.9 2.9 5.0 10.3 6.3 4.7 4.8 6.1 5.4 6.8 5.9 7.8 4.5 6.1 6.9 4.0 8.4 3.4 7.8 8.7 10.8 4.2 7.6 6.3 8.4 12.0 3.6 4.7 7.6 3.1 11.5 6.9 4.8 10.9 2.8 9.4 6.5 4.6 8.0 3.6 2.5 5.4 7.3 3.6 5.9 37.2 5.1 3.2 6.7 6.5 3.2 2.9 3.3 5.2 4.1 5.1 7.5 7.9 7.8 10.5 5.9 6.9 10.3 5.9 9.6 9.0 9.3 9.7 5.8 7.2 10.0 10.3 19.1 7.7 8.2 8.6 11.1 6.1 7.9 8.6 7.7 11.2 7.9 8.3 8.4 8.0 8.8 7.6 8.1 9.8 2.5 0.0 2.0 10.1 3.8 2.0 1.7 4.2 4.6 2.0 2.0 1.4 1.6 2.8 2.1 1.8 2.1 2.4 3.5 2.5 1.9 3.1 23.0 1.8 2.8 1.9 1.2 5.2 7.4 0.9 2.2 2.7 2.0 1.8 2.5 5.1 2.5 3.7 4.3 1.7 8.4 4.2 6.1 3.8 1.8 27.3 3.4 3.2 1.8 8.4 3.4 2.0 5.2 7.5 9.3 2.1 5.0 3.4 2.3 1.6 3.9 3.1 2.5 1.2 0.0 2.5 2.3 9.6 4.9 5.0 2.3 1.5 4.7 2.8 3.1 1.1 ZNF284 DKFZp781F1775 ENSG00000186026 "Zinc finger protein 284" Q2VY69 19 44072159-44089613 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (1.88e-2)" "unprognostic (2.51e-1)" "unprognostic (3.50e-1)" "unprognostic (5.59e-2)" "unprognostic (3.36e-2)" "unprognostic (2.81e-2)" "unprognostic (1.78e-3)" "unprognostic (8.56e-2)" "unprognostic (4.32e-2)" "unprognostic (4.15e-2)" "unprognostic (6.62e-3)" "unprognostic (3.10e-2)" "unprognostic (2.21e-1)" "unprognostic (2.46e-1)" "unprognostic (9.71e-2)" "unprognostic (7.63e-2)" "unprognostic (3.95e-3)" 1.2 1.6 1.4 1.1 1.7 0.7 1.2 2.7 1.8 1.3 1.9 1.3 1.3 1.2 1.4 0.9 1.2 0.8 1.4 1.4 1.6 1.3 1.0 1.1 1.6 1.6 1.4 1.3 1.2 1.1 1.5 0.9 1.6 1.4 0.7 2.3 1.3 0.7 1.7 3.0 1.5 0.7 1.1 2.1 1.2 0.5 2.1 1.7 1.5 0.5 1.2 1.1 1.3 2.2 0.8 0.7 2.2 4.6 2.2 1.9 1.2 1.3 1.0 0.8 2.4 1.3 0.9 0.1 0.9 1.1 0.5 1.7 1.5 1.1 1.6 0.0 1.4 2.8 4.3 1.2 1.2 0.1 2.0 1.9 1.8 1.4 2.1 3.1 1.0 0.5 0.1 0.3 1.5 0.3 2.3 1.8 2.6 0.7 1.1 0.0 3.8 0.6 1.2 2.0 1.3 3.4 0.1 0.3 0.9 1.5 0.9 1.7 2.4 2.5 4.0 1.0 1.0 3.1 1.9 0.1 1.2 0.1 1.0 1.4 1.0 1.8 2.0 1.4 1.7 1.5 2.0 1.6 1.0 1.6 2.4 2.5 1.0 3.7 0.9 0.8 2.2 0.8 1.4 1.7 2.7 1.8 1.4 1.6 1.6 1.4 1.6 1.1 2.1 2.2 1.9 3.2 1.1 0.7 1.7 1.9 0.4 0.6 0.0 1.0 1.3 0.9 1.6 1.5 0.3 0.0 2.1 0.8 1.1 1.0 3.9 1.1 0.0 0.4 1.5 2.5 2.4 0.8 1.3 0.4 0.5 1.5 0.5 0.5 1.3 2.2 2.2 0.6 0.8 0.0 1.6 1.4 2.0 2.2 1.0 0.8 1.8 1.3 3.6 0.0 0.9 1.1 1.0 1.0 1.6 1.4 4.2 3.0 1.6 0.7 1.6 2.0 1.0 1.3 6.6 1.0 1.5 0.9 1.5 0.5 1.8 1.0 2.2 1.8 1.1 0.7 ZNF57 ZNF424 ENSG00000171970 "Zinc finger protein 57" Q68EA5 19 2900898-2918473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 30.7;Early spermatids: 95.2;Late spermatids: 64.7;Squamous epithelial cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061915 Approved Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" Nucleoli "HPA061915: AB_2684635" "unprognostic (3.59e-2)" "unprognostic (1.53e-3)" "unprognostic (1.91e-2)" "unprognostic (8.86e-3)" "unprognostic (3.32e-2)" "unprognostic (3.07e-2)" "unprognostic (7.66e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.35e-1)" "unprognostic (4.04e-2)" "prognostic favorable (7.72e-4)" "unprognostic (2.34e-3)" "prognostic favorable (4.11e-9)" "unprognostic (6.26e-3)" "unprognostic (2.82e-2)" "unprognostic (7.35e-2)" "unprognostic (6.49e-3)" 2.8 2.5 1.8 2.0 1.9 4.0 6.4 8.0 3.2 5.5 1.3 8.2 7.2 2.6 3.6 9.1 4.2 1.9 3.0 2.1 1.8 4.6 3.4 3.3 2.8 2.0 1.9 3.7 4.0 4.0 2.9 4.8 2.2 3.9 9.2 4.2 4.4 3.5 1.7 18.3 6.2 1.8 1.5 2.4 11.7 25.9 2.1 3.8 4.6 2.4 3.3 3.3 7.9 2.1 7.4 3.4 4.7 6.8 4.4 3.8 7.8 3.1 2.5 4.9 5.1 7.1 2.9 6.3 3.8 2.5 7.1 8.5 7.5 10.7 6.0 0.0 3.9 3.7 3.8 9.6 3.3 0.0 6.5 3.0 11.8 4.3 9.3 4.0 3.7 14.8 6.6 0.1 3.8 7.5 9.7 4.1 3.0 8.7 5.9 8.9 14.1 1.4 6.7 12.0 2.3 3.5 4.6 8.4 3.1 6.6 5.2 6.1 2.9 3.3 3.2 7.7 4.4 1.3 7.4 3.0 2.7 1.0 2.7 0.0 2.4 1.1 4.4 4.2 3.6 3.2 4.8 4.5 2.6 3.6 5.4 4.8 0.9 5.1 2.3 2.5 5.5 3.0 1.8 1.9 8.0 3.2 2.1 1.8 2.0 1.9 2.2 1.5 2.1 2.1 2.2 0.0 5.3 1.6 0.8 21.4 20.3 8.1 30.7 2.2 3.4 3.8 4.1 1.5 7.8 0.0 6.2 4.4 1.9 13.5 3.9 3.1 95.2 7.4 3.4 2.1 0.0 0.4 2.6 2.3 3.7 2.8 7.7 12.3 0.0 2.3 1.4 1.9 2.3 1.7 2.7 7.4 8.2 1.0 2.7 64.7 2.5 1.3 5.4 0.0 1.7 1.9 0.0 1.0 1.5 1.5 9.5 3.0 0.2 5.4 19.8 3.4 4.2 2.8 0.0 0.8 2.5 5.7 9.7 36.6 28.7 6.6 1.7 3.1 8.1 9.7 ZNF711 "CMPX1, dJ75N13.1, MRX65, MRX97, Zfp711, ZNF4, ZNF5, ZNF6" ENSG00000147180 "Zinc finger protein 711" Q9Y462 X 85243991-85273362 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 37.3" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 38.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AF22: 34.4;HAP1: 50.3;HEK 293: 46.0;Karpas-707: 30.7;MOLT-4: 28.4;RH-30: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030654 Enhanced Approved Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm "HPA030654: AB_10670561" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.07e-2)" "unprognostic (5.51e-3)" "unprognostic (1.75e-2)" "unprognostic (9.11e-3)" "unprognostic (7.40e-3)" "unprognostic (1.37e-2)" "unprognostic (2.96e-1)" "unprognostic (2.50e-3)" "unprognostic (3.25e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (6.62e-3)" 1.4 15.1 6.3 1.6 8.0 7.2 5.7 6.7 7.9 5.8 1.7 3.6 3.1 9.2 2.8 2.6 4.6 4.1 3.8 7.7 7.6 5.1 0.5 1.8 2.4 5.7 6.3 9.4 4.9 1.4 10.9 7.7 5.2 4.0 1.7 5.7 4.1 2.6 1.6 12.2 4.6 3.3 6.5 5.0 2.7 37.3 7.5 16.3 4.9 1.5 2.5 3.0 3.2 5.5 0.0 3.3 34.4 27.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 7.5 3.0 0.1 1.2 0.5 5.5 0.7 50.3 0.0 0.0 0.0 46.0 16.5 0.9 1.9 1.3 0.0 0.4 3.2 0.3 0.0 6.3 0.0 0.3 15.6 5.1 30.7 6.1 1.7 28.4 0.0 16.7 3.1 0.7 0.0 41.9 0.0 0.0 2.5 10.0 25.8 0.1 0.9 0.0 20.0 4.6 4.5 0.1 0.0 11.1 0.1 0.0 11.4 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 1.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.3 8.0 6.7 7.9 7.7 7.6 5.7 6.3 5.2 6.5 7.5 5.5 1.8 3.2 1.1 14.0 3.6 12.0 7.6 2.7 18.2 9.0 18.1 17.4 6.6 1.5 1.8 1.8 0.0 0.3 1.0 0.3 5.9 2.1 2.7 2.9 18.8 4.2 18.5 5.9 19.0 0.5 0.1 8.1 1.1 4.2 0.0 15.2 3.6 0.1 0.3 3.3 21.3 2.3 2.0 0.6 3.2 5.7 3.1 0.9 5.4 11.2 0.1 7.8 0.0 38.2 12.0 0.6 1.9 3.8 2.2 3.0 0.9 2.7 1.2 1.4 0.0 8.7 8.1 13.0 23.6 10.9 9.1 0.3 0.9 12.6 2.6 2.9